US  ||| S:6 E:9 ||| PRP
20070003560  ||| S:9 E:21 ||| CD
A1  ||| S:21 E:24 ||| CD
20070104  ||| S:24 E:37 ||| CD
US  ||| S:37 E:40 ||| NNP
11471369  ||| S:40 E:49 ||| CD
20060620  ||| S:49 E:60 ||| CD
11  ||| S:60 E:65 ||| CD
20060101  ||| S:65 E:74 ||| CD
A  ||| S:74 E:76 ||| DT
A  ||| S:76 E:78 ||| NNP
61  ||| S:78 E:81 ||| CD
K  ||| S:81 E:83 ||| NNP
39  ||| S:83 E:86 ||| CD
40  ||| S:86 E:89 ||| CD
F  ||| S:89 E:91 ||| NN
I  ||| S:91 E:93 ||| PRP
20070104  ||| S:93 E:102 ||| CD
US  ||| S:102 E:105 ||| NNP
B  ||| S:105 E:107 ||| NNP
H  ||| S:107 E:111 ||| NNP
20060101  ||| S:111 E:120 ||| CD
A  ||| S:120 E:122 ||| DT
C  ||| S:122 E:124 ||| $
07  ||| S:124 E:127 ||| CD
H  ||| S:127 E:129 ||| NNP
21  ||| S:129 E:132 ||| CD
04  ||| S:132 E:135 ||| CD
L  ||| S:135 E:137 ||| NNP
I  ||| S:137 E:139 ||| NNP
20070104  ||| S:139 E:148 ||| CD
US  ||| S:148 E:151 ||| NNP
B  ||| S:151 E:153 ||| NNP
H  ||| S:153 E:157 ||| NNP
20060101  ||| S:157 E:166 ||| CD
A  ||| S:166 E:168 ||| DT
C  ||| S:168 E:170 ||| $
12  ||| S:170 E:173 ||| CD
P  ||| S:173 E:175 ||| NN
21  ||| S:175 E:178 ||| CD
06  ||| S:178 E:181 ||| CD
L  ||| S:181 E:183 ||| NNP
I  ||| S:183 E:185 ||| NNP
20070104  ||| S:185 E:194 ||| CD
US  ||| S:194 E:197 ||| NNP
B  ||| S:197 E:199 ||| NNP
H  ||| S:199 E:203 ||| NNP
20060101  ||| S:203 E:212 ||| CD
A  ||| S:212 E:214 ||| DT
C  ||| S:214 E:216 ||| $
12  ||| S:216 E:219 ||| CD
N  ||| S:219 E:221 ||| NNP
5  ||| S:221 E:223 ||| CD
06  ||| S:223 E:226 ||| CD
L  ||| S:226 E:228 ||| NNP
I  ||| S:228 E:230 ||| NNP
20070104  ||| S:230 E:239 ||| CD
US  ||| S:239 E:242 ||| NNP
B  ||| S:242 E:244 ||| NNP
H  ||| S:244 E:248 ||| NNP
20060101  ||| S:248 E:257 ||| CD
A  ||| S:257 E:259 ||| DT
C  ||| S:259 E:261 ||| $
07  ||| S:261 E:264 ||| CD
K  ||| S:264 E:266 ||| NNP
16  ||| S:266 E:269 ||| CD
12  ||| S:269 E:272 ||| CD
L  ||| S:272 E:274 ||| NNP
I  ||| S:274 E:276 ||| NNP
20070104  ||| S:276 E:285 ||| CD
US  ||| S:285 E:288 ||| NNP
B  ||| S:288 E:290 ||| NNP
H  ||| S:290 E:295 ||| NNP
US  ||| S:295 E:298 ||| NNP
424164100  ||| S:298 E:308 ||| CD
435069100  ||| S:308 E:318 ||| CD
435320100  ||| S:318 E:328 ||| CD
435326000  ||| S:328 E:338 ||| CD
530388400  ||| S:338 E:348 ||| CD
536023530  ||| S:348 E:359 ||| CD
Humanized  ||| S:359 E:369 ||| JJ
monoclonal  ||| S:369 E:380 ||| JJ
antibodies  ||| S:380 E:391 ||| NNS
that  ||| S:391 E:396 ||| WDT
protect  ||| S:396 E:404 ||| VBP
against  ||| S:404 E:412 ||| IN
shiga  ||| S:412 E:418 ||| JJ
toxin  ||| S:418 E:424 ||| NN
induced  ||| S:424 E:432 ||| NN
disease  ||| S:432 E:445 ||| NN
US  ||| S:445 E:448 ||| NNP
09215163  ||| S:448 E:457 ||| CD
19981218  ||| S:457 E:467 ||| CD
PENDING  ||| S:467 E:478 ||| NNP
US  ||| S:478 E:481 ||| NNP
11471369  ||| S:481 E:490 ||| CD
A1  ||| S:490 E:493 ||| CD
20060620  ||| S:493 E:508 ||| CD
US  ||| S:508 E:511 ||| NNP
60068635  ||| S:511 E:520 ||| CD
19971223  ||| S:520 E:536 ||| CD
Stinson  ||| S:536 E:544 ||| NNP
Jeffrey  ||| S:544 E:552 ||| NNP
R ||| S:552 E:553 ||| NNP
.  ||| S:553 E:556 ||| .
Davie  ||| S:556 E:562 ||| NNP
FL  ||| S:562 E:565 ||| NNP
US  ||| S:565 E:571 ||| NNP
Weston  ||| S:594 E:601 ||| NNP
FL  ||| S:601 E:604 ||| NNP
US  ||| S:604 E:610 ||| NNP
Bethesda  ||| S:641 E:650 ||| NNP
MD  ||| S:650 E:653 ||| NNP
US  ||| S:653 E:659 ||| NNP
Rockville  ||| S:689 E:699 ||| NNP
MD  ||| S:699 E:702 ||| NNP
US  ||| S:702 E:708 ||| NNP
Sterling  ||| S:741 E:750 ||| NNP
VA  ||| S:750 E:753 ||| NNP
US  ||| S:753 E:759 ||| NNP
101  ||| S:797 E:801 ||| CD
FEDERAL  ||| S:801 E:809 ||| NNP
STREET  ||| S:809 E:816 ||| NNP
BOSTON  ||| S:816 E:823 ||| NNP
MA  ||| S:823 E:826 ||| NNP
02110  ||| S:826 E:832 ||| CD
US  ||| S:832 E:841 ||| NNP
The  ||| S:841 E:845 ||| DT
present  ||| S:845 E:853 ||| JJ
invention  ||| S:853 E:863 ||| NN
describes  ||| S:863 E:873 ||| VBZ
the  ||| S:873 E:877 ||| DT
preparation  ||| S:877 E:889 ||| NN
and  ||| S:889 E:893 ||| CC
use  ||| S:893 E:897 ||| NN
of  ||| S:897 E:900 ||| IN
biologically  ||| S:900 E:913 ||| NN
and  ||| S:913 E:917 ||| CC
immunologically  ||| S:917 E:933 ||| JJ
active  ||| S:933 E:940 ||| JJ
humanized  ||| S:940 E:950 ||| JJ
monoclonal  ||| S:950 E:961 ||| JJ
antibodies  ||| S:961 E:972 ||| NNS
to  ||| S:972 E:975 ||| TO
Shiga  ||| S:975 E:981 ||| NNP
toxin ||| S:981 E:986 ||| NN
,  ||| S:986 E:988 ||| ,
a  ||| S:988 E:990 ||| DT
toxin  ||| S:990 E:996 ||| NN
associated  ||| S:996 E:1007 ||| VBN
with  ||| S:1007 E:1012 ||| IN
HC  ||| S:1012 E:1015 ||| NNP
and  ||| S:1015 E:1019 ||| CC
the  ||| S:1019 E:1023 ||| DT
potentially  ||| S:1023 E:1035 ||| RB
life-threatening  ||| S:1035 E:1052 ||| JJ
sequela  ||| S:1052 E:1060 ||| JJ
HUS  ||| S:1060 E:1064 ||| NNP
transmitted  ||| S:1064 E:1076 ||| VBD
by  ||| S:1076 E:1079 ||| IN
strains  ||| S:1079 E:1087 ||| NNS
of  ||| S:1087 E:1090 ||| IN
pathogenic  ||| S:1090 E:1101 ||| JJ
bacteria ||| S:1101 E:1109 ||| NNS
.  ||| S:1109 E:1111 ||| .
The  ||| S:1111 E:1115 ||| DT
present  ||| S:1115 E:1123 ||| JJ
invention  ||| S:1123 E:1133 ||| NN
describes  ||| S:1133 E:1143 ||| VBZ
how  ||| S:1143 E:1147 ||| WRB
these  ||| S:1147 E:1153 ||| DT
humanized  ||| S:1153 E:1163 ||| JJ
antibodies  ||| S:1163 E:1174 ||| NNS
may  ||| S:1174 E:1178 ||| MD
be  ||| S:1178 E:1181 ||| VB
used  ||| S:1181 E:1186 ||| VBN
in  ||| S:1186 E:1189 ||| IN
the  ||| S:1189 E:1193 ||| DT
treatment  ||| S:1193 E:1203 ||| NN
or  ||| S:1203 E:1206 ||| CC
prevention  ||| S:1206 E:1217 ||| NN
of  ||| S:1217 E:1220 ||| IN
Shiga  ||| S:1220 E:1226 ||| NNP
toxin  ||| S:1226 E:1232 ||| NN
induced  ||| S:1232 E:1240 ||| NN
diseases ||| S:1240 E:1248 ||| NNS
.  ||| S:1248 E:1250 ||| .
One  ||| S:1250 E:1254 ||| CD
aspect  ||| S:1254 E:1261 ||| NN
of  ||| S:1261 E:1264 ||| IN
the  ||| S:1264 E:1268 ||| DT
invention  ||| S:1268 E:1278 ||| NN
is  ||| S:1278 E:1281 ||| VBZ
the  ||| S:1281 E:1285 ||| DT
humanized  ||| S:1285 E:1295 ||| JJ
monoclonal  ||| S:1295 E:1306 ||| JJ
antibody  ||| S:1306 E:1315 ||| NN
which  ||| S:1315 E:1321 ||| WDT
binds  ||| S:1321 E:1327 ||| VBZ
Shiga  ||| S:1327 E:1333 ||| JJ
toxin  ||| S:1333 E:1339 ||| NN
where  ||| S:1339 E:1345 ||| WRB
the  ||| S:1345 E:1349 ||| DT
constant  ||| S:1349 E:1358 ||| JJ
regions  ||| S:1358 E:1366 ||| NNS
are  ||| S:1366 E:1370 ||| VBP
IgG1-kappa  ||| S:1370 E:1381 ||| NNP
and  ||| S:1381 E:1385 ||| CC
the  ||| S:1385 E:1389 ||| DT
variable  ||| S:1389 E:1398 ||| JJ
regions  ||| S:1398 E:1406 ||| NNS
are  ||| S:1406 E:1410 ||| VBP
murine  ||| S:1410 E:1417 ||| VBN
in  ||| S:1417 E:1420 ||| IN
origin ||| S:1420 E:1426 ||| NN
.  ||| S:1426 E:1428 ||| .
Yet  ||| S:1428 E:1432 ||| RB
another  ||| S:1432 E:1440 ||| DT
aspect  ||| S:1440 E:1447 ||| NN
of  ||| S:1447 E:1450 ||| IN
the  ||| S:1450 E:1454 ||| DT
invention  ||| S:1454 E:1464 ||| NN
is  ||| S:1464 E:1467 ||| VBZ
expression  ||| S:1467 E:1478 ||| JJ
vectors  ||| S:1478 E:1486 ||| NN
and  ||| S:1486 E:1490 ||| CC
host  ||| S:1490 E:1495 ||| NN
cells  ||| S:1495 E:1501 ||| NNS
transformed  ||| S:1501 E:1513 ||| VBN
with  ||| S:1513 E:1518 ||| IN
such  ||| S:1518 E:1523 ||| JJ
vectors  ||| S:1523 E:1531 ||| NN
which  ||| S:1531 E:1537 ||| WDT
express  ||| S:1537 E:1545 ||| VBP
the  ||| S:1545 E:1549 ||| DT
humanized  ||| S:1549 E:1559 ||| JJ
monoclonal  ||| S:1559 E:1570 ||| JJ
antibodies  ||| S:1570 E:1581 ||| NNS
of  ||| S:1581 E:1584 ||| IN
the  ||| S:1584 E:1588 ||| DT
present  ||| S:1588 E:1596 ||| JJ
invention ||| S:1596 E:1605 ||| NN
.  ||| S:1605 E:1661 ||| .
This  ||| S:1703 E:1708 ||| DT
application  ||| S:1708 E:1720 ||| NN
is  ||| S:1720 E:1723 ||| VBZ
a  ||| S:1723 E:1725 ||| DT
continuation  ||| S:1725 E:1738 ||| NN
of  ||| S:1738 E:1741 ||| IN
U.S.  ||| S:1741 E:1746 ||| NNP
patent  ||| S:1746 E:1753 ||| NN
application  ||| S:1753 E:1765 ||| NN
Ser ||| S:1765 E:1768 ||| NNP
.  ||| S:1768 E:1770 ||| .
No.  ||| S:1770 E:1774 ||| NNP
09 ||| S:1774 E:1776 ||| CD
/ ||| S:1776 E:1777 ||| CD
215,163 ||| S:1777 E:1784 ||| CD
,  ||| S:1784 E:1786 ||| ,
filed  ||| S:1786 E:1792 ||| VBD
Dec.  ||| S:1792 E:1797 ||| NNP
18 ||| S:1797 E:1799 ||| CD
,  ||| S:1799 E:1801 ||| ,
1998 ||| S:1801 E:1805 ||| CD
,  ||| S:1805 E:1807 ||| ,
which  ||| S:1807 E:1813 ||| WDT
claims  ||| S:1813 E:1820 ||| VBZ
the  ||| S:1820 E:1824 ||| DT
benefit  ||| S:1824 E:1832 ||| NN
of  ||| S:1832 E:1835 ||| IN
U.S.  ||| S:1835 E:1840 ||| NNP
Provisional  ||| S:1840 E:1852 ||| NNP
Application  ||| S:1852 E:1864 ||| NNP
No.  ||| S:1864 E:1868 ||| NNP
60 ||| S:1868 E:1870 ||| CD
/ ||| S:1870 E:1871 ||| CD
068,635 ||| S:1871 E:1878 ||| CD
,  ||| S:1878 E:1880 ||| ,
filed  ||| S:1880 E:1886 ||| VBD
Dec.  ||| S:1886 E:1891 ||| NNP
23 ||| S:1891 E:1893 ||| CD
,  ||| S:1893 E:1895 ||| ,
1997 ||| S:1895 E:1899 ||| CD
,  ||| S:1899 E:1901 ||| ,
each  ||| S:1901 E:1906 ||| DT
of  ||| S:1906 E:1909 ||| IN
which  ||| S:1909 E:1915 ||| WDT
is  ||| S:1915 E:1918 ||| VBZ
hereby  ||| S:1918 E:1925 ||| VBN
incorporated  ||| S:1925 E:1938 ||| VBN
by  ||| S:1938 E:1941 ||| IN
reference ||| S:1941 E:1950 ||| NN
.  ||| S:1950 E:1954 ||| .
The  ||| S:1979 E:1983 ||| DT
invention  ||| S:1983 E:1993 ||| NN
relates  ||| S:1993 E:2001 ||| VBZ
to  ||| S:2001 E:2004 ||| TO
a  ||| S:2004 E:2006 ||| DT
family  ||| S:2006 E:2013 ||| NN
of  ||| S:2013 E:2016 ||| IN
multi-unit  ||| S:2016 E:2027 ||| JJ
bacterial  ||| S:2027 E:2037 ||| JJ
proteins  ||| S:2037 E:2046 ||| NNS
that  ||| S:2046 E:2051 ||| WDT
are  ||| S:2051 E:2055 ||| VBP
associated  ||| S:2055 E:2066 ||| VBN
with  ||| S:2066 E:2071 ||| IN
hemorrhagic  ||| S:2071 E:2083 ||| JJ
colitis  ||| S:2083 E:2091 ||| NN
and  ||| S:2091 E:2095 ||| CC
the  ||| S:2095 E:2099 ||| DT
life-threatening  ||| S:2099 E:2116 ||| JJ
sequela ||| S:2116 E:2123 ||| NN
,  ||| S:2123 E:2125 ||| ,
hemolytic  ||| S:2125 E:2135 ||| JJ
uremic  ||| S:2135 E:2142 ||| JJ
syndrome ||| S:2142 E:2150 ||| NN
.  ||| S:2150 E:2152 ||| .
These  ||| S:2152 E:2158 ||| DT
proteins ||| S:2158 E:2166 ||| NNS
,  ||| S:2166 E:2168 ||| ,
defined  ||| S:2168 E:2176 ||| VBN
as  ||| S:2176 E:2179 ||| IN
members  ||| S:2179 E:2187 ||| NNS
of  ||| S:2187 E:2190 ||| IN
the  ||| S:2190 E:2194 ||| DT
& ||| S:2194 E:2195 ||| CC
# ||| S:2195 E:2196 ||| #
x201c ||| S:2196 E:2201 ||| CD
; ||| S:2201 E:2202 ||| :
Shiga  ||| S:2202 E:2208 ||| NNP
toxin  ||| S:2208 E:2214 ||| NN
family ||| S:2214 E:2220 ||| NN
& ||| S:2220 E:2221 ||| CC
# ||| S:2221 E:2222 ||| #
x201d ||| S:2222 E:2227 ||| CD
; ||| S:2227 E:2228 ||| :
,  ||| S:2228 E:2230 ||| ,
have  ||| S:2230 E:2235 ||| VBP
been  ||| S:2235 E:2240 ||| VBN
utilized  ||| S:2240 E:2249 ||| VBN
in  ||| S:2249 E:2252 ||| IN
the  ||| S:2252 E:2256 ||| DT
isolation  ||| S:2256 E:2266 ||| NN
and  ||| S:2266 E:2270 ||| CC
identification  ||| S:2270 E:2285 ||| NN
of  ||| S:2285 E:2288 ||| IN
murine  ||| S:2288 E:2295 ||| JJ
monoclonal  ||| S:2295 E:2306 ||| JJ
antibodies ||| S:2306 E:2316 ||| NNS
.  ||| S:2316 E:2318 ||| .
The  ||| S:2318 E:2322 ||| DT
invention  ||| S:2322 E:2332 ||| NN
further  ||| S:2332 E:2340 ||| RBR
relates  ||| S:2340 E:2348 ||| JJ
to  ||| S:2348 E:2351 ||| TO
the  ||| S:2351 E:2355 ||| DT
construction  ||| S:2355 E:2368 ||| NN
of  ||| S:2368 E:2371 ||| IN
humanized  ||| S:2371 E:2381 ||| JJ
monoclonal  ||| S:2381 E:2392 ||| JJ
antibodies  ||| S:2392 E:2403 ||| NNS
which  ||| S:2403 E:2409 ||| WDT
incorporate  ||| S:2409 E:2421 ||| VBZ
the  ||| S:2421 E:2425 ||| DT
mouse  ||| S:2425 E:2431 ||| NN
variable  ||| S:2431 E:2440 ||| NN
regions ||| S:2440 E:2447 ||| NNS
.  ||| S:2447 E:2449 ||| .
It  ||| S:2449 E:2452 ||| PRP
also  ||| S:2452 E:2457 ||| RB
relates  ||| S:2457 E:2465 ||| VBZ
to  ||| S:2465 E:2468 ||| TO
antibodies  ||| S:2468 E:2479 ||| VB
to  ||| S:2479 E:2482 ||| TO
Shiga  ||| S:2482 E:2488 ||| NNP
toxins  ||| S:2488 E:2495 ||| NN
or  ||| S:2495 E:2498 ||| CC
toxoids ||| S:2498 E:2505 ||| NN
,  ||| S:2505 E:2507 ||| ,
both  ||| S:2507 E:2512 ||| DT
monoclonal  ||| S:2512 E:2523 ||| NN
and  ||| S:2523 E:2527 ||| CC
polyclonal ||| S:2527 E:2537 ||| NN
,  ||| S:2537 E:2539 ||| ,
and  ||| S:2539 E:2543 ||| CC
their  ||| S:2543 E:2549 ||| PRP$
use  ||| S:2549 E:2553 ||| NN
in  ||| S:2553 E:2556 ||| IN
treating ||| S:2556 E:2564 ||| VBG
,  ||| S:2564 E:2566 ||| ,
diagnosing ||| S:2566 E:2576 ||| VBG
,  ||| S:2576 E:2578 ||| ,
and  ||| S:2578 E:2582 ||| CC
preventing  ||| S:2582 E:2593 ||| VBG
of  ||| S:2593 E:2596 ||| IN
disease  ||| S:2596 E:2604 ||| NN
and  ||| S:2604 E:2608 ||| CC
infections  ||| S:2608 E:2619 ||| NNS
caused  ||| S:2619 E:2626 ||| VBN
by  ||| S:2626 E:2629 ||| IN
pathogenic  ||| S:2629 E:2640 ||| JJ
E.  ||| S:2640 E:2643 ||| NNP
coli ||| S:2643 E:2647 ||| NNS
.  ||| S:2647 E:2649 ||| .
Finally ||| S:2649 E:2656 ||| RB
,  ||| S:2656 E:2658 ||| ,
the  ||| S:2658 E:2662 ||| DT
invention  ||| S:2662 E:2672 ||| NN
relates  ||| S:2672 E:2680 ||| VBZ
to  ||| S:2680 E:2683 ||| TO
preparing  ||| S:2683 E:2693 ||| VBG
the  ||| S:2693 E:2697 ||| DT
humanized  ||| S:2697 E:2707 ||| JJ
monoclonal  ||| S:2707 E:2718 ||| JJ
antibodies  ||| S:2718 E:2729 ||| NNS
to  ||| S:2729 E:2732 ||| TO
proteins  ||| S:2732 E:2741 ||| NNS
of  ||| S:2741 E:2744 ||| IN
the  ||| S:2744 E:2748 ||| DT
Shiga  ||| S:2748 E:2754 ||| JJ
toxin  ||| S:2754 E:2760 ||| NN
family ||| S:2760 E:2766 ||| NN
.  ||| S:2766 E:2769 ||| .
Enterohemorrhagic  ||| S:2799 E:2817 ||| NNP
Escherichia  ||| S:2817 E:2829 ||| NNP
coli  ||| S:2829 E:2834 ||| NNS
( ||| S:2834 E:2835 ||| -LRB-
EHEC ||| S:2835 E:2839 ||| NNP
)  ||| S:2839 E:2841 ||| -RRB-
are  ||| S:2841 E:2845 ||| VBP
associated  ||| S:2845 E:2856 ||| VBN
with  ||| S:2856 E:2861 ||| IN
food-borne  ||| S:2861 E:2872 ||| JJ
outbreaks  ||| S:2872 E:2882 ||| NNS
of  ||| S:2882 E:2885 ||| IN
bloody  ||| S:2885 E:2892 ||| JJ
diarrhea  ||| S:2892 E:2901 ||| NN
or  ||| S:2901 E:2904 ||| CC
& ||| S:2904 E:2905 ||| CC
# ||| S:2905 E:2906 ||| #
x201c ||| S:2906 E:2911 ||| CD
; ||| S:2911 E:2912 ||| :
hemorrhagic  ||| S:2912 E:2924 ||| JJ
colitis ||| S:2924 E:2931 ||| NN
& ||| S:2931 E:2932 ||| CC
# ||| S:2932 E:2933 ||| #
x201d ||| S:2933 E:2938 ||| CD
;  ||| S:2938 E:2940 ||| :
( ||| S:2940 E:2941 ||| -LRB-
HC ||| S:2941 E:2943 ||| NNP
)  ||| S:2943 E:2945 ||| -RRB-
and  ||| S:2945 E:2949 ||| CC
the  ||| S:2949 E:2953 ||| DT
hemolytic  ||| S:2953 E:2963 ||| JJ
uremic  ||| S:2963 E:2970 ||| JJ
syndrome  ||| S:2970 E:2979 ||| NN
( ||| S:2979 E:2980 ||| -LRB-
HUS ||| S:2980 E:2983 ||| NNP
) ||| S:2983 E:2984 ||| -RRB-
.  ||| S:2984 E:2986 ||| .
( ||| S:2986 E:2987 ||| -LRB-
Spika ||| S:2987 E:2992 ||| NNP
,  ||| S:2992 E:2994 ||| ,
J.  ||| S:2994 E:2997 ||| NNP
et  ||| S:2997 E:3000 ||| NNP
al. ||| S:3000 E:3003 ||| NNP
,  ||| S:3003 E:3005 ||| ,
J.  ||| S:3005 E:3008 ||| NNP
Pediatr. ||| S:3008 E:3016 ||| NNP
,  ||| S:3016 E:3018 ||| ,
109 ||| S:3018 E:3021 ||| CD
:  ||| S:3021 E:3023 ||| :
287-291  ||| S:3023 E:3031 ||| CD
( ||| S:3031 E:3032 ||| -LRB-
1986 ||| S:3032 E:3036 ||| CD
) ||| S:3036 E:3037 ||| -RRB-
;  ||| S:3037 E:3039 ||| :
Remis ||| S:3039 E:3044 ||| NNP
,  ||| S:3044 E:3046 ||| ,
R. ||| S:3046 E:3048 ||| NNP
,  ||| S:3048 E:3050 ||| ,
Ann ||| S:3050 E:3053 ||| NNP
.  ||| S:3053 E:3055 ||| .
Intern ||| S:3055 E:3061 ||| NNP
.  ||| S:3061 E:3063 ||| .
Med. ||| S:3063 E:3067 ||| NNP
,  ||| S:3067 E:3069 ||| ,
101 ||| S:3069 E:3072 ||| CD
: ||| S:3072 E:3073 ||| :
624-626  ||| S:3073 E:3081 ||| CD
( ||| S:3081 E:3082 ||| -LRB-
1984 ||| S:3082 E:3086 ||| CD
) ||| S:3086 E:3087 ||| -RRB-
;  ||| S:3087 E:3089 ||| :
Riley ||| S:3089 E:3094 ||| NNP
,  ||| S:3094 E:3096 ||| ,
L.  ||| S:3096 E:3099 ||| NNP
et  ||| S:3099 E:3102 ||| NNP
al. ||| S:3102 E:3105 ||| NNP
,  ||| S:3105 E:3107 ||| ,
N.  ||| S:3107 E:3110 ||| NNP
Engl ||| S:3110 E:3114 ||| NNP
.  ||| S:3114 E:3116 ||| .
J.  ||| S:3116 E:3119 ||| NNP
Med. ||| S:3119 E:3123 ||| NNP
,  ||| S:3123 E:3125 ||| ,
308 ||| S:3125 E:3128 ||| CD
: ||| S:3128 E:3129 ||| :
681-685  ||| S:3129 E:3137 ||| CD
( ||| S:3137 E:3138 ||| -LRB-
1983 ||| S:3138 E:3142 ||| CD
) ||| S:3142 E:3143 ||| -RRB-
) ||| S:3143 E:3144 ||| -RRB-
.  ||| S:3144 E:3146 ||| .
EHEC  ||| S:3146 E:3151 ||| NNP
infection  ||| S:3151 E:3161 ||| NN
can  ||| S:3161 E:3165 ||| MD
be  ||| S:3165 E:3168 ||| VB
deadly  ||| S:3168 E:3175 ||| JJ
and  ||| S:3175 E:3179 ||| CC
poses  ||| S:3179 E:3185 ||| VBZ
a  ||| S:3185 E:3187 ||| DT
significant  ||| S:3187 E:3199 ||| JJ
threat  ||| S:3199 E:3206 ||| NN
to  ||| S:3206 E:3209 ||| TO
the  ||| S:3209 E:3213 ||| DT
young  ||| S:3213 E:3219 ||| JJ
and  ||| S:3219 E:3223 ||| CC
the  ||| S:3223 E:3227 ||| DT
elderly ||| S:3227 E:3234 ||| JJ
,  ||| S:3234 E:3236 ||| ,
who  ||| S:3236 E:3240 ||| WP
are  ||| S:3240 E:3244 ||| VBP
the  ||| S:3244 E:3248 ||| DT
most  ||| S:3248 E:3253 ||| RBS
likely  ||| S:3253 E:3260 ||| JJ
to  ||| S:3260 E:3263 ||| TO
develop  ||| S:3263 E:3271 ||| VB
serious  ||| S:3271 E:3279 ||| JJ
complications  ||| S:3279 E:3293 ||| NNS
from  ||| S:3293 E:3298 ||| IN
EHEC  ||| S:3298 E:3303 ||| NNP
infections ||| S:3303 E:3313 ||| NNS
.  ||| S:3313 E:3315 ||| .
Several  ||| S:3315 E:3323 ||| JJ
outbreaks  ||| S:3323 E:3333 ||| NNS
and  ||| S:3333 E:3337 ||| CC
sporadic  ||| S:3337 E:3346 ||| JJ
cases  ||| S:3346 E:3352 ||| NNS
of  ||| S:3352 E:3355 ||| IN
HC  ||| S:3355 E:3358 ||| NNP
and  ||| S:3358 E:3362 ||| CC
HUS  ||| S:3362 E:3366 ||| NNP
have  ||| S:3366 E:3371 ||| VBP
occurred  ||| S:3371 E:3380 ||| VBN
over  ||| S:3380 E:3385 ||| IN
the  ||| S:3385 E:3389 ||| DT
past  ||| S:3389 E:3394 ||| JJ
few  ||| S:3394 E:3398 ||| JJ
years ||| S:3398 E:3403 ||| NNS
,  ||| S:3403 E:3405 ||| ,
with  ||| S:3405 E:3410 ||| IN
the  ||| S:3410 E:3414 ||| DT
largest  ||| S:3414 E:3422 ||| JJS
U.S.  ||| S:3422 E:3427 ||| NNP
outbreak  ||| S:3427 E:3436 ||| NN
in  ||| S:3436 E:3439 ||| IN
1993 ||| S:3439 E:3443 ||| CD
.  ||| S:3443 E:3445 ||| .
In  ||| S:3445 E:3448 ||| IN
that  ||| S:3448 E:3453 ||| DT
outbreak ||| S:3453 E:3461 ||| NN
,  ||| S:3461 E:3463 ||| ,
over  ||| S:3463 E:3468 ||| IN
500  ||| S:3468 E:3472 ||| CD
cases  ||| S:3472 E:3478 ||| NNS
of  ||| S:3478 E:3481 ||| IN
HC  ||| S:3481 E:3484 ||| NNP
and  ||| S:3484 E:3488 ||| CC
HUS  ||| S:3488 E:3492 ||| NNP
were  ||| S:3492 E:3497 ||| VBD
traced  ||| S:3497 E:3504 ||| VBN
to  ||| S:3504 E:3507 ||| TO
contaminated  ||| S:3507 E:3520 ||| VB
hamburgers  ||| S:3520 E:3531 ||| VBN
from  ||| S:3531 E:3536 ||| IN
a  ||| S:3536 E:3538 ||| DT
Jack-in-the  ||| S:3538 E:3550 ||| JJ
Box  ||| S:3550 E:3554 ||| NNP
fast  ||| S:3554 E:3559 ||| JJ
food  ||| S:3559 E:3564 ||| NN
restaurant ||| S:3564 E:3574 ||| NN
.  ||| S:3574 E:3576 ||| .
( ||| S:3576 E:3577 ||| -LRB-
Centers  ||| S:3577 E:3585 ||| NNS
for  ||| S:3585 E:3589 ||| IN
Disease  ||| S:3589 E:3597 ||| NNP
Control  ||| S:3597 E:3605 ||| NNP
and  ||| S:3605 E:3609 ||| CC
Prevention ||| S:3609 E:3619 ||| NNP
,  ||| S:3619 E:3621 ||| ,
Morbid ||| S:3621 E:3627 ||| NNP
.  ||| S:3627 E:3629 ||| .
Mortal ||| S:3629 E:3635 ||| NNP
.  ||| S:3635 E:3637 ||| .
Weekly  ||| S:3637 E:3644 ||| NNP
Rep. ||| S:3644 E:3648 ||| NNP
,  ||| S:3648 E:3650 ||| ,
42 ||| S:3650 E:3652 ||| CD
: ||| S:3652 E:3653 ||| :
258  ||| S:3653 E:3657 ||| CD
( ||| S:3657 E:3658 ||| -LRB-
1993 ||| S:3658 E:3662 ||| CD
) ||| S:3662 E:3663 ||| -RRB-
) ||| S:3663 E:3664 ||| -RRB-
.  ||| S:3664 E:3666 ||| .
In  ||| S:3666 E:3669 ||| IN
July  ||| S:3669 E:3674 ||| NNP
1996 ||| S:3674 E:3678 ||| CD
,  ||| S:3678 E:3680 ||| ,
a  ||| S:3680 E:3682 ||| DT
large  ||| S:3682 E:3688 ||| JJ
outbreak  ||| S:3688 E:3697 ||| NN
of  ||| S:3697 E:3700 ||| IN
EHEC  ||| S:3700 E:3705 ||| NNP
in  ||| S:3705 E:3708 ||| IN
Japan  ||| S:3708 E:3714 ||| NNP
resulted  ||| S:3714 E:3723 ||| VBD
in  ||| S:3723 E:3726 ||| IN
over  ||| S:3726 E:3731 ||| IN
10,000  ||| S:3731 E:3738 ||| CD
infected  ||| S:3738 E:3747 ||| JJ
individuals  ||| S:3747 E:3759 ||| NNS
and  ||| S:3759 E:3763 ||| CC
8  ||| S:3763 E:3765 ||| CD
deaths ||| S:3765 E:3771 ||| NNS
.  ||| S:3771 E:3773 ||| .
Many  ||| S:3773 E:3778 ||| JJ
Japanese  ||| S:3778 E:3787 ||| JJ
children  ||| S:3787 E:3796 ||| NNS
required  ||| S:3796 E:3805 ||| VBN
hospitalization ||| S:3805 E:3820 ||| NN
.  ||| S:3820 E:3824 ||| .
Primarily ||| S:3824 E:3833 ||| RB
,  ||| S:3833 E:3835 ||| ,
HC  ||| S:3835 E:3838 ||| NNP
and  ||| S:3838 E:3842 ||| CC
HUS  ||| S:3842 E:3846 ||| NNP
are  ||| S:3846 E:3850 ||| VBP
transmitted  ||| S:3850 E:3862 ||| VBN
by  ||| S:3862 E:3865 ||| IN
the  ||| S:3865 E:3869 ||| DT
ingestion  ||| S:3869 E:3879 ||| NN
of  ||| S:3879 E:3882 ||| IN
contaminated  ||| S:3882 E:3895 ||| JJ
food ||| S:3895 E:3899 ||| NN
,  ||| S:3899 E:3901 ||| ,
particularly  ||| S:3901 E:3914 ||| RB
undercooked  ||| S:3914 E:3926 ||| JJ
beef  ||| S:3926 E:3931 ||| NN
products ||| S:3931 E:3939 ||| NNS
,  ||| S:3939 E:3941 ||| ,
such  ||| S:3941 E:3946 ||| JJ
as  ||| S:3946 E:3949 ||| IN
hamburger ||| S:3949 E:3958 ||| NN
.  ||| S:3958 E:3960 ||| .
( ||| S:3960 E:3961 ||| -LRB-
Doyle  ||| S:3961 E:3967 ||| FW
et  ||| S:3967 E:3970 ||| FW
al. ||| S:3970 E:3973 ||| FW
,  ||| S:3973 E:3975 ||| ,
J.  ||| S:3975 E:3978 ||| NNP
Appl ||| S:3978 E:3982 ||| NNP
.  ||| S:3982 E:3984 ||| .
Environ ||| S:3984 E:3991 ||| NNP
.  ||| S:3991 E:3993 ||| .
Microbiol.  ||| S:3993 E:4004 ||| CD
53 ||| S:4004 E:4006 ||| CD
: ||| S:4006 E:4007 ||| :
2394  ||| S:4007 E:4012 ||| CD
( ||| S:4012 E:4013 ||| -LRB-
1987 ||| S:4013 E:4017 ||| CD
) ||| S:4017 E:4018 ||| -RRB-
;  ||| S:4018 E:4020 ||| :
Samadpour  ||| S:4020 E:4030 ||| FW
et  ||| S:4030 E:4033 ||| FW
al. ||| S:4033 E:4036 ||| FW
, ||| S:4036 E:4037 ||| ,
J  ||| S:4037 E:4039 ||| NNP
Appl ||| S:4039 E:4043 ||| NNP
.  ||| S:4043 E:4045 ||| .
Environ ||| S:4045 E:4052 ||| NNP
.  ||| S:4052 E:4054 ||| .
Microbiol.  ||| S:4054 E:4065 ||| CD
60 ||| S:4065 E:4067 ||| CD
: ||| S:4067 E:4068 ||| :
1038  ||| S:4068 E:4073 ||| CD
( ||| S:4073 E:4074 ||| -LRB-
1994 ||| S:4074 E:4078 ||| CD
) ||| S:4078 E:4079 ||| -RRB-
) ||| S:4079 E:4080 ||| -RRB-
.  ||| S:4080 E:4082 ||| .
With  ||| S:4082 E:4087 ||| IN
the  ||| S:4087 E:4091 ||| DT
prevalence  ||| S:4091 E:4102 ||| NN
of  ||| S:4102 E:4105 ||| IN
EHEC  ||| S:4105 E:4110 ||| NNP
in  ||| S:4110 E:4113 ||| IN
cattle  ||| S:4113 E:4120 ||| NNS
and  ||| S:4120 E:4124 ||| CC
the  ||| S:4124 E:4128 ||| DT
subjective  ||| S:4128 E:4139 ||| JJ
nature  ||| S:4139 E:4146 ||| NN
of  ||| S:4146 E:4149 ||| IN
differentiating  ||| S:4149 E:4165 ||| VBG
between  ||| S:4165 E:4173 ||| IN
cooked  ||| S:4173 E:4180 ||| NN
and  ||| S:4180 E:4184 ||| CC
undercooked  ||| S:4184 E:4196 ||| JJ
hamburgers ||| S:4196 E:4206 ||| NNS
,  ||| S:4206 E:4208 ||| ,
a  ||| S:4208 E:4210 ||| DT
stop  ||| S:4210 E:4215 ||| NN
at  ||| S:4215 E:4218 ||| IN
a  ||| S:4218 E:4220 ||| DT
fast  ||| S:4220 E:4225 ||| JJ
food  ||| S:4225 E:4230 ||| NN
restaurant  ||| S:4230 E:4241 ||| NN
or  ||| S:4241 E:4244 ||| CC
a  ||| S:4244 E:4246 ||| DT
family  ||| S:4246 E:4253 ||| NN
barbecue  ||| S:4253 E:4262 ||| NN
can  ||| S:4262 E:4266 ||| MD
result  ||| S:4266 E:4273 ||| VB
in  ||| S:4273 E:4276 ||| IN
tragedy ||| S:4276 E:4283 ||| NN
.  ||| S:4283 E:4287 ||| .
HC  ||| S:4287 E:4290 ||| NNP
and  ||| S:4290 E:4294 ||| CC
HUS  ||| S:4294 E:4298 ||| NNP
appear  ||| S:4298 E:4305 ||| VBP
to  ||| S:4305 E:4308 ||| TO
be  ||| S:4308 E:4311 ||| VB
mediated  ||| S:4311 E:4320 ||| VBN
by  ||| S:4320 E:4323 ||| IN
the  ||| S:4323 E:4327 ||| DT
toxin  ||| S:4327 E:4333 ||| NN
produced  ||| S:4333 E:4342 ||| VBN
by  ||| S:4342 E:4345 ||| IN
EHEC  ||| S:4345 E:4350 ||| NNP
and  ||| S:4350 E:4354 ||| CC
Shigella  ||| S:4354 E:4363 ||| NNP
dysenteriae  ||| S:4363 E:4375 ||| NNS
( ||| S:4375 E:4376 ||| -LRB-
for  ||| S:4376 E:4380 ||| IN
a  ||| S:4380 E:4382 ||| DT
review ||| S:4382 E:4388 ||| NN
,  ||| S:4388 E:4390 ||| ,
see  ||| S:4390 E:4394 ||| VB
O ||| S:4394 E:4395 ||| NNP
' ||| S:4395 E:4396 ||| POS
Brien  ||| S:4396 E:4402 ||| NNP
and  ||| S:4402 E:4406 ||| CC
Holmes ||| S:4406 E:4412 ||| NNP
,  ||| S:4412 E:4414 ||| ,
Microbiol ||| S:4414 E:4423 ||| NNP
.  ||| S:4423 E:4425 ||| .
Rev. ||| S:4425 E:4429 ||| NNP
,  ||| S:4429 E:4431 ||| ,
51 ||| S:4431 E:4433 ||| CD
: ||| S:4433 E:4434 ||| :
206-220  ||| S:4434 E:4442 ||| CD
( ||| S:4442 E:4443 ||| -LRB-
1987 ||| S:4443 E:4447 ||| CD
) ||| S:4447 E:4448 ||| -RRB-
) ||| S:4448 E:4449 ||| -RRB-
.  ||| S:4449 E:4451 ||| .
These  ||| S:4451 E:4457 ||| DT
bacteria  ||| S:4457 E:4466 ||| NNS
produce  ||| S:4466 E:4474 ||| VBP
a  ||| S:4474 E:4476 ||| DT
family  ||| S:4476 E:4483 ||| NN
of  ||| S:4483 E:4486 ||| IN
closely  ||| S:4486 E:4494 ||| RB
related  ||| S:4494 E:4502 ||| VBN
cytotoxins  ||| S:4502 E:4513 ||| NNS
that  ||| S:4513 E:4518 ||| WDT
collectively  ||| S:4518 E:4531 ||| RB
will  ||| S:4531 E:4536 ||| MD
be  ||| S:4536 E:4539 ||| VB
called  ||| S:4539 E:4546 ||| VBN
& ||| S:4546 E:4547 ||| CC
# ||| S:4547 E:4548 ||| #
x201c ||| S:4548 E:4553 ||| CD
; ||| S:4553 E:4554 ||| :
Shiga  ||| S:4554 E:4560 ||| NNP
toxins ||| S:4560 E:4566 ||| NN
& ||| S:4566 E:4567 ||| CC
# ||| S:4567 E:4568 ||| #
x201d ||| S:4568 E:4573 ||| CD
;  ||| S:4573 E:4575 ||| :
for  ||| S:4575 E:4579 ||| IN
the  ||| S:4579 E:4583 ||| DT
purpose  ||| S:4583 E:4591 ||| NN
of  ||| S:4591 E:4594 ||| IN
this  ||| S:4594 E:4599 ||| DT
application ||| S:4599 E:4610 ||| NN
.  ||| S:4610 E:4612 ||| .
Shiga  ||| S:4612 E:4618 ||| JJ
toxins  ||| S:4618 E:4625 ||| NNS
( ||| S:4625 E:4626 ||| -LRB-
alternatively ||| S:4626 E:4639 ||| RB
,  ||| S:4639 E:4641 ||| ,
& ||| S:4641 E:4642 ||| CC
# ||| S:4642 E:4643 ||| #
x201c ||| S:4643 E:4648 ||| CD
; ||| S:4648 E:4649 ||| :
verotoxins ||| S:4649 E:4659 ||| NNS
& ||| S:4659 E:4660 ||| CC
# ||| S:4660 E:4661 ||| #
x201d ||| S:4661 E:4666 ||| CD
; ||| S:4666 E:4667 ||| CD
)  ||| S:4667 E:4669 ||| -RRB-
have  ||| S:4669 E:4674 ||| VBP
cytotoxic ||| S:4674 E:4683 ||| VBN
,  ||| S:4683 E:4685 ||| ,
and  ||| S:4685 E:4689 ||| CC
enterotoxic  ||| S:4689 E:4701 ||| JJ
activity  ||| S:4701 E:4710 ||| NN
( ||| S:4710 E:4711 ||| -LRB-
Strockbine ||| S:4711 E:4721 ||| NNP
,  ||| S:4721 E:4723 ||| ,
N.  ||| S:4723 E:4726 ||| NNP
et  ||| S:4726 E:4729 ||| NNP
al. ||| S:4729 E:4732 ||| NNP
,  ||| S:4732 E:4734 ||| ,
Infect ||| S:4734 E:4740 ||| NNP
.  ||| S:4740 E:4742 ||| .
Immun. ||| S:4742 E:4748 ||| NNP
,  ||| S:4748 E:4750 ||| ,
53 ||| S:4750 E:4752 ||| CD
: ||| S:4752 E:4753 ||| :
135-140  ||| S:4753 E:4761 ||| CD
( ||| S:4761 E:4762 ||| -LRB-
1986 ||| S:4762 E:4766 ||| CD
) ||| S:4766 E:4767 ||| -RRB-
) ||| S:4767 E:4768 ||| -RRB-
.  ||| S:4768 E:4772 ||| .
Based  ||| S:4772 E:4778 ||| VBN
on  ||| S:4778 E:4781 ||| IN
the  ||| S:4781 E:4785 ||| DT
exhibition  ||| S:4785 E:4796 ||| NN
of  ||| S:4796 E:4799 ||| IN
immunological  ||| S:4799 E:4813 ||| JJ
non-cross-reactivity ||| S:4813 E:4833 ||| NN
,  ||| S:4833 E:4835 ||| ,
the  ||| S:4835 E:4839 ||| DT
Shiga  ||| S:4839 E:4845 ||| JJ
toxins  ||| S:4845 E:4852 ||| NNS
have  ||| S:4852 E:4857 ||| VBP
been  ||| S:4857 E:4862 ||| VBN
divided  ||| S:4862 E:4870 ||| VBN
into  ||| S:4870 E:4875 ||| IN
two  ||| S:4875 E:4879 ||| CD
groups ||| S:4879 E:4885 ||| NNS
.  ||| S:4885 E:4887 ||| .
( ||| S:4887 E:4888 ||| -LRB-
Strockbine  ||| S:4888 E:4899 ||| FW
et  ||| S:4899 E:4902 ||| FW
al. ||| S:4902 E:4905 ||| FW
,  ||| S:4905 E:4907 ||| ,
supra ||| S:4907 E:4912 ||| CD
) ||| S:4912 E:4913 ||| -RRB-
.  ||| S:4913 E:4915 ||| .
These  ||| S:4915 E:4921 ||| DT
groups  ||| S:4921 E:4928 ||| NNS
have  ||| S:4928 E:4933 ||| VBP
been  ||| S:4933 E:4938 ||| VBN
designated  ||| S:4938 E:4949 ||| VBN
Shiga  ||| S:4949 E:4955 ||| JJ
toxin  ||| S:4955 E:4961 ||| NN
type  ||| S:4961 E:4966 ||| NN
1  ||| S:4966 E:4968 ||| CD
( ||| S:4968 E:4969 ||| -LRB-
Stx1 ||| S:4969 E:4973 ||| NNP
)  ||| S:4973 E:4975 ||| -RRB-
and  ||| S:4975 E:4979 ||| CC
Shiga  ||| S:4979 E:4985 ||| NNP
toxin  ||| S:4985 E:4991 ||| NN
type  ||| S:4991 E:4996 ||| NN
2  ||| S:4996 E:4998 ||| CD
( ||| S:4998 E:4999 ||| -LRB-
Stx2 ||| S:4999 E:5003 ||| NNP
) ||| S:5003 E:5004 ||| -RRB-
.  ||| S:5004 E:5006 ||| .
The  ||| S:5006 E:5010 ||| DT
Stx1  ||| S:5010 E:5015 ||| JJ
group  ||| S:5015 E:5021 ||| NN
contains  ||| S:5021 E:5030 ||| VBZ
the  ||| S:5030 E:5034 ||| DT
prototype  ||| S:5034 E:5044 ||| NN
Stx1  ||| S:5044 E:5049 ||| CD
toxin  ||| S:5049 E:5055 ||| NN
from  ||| S:5055 E:5060 ||| IN
EHEC  ||| S:5060 E:5065 ||| NNP
as  ||| S:5065 E:5068 ||| IN
well  ||| S:5068 E:5073 ||| RB
as  ||| S:5073 E:5076 ||| IN
the  ||| S:5076 E:5080 ||| DT
Shiga  ||| S:5080 E:5086 ||| JJ
toxin  ||| S:5086 E:5092 ||| NN
from  ||| S:5092 E:5097 ||| IN
Shigella  ||| S:5097 E:5106 ||| NNP
dysenteriae  ||| S:5106 E:5118 ||| JJ
type  ||| S:5118 E:5123 ||| NN
1 ||| S:5123 E:5124 ||| CD
.  ||| S:5124 E:5126 ||| .
In  ||| S:5126 E:5129 ||| IN
recent  ||| S:5129 E:5136 ||| JJ
years ||| S:5136 E:5141 ||| NNS
,  ||| S:5141 E:5143 ||| ,
other  ||| S:5143 E:5149 ||| JJ
types  ||| S:5149 E:5155 ||| NNS
of  ||| S:5155 E:5158 ||| IN
toxins  ||| S:5158 E:5165 ||| NNS
have  ||| S:5165 E:5170 ||| VBP
been  ||| S:5170 E:5175 ||| VBN
discovered  ||| S:5175 E:5186 ||| VBN
and  ||| S:5186 E:5190 ||| CC
considered  ||| S:5190 E:5201 ||| VBN
to  ||| S:5201 E:5204 ||| TO
be  ||| S:5204 E:5207 ||| VB
members  ||| S:5207 E:5215 ||| NNS
of  ||| S:5215 E:5218 ||| IN
the  ||| S:5218 E:5222 ||| DT
Stx2  ||| S:5222 E:5227 ||| JJ
group ||| S:5227 E:5232 ||| NN
.  ||| S:5232 E:5234 ||| .
These  ||| S:5234 E:5240 ||| DT
are  ||| S:5240 E:5244 ||| VBP
Stx2e ||| S:5244 E:5249 ||| RB
,  ||| S:5249 E:5251 ||| ,
Stx2c ||| S:5251 E:5256 ||| NNP
,  ||| S:5256 E:5258 ||| ,
and  ||| S:5258 E:5262 ||| CC
Stx2d ||| S:5262 E:5267 ||| NNP
.  ||| S:5267 E:5269 ||| .
( ||| S:5269 E:5270 ||| -LRB-
Lindgren  ||| S:5270 E:5279 ||| FW
et  ||| S:5279 E:5282 ||| FW
al. ||| S:5282 E:5285 ||| FW
,  ||| S:5285 E:5287 ||| ,
Infection  ||| S:5287 E:5297 ||| NNP
and  ||| S:5297 E:5301 ||| CC
Immunology ||| S:5301 E:5311 ||| NNP
,  ||| S:5311 E:5313 ||| ,
61 ||| S:5313 E:5315 ||| CD
: ||| S:5315 E:5316 ||| :
3832  ||| S:5316 E:5321 ||| CD
( ||| S:5321 E:5322 ||| -LRB-
1993 ||| S:5322 E:5326 ||| CD
) ||| S:5326 E:5327 ||| -RRB-
;  ||| S:5327 E:5329 ||| :
Schmitt ||| S:5329 E:5336 ||| NNP
,  ||| S:5336 E:5338 ||| ,
C.  ||| S:5338 E:5341 ||| NNP
et  ||| S:5341 E:5344 ||| NNP
al. ||| S:5344 E:5347 ||| NNP
,  ||| S:5347 E:5349 ||| ,
Infect ||| S:5349 E:5355 ||| NNP
.  ||| S:5355 E:5357 ||| .
Immun. ||| S:5357 E:5363 ||| NNP
,  ||| S:5363 E:5365 ||| ,
59 ||| S:5365 E:5367 ||| CD
: ||| S:5367 E:5368 ||| :
1065-1073  ||| S:5368 E:5378 ||| CD
( ||| S:5378 E:5379 ||| -LRB-
1991 ||| S:5379 E:5383 ||| CD
) ||| S:5383 E:5384 ||| -RRB-
;  ||| S:5384 E:5386 ||| :
Marques ||| S:5386 E:5393 ||| NNP
,  ||| S:5393 E:5395 ||| ,
L.  ||| S:5395 E:5398 ||| NNP
et  ||| S:5398 E:5401 ||| NNP
al. ||| S:5401 E:5404 ||| NNP
,  ||| S:5404 E:5406 ||| ,
FEMS  ||| S:5406 E:5411 ||| NNP
Lett. ||| S:5411 E:5416 ||| NNP
,  ||| S:5416 E:5418 ||| ,
44 ||| S:5418 E:5420 ||| CD
: ||| S:5420 E:5421 ||| :
33-38  ||| S:5421 E:5427 ||| CD
( ||| S:5427 E:5428 ||| -LRB-
1987 ||| S:5428 E:5432 ||| CD
) ||| S:5432 E:5433 ||| -RRB-
) ||| S:5433 E:5434 ||| -RRB-
.  ||| S:5434 E:5438 ||| .
For  ||| S:5438 E:5442 ||| IN
the  ||| S:5442 E:5446 ||| DT
purposes  ||| S:5446 E:5455 ||| NNS
of  ||| S:5455 E:5458 ||| IN
this  ||| S:5458 E:5463 ||| DT
application  ||| S:5463 E:5475 ||| NN
the  ||| S:5475 E:5479 ||| DT
term  ||| S:5479 E:5484 ||| NN
& ||| S:5484 E:5485 ||| CC
# ||| S:5485 E:5486 ||| #
x201c ||| S:5486 E:5491 ||| CD
; ||| S:5491 E:5492 ||| :
Shiga  ||| S:5492 E:5498 ||| NNP
toxin ||| S:5498 E:5503 ||| NN
& ||| S:5503 E:5504 ||| CC
# ||| S:5504 E:5505 ||| #
x201d ||| S:5505 E:5510 ||| CD
;  ||| S:5510 E:5512 ||| :
encompasses  ||| S:5512 E:5524 ||| JJ
Shiga  ||| S:5524 E:5530 ||| JJ
toxin  ||| S:5530 E:5536 ||| NN
and  ||| S:5536 E:5540 ||| CC
any  ||| S:5540 E:5544 ||| DT
other  ||| S:5544 E:5550 ||| JJ
toxins  ||| S:5550 E:5557 ||| NN
in  ||| S:5557 E:5560 ||| IN
the  ||| S:5560 E:5564 ||| DT
Stx1  ||| S:5564 E:5569 ||| NNP
or  ||| S:5569 E:5572 ||| CC
Stx2  ||| S:5572 E:5577 ||| CD
group  ||| S:5577 E:5583 ||| NN
or  ||| S:5583 E:5586 ||| CC
their  ||| S:5586 E:5592 ||| PRP$
variants ||| S:5592 E:5600 ||| NN
.  ||| S:5600 E:5602 ||| .
The  ||| S:5602 E:5606 ||| DT
abbreviation  ||| S:5606 E:5619 ||| NN
& ||| S:5619 E:5620 ||| CC
# ||| S:5620 E:5621 ||| #
x201c ||| S:5621 E:5626 ||| CD
; ||| S:5626 E:5627 ||| :
Stx ||| S:5627 E:5630 ||| NNP
& ||| S:5630 E:5631 ||| CC
# ||| S:5631 E:5632 ||| #
x201d ||| S:5632 E:5637 ||| CD
;  ||| S:5637 E:5639 ||| :
will  ||| S:5639 E:5644 ||| MD
refer  ||| S:5644 E:5650 ||| VB
to  ||| S:5650 E:5653 ||| TO
the  ||| S:5653 E:5657 ||| DT
toxin  ||| S:5657 E:5663 ||| NN
protein  ||| S:5663 E:5671 ||| NN
itself ||| S:5671 E:5677 ||| PRP
.  ||| S:5677 E:5681 ||| .
Despite  ||| S:5681 E:5689 ||| IN
this  ||| S:5689 E:5694 ||| DT
knowledge  ||| S:5694 E:5704 ||| NN
about  ||| S:5704 E:5710 ||| IN
the  ||| S:5710 E:5714 ||| DT
results  ||| S:5714 E:5722 ||| NNS
of  ||| S:5722 E:5725 ||| IN
exposure  ||| S:5725 E:5734 ||| NN
to  ||| S:5734 E:5737 ||| TO
these  ||| S:5737 E:5743 ||| DT
toxins ||| S:5743 E:5749 ||| NN
,  ||| S:5749 E:5751 ||| ,
currently  ||| S:5751 E:5761 ||| RB
there  ||| S:5761 E:5767 ||| EX
is  ||| S:5767 E:5770 ||| VBZ
no  ||| S:5770 E:5773 ||| DT
known  ||| S:5773 E:5779 ||| JJ
cure  ||| S:5779 E:5784 ||| NN
or  ||| S:5784 E:5787 ||| CC
vaccine  ||| S:5787 E:5795 ||| NN
for  ||| S:5795 E:5799 ||| IN
HC  ||| S:5799 E:5802 ||| NNP
or  ||| S:5802 E:5805 ||| CC
HUS ||| S:5805 E:5808 ||| NNP
.  ||| S:5808 E:5810 ||| .
Antibiotics  ||| S:5810 E:5822 ||| NNP
may  ||| S:5822 E:5826 ||| MD
even  ||| S:5826 E:5831 ||| RB
make  ||| S:5831 E:5836 ||| VB
the  ||| S:5836 E:5840 ||| DT
severe  ||| S:5840 E:5847 ||| JJ
complications  ||| S:5847 E:5861 ||| NNS
worse  ||| S:5861 E:5867 ||| JJR
by  ||| S:5867 E:5870 ||| IN
increasing  ||| S:5870 E:5881 ||| VBG
toxin  ||| S:5881 E:5887 ||| NN
release  ||| S:5887 E:5895 ||| NN
from  ||| S:5895 E:5900 ||| IN
bacteria ||| S:5900 E:5908 ||| NNS
.  ||| S:5908 E:5910 ||| .
Thus ||| S:5910 E:5914 ||| RB
,  ||| S:5914 E:5916 ||| ,
there  ||| S:5916 E:5922 ||| EX
is  ||| S:5922 E:5925 ||| VBZ
a  ||| S:5925 E:5927 ||| DT
need  ||| S:5927 E:5932 ||| NN
for  ||| S:5932 E:5936 ||| IN
a  ||| S:5936 E:5938 ||| DT
compound  ||| S:5938 E:5947 ||| NN
to  ||| S:5947 E:5950 ||| TO
prevent  ||| S:5950 E:5958 ||| VB
or  ||| S:5958 E:5961 ||| CC
to  ||| S:5961 E:5964 ||| TO
treat  ||| S:5964 E:5970 ||| VB
the  ||| S:5970 E:5974 ||| DT
complications  ||| S:5974 E:5988 ||| NNS
of  ||| S:5988 E:5991 ||| IN
EHEC  ||| S:5991 E:5996 ||| NNP
produced  ||| S:5996 E:6005 ||| VBD
by  ||| S:6005 E:6008 ||| IN
Shiga  ||| S:6008 E:6014 ||| NNP
toxin ||| S:6014 E:6019 ||| NN
.  ||| S:6019 E:6021 ||| .
Such  ||| S:6021 E:6026 ||| PDT
a  ||| S:6026 E:6028 ||| DT
compound  ||| S:6028 E:6037 ||| NN
could  ||| S:6037 E:6043 ||| MD
be  ||| S:6043 E:6046 ||| VB
used  ||| S:6046 E:6051 ||| VBN
to  ||| S:6051 E:6054 ||| TO
treat  ||| S:6054 E:6060 ||| VB
infected  ||| S:6060 E:6069 ||| JJ
patients  ||| S:6069 E:6078 ||| NNS
and  ||| S:6078 E:6082 ||| CC
decrease  ||| S:6082 E:6091 ||| VB
the  ||| S:6091 E:6095 ||| DT
systemic  ||| S:6095 E:6104 ||| JJ
effects  ||| S:6104 E:6112 ||| NNS
of  ||| S:6112 E:6115 ||| IN
toxin  ||| S:6115 E:6121 ||| NN
on  ||| S:6121 E:6124 ||| IN
the  ||| S:6124 E:6128 ||| DT
CNS ||| S:6128 E:6131 ||| NNP
,  ||| S:6131 E:6133 ||| ,
blood  ||| S:6133 E:6139 ||| NN
and  ||| S:6139 E:6143 ||| CC
kidneys ||| S:6143 E:6150 ||| NN
.  ||| S:6150 E:6152 ||| .
In  ||| S:6152 E:6155 ||| IN
addition ||| S:6155 E:6163 ||| NN
,  ||| S:6163 E:6165 ||| ,
if  ||| S:6165 E:6168 ||| IN
the  ||| S:6168 E:6172 ||| DT
toxin  ||| S:6172 E:6178 ||| NN
could  ||| S:6178 E:6184 ||| MD
be  ||| S:6184 E:6187 ||| VB
neutralized ||| S:6187 E:6198 ||| NNS
,  ||| S:6198 E:6200 ||| ,
antibiotics  ||| S:6200 E:6212 ||| NNS
could  ||| S:6212 E:6218 ||| MD
be  ||| S:6218 E:6221 ||| VB
safely  ||| S:6221 E:6228 ||| RB
given  ||| S:6228 E:6234 ||| VBN
to  ||| S:6234 E:6237 ||| TO
kill  ||| S:6237 E:6242 ||| VB
the  ||| S:6242 E:6246 ||| DT
bacteria  ||| S:6246 E:6255 ||| NNS
in  ||| S:6255 E:6258 ||| IN
the  ||| S:6258 E:6262 ||| DT
GI  ||| S:6262 E:6265 ||| NNP
tract ||| S:6265 E:6270 ||| NN
.  ||| S:6270 E:6272 ||| .
Such  ||| S:6272 E:6277 ||| PDT
a  ||| S:6277 E:6279 ||| DT
compound  ||| S:6279 E:6288 ||| NN
could  ||| S:6288 E:6294 ||| MD
also  ||| S:6294 E:6299 ||| RB
be  ||| S:6299 E:6302 ||| VB
used  ||| S:6302 E:6307 ||| VBN
to  ||| S:6307 E:6310 ||| TO
prevent  ||| S:6310 E:6318 ||| VB
infectious  ||| S:6318 E:6329 ||| JJ
complications ||| S:6329 E:6342 ||| NNS
,  ||| S:6342 E:6344 ||| ,
by  ||| S:6344 E:6347 ||| IN
treating  ||| S:6347 E:6356 ||| VBG
exposed  ||| S:6356 E:6364 ||| VBN
or  ||| S:6364 E:6367 ||| CC
high  ||| S:6367 E:6372 ||| JJ
risk  ||| S:6372 E:6377 ||| NN
individuals  ||| S:6377 E:6389 ||| NNS
before  ||| S:6389 E:6396 ||| IN
they  ||| S:6396 E:6401 ||| PRP
acquire  ||| S:6401 E:6409 ||| VB
EHEC  ||| S:6409 E:6414 ||| JJ
infection ||| S:6414 E:6423 ||| NN
.  ||| S:6423 E:6425 ||| .
Such  ||| S:6425 E:6430 ||| JJ
individuals  ||| S:6430 E:6442 ||| NNS
would  ||| S:6442 E:6448 ||| MD
include  ||| S:6448 E:6456 ||| VB
children  ||| S:6456 E:6465 ||| NNS
in  ||| S:6465 E:6468 ||| IN
day  ||| S:6468 E:6472 ||| NN
care  ||| S:6472 E:6477 ||| NN
or  ||| S:6477 E:6480 ||| CC
the  ||| S:6480 E:6484 ||| DT
elderly  ||| S:6484 E:6492 ||| JJ
in  ||| S:6492 E:6495 ||| IN
nursing  ||| S:6495 E:6503 ||| NN
homes ||| S:6503 E:6508 ||| NNS
,  ||| S:6508 E:6510 ||| ,
where  ||| S:6510 E:6516 ||| WRB
a  ||| S:6516 E:6518 ||| DT
case  ||| S:6518 E:6523 ||| NN
of  ||| S:6523 E:6526 ||| IN
EHEC  ||| S:6526 E:6531 ||| NNP
diarrhea  ||| S:6531 E:6540 ||| NN
has  ||| S:6540 E:6544 ||| VBZ
been  ||| S:6544 E:6549 ||| VBN
detected ||| S:6549 E:6557 ||| VBN
.  ||| S:6557 E:6559 ||| .
These  ||| S:6559 E:6565 ||| DT
individuals  ||| S:6565 E:6577 ||| NNS
are  ||| S:6577 E:6581 ||| VBP
at  ||| S:6581 E:6584 ||| IN
increased  ||| S:6584 E:6594 ||| JJ
risk  ||| S:6594 E:6599 ||| NN
to  ||| S:6599 E:6602 ||| TO
develop  ||| S:6602 E:6610 ||| VB
severe  ||| S:6610 E:6617 ||| JJ
complications  ||| S:6617 E:6631 ||| NNS
and  ||| S:6631 E:6635 ||| CC
spread  ||| S:6635 E:6642 ||| NN
of  ||| S:6642 E:6645 ||| IN
EHEC  ||| S:6645 E:6650 ||| NNP
in  ||| S:6650 E:6653 ||| IN
these  ||| S:6653 E:6659 ||| DT
environments  ||| S:6659 E:6672 ||| NN
is  ||| S:6672 E:6675 ||| VBZ
not  ||| S:6675 E:6679 ||| RB
unusual ||| S:6679 E:6686 ||| JJ
.  ||| S:6686 E:6690 ||| .
The  ||| S:6690 E:6694 ||| DT
knowledge  ||| S:6694 E:6704 ||| NN
of  ||| S:6704 E:6707 ||| IN
the  ||| S:6707 E:6711 ||| DT
immunological  ||| S:6711 E:6725 ||| NNS
cross  ||| S:6725 E:6731 ||| VBP
reactivity  ||| S:6731 E:6742 ||| VBN
of  ||| S:6742 E:6745 ||| IN
the  ||| S:6745 E:6749 ||| DT
Shiga  ||| S:6749 E:6755 ||| JJ
toxins  ||| S:6755 E:6762 ||| NN
offers  ||| S:6762 E:6769 ||| VBZ
a  ||| S:6769 E:6771 ||| DT
tantalizing  ||| S:6771 E:6783 ||| JJ
prospect  ||| S:6783 E:6792 ||| NN
for  ||| S:6792 E:6796 ||| IN
pharmacological  ||| S:6796 E:6812 ||| JJ
approaches  ||| S:6812 E:6823 ||| NNS
to  ||| S:6823 E:6826 ||| TO
EHEC  ||| S:6826 E:6831 ||| NNP
treatment ||| S:6831 E:6840 ||| NN
.  ||| S:6840 E:6842 ||| .
Currently ||| S:6842 E:6851 ||| RB
,  ||| S:6851 E:6853 ||| ,
there  ||| S:6853 E:6859 ||| EX
are  ||| S:6859 E:6863 ||| VBP
no  ||| S:6863 E:6866 ||| RB
known  ||| S:6866 E:6872 ||| VBN
prophylactic  ||| S:6872 E:6885 ||| NNS
or  ||| S:6885 E:6888 ||| CC
therapeutic  ||| S:6888 E:6900 ||| JJ
agents  ||| S:6900 E:6907 ||| NNS
available  ||| S:6907 E:6917 ||| JJ
for  ||| S:6917 E:6921 ||| IN
this  ||| S:6921 E:6926 ||| DT
disease ||| S:6926 E:6933 ||| NN
.  ||| S:6933 E:6935 ||| .
Accordingly ||| S:6935 E:6946 ||| RB
,  ||| S:6946 E:6948 ||| ,
there  ||| S:6948 E:6954 ||| EX
is  ||| S:6954 E:6957 ||| VBZ
a  ||| S:6957 E:6959 ||| DT
need  ||| S:6959 E:6964 ||| NN
in  ||| S:6964 E:6967 ||| IN
the  ||| S:6967 E:6971 ||| DT
art  ||| S:6971 E:6975 ||| NN
to  ||| S:6975 E:6978 ||| TO
provide  ||| S:6978 E:6986 ||| VB
monoclonal  ||| S:6986 E:6997 ||| JJ
antibodies  ||| S:6997 E:7008 ||| NNS
that  ||| S:7008 E:7013 ||| WDT
can  ||| S:7013 E:7017 ||| MD
bind  ||| S:7017 E:7022 ||| VB
to  ||| S:7022 E:7025 ||| TO
Shiga  ||| S:7025 E:7031 ||| NNP
toxins  ||| S:7031 E:7038 ||| NN
which  ||| S:7038 E:7044 ||| WDT
could  ||| S:7044 E:7050 ||| MD
prevent  ||| S:7050 E:7058 ||| VB
or  ||| S:7058 E:7061 ||| CC
lessen  ||| S:7061 E:7068 ||| VB
the  ||| S:7068 E:7072 ||| DT
devastating  ||| S:7072 E:7084 ||| JJ
effects  ||| S:7084 E:7092 ||| NNS
of  ||| S:7092 E:7095 ||| IN
these  ||| S:7095 E:7101 ||| DT
toxins ||| S:7101 E:7107 ||| NN
.  ||| S:7107 E:7109 ||| .
There  ||| S:7109 E:7115 ||| EX
is  ||| S:7115 E:7118 ||| VBZ
also  ||| S:7118 E:7123 ||| RB
a  ||| S:7123 E:7125 ||| DT
need  ||| S:7125 E:7130 ||| NN
in  ||| S:7130 E:7133 ||| IN
the  ||| S:7133 E:7137 ||| DT
art  ||| S:7137 E:7141 ||| NN
for  ||| S:7141 E:7145 ||| IN
data  ||| S:7145 E:7150 ||| NNS
concerning  ||| S:7150 E:7161 ||| VBG
the  ||| S:7161 E:7165 ||| DT
binding  ||| S:7165 E:7173 ||| JJ
site  ||| S:7173 E:7178 ||| NN
of  ||| S:7178 E:7181 ||| IN
such  ||| S:7181 E:7186 ||| JJ
antibodies  ||| S:7186 E:7197 ||| NNS
so  ||| S:7197 E:7200 ||| RB
that  ||| S:7200 E:7205 ||| IN
other  ||| S:7205 E:7211 ||| JJ
antibodies  ||| S:7211 E:7222 ||| NNS
with  ||| S:7222 E:7227 ||| IN
similar  ||| S:7227 E:7235 ||| JJ
abilities  ||| S:7235 E:7245 ||| NNS
can  ||| S:7245 E:7249 ||| MD
be  ||| S:7249 E:7252 ||| VB
identified  ||| S:7252 E:7263 ||| VBN
and  ||| S:7263 E:7267 ||| CC
isolated ||| S:7267 E:7275 ||| VBN
.  ||| S:7275 E:7279 ||| .
There  ||| S:7279 E:7285 ||| EX
is  ||| S:7285 E:7288 ||| VBZ
a  ||| S:7288 E:7290 ||| DT
related  ||| S:7290 E:7298 ||| JJ
need  ||| S:7298 E:7303 ||| NN
in  ||| S:7303 E:7306 ||| IN
the  ||| S:7306 E:7310 ||| DT
art  ||| S:7310 E:7314 ||| NN
for  ||| S:7314 E:7318 ||| IN
humanized  ||| S:7318 E:7328 ||| NN
or  ||| S:7328 E:7331 ||| CC
other  ||| S:7331 E:7337 ||| JJ
chimeric  ||| S:7337 E:7346 ||| FW
human ||| S:7346 E:7351 ||| FW
/ ||| S:7351 E:7352 ||| FW
mouse  ||| S:7352 E:7358 ||| FW
monoclonal  ||| S:7358 E:7369 ||| FW
antibodies ||| S:7369 E:7379 ||| FW
.  ||| S:7379 E:7381 ||| .
In  ||| S:7381 E:7384 ||| IN
well  ||| S:7384 E:7389 ||| RB
publicized  ||| S:7389 E:7400 ||| VBN
studies ||| S:7400 E:7407 ||| NNS
,  ||| S:7407 E:7409 ||| ,
patients  ||| S:7409 E:7418 ||| FW
administered  ||| S:7418 E:7431 ||| FW
murine  ||| S:7431 E:7438 ||| FW
anti-TNF  ||| S:7438 E:7447 ||| FW
( ||| S:7447 E:7448 ||| -LRB-
tumor  ||| S:7448 E:7454 ||| NN
necrosis  ||| S:7454 E:7463 ||| NN
factor ||| S:7463 E:7469 ||| NN
)  ||| S:7469 E:7471 ||| -RRB-
monoclonal  ||| S:7471 E:7482 ||| JJ
antibodies  ||| S:7482 E:7493 ||| NNS
developed  ||| S:7493 E:7503 ||| VBD
anti-murine  ||| S:7503 E:7515 ||| JJ
antibody  ||| S:7515 E:7524 ||| NN
responses  ||| S:7524 E:7534 ||| NNS
to  ||| S:7534 E:7537 ||| TO
the  ||| S:7537 E:7541 ||| DT
administered  ||| S:7541 E:7554 ||| JJ
antibody ||| S:7554 E:7562 ||| NN
.  ||| S:7562 E:7564 ||| .
( ||| S:7564 E:7565 ||| -LRB-
See ||| S:7565 E:7568 ||| VB
,  ||| S:7568 E:7570 ||| ,
e.g. ||| S:7570 E:7574 ||| NNP
,  ||| S:7574 E:7576 ||| ,
Exley  ||| S:7576 E:7582 ||| NNP
A.  ||| S:7582 E:7585 ||| NNP
R. ||| S:7585 E:7587 ||| NNP
,  ||| S:7587 E:7589 ||| ,
et  ||| S:7589 E:7592 ||| FW
al. ||| S:7592 E:7595 ||| FW
,  ||| S:7595 E:7597 ||| ,
Lancet  ||| S:7597 E:7604 ||| NNP
335 ||| S:7604 E:7607 ||| CD
: ||| S:7607 E:7608 ||| :
1275-1277  ||| S:7608 E:7618 ||| CD
( ||| S:7618 E:7619 ||| -LRB-
1990 ||| S:7619 E:7623 ||| CD
) ||| S:7623 E:7624 ||| -RRB-
) ||| S:7624 E:7625 ||| -RRB-
.  ||| S:7625 E:7627 ||| .
This  ||| S:7627 E:7632 ||| DT
type  ||| S:7632 E:7637 ||| NN
of  ||| S:7637 E:7640 ||| IN
immune  ||| S:7640 E:7647 ||| JJ
response  ||| S:7647 E:7656 ||| NN
to  ||| S:7656 E:7659 ||| TO
the  ||| S:7659 E:7663 ||| DT
treatment  ||| S:7663 E:7673 ||| NN
regimen ||| S:7673 E:7680 ||| NN
,  ||| S:7680 E:7682 ||| ,
commonly  ||| S:7682 E:7691 ||| RB
referred  ||| S:7691 E:7700 ||| VBN
to  ||| S:7700 E:7703 ||| TO
as  ||| S:7703 E:7706 ||| IN
the  ||| S:7706 E:7710 ||| DT
HAMA  ||| S:7710 E:7715 ||| NNP
response  ||| S:7715 E:7724 ||| NN
( ||| S:7724 E:7725 ||| -LRB-
for  ||| S:7725 E:7729 ||| IN
human  ||| S:7729 E:7735 ||| JJ
anti-mouse  ||| S:7735 E:7746 ||| JJ
antibodies ||| S:7746 E:7756 ||| NNS
) ||| S:7756 E:7757 ||| -RRB-
,  ||| S:7757 E:7759 ||| ,
decreases  ||| S:7759 E:7769 ||| VBZ
the  ||| S:7769 E:7773 ||| DT
effectiveness  ||| S:7773 E:7787 ||| NN
of  ||| S:7787 E:7790 ||| IN
the  ||| S:7790 E:7794 ||| DT
treatment  ||| S:7794 E:7804 ||| NN
and  ||| S:7804 E:7808 ||| CC
may  ||| S:7808 E:7812 ||| MD
even  ||| S:7812 E:7817 ||| RB
render  ||| S:7817 E:7824 ||| VB
the  ||| S:7824 E:7828 ||| DT
treatment  ||| S:7828 E:7838 ||| NN
completely  ||| S:7838 E:7849 ||| RB
ineffective ||| S:7849 E:7860 ||| JJ
.  ||| S:7860 E:7862 ||| .
Humanized  ||| S:7862 E:7872 ||| NNP
or  ||| S:7872 E:7875 ||| CC
chimeric  ||| S:7875 E:7884 ||| JJ
human ||| S:7884 E:7889 ||| JJ
/ ||| S:7889 E:7890 ||| CD
mouse  ||| S:7890 E:7896 ||| NN
monoclonal  ||| S:7896 E:7907 ||| NN
antibodies  ||| S:7907 E:7918 ||| NNS
have  ||| S:7918 E:7923 ||| VBP
been  ||| S:7923 E:7928 ||| VBN
shown  ||| S:7928 E:7934 ||| VBN
to  ||| S:7934 E:7937 ||| TO
significantly  ||| S:7937 E:7951 ||| RB
decrease  ||| S:7951 E:7960 ||| VB
the  ||| S:7960 E:7964 ||| DT
HAMA  ||| S:7964 E:7969 ||| NNP
response  ||| S:7969 E:7978 ||| NN
and  ||| S:7978 E:7982 ||| CC
to  ||| S:7982 E:7985 ||| TO
increase  ||| S:7985 E:7994 ||| VB
the  ||| S:7994 E:7998 ||| DT
therapeutic  ||| S:7998 E:8010 ||| JJ
effectiveness ||| S:8010 E:8023 ||| NN
.  ||| S:8023 E:8025 ||| .
( ||| S:8025 E:8026 ||| -LRB-
LoBuglio  ||| S:8026 E:8035 ||| FW
et  ||| S:8035 E:8038 ||| FW
al. ||| S:8038 E:8041 ||| FW
,  ||| S:8041 E:8043 ||| ,
P.N.A.S.  ||| S:8043 E:8052 ||| CD
86 ||| S:8052 E:8054 ||| CD
: ||| S:8054 E:8055 ||| :
4220-4224  ||| S:8055 E:8065 ||| CD
( ||| S:8065 E:8066 ||| -LRB-
June  ||| S:8066 E:8071 ||| NNP
1989 ||| S:8071 E:8075 ||| CD
) ||| S:8075 E:8076 ||| -RRB-
) ||| S:8076 E:8077 ||| -RRB-
.  ||| S:8077 E:8080 ||| .
To  ||| S:8107 E:8110 ||| TO
satisfy  ||| S:8110 E:8118 ||| VB
these  ||| S:8118 E:8124 ||| DT
needs  ||| S:8124 E:8130 ||| NNS
in  ||| S:8130 E:8133 ||| IN
the  ||| S:8133 E:8137 ||| DT
art ||| S:8137 E:8140 ||| NN
,  ||| S:8140 E:8142 ||| ,
applicants  ||| S:8142 E:8153 ||| NNS
provide  ||| S:8153 E:8161 ||| VBP
humanized  ||| S:8161 E:8171 ||| JJ
mouse  ||| S:8171 E:8177 ||| NN
monoclonal  ||| S:8177 E:8188 ||| NN
antibodies  ||| S:8188 E:8199 ||| NNS
to  ||| S:8199 E:8202 ||| TO
Shiga  ||| S:8202 E:8208 ||| NNP
toxin  ||| S:8208 E:8214 ||| NN
1  ||| S:8214 E:8216 ||| CD
and  ||| S:8216 E:8220 ||| CC
Shiga  ||| S:8220 E:8226 ||| NNP
toxin  ||| S:8226 E:8232 ||| NN
2 ||| S:8232 E:8233 ||| CD
.  ||| S:8233 E:8235 ||| .
In  ||| S:8235 E:8238 ||| IN
addition ||| S:8238 E:8246 ||| NN
,  ||| S:8246 E:8248 ||| ,
this  ||| S:8248 E:8253 ||| DT
invention  ||| S:8253 E:8263 ||| NN
sets  ||| S:8263 E:8268 ||| VBZ
forth  ||| S:8268 E:8274 ||| RB
the  ||| S:8274 E:8278 ||| DT
variable  ||| S:8278 E:8287 ||| JJ
region  ||| S:8287 E:8294 ||| NN
associated  ||| S:8294 E:8305 ||| VBN
with  ||| S:8305 E:8310 ||| IN
Shiga  ||| S:8310 E:8316 ||| NNP
toxin  ||| S:8316 E:8322 ||| NN
neutralization  ||| S:8322 E:8337 ||| NN
as  ||| S:8337 E:8340 ||| IN
well  ||| S:8340 E:8345 ||| RB
as  ||| S:8345 E:8348 ||| IN
the  ||| S:8348 E:8352 ||| DT
specific  ||| S:8352 E:8361 ||| JJ
complementarity  ||| S:8361 E:8377 ||| NNS
determining  ||| S:8377 E:8389 ||| VBG
regions  ||| S:8389 E:8397 ||| NNS
( ||| S:8397 E:8398 ||| -LRB-
CDRs ||| S:8398 E:8402 ||| NNP
)  ||| S:8402 E:8404 ||| -RRB-
of  ||| S:8404 E:8407 ||| IN
the  ||| S:8407 E:8411 ||| DT
variable  ||| S:8411 E:8420 ||| JJ
region ||| S:8420 E:8426 ||| NN
.  ||| S:8426 E:8428 ||| .
The  ||| S:8428 E:8432 ||| DT
present  ||| S:8432 E:8440 ||| JJ
invention  ||| S:8440 E:8450 ||| NN
particularly  ||| S:8450 E:8463 ||| RB
provides  ||| S:8463 E:8472 ||| VBZ
human  ||| S:8472 E:8478 ||| JJ
monoclonal  ||| S:8478 E:8489 ||| JJ
antibodies ||| S:8489 E:8499 ||| NNS
,  ||| S:8499 E:8501 ||| ,
derived  ||| S:8501 E:8509 ||| VBN
from  ||| S:8509 E:8514 ||| IN
the  ||| S:8514 E:8518 ||| DT
mouse  ||| S:8518 E:8524 ||| FW
monoclonal  ||| S:8524 E:8535 ||| FW
antibodies  ||| S:8535 E:8546 ||| FW
13C4  ||| S:8546 E:8551 ||| FW
and  ||| S:8551 E:8555 ||| CC
11E10 ||| S:8555 E:8560 ||| NNP
,  ||| S:8560 E:8562 ||| ,
which  ||| S:8562 E:8568 ||| WDT
are  ||| S:8568 E:8572 ||| VBP
specifically  ||| S:8572 E:8585 ||| RB
reactive  ||| S:8585 E:8594 ||| VBN
with  ||| S:8594 E:8599 ||| IN
Stx1  ||| S:8599 E:8604 ||| NNP
and  ||| S:8604 E:8608 ||| CC
Stx2 ||| S:8608 E:8612 ||| NNP
,  ||| S:8612 E:8614 ||| ,
respectively ||| S:8614 E:8626 ||| RB
.  ||| S:8626 E:8630 ||| .
In  ||| S:8630 E:8633 ||| IN
another  ||| S:8633 E:8641 ||| DT
aspect ||| S:8641 E:8647 ||| NN
,  ||| S:8647 E:8649 ||| ,
the  ||| S:8649 E:8653 ||| DT
invention  ||| S:8653 E:8663 ||| NN
includes  ||| S:8663 E:8672 ||| VBZ
a  ||| S:8672 E:8674 ||| DT
pharmaceutical  ||| S:8674 E:8689 ||| JJ
composition  ||| S:8689 E:8701 ||| NN
and  ||| S:8701 E:8705 ||| CC
a  ||| S:8705 E:8707 ||| DT
method  ||| S:8707 E:8714 ||| NN
of  ||| S:8714 E:8717 ||| IN
treatment  ||| S:8717 E:8727 ||| NN
with  ||| S:8727 E:8732 ||| IN
such  ||| S:8732 E:8737 ||| JJ
composition  ||| S:8737 E:8749 ||| NN
which  ||| S:8749 E:8755 ||| WDT
will  ||| S:8755 E:8760 ||| MD
prevent  ||| S:8760 E:8768 ||| VB
or  ||| S:8768 E:8771 ||| CC
treat  ||| S:8771 E:8777 ||| VB
Shiga  ||| S:8777 E:8783 ||| JJ
toxin  ||| S:8783 E:8789 ||| NN
induced  ||| S:8789 E:8797 ||| NN
disease ||| S:8797 E:8804 ||| NN
.  ||| S:8804 E:8808 ||| .
It  ||| S:8808 E:8811 ||| PRP
is  ||| S:8811 E:8814 ||| VBZ
to  ||| S:8814 E:8817 ||| TO
be  ||| S:8817 E:8820 ||| VB
understood  ||| S:8820 E:8831 ||| VBN
that  ||| S:8831 E:8836 ||| IN
both  ||| S:8836 E:8841 ||| PDT
the  ||| S:8841 E:8845 ||| DT
foregoing  ||| S:8845 E:8855 ||| JJ
general  ||| S:8855 E:8863 ||| JJ
description  ||| S:8863 E:8875 ||| NN
and  ||| S:8875 E:8879 ||| CC
the  ||| S:8879 E:8883 ||| DT
following  ||| S:8883 E:8893 ||| JJ
detailed  ||| S:8893 E:8902 ||| JJ
description  ||| S:8902 E:8914 ||| NNS
are  ||| S:8914 E:8918 ||| VBP
exemplary  ||| S:8918 E:8928 ||| JJ
and  ||| S:8928 E:8932 ||| CC
explanatory  ||| S:8932 E:8944 ||| JJ
and  ||| S:8944 E:8948 ||| CC
are  ||| S:8948 E:8952 ||| VBP
intended  ||| S:8952 E:8961 ||| VBN
to  ||| S:8961 E:8964 ||| TO
provide  ||| S:8964 E:8972 ||| VB
further  ||| S:8972 E:8980 ||| JJ
explanation  ||| S:8980 E:8992 ||| NN
of  ||| S:8992 E:8995 ||| IN
the  ||| S:8995 E:8999 ||| DT
invention  ||| S:8999 E:9009 ||| NN
as  ||| S:9009 E:9012 ||| IN
claimed ||| S:9012 E:9019 ||| VBN
.  ||| S:9019 E:9023 ||| .
The  ||| S:9023 E:9027 ||| DT
accompanying  ||| S:9027 E:9040 ||| JJ
drawings  ||| S:9040 E:9049 ||| NNS
are  ||| S:9049 E:9053 ||| VBP
included  ||| S:9053 E:9062 ||| VBN
to  ||| S:9062 E:9065 ||| TO
provide  ||| S:9065 E:9073 ||| VB
a  ||| S:9073 E:9075 ||| DT
further  ||| S:9075 E:9083 ||| JJ
understanding  ||| S:9083 E:9097 ||| NN
of  ||| S:9097 E:9100 ||| IN
the  ||| S:9100 E:9104 ||| DT
invention  ||| S:9104 E:9114 ||| NN
and  ||| S:9114 E:9118 ||| CC
are  ||| S:9118 E:9122 ||| VBP
incorporated  ||| S:9122 E:9135 ||| VBN
in  ||| S:9135 E:9138 ||| IN
and  ||| S:9138 E:9142 ||| CC
constitute  ||| S:9142 E:9153 ||| VB
a  ||| S:9153 E:9155 ||| DT
part  ||| S:9155 E:9160 ||| NN
of  ||| S:9160 E:9163 ||| IN
this  ||| S:9163 E:9168 ||| DT
specification ||| S:9168 E:9181 ||| NN
.  ||| S:9181 E:9183 ||| .
They  ||| S:9183 E:9188 ||| PRP
illustrate  ||| S:9188 E:9199 ||| VBP
several  ||| S:9199 E:9207 ||| JJ
embodiments  ||| S:9207 E:9219 ||| NN
of  ||| S:9219 E:9222 ||| IN
the  ||| S:9222 E:9226 ||| DT
invention  ||| S:9226 E:9236 ||| NN
and ||| S:9236 E:9239 ||| CC
,  ||| S:9239 E:9241 ||| ,
together  ||| S:9241 E:9250 ||| RB
with  ||| S:9250 E:9255 ||| IN
the  ||| S:9255 E:9259 ||| DT
description ||| S:9259 E:9270 ||| NN
,  ||| S:9270 E:9272 ||| ,
serve  ||| S:9272 E:9278 ||| VBP
to  ||| S:9278 E:9281 ||| TO
explain  ||| S:9281 E:9289 ||| VB
the  ||| S:9289 E:9293 ||| DT
principles  ||| S:9293 E:9304 ||| NNS
of  ||| S:9304 E:9307 ||| IN
the  ||| S:9307 E:9311 ||| DT
invention ||| S:9311 E:9320 ||| NN
.  ||| S:9320 E:9324 ||| .
FIG.  ||| S:9360 E:9365 ||| CD
1  ||| S:9365 E:9367 ||| CD
provides  ||| S:9367 E:9376 ||| VBZ
a  ||| S:9376 E:9378 ||| DT
schematic  ||| S:9378 E:9388 ||| JJ
representation  ||| S:9388 E:9403 ||| NN
of  ||| S:9403 E:9406 ||| IN
the  ||| S:9406 E:9410 ||| DT
general  ||| S:9410 E:9418 ||| JJ
cloning  ||| S:9418 E:9426 ||| JJ
strategy  ||| S:9426 E:9435 ||| NN
used  ||| S:9435 E:9440 ||| VBN
for  ||| S:9440 E:9444 ||| IN
cloning  ||| S:9444 E:9452 ||| VBG
the  ||| S:9452 E:9456 ||| DT
variable  ||| S:9456 E:9465 ||| JJ
region  ||| S:9465 E:9472 ||| NN
gene  ||| S:9472 E:9477 ||| NN
fragments  ||| S:9477 E:9487 ||| NNS
of  ||| S:9487 E:9490 ||| IN
both  ||| S:9490 E:9495 ||| PDT
the  ||| S:9495 E:9499 ||| DT
11E10  ||| S:9499 E:9505 ||| NNP
and  ||| S:9505 E:9509 ||| CC
13C4  ||| S:9509 E:9514 ||| CD
antibodies ||| S:9514 E:9524 ||| NNS
.  ||| S:9524 E:9528 ||| .
FIG.  ||| S:9528 E:9533 ||| CD
2  ||| S:9533 E:9535 ||| CD
lists  ||| S:9535 E:9541 ||| NNS
the  ||| S:9541 E:9545 ||| DT
oligonucleotide  ||| S:9545 E:9561 ||| JJ
sequences  ||| S:9561 E:9571 ||| NNS
used  ||| S:9571 E:9576 ||| VBN
for  ||| S:9576 E:9580 ||| IN
PCR  ||| S:9580 E:9584 ||| NNP
amplification  ||| S:9584 E:9598 ||| NN
of  ||| S:9598 E:9601 ||| IN
the  ||| S:9601 E:9605 ||| DT
variable  ||| S:9605 E:9614 ||| JJ
regions  ||| S:9614 E:9622 ||| NNS
of  ||| S:9622 E:9625 ||| IN
the  ||| S:9625 E:9629 ||| DT
13C4  ||| S:9629 E:9634 ||| JJ
antibody ||| S:9634 E:9642 ||| NN
.  ||| S:9642 E:9646 ||| .
FIG.  ||| S:9646 E:9651 ||| CD
3  ||| S:9651 E:9653 ||| CD
recites  ||| S:9653 E:9661 ||| CD
the  ||| S:9661 E:9665 ||| DT
DNA  ||| S:9665 E:9669 ||| NN
and  ||| S:9669 E:9673 ||| CC
amino  ||| S:9673 E:9679 ||| JJ
acid  ||| S:9679 E:9684 ||| NN
consensus  ||| S:9684 E:9694 ||| NN
sequences  ||| S:9694 E:9704 ||| NN
for  ||| S:9704 E:9708 ||| IN
the  ||| S:9708 E:9712 ||| DT
variable  ||| S:9712 E:9721 ||| JJ
regions  ||| S:9721 E:9729 ||| NNS
of  ||| S:9729 E:9732 ||| IN
both  ||| S:9732 E:9737 ||| PDT
the  ||| S:9737 E:9741 ||| DT
heavy  ||| S:9741 E:9747 ||| JJ
and  ||| S:9747 E:9751 ||| CC
light  ||| S:9751 E:9757 ||| JJ
chains  ||| S:9757 E:9764 ||| NNS
of  ||| S:9764 E:9767 ||| IN
the  ||| S:9767 E:9771 ||| DT
13C4  ||| S:9771 E:9776 ||| JJ
antibody ||| S:9776 E:9784 ||| NN
.  ||| S:9784 E:9786 ||| .
The  ||| S:9786 E:9790 ||| DT
DNA  ||| S:9790 E:9794 ||| NN
consensus  ||| S:9794 E:9804 ||| NN
sequence  ||| S:9804 E:9813 ||| NN
was  ||| S:9813 E:9817 ||| VBD
determined  ||| S:9817 E:9828 ||| VBN
using  ||| S:9828 E:9834 ||| VBG
automated  ||| S:9834 E:9844 ||| JJ
fluorescent  ||| S:9844 E:9856 ||| JJ
dye-terminator  ||| S:9856 E:9871 ||| JJ
sequence  ||| S:9871 E:9880 ||| NN
reactions  ||| S:9880 E:9890 ||| NNS
of  ||| S:9890 E:9893 ||| IN
the  ||| S:9893 E:9897 ||| DT
amplified  ||| S:9897 E:9907 ||| JJ
cDNAs  ||| S:9907 E:9913 ||| JJ
analyzed  ||| S:9913 E:9922 ||| NN
with  ||| S:9922 E:9927 ||| IN
an  ||| S:9927 E:9930 ||| DT
ABI  ||| S:9930 E:9934 ||| NNP
373  ||| S:9934 E:9938 ||| CD
sequencing  ||| S:9938 E:9949 ||| JJ
instrument ||| S:9949 E:9959 ||| NN
.  ||| S:9959 E:9961 ||| .
The  ||| S:9961 E:9965 ||| DT
CDRs  ||| S:9965 E:9970 ||| NN
were  ||| S:9970 E:9975 ||| VBD
identified  ||| S:9975 E:9986 ||| VBN
according  ||| S:9986 E:9996 ||| VBG
to  ||| S:9996 E:9999 ||| TO
the  ||| S:9999 E:10003 ||| DT
nomenclature  ||| S:10003 E:10016 ||| NN
of  ||| S:10016 E:10019 ||| IN
Kabat  ||| S:10019 E:10025 ||| NNP
and  ||| S:10025 E:10029 ||| CC
Wu  ||| S:10029 E:10032 ||| NNP
( ||| S:10032 E:10033 ||| -LRB-
Kabat ||| S:10033 E:10038 ||| NNP
,  ||| S:10038 E:10040 ||| ,
et  ||| S:10040 E:10043 ||| FW
al.  ||| S:10043 E:10047 ||| FW
( ||| S:10047 E:10048 ||| -LRB-
1991 ||| S:10048 E:10052 ||| CD
) ||| S:10052 E:10053 ||| -RRB-
,  ||| S:10053 E:10055 ||| ,
Sequences  ||| S:10055 E:10065 ||| NNP
of  ||| S:10065 E:10068 ||| IN
Proteins  ||| S:10068 E:10077 ||| NNPS
of  ||| S:10077 E:10080 ||| IN
Immunological  ||| S:10080 E:10094 ||| NNP
Interest ||| S:10094 E:10102 ||| NNP
,  ||| S:10102 E:10104 ||| ,
Vol ||| S:10104 E:10107 ||| NNP
.  ||| S:10107 E:10109 ||| .
I ||| S:10109 E:10110 ||| PRP
,  ||| S:10110 E:10112 ||| ,
5th  ||| S:10112 E:10116 ||| JJ
edition ||| S:10116 E:10123 ||| NN
,  ||| S:10123 E:10125 ||| ,
U.S.  ||| S:10125 E:10130 ||| NNP
Department  ||| S:10130 E:10141 ||| NNP
of  ||| S:10141 E:10144 ||| IN
Health  ||| S:10144 E:10151 ||| NNP
and  ||| S:10151 E:10155 ||| CC
Human  ||| S:10155 E:10161 ||| NNP
Services ||| S:10161 E:10169 ||| NNPS
)  ||| S:10169 E:10171 ||| -RRB-
and  ||| S:10171 E:10175 ||| CC
are  ||| S:10175 E:10179 ||| VBP
located  ||| S:10179 E:10187 ||| VBN
as  ||| S:10187 E:10190 ||| RB
follows ||| S:10190 E:10197 ||| VBZ
:  ||| S:10197 E:10220 ||| :
Heavy  ||| S:10220 E:10226 ||| NNP
Chain  ||| S:10226 E:10232 ||| NNP
CDRs ||| S:10232 E:10236 ||| NNP
:  ||| S:10236 E:10238 ||| :
CDR1-aa31-35  ||| S:10238 E:10254 ||| CD
( ||| S:10254 E:10255 ||| -LRB-
SEQ  ||| S:10255 E:10259 ||| UH
ID  ||| S:10259 E:10262 ||| UH
NO ||| S:10262 E:10264 ||| UH
:  ||| S:10264 E:10266 ||| :
19 ||| S:10266 E:10268 ||| CD
)  ||| S:10268 E:10270 ||| -RRB-
CDR2-aa50-66  ||| S:10270 E:10287 ||| NNP
CDR3-aa99-111  ||| S:10287 E:10304 ||| NNP
Light  ||| S:10304 E:10310 ||| NNP
Chain  ||| S:10310 E:10316 ||| NNP
CDRs ||| S:10316 E:10320 ||| NNP
:  ||| S:10320 E:10322 ||| :
CDR1-aa24-34  ||| S:10322 E:10338 ||| CD
( ||| S:10338 E:10339 ||| -LRB-
SEQ  ||| S:10339 E:10343 ||| UH
ID  ||| S:10343 E:10346 ||| UH
NO ||| S:10346 E:10348 ||| UH
:  ||| S:10348 E:10350 ||| :
21 ||| S:10350 E:10352 ||| CD
)  ||| S:10352 E:10354 ||| -RRB-
CDR2-aa50-56  ||| S:10354 E:10371 ||| FW
CDR3-aa89-97  ||| S:10371 E:10395 ||| FW
FIG.  ||| S:10395 E:10400 ||| CD
4  ||| S:10400 E:10402 ||| CD
illustrates  ||| S:10402 E:10414 ||| VBZ
the  ||| S:10414 E:10418 ||| DT
strategy  ||| S:10418 E:10427 ||| NN
for  ||| S:10427 E:10431 ||| IN
construction  ||| S:10431 E:10444 ||| NN
of  ||| S:10444 E:10447 ||| IN
the  ||| S:10447 E:10451 ||| DT
mammalian  ||| S:10451 E:10461 ||| JJ
expression  ||| S:10461 E:10472 ||| NN
vector  ||| S:10472 E:10479 ||| NNS
tKMC249A  ||| S:10479 E:10488 ||| VBP
containing  ||| S:10488 E:10499 ||| VBG
the  ||| S:10499 E:10503 ||| DT
variable  ||| S:10503 E:10512 ||| JJ
regions  ||| S:10512 E:10520 ||| NNS
of  ||| S:10520 E:10523 ||| IN
the  ||| S:10523 E:10527 ||| DT
13C4  ||| S:10527 E:10532 ||| JJ
antibody ||| S:10532 E:10540 ||| NN
.  ||| S:10540 E:10544 ||| .
FIG.  ||| S:10544 E:10549 ||| CD
5  ||| S:10549 E:10551 ||| CD
lists  ||| S:10551 E:10557 ||| NNS
the  ||| S:10557 E:10561 ||| DT
oligonucleotides  ||| S:10561 E:10578 ||| NN
used  ||| S:10578 E:10583 ||| VBN
for  ||| S:10583 E:10587 ||| IN
PCR  ||| S:10587 E:10591 ||| NNP
amplification  ||| S:10591 E:10605 ||| NN
of  ||| S:10605 E:10608 ||| IN
the  ||| S:10608 E:10612 ||| DT
variable  ||| S:10612 E:10621 ||| JJ
regions  ||| S:10621 E:10629 ||| NNS
of  ||| S:10629 E:10632 ||| IN
the  ||| S:10632 E:10636 ||| DT
11E10  ||| S:10636 E:10642 ||| JJ
antibody ||| S:10642 E:10650 ||| NN
.  ||| S:10650 E:10654 ||| .
FIG.  ||| S:10654 E:10659 ||| CD
6  ||| S:10659 E:10661 ||| CD
recites  ||| S:10661 E:10669 ||| CD
the  ||| S:10669 E:10673 ||| DT
DNA  ||| S:10673 E:10677 ||| NN
and  ||| S:10677 E:10681 ||| CC
amino  ||| S:10681 E:10687 ||| JJ
acid  ||| S:10687 E:10692 ||| NN
consensus  ||| S:10692 E:10702 ||| NN
sequences  ||| S:10702 E:10712 ||| NN
for  ||| S:10712 E:10716 ||| IN
the  ||| S:10716 E:10720 ||| DT
variable  ||| S:10720 E:10729 ||| JJ
regions  ||| S:10729 E:10737 ||| NNS
of  ||| S:10737 E:10740 ||| IN
both  ||| S:10740 E:10745 ||| PDT
the  ||| S:10745 E:10749 ||| DT
heavy  ||| S:10749 E:10755 ||| JJ
and  ||| S:10755 E:10759 ||| CC
light  ||| S:10759 E:10765 ||| JJ
chains  ||| S:10765 E:10772 ||| NNS
of  ||| S:10772 E:10775 ||| IN
the  ||| S:10775 E:10779 ||| DT
11E10  ||| S:10779 E:10785 ||| JJ
antibody ||| S:10785 E:10793 ||| NN
.  ||| S:10793 E:10795 ||| .
The  ||| S:10795 E:10799 ||| DT
DNA  ||| S:10799 E:10803 ||| NN
consensus  ||| S:10803 E:10813 ||| NN
sequence  ||| S:10813 E:10822 ||| NN
was  ||| S:10822 E:10826 ||| VBD
determined  ||| S:10826 E:10837 ||| VBN
using  ||| S:10837 E:10843 ||| VBG
automated  ||| S:10843 E:10853 ||| JJ
fluorescent  ||| S:10853 E:10865 ||| JJ
dye-terminator  ||| S:10865 E:10880 ||| JJ
sequence  ||| S:10880 E:10889 ||| NN
reactions  ||| S:10889 E:10899 ||| NNS
of  ||| S:10899 E:10902 ||| IN
the  ||| S:10902 E:10906 ||| DT
amplified  ||| S:10906 E:10916 ||| JJ
cDNAs  ||| S:10916 E:10922 ||| JJ
analyzed  ||| S:10922 E:10931 ||| NN
with  ||| S:10931 E:10936 ||| IN
an  ||| S:10936 E:10939 ||| DT
ABI  ||| S:10939 E:10943 ||| NNP
373  ||| S:10943 E:10947 ||| CD
sequencing  ||| S:10947 E:10958 ||| JJ
instrument ||| S:10958 E:10968 ||| NN
.  ||| S:10968 E:10970 ||| .
The  ||| S:10970 E:10974 ||| DT
CDRs  ||| S:10974 E:10979 ||| NN
were  ||| S:10979 E:10984 ||| VBD
identified  ||| S:10984 E:10995 ||| VBN
according  ||| S:10995 E:11005 ||| VBG
to  ||| S:11005 E:11008 ||| TO
the  ||| S:11008 E:11012 ||| DT
nomenclature  ||| S:11012 E:11025 ||| NN
of  ||| S:11025 E:11028 ||| IN
Kabat  ||| S:11028 E:11034 ||| NNP
and  ||| S:11034 E:11038 ||| CC
Wu  ||| S:11038 E:11041 ||| NNP
( ||| S:11041 E:11042 ||| -LRB-
Kabat  ||| S:11042 E:11048 ||| NNP
and  ||| S:11048 E:11052 ||| CC
Wu ||| S:11052 E:11054 ||| NNP
;  ||| S:11054 E:11056 ||| :
supra ||| S:11056 E:11061 ||| LS
)  ||| S:11061 E:11063 ||| -RRB-
and  ||| S:11063 E:11067 ||| CC
are  ||| S:11067 E:11071 ||| VBP
located  ||| S:11071 E:11079 ||| VBN
as  ||| S:11079 E:11082 ||| RB
follows ||| S:11082 E:11089 ||| VBZ
:  ||| S:11089 E:11112 ||| :
Heavy  ||| S:11112 E:11118 ||| NNP
Chain  ||| S:11118 E:11124 ||| NNP
CDRs ||| S:11124 E:11128 ||| NNP
:  ||| S:11128 E:11130 ||| :
CDR1-aa31-35  ||| S:11130 E:11146 ||| CD
( ||| S:11146 E:11147 ||| -LRB-
SEQ  ||| S:11147 E:11151 ||| UH
ID  ||| S:11151 E:11154 ||| UH
NO ||| S:11154 E:11156 ||| UH
:  ||| S:11156 E:11158 ||| :
44 ||| S:11158 E:11160 ||| CD
)  ||| S:11160 E:11162 ||| -RRB-
CDR2-aa50-66  ||| S:11162 E:11179 ||| NNP
CDR3-aa99-108  ||| S:11179 E:11196 ||| NNP
Light  ||| S:11196 E:11202 ||| NNP
Chain  ||| S:11202 E:11208 ||| NNP
CDRs ||| S:11208 E:11212 ||| NNP
:  ||| S:11212 E:11214 ||| :
CDR1-aa24-40  ||| S:11214 E:11230 ||| CD
( ||| S:11230 E:11231 ||| -LRB-
SEQ  ||| S:11231 E:11235 ||| UH
ID  ||| S:11235 E:11238 ||| UH
NO ||| S:11238 E:11240 ||| UH
:  ||| S:11240 E:11242 ||| :
42 ||| S:11242 E:11244 ||| CD
)  ||| S:11244 E:11246 ||| -RRB-
CDR2-aa56-62  ||| S:11246 E:11263 ||| FW
CDR3-aa95-103  ||| S:11263 E:11288 ||| FW
FIG.  ||| S:11288 E:11293 ||| CD
7  ||| S:11293 E:11295 ||| CD
illustrates  ||| S:11295 E:11307 ||| VBZ
the  ||| S:11307 E:11311 ||| DT
strategy  ||| S:11311 E:11320 ||| NN
for  ||| S:11320 E:11324 ||| IN
construction  ||| S:11324 E:11337 ||| NN
of  ||| S:11337 E:11340 ||| IN
the  ||| S:11340 E:11344 ||| DT
mammalian  ||| S:11344 E:11354 ||| JJ
expression  ||| S:11354 E:11365 ||| NN
vector  ||| S:11365 E:11372 ||| NNS
pACE4  ||| S:11372 E:11378 ||| VBP
containing  ||| S:11378 E:11389 ||| VBG
the  ||| S:11389 E:11393 ||| DT
variable  ||| S:11393 E:11402 ||| JJ
regions  ||| S:11402 E:11410 ||| NNS
of  ||| S:11410 E:11413 ||| IN
the  ||| S:11413 E:11417 ||| DT
11E10  ||| S:11417 E:11423 ||| JJ
antibody ||| S:11423 E:11431 ||| NN
.  ||| S:11431 E:11435 ||| .
FIG.  ||| S:11435 E:11440 ||| CD
8  ||| S:11440 E:11442 ||| CD
shows  ||| S:11442 E:11448 ||| NNS
the  ||| S:11448 E:11452 ||| DT
anti-Stx1  ||| S:11452 E:11462 ||| CD
13C4  ||| S:11462 E:11467 ||| CD
antibody  ||| S:11467 E:11476 ||| NN
production  ||| S:11476 E:11487 ||| NN
ELISA  ||| S:11487 E:11493 ||| NNP
and  ||| S:11493 E:11497 ||| CC
demonstrates  ||| S:11497 E:11510 ||| VBZ
that  ||| S:11510 E:11515 ||| IN
the  ||| S:11515 E:11519 ||| DT
H13C4  ||| S:11519 E:11525 ||| JJ
cell  ||| S:11525 E:11530 ||| NN
line  ||| S:11530 E:11535 ||| NN
produces  ||| S:11535 E:11544 ||| VBZ
an  ||| S:11544 E:11547 ||| DT
antibody  ||| S:11547 E:11556 ||| NN
consisting  ||| S:11556 E:11567 ||| VBG
of  ||| S:11567 E:11570 ||| IN
human  ||| S:11570 E:11576 ||| JJ
IgG  ||| S:11576 E:11580 ||| JJ
and  ||| S:11580 E:11584 ||| CC
kappa  ||| S:11584 E:11590 ||| JJ
constant  ||| S:11590 E:11599 ||| JJ
domains ||| S:11599 E:11606 ||| NN
.  ||| S:11606 E:11610 ||| .
FIG.  ||| S:11610 E:11615 ||| CD
9  ||| S:11615 E:11617 ||| CD
shows  ||| S:11617 E:11623 ||| NNS
the  ||| S:11623 E:11627 ||| DT
anti-Stx1  ||| S:11627 E:11637 ||| CD
13C4  ||| S:11637 E:11642 ||| CD
toxin  ||| S:11642 E:11648 ||| NN
binding  ||| S:11648 E:11656 ||| JJ
activity  ||| S:11656 E:11665 ||| NN
ELISA  ||| S:11665 E:11671 ||| NNP
and  ||| S:11671 E:11675 ||| CC
demonstrates  ||| S:11675 E:11688 ||| VBZ
that  ||| S:11688 E:11693 ||| IN
the  ||| S:11693 E:11697 ||| DT
antibody  ||| S:11697 E:11706 ||| NN
produced  ||| S:11706 E:11715 ||| VBN
by  ||| S:11715 E:11718 ||| IN
the  ||| S:11718 E:11722 ||| DT
H13C4  ||| S:11722 E:11728 ||| JJ
cell  ||| S:11728 E:11733 ||| NN
line  ||| S:11733 E:11738 ||| NN
binds  ||| S:11738 E:11744 ||| NN
to  ||| S:11744 E:11747 ||| TO
Stx1  ||| S:11747 E:11752 ||| CD
toxin ||| S:11752 E:11757 ||| NN
.  ||| S:11757 E:11761 ||| .
FIG.  ||| S:11761 E:11766 ||| CD
10  ||| S:11766 E:11769 ||| CD
shows  ||| S:11769 E:11775 ||| NNS
the  ||| S:11775 E:11779 ||| DT
anti-Stx2  ||| S:11779 E:11789 ||| CD
11E10  ||| S:11789 E:11795 ||| CD
antibody  ||| S:11795 E:11804 ||| NN
production  ||| S:11804 E:11815 ||| NN
ELISA  ||| S:11815 E:11821 ||| NNP
and  ||| S:11821 E:11825 ||| CC
demonstrates  ||| S:11825 E:11838 ||| VBZ
that  ||| S:11838 E:11843 ||| IN
the  ||| S:11843 E:11847 ||| DT
H11E10  ||| S:11847 E:11854 ||| JJ
cell  ||| S:11854 E:11859 ||| NN
line  ||| S:11859 E:11864 ||| NN
produces  ||| S:11864 E:11873 ||| VBZ
an  ||| S:11873 E:11876 ||| DT
antibody  ||| S:11876 E:11885 ||| NN
consisting  ||| S:11885 E:11896 ||| VBG
of  ||| S:11896 E:11899 ||| IN
human  ||| S:11899 E:11905 ||| JJ
IgG  ||| S:11905 E:11909 ||| JJ
and  ||| S:11909 E:11913 ||| CC
kappa  ||| S:11913 E:11919 ||| JJ
constant  ||| S:11919 E:11928 ||| JJ
domains ||| S:11928 E:11935 ||| NN
.  ||| S:11935 E:11939 ||| .
FIG.  ||| S:11939 E:11944 ||| CD
11  ||| S:11944 E:11947 ||| CD
shows  ||| S:11947 E:11953 ||| NNS
the  ||| S:11953 E:11957 ||| DT
anti-Stx2  ||| S:11957 E:11967 ||| CD
11E10  ||| S:11967 E:11973 ||| CD
toxin  ||| S:11973 E:11979 ||| NN
binding  ||| S:11979 E:11987 ||| JJ
activity  ||| S:11987 E:11996 ||| NN
ELISA  ||| S:11996 E:12002 ||| NNP
and  ||| S:12002 E:12006 ||| CC
demonstrates  ||| S:12006 E:12019 ||| VBZ
that  ||| S:12019 E:12024 ||| IN
the  ||| S:12024 E:12028 ||| DT
antibody  ||| S:12028 E:12037 ||| NN
produced  ||| S:12037 E:12046 ||| VBN
by  ||| S:12046 E:12049 ||| IN
the  ||| S:12049 E:12053 ||| DT
H11E10  ||| S:12053 E:12060 ||| JJ
cell  ||| S:12060 E:12065 ||| NN
line  ||| S:12065 E:12070 ||| NN
binds  ||| S:12070 E:12076 ||| NN
to  ||| S:12076 E:12079 ||| TO
Stx2  ||| S:12079 E:12084 ||| CD
toxin ||| S:12084 E:12089 ||| NN
.  ||| S:12089 E:12093 ||| .
FIG.  ||| S:12093 E:12098 ||| CD
12  ||| S:12098 E:12101 ||| CD
illustrates  ||| S:12101 E:12113 ||| VBZ
the  ||| S:12113 E:12117 ||| DT
strategy  ||| S:12117 E:12126 ||| NN
for  ||| S:12126 E:12130 ||| IN
construction  ||| S:12130 E:12143 ||| NN
of  ||| S:12143 E:12146 ||| IN
the  ||| S:12146 E:12150 ||| DT
plasmid  ||| S:12150 E:12158 ||| JJ
pCDNA3mut.LCPL.LCVK ||| S:12158 E:12177 ||| NN
.  ||| S:12177 E:12181 ||| .
FIG.  ||| S:12181 E:12186 ||| CD
13  ||| S:12186 E:12189 ||| CD
illustrates  ||| S:12189 E:12201 ||| VBZ
the  ||| S:12201 E:12205 ||| DT
strategy  ||| S:12205 E:12214 ||| NN
for  ||| S:12214 E:12218 ||| IN
construction  ||| S:12218 E:12231 ||| NN
of  ||| S:12231 E:12234 ||| IN
the  ||| S:12234 E:12238 ||| DT
plasmid  ||| S:12238 E:12246 ||| JJ
pCDNA3mut.HCPL.HCV2b ||| S:12246 E:12266 ||| NN
.  ||| S:12266 E:12270 ||| .
FIG.  ||| S:12270 E:12275 ||| CD
14  ||| S:12275 E:12278 ||| CD
illustrates  ||| S:12278 E:12290 ||| VBZ
the  ||| S:12290 E:12294 ||| DT
strategy  ||| S:12294 E:12303 ||| NN
for  ||| S:12303 E:12307 ||| IN
construction  ||| S:12307 E:12320 ||| NN
of  ||| S:12320 E:12323 ||| IN
the  ||| S:12323 E:12327 ||| DT
plasmids  ||| S:12327 E:12336 ||| JJ
pSUN9  ||| S:12336 E:12342 ||| NN
and  ||| S:12342 E:12346 ||| CC
pSUN9 ||| S:12346 E:12351 ||| NNP
: ||| S:12351 E:12352 ||| :
kappa ||| S:12352 E:12357 ||| CD
.  ||| S:12357 E:12361 ||| .
FIG.  ||| S:12361 E:12366 ||| CD
15  ||| S:12366 E:12369 ||| CD
illustrates  ||| S:12369 E:12381 ||| VBZ
the  ||| S:12381 E:12385 ||| DT
strategy  ||| S:12385 E:12394 ||| NN
for  ||| S:12394 E:12398 ||| IN
construction  ||| S:12398 E:12411 ||| NN
of  ||| S:12411 E:12414 ||| IN
the  ||| S:12414 E:12418 ||| DT
plasmids  ||| S:12418 E:12427 ||| JJ
pSUN10  ||| S:12427 E:12434 ||| NN
and  ||| S:12434 E:12438 ||| CC
pSUN10 ||| S:12438 E:12444 ||| NNP
: ||| S:12444 E:12445 ||| :
IgG1 ||| S:12445 E:12449 ||| CD
.  ||| S:12449 E:12453 ||| .
FIG.  ||| S:12453 E:12458 ||| CD
16  ||| S:12458 E:12461 ||| CD
illustrates  ||| S:12461 E:12473 ||| VBZ
the  ||| S:12473 E:12477 ||| DT
strategy  ||| S:12477 E:12486 ||| NN
for  ||| S:12486 E:12490 ||| IN
construction  ||| S:12490 E:12503 ||| NN
of  ||| S:12503 E:12506 ||| IN
the  ||| S:12506 E:12510 ||| DT
plasmid  ||| S:12510 E:12518 ||| JJ
pJRS311 ||| S:12518 E:12525 ||| NN
.  ||| S:12525 E:12529 ||| .
FIG.  ||| S:12529 E:12534 ||| CD
17  ||| S:12534 E:12537 ||| CD
illustrates  ||| S:12537 E:12549 ||| VBZ
the  ||| S:12549 E:12553 ||| DT
strategy  ||| S:12553 E:12562 ||| NN
for  ||| S:12562 E:12566 ||| IN
construction  ||| S:12566 E:12579 ||| NN
of  ||| S:12579 E:12582 ||| IN
the  ||| S:12582 E:12586 ||| DT
plasmid  ||| S:12586 E:12594 ||| JJ
pJRS315 ||| S:12594 E:12601 ||| NN
.  ||| S:12601 E:12606 ||| .
Additional  ||| S:12606 E:12617 ||| JJ
features  ||| S:12617 E:12626 ||| NNS
and  ||| S:12626 E:12630 ||| CC
advantages  ||| S:12630 E:12641 ||| NNS
of  ||| S:12641 E:12644 ||| IN
the  ||| S:12644 E:12648 ||| DT
invention  ||| S:12648 E:12658 ||| NN
will  ||| S:12658 E:12663 ||| MD
be  ||| S:12663 E:12666 ||| VB
set  ||| S:12666 E:12670 ||| VBN
forth  ||| S:12670 E:12676 ||| RB
in  ||| S:12676 E:12679 ||| IN
the  ||| S:12679 E:12683 ||| DT
description  ||| S:12683 E:12695 ||| NN
which  ||| S:12695 E:12701 ||| WDT
follows ||| S:12701 E:12708 ||| VBZ
.  ||| S:12708 E:12710 ||| .
The  ||| S:12710 E:12714 ||| DT
objectives  ||| S:12714 E:12725 ||| NNS
and  ||| S:12725 E:12729 ||| CC
other  ||| S:12729 E:12735 ||| JJ
advantages  ||| S:12735 E:12746 ||| NNS
of  ||| S:12746 E:12749 ||| IN
the  ||| S:12749 E:12753 ||| DT
invention  ||| S:12753 E:12763 ||| NN
will  ||| S:12763 E:12768 ||| MD
be  ||| S:12768 E:12771 ||| VB
realized  ||| S:12771 E:12780 ||| VBN
and  ||| S:12780 E:12784 ||| CC
attained  ||| S:12784 E:12793 ||| VBN
by  ||| S:12793 E:12796 ||| IN
the  ||| S:12796 E:12800 ||| DT
composition  ||| S:12800 E:12812 ||| NN
of  ||| S:12812 E:12815 ||| IN
matter  ||| S:12815 E:12822 ||| NN
and  ||| S:12822 E:12826 ||| CC
process  ||| S:12826 E:12834 ||| NN
particularly  ||| S:12834 E:12847 ||| RB
pointed  ||| S:12847 E:12855 ||| VBD
out  ||| S:12855 E:12859 ||| RP
in  ||| S:12859 E:12862 ||| IN
the  ||| S:12862 E:12866 ||| DT
written  ||| S:12866 E:12874 ||| JJ
description  ||| S:12874 E:12886 ||| NN
and  ||| S:12886 E:12890 ||| CC
the  ||| S:12890 E:12894 ||| DT
claims  ||| S:12894 E:12901 ||| NNS
hereof  ||| S:12901 E:12908 ||| VBP
as  ||| S:12908 E:12911 ||| RB
well  ||| S:12911 E:12916 ||| RB
as  ||| S:12916 E:12919 ||| IN
the  ||| S:12919 E:12923 ||| DT
appended  ||| S:12923 E:12932 ||| JJ
drawings ||| S:12932 E:12940 ||| NNS
.  ||| S:12940 E:12942 ||| .
To  ||| S:12942 E:12945 ||| TO
achieve  ||| S:12945 E:12953 ||| VB
these  ||| S:12953 E:12959 ||| DT
and  ||| S:12959 E:12963 ||| CC
other  ||| S:12963 E:12969 ||| JJ
advantages  ||| S:12969 E:12980 ||| NNS
and  ||| S:12980 E:12984 ||| CC
in  ||| S:12984 E:12987 ||| IN
accordance  ||| S:12987 E:12998 ||| NN
with  ||| S:12998 E:13003 ||| IN
the  ||| S:13003 E:13007 ||| DT
purpose  ||| S:13007 E:13015 ||| NN
of  ||| S:13015 E:13018 ||| IN
the  ||| S:13018 E:13022 ||| DT
invention ||| S:13022 E:13031 ||| NN
,  ||| S:13031 E:13033 ||| ,
as  ||| S:13033 E:13036 ||| RB
embodied  ||| S:13036 E:13045 ||| VBN
and  ||| S:13045 E:13049 ||| CC
broadly  ||| S:13049 E:13057 ||| RB
described ||| S:13057 E:13066 ||| VBN
,  ||| S:13066 E:13068 ||| ,
the  ||| S:13068 E:13072 ||| DT
invention  ||| S:13072 E:13082 ||| NN
describes  ||| S:13082 E:13092 ||| VBZ
monoclonal  ||| S:13092 E:13103 ||| JJ
humanized  ||| S:13103 E:13113 ||| JJ
antibodies  ||| S:13113 E:13124 ||| NNS
which  ||| S:13124 E:13130 ||| WDT
bind  ||| S:13130 E:13135 ||| VBZ
Shiga  ||| S:13135 E:13141 ||| JJ
toxin  ||| S:13141 E:13147 ||| NN
proteins ||| S:13147 E:13155 ||| NNS
.  ||| S:13155 E:13158 ||| .
The  ||| S:13198 E:13202 ||| DT
present  ||| S:13202 E:13210 ||| JJ
invention  ||| S:13210 E:13220 ||| NN
relates  ||| S:13220 E:13228 ||| VBZ
to  ||| S:13228 E:13231 ||| TO
humanized  ||| S:13231 E:13241 ||| VB
monoclonal  ||| S:13241 E:13252 ||| JJ
antibodies  ||| S:13252 E:13263 ||| NNS
that  ||| S:13263 E:13268 ||| IN
bind  ||| S:13268 E:13273 ||| NN
to  ||| S:13273 E:13276 ||| TO
Shiga  ||| S:13276 E:13282 ||| NNP
toxin  ||| S:13282 E:13288 ||| NN
proteins ||| S:13288 E:13296 ||| NNS
,  ||| S:13296 E:13298 ||| ,
and  ||| S:13298 E:13302 ||| CC
the  ||| S:13302 E:13306 ||| DT
use  ||| S:13306 E:13310 ||| NN
of  ||| S:13310 E:13313 ||| IN
such  ||| S:13313 E:13318 ||| JJ
antibodies  ||| S:13318 E:13329 ||| NNS
in  ||| S:13329 E:13332 ||| IN
the  ||| S:13332 E:13336 ||| DT
treatment  ||| S:13336 E:13346 ||| NN
or  ||| S:13346 E:13349 ||| CC
prevention  ||| S:13349 E:13360 ||| NN
of  ||| S:13360 E:13363 ||| IN
Shiga  ||| S:13363 E:13369 ||| NNP
toxin-induced  ||| S:13369 E:13383 ||| JJ
diseases ||| S:13383 E:13391 ||| NNS
.  ||| S:13391 E:13393 ||| .
Antibodies  ||| S:13393 E:13404 ||| NNS
are  ||| S:13404 E:13408 ||| VBP
proteinaceous  ||| S:13408 E:13422 ||| JJ
structures  ||| S:13422 E:13433 ||| NNS
made  ||| S:13433 E:13438 ||| VBD
up  ||| S:13438 E:13441 ||| RP
of  ||| S:13441 E:13444 ||| IN
two  ||| S:13444 E:13448 ||| CD
heavy  ||| S:13448 E:13454 ||| JJ
and  ||| S:13454 E:13458 ||| CC
two  ||| S:13458 E:13462 ||| CD
light  ||| S:13462 E:13468 ||| JJ
chains ||| S:13468 E:13474 ||| NNS
.  ||| S:13474 E:13476 ||| .
The  ||| S:13476 E:13480 ||| DT
five  ||| S:13480 E:13485 ||| CD
different  ||| S:13485 E:13495 ||| JJ
classes  ||| S:13495 E:13503 ||| NNS
of  ||| S:13503 E:13506 ||| IN
higher  ||| S:13506 E:13513 ||| JJR
vertebrate  ||| S:13513 E:13524 ||| JJ
antibodies ||| S:13524 E:13534 ||| NNS
& ||| S:13534 E:13535 ||| CC
# ||| S:13535 E:13536 ||| #
x2014 ||| S:13536 E:13541 ||| CD
; ||| S:13541 E:13542 ||| :
IgM ||| S:13542 E:13545 ||| NNP
,  ||| S:13545 E:13547 ||| ,
IgD ||| S:13547 E:13550 ||| NNP
,  ||| S:13550 E:13552 ||| ,
IgG ||| S:13552 E:13555 ||| NNP
,  ||| S:13555 E:13557 ||| ,
IgA  ||| S:13557 E:13561 ||| JJ
and  ||| S:13561 E:13565 ||| CC
IgE ||| S:13565 E:13568 ||| JJ
& ||| S:13568 E:13569 ||| CC
# ||| S:13569 E:13570 ||| #
x2014 ||| S:13570 E:13575 ||| CD
; ||| S:13575 E:13576 ||| :
are  ||| S:13576 E:13580 ||| VBP
distinguished  ||| S:13580 E:13594 ||| VBN
by  ||| S:13594 E:13597 ||| IN
their  ||| S:13597 E:13603 ||| PRP$
heavy  ||| S:13603 E:13609 ||| JJ
chains  ||| S:13609 E:13616 ||| NNS
( ||| S:13616 E:13617 ||| -LRB-
mu ||| S:13617 E:13619 ||| UH
,  ||| S:13619 E:13621 ||| ,
delta ||| S:13621 E:13626 ||| NN
,  ||| S:13626 E:13628 ||| ,
gamma ||| S:13628 E:13633 ||| NN
,  ||| S:13633 E:13635 ||| ,
alpha  ||| S:13635 E:13641 ||| NN
and  ||| S:13641 E:13645 ||| CC
epsilon ||| S:13645 E:13652 ||| NN
,  ||| S:13652 E:13654 ||| ,
respectively ||| S:13654 E:13666 ||| RB
) ||| S:13666 E:13667 ||| -RRB-
.  ||| S:13667 E:13669 ||| .
Each  ||| S:13669 E:13674 ||| DT
class  ||| S:13674 E:13680 ||| NN
has  ||| S:13680 E:13684 ||| VBZ
further  ||| S:13684 E:13692 ||| JJ
subclasses ||| S:13692 E:13702 ||| NN
;  ||| S:13702 E:13704 ||| :
IgG ||| S:13704 E:13707 ||| NNP
,  ||| S:13707 E:13709 ||| ,
for  ||| S:13709 E:13713 ||| IN
example ||| S:13713 E:13720 ||| NN
,  ||| S:13720 E:13722 ||| ,
may  ||| S:13722 E:13726 ||| MD
be  ||| S:13726 E:13729 ||| VB
IgG1 ||| S:13729 E:13733 ||| CD
,  ||| S:13733 E:13735 ||| ,
IgG2 ||| S:13735 E:13739 ||| NNP
,  ||| S:13739 E:13741 ||| ,
IgG3 ||| S:13741 E:13745 ||| NNP
,  ||| S:13745 E:13747 ||| ,
or  ||| S:13747 E:13750 ||| CC
IgG4 ||| S:13750 E:13754 ||| NNP
,  ||| S:13754 E:13756 ||| ,
where  ||| S:13756 E:13762 ||| WRB
the  ||| S:13762 E:13766 ||| DT
heavy  ||| S:13766 E:13772 ||| JJ
chain  ||| S:13772 E:13778 ||| NN
is  ||| S:13778 E:13781 ||| VBZ
gamma  ||| S:13781 E:13787 ||| CD
1 ||| S:13787 E:13788 ||| CD
,  ||| S:13788 E:13790 ||| ,
gamma  ||| S:13790 E:13796 ||| CD
2 ||| S:13796 E:13797 ||| CD
,  ||| S:13797 E:13799 ||| ,
gamma  ||| S:13799 E:13805 ||| CD
3  ||| S:13805 E:13807 ||| CD
or  ||| S:13807 E:13810 ||| CC
gamma  ||| S:13810 E:13816 ||| CD
4 ||| S:13816 E:13817 ||| CD
,  ||| S:13817 E:13819 ||| ,
respectively ||| S:13819 E:13831 ||| RB
.  ||| S:13831 E:13833 ||| .
The  ||| S:13833 E:13837 ||| DT
pair  ||| S:13837 E:13842 ||| NN
of  ||| S:13842 E:13845 ||| IN
light  ||| S:13845 E:13851 ||| JJ
chains  ||| S:13851 E:13858 ||| NNS
in  ||| S:13858 E:13861 ||| IN
these  ||| S:13861 E:13867 ||| DT
classes  ||| S:13867 E:13875 ||| NNS
or  ||| S:13875 E:13878 ||| CC
subclasses  ||| S:13878 E:13889 ||| NNS
may  ||| S:13889 E:13893 ||| MD
be  ||| S:13893 E:13896 ||| VB
either  ||| S:13896 E:13903 ||| DT
kappa  ||| S:13903 E:13909 ||| NN
or  ||| S:13909 E:13912 ||| CC
lambda ||| S:13912 E:13918 ||| NN
.  ||| S:13918 E:13922 ||| .
Antibodies  ||| S:13922 E:13933 ||| NNS
are  ||| S:13933 E:13937 ||| VBP
further  ||| S:13937 E:13945 ||| RB
divided  ||| S:13945 E:13953 ||| VBN
into  ||| S:13953 E:13958 ||| IN
a  ||| S:13958 E:13960 ||| DT
constant  ||| S:13960 E:13969 ||| JJ
region  ||| S:13969 E:13976 ||| NN
and  ||| S:13976 E:13980 ||| CC
a  ||| S:13980 E:13982 ||| DT
variable  ||| S:13982 E:13991 ||| JJ
region ||| S:13991 E:13997 ||| NN
.  ||| S:13997 E:13999 ||| .
For  ||| S:13999 E:14003 ||| IN
both  ||| S:14003 E:14008 ||| PDT
the  ||| S:14008 E:14012 ||| DT
heavy  ||| S:14012 E:14018 ||| JJ
and  ||| S:14018 E:14022 ||| CC
light  ||| S:14022 E:14028 ||| JJ
chains ||| S:14028 E:14034 ||| NNS
,  ||| S:14034 E:14036 ||| ,
the  ||| S:14036 E:14040 ||| DT
carboxy-terminal  ||| S:14040 E:14057 ||| JJ
ends  ||| S:14057 E:14062 ||| NNS
make  ||| S:14062 E:14067 ||| VBP
up  ||| S:14067 E:14070 ||| RP
the  ||| S:14070 E:14074 ||| DT
constant  ||| S:14074 E:14083 ||| JJ
sequence  ||| S:14083 E:14092 ||| NN
region ||| S:14092 E:14098 ||| NN
,  ||| S:14098 E:14100 ||| ,
while  ||| S:14100 E:14106 ||| IN
the  ||| S:14106 E:14110 ||| DT
amino  ||| S:14110 E:14116 ||| JJ
terminal  ||| S:14116 E:14125 ||| NN
ends  ||| S:14125 E:14130 ||| NNS
contain  ||| S:14130 E:14138 ||| VBP
the  ||| S:14138 E:14142 ||| DT
variable  ||| S:14142 E:14151 ||| JJ
sequence  ||| S:14151 E:14160 ||| NN
region ||| S:14160 E:14166 ||| NN
.  ||| S:14166 E:14168 ||| .
Within  ||| S:14168 E:14175 ||| IN
these  ||| S:14175 E:14181 ||| DT
variable  ||| S:14181 E:14190 ||| JJ
regions ||| S:14190 E:14197 ||| NNS
,  ||| S:14197 E:14199 ||| ,
the  ||| S:14199 E:14203 ||| DT
complementarity  ||| S:14203 E:14219 ||| NN
determining  ||| S:14219 E:14231 ||| VBG
regions  ||| S:14231 E:14239 ||| NNS
( ||| S:14239 E:14240 ||| -LRB-
CDRs ||| S:14240 E:14244 ||| NNP
)  ||| S:14244 E:14246 ||| -RRB-
are  ||| S:14246 E:14250 ||| VBP
located  ||| S:14250 E:14258 ||| VBN
which  ||| S:14258 E:14264 ||| WDT
are  ||| S:14264 E:14268 ||| VBP
primarily  ||| S:14268 E:14278 ||| RB
responsible  ||| S:14278 E:14290 ||| JJ
for  ||| S:14290 E:14294 ||| IN
the  ||| S:14294 E:14298 ||| DT
observed  ||| S:14298 E:14307 ||| JJ
antigen  ||| S:14307 E:14315 ||| NN
binding  ||| S:14315 E:14323 ||| NNS
which  ||| S:14323 E:14329 ||| WDT
is  ||| S:14329 E:14332 ||| VBZ
characteristic  ||| S:14332 E:14347 ||| VBN
of  ||| S:14347 E:14350 ||| IN
antibodies ||| S:14350 E:14360 ||| NNS
.  ||| S:14360 E:14364 ||| .
& ||| S:14364 E:14365 ||| CC
# ||| S:14365 E:14366 ||| #
x201c ||| S:14366 E:14371 ||| CD
; ||| S:14371 E:14372 ||| :
Humanized ||| S:14372 E:14381 ||| NNP
& ||| S:14381 E:14382 ||| CC
# ||| S:14382 E:14383 ||| #
x201d ||| S:14383 E:14388 ||| CD
;  ||| S:14388 E:14390 ||| :
monoclonal  ||| S:14390 E:14401 ||| JJ
antibodies  ||| S:14401 E:14412 ||| NNS
mean  ||| S:14412 E:14417 ||| VBP
monoclonal  ||| S:14417 E:14428 ||| JJ
antibodies  ||| S:14428 E:14439 ||| NNS
originally  ||| S:14439 E:14450 ||| RB
from  ||| S:14450 E:14455 ||| IN
a  ||| S:14455 E:14457 ||| DT
non-human  ||| S:14457 E:14467 ||| JJ
source  ||| S:14467 E:14474 ||| NN
to  ||| S:14474 E:14477 ||| TO
which  ||| S:14477 E:14483 ||| WDT
human  ||| S:14483 E:14489 ||| JJ
components  ||| S:14489 E:14500 ||| NNS
have  ||| S:14500 E:14505 ||| VBP
been  ||| S:14505 E:14510 ||| VBN
substituted ||| S:14510 E:14521 ||| VBN
.  ||| S:14521 E:14523 ||| .
In  ||| S:14523 E:14526 ||| IN
a  ||| S:14526 E:14528 ||| DT
preferred  ||| S:14528 E:14538 ||| JJ
embodiment ||| S:14538 E:14548 ||| NN
,  ||| S:14548 E:14550 ||| ,
the  ||| S:14550 E:14554 ||| DT
humanized  ||| S:14554 E:14564 ||| JJ
monoclonal  ||| S:14564 E:14575 ||| JJ
antibodies  ||| S:14575 E:14586 ||| NNS
of  ||| S:14586 E:14589 ||| IN
this  ||| S:14589 E:14594 ||| DT
invention  ||| S:14594 E:14604 ||| NNS
comprise  ||| S:14604 E:14613 ||| VBP
variable  ||| S:14613 E:14622 ||| JJ
regions  ||| S:14622 E:14630 ||| NNS
which  ||| S:14630 E:14636 ||| WDT
derive  ||| S:14636 E:14643 ||| VBZ
from  ||| S:14643 E:14648 ||| IN
non-human  ||| S:14648 E:14658 ||| JJ
sources  ||| S:14658 E:14666 ||| NNS
and  ||| S:14666 E:14670 ||| CC
constant  ||| S:14670 E:14679 ||| JJ
regions  ||| S:14679 E:14687 ||| NNS
which  ||| S:14687 E:14693 ||| WDT
derive  ||| S:14693 E:14700 ||| VBZ
from  ||| S:14700 E:14705 ||| IN
human  ||| S:14705 E:14711 ||| JJ
sources ||| S:14711 E:14718 ||| NNS
.  ||| S:14718 E:14722 ||| .
As  ||| S:14722 E:14725 ||| RB
set  ||| S:14725 E:14729 ||| VBN
forth  ||| S:14729 E:14735 ||| RB
above ||| S:14735 E:14740 ||| RB
,  ||| S:14740 E:14742 ||| ,
Shiga  ||| S:14742 E:14748 ||| NNP
toxin  ||| S:14748 E:14754 ||| NN
proteins  ||| S:14754 E:14763 ||| NNS
( ||| S:14763 E:14764 ||| -LRB-
Stx ||| S:14764 E:14767 ||| NNP
)  ||| S:14767 E:14769 ||| -RRB-
refer  ||| S:14769 E:14775 ||| VBP
to  ||| S:14775 E:14778 ||| TO
the  ||| S:14778 E:14782 ||| DT
family  ||| S:14782 E:14789 ||| NN
of  ||| S:14789 E:14792 ||| IN
multi-unit  ||| S:14792 E:14803 ||| JJ
bacterial  ||| S:14803 E:14813 ||| JJ
proteins  ||| S:14813 E:14822 ||| NNS
produced  ||| S:14822 E:14831 ||| VBN
by  ||| S:14831 E:14834 ||| IN
EHEC  ||| S:14834 E:14839 ||| NNP
and  ||| S:14839 E:14843 ||| CC
Shigella  ||| S:14843 E:14852 ||| NNP
dysenteriae  ||| S:14852 E:14864 ||| NN
which  ||| S:14864 E:14870 ||| WDT
are  ||| S:14870 E:14874 ||| VBP
associated  ||| S:14874 E:14885 ||| VBN
with  ||| S:14885 E:14890 ||| IN
outbreaks  ||| S:14890 E:14900 ||| NNS
of  ||| S:14900 E:14903 ||| IN
Shiga  ||| S:14903 E:14909 ||| NNP
toxin  ||| S:14909 E:14915 ||| NN
induced  ||| S:14915 E:14923 ||| NN
diseases ||| S:14923 E:14931 ||| NNS
.  ||| S:14931 E:14933 ||| .
Shiga  ||| S:14933 E:14939 ||| JJ
toxin  ||| S:14939 E:14945 ||| NN
proteins  ||| S:14945 E:14954 ||| NNS
are  ||| S:14954 E:14958 ||| VBP
meant  ||| S:14958 E:14964 ||| VBN
to  ||| S:14964 E:14967 ||| TO
encompass  ||| S:14967 E:14977 ||| VB
Stx  ||| S:14977 E:14981 ||| NNP
of  ||| S:14981 E:14984 ||| IN
Shigella  ||| S:14984 E:14993 ||| NNP
dysenteriae-type  ||| S:14993 E:15010 ||| NNP
1  ||| S:15010 E:15012 ||| CD
and  ||| S:15012 E:15016 ||| CC
Stx  ||| S:15016 E:15020 ||| NNP
type  ||| S:15020 E:15025 ||| NN
1  ||| S:15025 E:15027 ||| CD
and  ||| S:15027 E:15031 ||| CC
type  ||| S:15031 E:15036 ||| NN
2 ||| S:15036 E:15037 ||| CD
,  ||| S:15037 E:15039 ||| ,
and  ||| S:15039 E:15043 ||| CC
type  ||| S:15043 E:15048 ||| NN
2  ||| S:15048 E:15050 ||| CD
variant  ||| S:15050 E:15058 ||| JJ
toxins  ||| S:15058 E:15065 ||| NN
of  ||| S:15065 E:15068 ||| IN
E.  ||| S:15068 E:15071 ||| NNP
coli ||| S:15071 E:15075 ||| NNS
.  ||| S:15075 E:15079 ||| .
Shiga  ||| S:15079 E:15085 ||| JJ
toxin-induced  ||| S:15085 E:15099 ||| JJ
diseases  ||| S:15099 E:15108 ||| NNS
of  ||| S:15108 E:15111 ||| IN
humans  ||| S:15111 E:15118 ||| NNS
include  ||| S:15118 E:15126 ||| VBP
bloody  ||| S:15126 E:15133 ||| JJ
diarrhea ||| S:15133 E:15141 ||| NN
,  ||| S:15141 E:15143 ||| ,
hemorrhagic  ||| S:15143 E:15155 ||| JJ
colitis ||| S:15155 E:15162 ||| NN
,  ||| S:15162 E:15164 ||| ,
hemolytic  ||| S:15164 E:15174 ||| JJ
uremic  ||| S:15174 E:15181 ||| JJ
syndrome ||| S:15181 E:15189 ||| NN
,  ||| S:15189 E:15191 ||| ,
and  ||| S:15191 E:15195 ||| CC
thrombotic  ||| S:15195 E:15206 ||| JJ
thrombocytopenic  ||| S:15206 E:15223 ||| JJ
purpura ||| S:15223 E:15230 ||| NN
.  ||| S:15230 E:15234 ||| .
In  ||| S:15234 E:15237 ||| IN
a  ||| S:15237 E:15239 ||| DT
more  ||| S:15239 E:15244 ||| RBR
specific  ||| S:15244 E:15253 ||| JJ
embodiment ||| S:15253 E:15263 ||| NN
,  ||| S:15263 E:15265 ||| ,
the  ||| S:15265 E:15269 ||| DT
invention  ||| S:15269 E:15279 ||| NN
relates  ||| S:15279 E:15287 ||| VBZ
to  ||| S:15287 E:15290 ||| TO
humanized  ||| S:15290 E:15300 ||| VB
monoclonal  ||| S:15300 E:15311 ||| JJ
antibodies  ||| S:15311 E:15322 ||| NNS
that  ||| S:15322 E:15327 ||| WDT
have  ||| S:15327 E:15332 ||| VBP
the  ||| S:15332 E:15336 ||| DT
same  ||| S:15336 E:15341 ||| JJ
binding  ||| S:15341 E:15349 ||| JJ
specificity  ||| S:15349 E:15361 ||| NN
of  ||| S:15361 E:15364 ||| IN
at  ||| S:15364 E:15367 ||| IN
least  ||| S:15367 E:15373 ||| JJS
two  ||| S:15373 E:15377 ||| CD
well  ||| S:15377 E:15382 ||| RB
characterized  ||| S:15382 E:15396 ||| VBN
murine  ||| S:15396 E:15403 ||| JJ
monoclonal  ||| S:15403 E:15414 ||| JJ
antibodies ||| S:15414 E:15424 ||| NNS
.  ||| S:15424 E:15426 ||| .
These  ||| S:15426 E:15432 ||| DT
two  ||| S:15432 E:15436 ||| CD
monoclonal  ||| S:15436 E:15447 ||| CD
antibodies  ||| S:15447 E:15458 ||| NNS
were  ||| S:15458 E:15463 ||| VBD
developed  ||| S:15463 E:15473 ||| VBN
in  ||| S:15473 E:15476 ||| IN
Dr.  ||| S:15476 E:15480 ||| NNP
Alison  ||| S:15480 E:15487 ||| NNP
O ||| S:15487 E:15488 ||| NNP
' ||| S:15488 E:15489 ||| POS
Brien ||| S:15489 E:15494 ||| NNP
's  ||| S:15494 E:15497 ||| POS
laboratory  ||| S:15497 E:15508 ||| NN
as  ||| S:15508 E:15511 ||| IN
set  ||| S:15511 E:15515 ||| VBN
forth  ||| S:15515 E:15521 ||| RB
in  ||| S:15521 E:15524 ||| IN
Strockbine ||| S:15524 E:15534 ||| NNP
,  ||| S:15534 E:15536 ||| ,
N.  ||| S:15536 E:15539 ||| NNP
A.  ||| S:15539 E:15542 ||| NNP
et  ||| S:15542 E:15545 ||| NNP
al. ||| S:15545 E:15548 ||| NNP
,  ||| S:15548 E:15550 ||| ,
Infection  ||| S:15550 E:15560 ||| NNP
and  ||| S:15560 E:15564 ||| CC
Immunity ||| S:15564 E:15572 ||| NNP
,  ||| S:15572 E:15574 ||| ,
1985 ||| S:15574 E:15578 ||| CD
,  ||| S:15578 E:15580 ||| ,
50 ||| S:15580 E:15582 ||| CD
: ||| S:15582 E:15583 ||| :
695-700  ||| S:15583 E:15591 ||| CD
and  ||| S:15591 E:15595 ||| CC
Perera ||| S:15595 E:15601 ||| NNP
,  ||| S:15601 E:15603 ||| ,
L.  ||| S:15603 E:15606 ||| NNP
P.  ||| S:15606 E:15609 ||| NNP
et  ||| S:15609 E:15612 ||| NNP
al. ||| S:15612 E:15615 ||| NNP
,  ||| S:15615 E:15617 ||| ,
J.  ||| S:15617 E:15620 ||| NNP
Clinical  ||| S:15620 E:15629 ||| NNP
Microbiol. ||| S:15629 E:15639 ||| NNP
,  ||| S:15639 E:15641 ||| ,
1988 ||| S:15641 E:15645 ||| CD
,  ||| S:15645 E:15647 ||| ,
26 ||| S:15647 E:15649 ||| CD
: ||| S:15649 E:15650 ||| :
2127-2131 ||| S:15650 E:15659 ||| CD
,  ||| S:15659 E:15661 ||| ,
and  ||| S:15661 E:15665 ||| CC
have  ||| S:15665 E:15670 ||| VBP
been  ||| S:15670 E:15675 ||| VBN
deposited  ||| S:15675 E:15685 ||| VBN
at  ||| S:15685 E:15688 ||| IN
the  ||| S:15688 E:15692 ||| DT
ATCC  ||| S:15692 E:15697 ||| NNP
as  ||| S:15697 E:15700 ||| RB
set  ||| S:15700 E:15704 ||| VBN
forth  ||| S:15704 E:15710 ||| RB
below ||| S:15710 E:15715 ||| RB
.  ||| S:15715 E:15719 ||| .
By  ||| S:15719 E:15722 ||| IN
& ||| S:15722 E:15723 ||| CC
# ||| S:15723 E:15724 ||| #
x201c ||| S:15724 E:15729 ||| CD
; ||| S:15729 E:15730 ||| :
same  ||| S:15730 E:15735 ||| JJ
binding  ||| S:15735 E:15743 ||| JJ
specificity ||| S:15743 E:15754 ||| NN
& ||| S:15754 E:15755 ||| CC
# ||| S:15755 E:15756 ||| #
x201d ||| S:15756 E:15761 ||| CD
;  ||| S:15761 E:15763 ||| :
is  ||| S:15763 E:15766 ||| VBZ
meant  ||| S:15766 E:15772 ||| VBN
a  ||| S:15772 E:15774 ||| DT
level  ||| S:15774 E:15780 ||| NN
of  ||| S:15780 E:15783 ||| IN
binding  ||| S:15783 E:15791 ||| VBG
sufficiently  ||| S:15791 E:15804 ||| RB
detectable  ||| S:15804 E:15815 ||| VBN
in  ||| S:15815 E:15818 ||| IN
a  ||| S:15818 E:15820 ||| DT
standard  ||| S:15820 E:15829 ||| JJ
binding  ||| S:15829 E:15837 ||| JJ
assay  ||| S:15837 E:15843 ||| NN
to  ||| S:15843 E:15846 ||| TO
distinguish  ||| S:15846 E:15858 ||| VB
between  ||| S:15858 E:15866 ||| IN
toxin  ||| S:15866 E:15872 ||| NN
binding  ||| S:15872 E:15880 ||| NNS
and  ||| S:15880 E:15884 ||| CC
non-specific  ||| S:15884 E:15897 ||| JJ
background  ||| S:15897 E:15908 ||| NN
binding  ||| S:15908 E:15916 ||| NN
as  ||| S:15916 E:15919 ||| IN
exemplified  ||| S:15919 E:15931 ||| NN
by  ||| S:15931 E:15934 ||| IN
appropriate  ||| S:15934 E:15946 ||| JJ
controls  ||| S:15946 E:15955 ||| NNS
( ||| S:15955 E:15956 ||| -LRB-
for  ||| S:15956 E:15960 ||| IN
examples ||| S:15960 E:15968 ||| NNS
,  ||| S:15968 E:15970 ||| ,
see  ||| S:15970 E:15974 ||| VB
FIG.  ||| S:15974 E:15979 ||| CD
9  ||| S:15979 E:15981 ||| CD
and  ||| S:15981 E:15985 ||| CC
FIG.  ||| S:15985 E:15990 ||| CD
11 ||| S:15990 E:15992 ||| CD
) ||| S:15992 E:15993 ||| -RRB-
.  ||| S:15993 E:15995 ||| .
Those  ||| S:15995 E:16001 ||| DT
of  ||| S:16001 E:16004 ||| IN
ordinary  ||| S:16004 E:16013 ||| JJ
skill  ||| S:16013 E:16019 ||| NN
in  ||| S:16019 E:16022 ||| IN
the  ||| S:16022 E:16026 ||| DT
art  ||| S:16026 E:16030 ||| NN
can  ||| S:16030 E:16034 ||| MD
readily  ||| S:16034 E:16042 ||| RB
test  ||| S:16042 E:16047 ||| VB
for  ||| S:16047 E:16051 ||| IN
binding  ||| S:16051 E:16059 ||| JJ
levels  ||| S:16059 E:16066 ||| NNS
using  ||| S:16066 E:16072 ||| VBG
routine  ||| S:16072 E:16080 ||| JJ
skills  ||| S:16080 E:16087 ||| NNS
and  ||| S:16087 E:16091 ||| CC
techniques ||| S:16091 E:16101 ||| NNS
.  ||| S:16101 E:16105 ||| .
In  ||| S:16105 E:16108 ||| IN
another  ||| S:16108 E:16116 ||| DT
preferred  ||| S:16116 E:16126 ||| JJ
embodiment ||| S:16126 E:16136 ||| NN
,  ||| S:16136 E:16138 ||| ,
the  ||| S:16138 E:16142 ||| DT
humanized  ||| S:16142 E:16152 ||| JJ
antibodies  ||| S:16152 E:16163 ||| NNS
are  ||| S:16163 E:16167 ||| VBP
characterized  ||| S:16167 E:16181 ||| VBN
by  ||| S:16181 E:16184 ||| IN
their  ||| S:16184 E:16190 ||| PRP$
structural  ||| S:16190 E:16201 ||| JJ
features ||| S:16201 E:16209 ||| NNS
.  ||| S:16209 E:16211 ||| .
In  ||| S:16211 E:16214 ||| IN
one  ||| S:16214 E:16218 ||| CD
aspect  ||| S:16218 E:16225 ||| NN
of  ||| S:16225 E:16228 ||| IN
this  ||| S:16228 E:16233 ||| DT
embodiment ||| S:16233 E:16243 ||| NN
,  ||| S:16243 E:16245 ||| ,
the  ||| S:16245 E:16249 ||| DT
constant  ||| S:16249 E:16258 ||| JJ
region  ||| S:16258 E:16265 ||| NN
is  ||| S:16265 E:16268 ||| VBZ
a  ||| S:16268 E:16270 ||| DT
human  ||| S:16270 E:16276 ||| JJ
constant  ||| S:16276 E:16285 ||| JJ
region  ||| S:16285 E:16292 ||| NN
and  ||| S:16292 E:16296 ||| CC
the  ||| S:16296 E:16300 ||| DT
variable  ||| S:16300 E:16309 ||| JJ
region  ||| S:16309 E:16316 ||| NN
derives  ||| S:16316 E:16324 ||| VBZ
from  ||| S:16324 E:16329 ||| IN
a  ||| S:16329 E:16331 ||| DT
rodent ||| S:16331 E:16337 ||| NN
,  ||| S:16337 E:16339 ||| ,
preferably  ||| S:16339 E:16350 ||| RB
a  ||| S:16350 E:16352 ||| DT
mouse ||| S:16352 E:16357 ||| NN
.  ||| S:16357 E:16359 ||| .
Although  ||| S:16359 E:16368 ||| IN
not  ||| S:16368 E:16372 ||| RB
limited  ||| S:16372 E:16380 ||| VBN
to  ||| S:16380 E:16383 ||| TO
these ||| S:16383 E:16388 ||| DT
,  ||| S:16388 E:16390 ||| ,
the  ||| S:16390 E:16394 ||| DT
four  ||| S:16394 E:16399 ||| CD
variable  ||| S:16399 E:16408 ||| CD
regions  ||| S:16408 E:16416 ||| NNS
set  ||| S:16416 E:16420 ||| VBD
forth  ||| S:16420 E:16426 ||| RB
in  ||| S:16426 E:16429 ||| IN
the  ||| S:16429 E:16433 ||| DT
specification ||| S:16433 E:16446 ||| NN
,  ||| S:16446 E:16448 ||| ,
particularly  ||| S:16448 E:16461 ||| RB
in  ||| S:16461 E:16464 ||| IN
FIG.  ||| S:16464 E:16469 ||| CD
3  ||| S:16469 E:16471 ||| CD
and  ||| S:16471 E:16475 ||| CC
FIG.  ||| S:16475 E:16480 ||| CD
6 ||| S:16480 E:16481 ||| CD
,  ||| S:16481 E:16483 ||| ,
are  ||| S:16483 E:16487 ||| VBP
preferred ||| S:16487 E:16496 ||| VBN
.  ||| S:16496 E:16498 ||| .
Of  ||| S:16498 E:16501 ||| IN
course ||| S:16501 E:16507 ||| NN
,  ||| S:16507 E:16509 ||| ,
the  ||| S:16509 E:16513 ||| DT
invention  ||| S:16513 E:16523 ||| NN
includes  ||| S:16523 E:16532 ||| VBZ
modifications  ||| S:16532 E:16546 ||| NNS
( ||| S:16546 E:16547 ||| -LRB-
i.e. ||| S:16547 E:16551 ||| FW
,  ||| S:16551 E:16553 ||| ,
deletions ||| S:16553 E:16562 ||| NNS
,  ||| S:16562 E:16564 ||| ,
additions ||| S:16564 E:16573 ||| NNS
,  ||| S:16573 E:16575 ||| ,
and  ||| S:16575 E:16579 ||| CC
substitutions ||| S:16579 E:16592 ||| CD
)  ||| S:16592 E:16594 ||| -RRB-
that  ||| S:16594 E:16599 ||| WDT
do  ||| S:16599 E:16602 ||| VBP
not  ||| S:16602 E:16606 ||| RB
appreciably  ||| S:16606 E:16618 ||| RB
diminish  ||| S:16618 E:16627 ||| VB
the  ||| S:16627 E:16631 ||| DT
characteristic  ||| S:16631 E:16646 ||| JJ
binding  ||| S:16646 E:16654 ||| NNS
associated  ||| S:16654 E:16665 ||| VBN
with  ||| S:16665 E:16670 ||| IN
the  ||| S:16670 E:16674 ||| DT
exemplified  ||| S:16674 E:16686 ||| JJ
variable  ||| S:16686 E:16695 ||| JJ
regions ||| S:16695 E:16702 ||| NNS
.  ||| S:16702 E:16706 ||| .
In  ||| S:16706 E:16709 ||| IN
yet  ||| S:16709 E:16713 ||| RB
another  ||| S:16713 E:16721 ||| DT
embodiment ||| S:16721 E:16731 ||| NN
,  ||| S:16731 E:16733 ||| ,
the  ||| S:16733 E:16737 ||| DT
CDRs  ||| S:16737 E:16742 ||| JJ
of  ||| S:16742 E:16745 ||| IN
the  ||| S:16745 E:16749 ||| DT
variable  ||| S:16749 E:16758 ||| JJ
region  ||| S:16758 E:16765 ||| NN
are  ||| S:16765 E:16769 ||| VBP
employed  ||| S:16769 E:16778 ||| VBN
in  ||| S:16778 E:16781 ||| IN
the  ||| S:16781 E:16785 ||| DT
invention ||| S:16785 E:16794 ||| NN
.  ||| S:16794 E:16796 ||| .
As  ||| S:16796 E:16799 ||| RB
noted  ||| S:16799 E:16805 ||| VBD
above ||| S:16805 E:16810 ||| RB
,  ||| S:16810 E:16812 ||| ,
CDRs  ||| S:16812 E:16817 ||| NNS
are  ||| S:16817 E:16821 ||| VBP
located  ||| S:16821 E:16829 ||| VBN
in  ||| S:16829 E:16832 ||| IN
the  ||| S:16832 E:16836 ||| DT
variable  ||| S:16836 E:16845 ||| JJ
regions  ||| S:16845 E:16853 ||| NNS
of  ||| S:16853 E:16856 ||| IN
both  ||| S:16856 E:16861 ||| PDT
the  ||| S:16861 E:16865 ||| DT
light  ||| S:16865 E:16871 ||| NN
and  ||| S:16871 E:16875 ||| CC
heavy  ||| S:16875 E:16881 ||| JJ
chains  ||| S:16881 E:16888 ||| NNS
and  ||| S:16888 E:16892 ||| CC
are  ||| S:16892 E:16896 ||| VBP
responsible  ||| S:16896 E:16908 ||| JJ
for  ||| S:16908 E:16912 ||| IN
antigen  ||| S:16912 E:16920 ||| JJ
binding ||| S:16920 E:16927 ||| NN
.  ||| S:16927 E:16929 ||| .
In  ||| S:16929 E:16932 ||| IN
view  ||| S:16932 E:16937 ||| NN
of  ||| S:16937 E:16940 ||| IN
the  ||| S:16940 E:16944 ||| DT
ready  ||| S:16944 E:16950 ||| JJ
ability  ||| S:16950 E:16958 ||| NN
of  ||| S:16958 E:16961 ||| IN
those  ||| S:16961 E:16967 ||| DT
in  ||| S:16967 E:16970 ||| IN
this  ||| S:16970 E:16975 ||| DT
art  ||| S:16975 E:16979 ||| NN
to  ||| S:16979 E:16982 ||| TO
determine  ||| S:16982 E:16992 ||| VB
the  ||| S:16992 E:16996 ||| DT
CDR  ||| S:16996 E:17000 ||| NNP
regions ||| S:17000 E:17007 ||| NNS
,  ||| S:17007 E:17009 ||| ,
the  ||| S:17009 E:17013 ||| DT
present  ||| S:17013 E:17021 ||| JJ
invention  ||| S:17021 E:17031 ||| NN
is  ||| S:17031 E:17034 ||| VBZ
not  ||| S:17034 E:17038 ||| RB
limited  ||| S:17038 E:17046 ||| VBN
to  ||| S:17046 E:17049 ||| TO
the  ||| S:17049 E:17053 ||| DT
CDRs  ||| S:17053 E:17058 ||| JJ
specifically  ||| S:17058 E:17071 ||| RB
set  ||| S:17071 E:17075 ||| VBN
forth ||| S:17075 E:17080 ||| RB
.  ||| S:17080 E:17082 ||| .
Indeed ||| S:17082 E:17088 ||| RB
,  ||| S:17088 E:17090 ||| ,
the  ||| S:17090 E:17094 ||| DT
vectors  ||| S:17094 E:17102 ||| NN
created  ||| S:17102 E:17110 ||| VBN
by  ||| S:17110 E:17113 ||| IN
the  ||| S:17113 E:17117 ||| DT
applicants  ||| S:17117 E:17128 ||| NNS
and  ||| S:17128 E:17132 ||| CC
described  ||| S:17132 E:17142 ||| VBN
in  ||| S:17142 E:17145 ||| IN
great  ||| S:17145 E:17151 ||| JJ
detail  ||| S:17151 E:17158 ||| NN
below  ||| S:17158 E:17164 ||| RB
are  ||| S:17164 E:17168 ||| VBP
sufficient  ||| S:17168 E:17179 ||| JJ
for  ||| S:17179 E:17183 ||| IN
use  ||| S:17183 E:17187 ||| NN
with  ||| S:17187 E:17192 ||| IN
any  ||| S:17192 E:17196 ||| DT
CDRs  ||| S:17196 E:17201 ||| JJ
of  ||| S:17201 E:17204 ||| IN
non-human  ||| S:17204 E:17214 ||| JJ
antibodies  ||| S:17214 E:17225 ||| NNS
to  ||| S:17225 E:17228 ||| TO
Shiga  ||| S:17228 E:17234 ||| NNP
toxins ||| S:17234 E:17240 ||| NN
.  ||| S:17240 E:17244 ||| .
In  ||| S:17244 E:17247 ||| IN
the  ||| S:17247 E:17251 ||| DT
most  ||| S:17251 E:17256 ||| RBS
preferred  ||| S:17256 E:17266 ||| JJ
embodiment  ||| S:17266 E:17277 ||| NN
of  ||| S:17277 E:17280 ||| IN
the  ||| S:17280 E:17284 ||| DT
present  ||| S:17284 E:17292 ||| JJ
invention ||| S:17292 E:17301 ||| NN
,  ||| S:17301 E:17303 ||| ,
the  ||| S:17303 E:17307 ||| DT
humanized  ||| S:17307 E:17317 ||| JJ
monoclonal  ||| S:17317 E:17328 ||| JJ
antibody  ||| S:17328 E:17337 ||| NN
derives  ||| S:17337 E:17345 ||| VBZ
its  ||| S:17345 E:17349 ||| PRP$
constant  ||| S:17349 E:17358 ||| JJ
regions  ||| S:17358 E:17366 ||| NNS
from  ||| S:17366 E:17371 ||| IN
IgG1-kappa  ||| S:17371 E:17382 ||| NNP
and  ||| S:17382 E:17386 ||| CC
its  ||| S:17386 E:17390 ||| PRP$
variable  ||| S:17390 E:17399 ||| JJ
regions  ||| S:17399 E:17407 ||| NNS
from  ||| S:17407 E:17412 ||| IN
all  ||| S:17412 E:17416 ||| DT
or  ||| S:17416 E:17419 ||| CC
part  ||| S:17419 E:17424 ||| NN
of  ||| S:17424 E:17427 ||| IN
the  ||| S:17427 E:17431 ||| DT
sequences  ||| S:17431 E:17441 ||| NN
as  ||| S:17441 E:17444 ||| IN
set  ||| S:17444 E:17448 ||| VBN
forth  ||| S:17448 E:17454 ||| RB
in  ||| S:17454 E:17457 ||| IN
FIGS.  ||| S:17457 E:17463 ||| CD
3  ||| S:17463 E:17465 ||| CD
and  ||| S:17465 E:17469 ||| CC
6 ||| S:17469 E:17470 ||| CD
.  ||| S:17470 E:17472 ||| .
In  ||| S:17472 E:17475 ||| IN
further  ||| S:17475 E:17483 ||| JJ
embodiments ||| S:17483 E:17494 ||| NN
,  ||| S:17494 E:17496 ||| ,
the  ||| S:17496 E:17500 ||| DT
invention  ||| S:17500 E:17510 ||| NN
also  ||| S:17510 E:17515 ||| RB
relates  ||| S:17515 E:17523 ||| VBZ
to  ||| S:17523 E:17526 ||| TO
the  ||| S:17526 E:17530 ||| DT
expression  ||| S:17530 E:17541 ||| NN
vectors  ||| S:17541 E:17549 ||| NNS
which  ||| S:17549 E:17555 ||| WDT
code  ||| S:17555 E:17560 ||| NN
for  ||| S:17560 E:17564 ||| IN
these  ||| S:17564 E:17570 ||| DT
monoclonal  ||| S:17570 E:17581 ||| JJ
humanized  ||| S:17581 E:17591 ||| JJ
antibodies ||| S:17591 E:17601 ||| NNS
,  ||| S:17601 E:17603 ||| ,
and  ||| S:17603 E:17607 ||| CC
to  ||| S:17607 E:17610 ||| TO
host  ||| S:17610 E:17615 ||| VB
cells  ||| S:17615 E:17621 ||| NNS
which  ||| S:17621 E:17627 ||| WDT
have  ||| S:17627 E:17632 ||| VBP
been  ||| S:17632 E:17637 ||| VBN
transformed  ||| S:17637 E:17649 ||| VBN
with  ||| S:17649 E:17654 ||| IN
such  ||| S:17654 E:17659 ||| JJ
expression  ||| S:17659 E:17670 ||| NN
vectors ||| S:17670 E:17677 ||| NN
.  ||| S:17677 E:17681 ||| .
Finally ||| S:17681 E:17688 ||| RB
,  ||| S:17688 E:17690 ||| ,
the  ||| S:17690 E:17694 ||| DT
invention  ||| S:17694 E:17704 ||| NN
comprises  ||| S:17704 E:17714 ||| VBZ
the  ||| S:17714 E:17718 ||| DT
pharmaceutical  ||| S:17718 E:17733 ||| JJ
compositions  ||| S:17733 E:17746 ||| NNS
and  ||| S:17746 E:17750 ||| CC
the  ||| S:17750 E:17754 ||| DT
methods  ||| S:17754 E:17762 ||| NNS
of  ||| S:17762 E:17765 ||| IN
use  ||| S:17765 E:17769 ||| NN
of  ||| S:17769 E:17772 ||| IN
these  ||| S:17772 E:17778 ||| DT
humanized  ||| S:17778 E:17788 ||| JJ
monoclonal  ||| S:17788 E:17799 ||| JJ
antibodies  ||| S:17799 E:17810 ||| NNS
to  ||| S:17810 E:17813 ||| TO
treat  ||| S:17813 E:17819 ||| VB
or  ||| S:17819 E:17822 ||| CC
prevent  ||| S:17822 E:17830 ||| VB
Shiga  ||| S:17830 E:17836 ||| JJ
toxin-producing  ||| S:17836 E:17852 ||| JJ
bacterial  ||| S:17852 E:17862 ||| JJ
infections ||| S:17862 E:17872 ||| NNS
.  ||| S:17872 E:17874 ||| .
As  ||| S:17874 E:17877 ||| IN
a  ||| S:17877 E:17879 ||| DT
pharmaceutical ||| S:17879 E:17893 ||| JJ
,  ||| S:17893 E:17895 ||| ,
this  ||| S:17895 E:17900 ||| DT
invention  ||| S:17900 E:17910 ||| NN
includes  ||| S:17910 E:17919 ||| VBZ
but  ||| S:17919 E:17923 ||| CC
is  ||| S:17923 E:17926 ||| VBZ
not  ||| S:17926 E:17930 ||| RB
limited  ||| S:17930 E:17938 ||| VBN
to  ||| S:17938 E:17941 ||| TO
diluents  ||| S:17941 E:17950 ||| VB
and  ||| S:17950 E:17954 ||| CC
carriers  ||| S:17954 E:17963 ||| NNS
known  ||| S:17963 E:17969 ||| VBN
in  ||| S:17969 E:17972 ||| IN
the  ||| S:17972 E:17976 ||| DT
art ||| S:17976 E:17979 ||| NN
,  ||| S:17979 E:17981 ||| ,
such  ||| S:17981 E:17986 ||| JJ
as  ||| S:17986 E:17989 ||| IN
saline  ||| S:17989 E:17996 ||| NN
and  ||| S:17996 E:18000 ||| CC
sucrose  ||| S:18000 E:18008 ||| JJ
solutions  ||| S:18008 E:18018 ||| NNS
appropriate  ||| S:18018 E:18030 ||| JJ
for  ||| S:18030 E:18034 ||| IN
application  ||| S:18034 E:18046 ||| NN
to  ||| S:18046 E:18049 ||| TO
patients ||| S:18049 E:18057 ||| NNS
.  ||| S:18057 E:18059 ||| .
As  ||| S:18059 E:18062 ||| RB
used  ||| S:18062 E:18067 ||| VBN
herein ||| S:18067 E:18073 ||| NN
,  ||| S:18073 E:18075 ||| ,
& ||| S:18075 E:18076 ||| CC
# ||| S:18076 E:18077 ||| #
x201c ||| S:18077 E:18082 ||| CD
; ||| S:18082 E:18083 ||| :
patients ||| S:18083 E:18091 ||| NNS
& ||| S:18091 E:18092 ||| CC
# ||| S:18092 E:18093 ||| #
x201d ||| S:18093 E:18098 ||| CD
;  ||| S:18098 E:18100 ||| :
refers  ||| S:18100 E:18107 ||| VBZ
to  ||| S:18107 E:18110 ||| TO
any  ||| S:18110 E:18114 ||| DT
susceptible  ||| S:18114 E:18126 ||| JJ
mammal ||| S:18126 E:18132 ||| NN
,  ||| S:18132 E:18134 ||| ,
such  ||| S:18134 E:18139 ||| JJ
as  ||| S:18139 E:18142 ||| IN
dogs ||| S:18142 E:18146 ||| NNS
,  ||| S:18146 E:18148 ||| ,
horses ||| S:18148 E:18154 ||| NNS
,  ||| S:18154 E:18156 ||| ,
mice ||| S:18156 E:18160 ||| NNS
,  ||| S:18160 E:18162 ||| ,
etc. ||| S:18162 E:18166 ||| FW
,  ||| S:18166 E:18168 ||| ,
but  ||| S:18168 E:18172 ||| CC
is  ||| S:18172 E:18175 ||| VBZ
particularly  ||| S:18175 E:18188 ||| RB
preferred  ||| S:18188 E:18198 ||| VBN
to  ||| S:18198 E:18201 ||| TO
mean  ||| S:18201 E:18206 ||| VB
humans ||| S:18206 E:18212 ||| NNS
.  ||| S:18212 E:18216 ||| .
The  ||| S:18216 E:18220 ||| DT
invention  ||| S:18220 E:18230 ||| NN
further  ||| S:18230 E:18238 ||| RB
involves  ||| S:18238 E:18247 ||| VBZ
the  ||| S:18247 E:18251 ||| DT
administration  ||| S:18251 E:18266 ||| NN
of  ||| S:18266 E:18269 ||| IN
a  ||| S:18269 E:18271 ||| DT
therapeutically  ||| S:18271 E:18287 ||| JJ
effective  ||| S:18287 E:18297 ||| JJ
amount ||| S:18297 E:18303 ||| NN
,  ||| S:18303 E:18305 ||| ,
as  ||| S:18305 E:18308 ||| RB
well  ||| S:18308 E:18313 ||| RB
as  ||| S:18313 E:18316 ||| IN
a  ||| S:18316 E:18318 ||| DT
prophylatically  ||| S:18318 E:18334 ||| JJ
effective  ||| S:18334 E:18344 ||| JJ
amount ||| S:18344 E:18350 ||| NN
,  ||| S:18350 E:18352 ||| ,
of  ||| S:18352 E:18355 ||| IN
the  ||| S:18355 E:18359 ||| DT
humanized  ||| S:18359 E:18369 ||| JJ
monoclonal  ||| S:18369 E:18380 ||| JJ
antibody  ||| S:18380 E:18389 ||| NN
of  ||| S:18389 E:18392 ||| IN
the  ||| S:18392 E:18396 ||| DT
invention ||| S:18396 E:18405 ||| NN
.  ||| S:18405 E:18407 ||| .
As  ||| S:18407 E:18410 ||| IN
those  ||| S:18410 E:18416 ||| DT
in  ||| S:18416 E:18419 ||| IN
the  ||| S:18419 E:18423 ||| DT
art  ||| S:18423 E:18427 ||| NN
would  ||| S:18427 E:18433 ||| MD
recognize ||| S:18433 E:18442 ||| VB
,  ||| S:18442 E:18444 ||| ,
a  ||| S:18444 E:18446 ||| DT
therapeutically  ||| S:18446 E:18462 ||| JJ
effective  ||| S:18462 E:18472 ||| JJ
amount  ||| S:18472 E:18479 ||| NN
is  ||| S:18479 E:18482 ||| VBZ
a  ||| S:18482 E:18484 ||| DT
dose  ||| S:18484 E:18489 ||| NN
that  ||| S:18489 E:18494 ||| IN
ameliorates  ||| S:18494 E:18506 ||| JJ
edema ||| S:18506 E:18511 ||| NN
,  ||| S:18511 E:18513 ||| ,
thrombocytopenia ||| S:18513 E:18529 ||| NN
,  ||| S:18529 E:18531 ||| ,
and  ||| S:18531 E:18535 ||| CC
uremia  ||| S:18535 E:18542 ||| VB
associated  ||| S:18542 E:18553 ||| VBN
with  ||| S:18553 E:18558 ||| IN
EHEC-mediated  ||| S:18558 E:18572 ||| NNP
HUS ||| S:18572 E:18575 ||| NNP
.  ||| S:18575 E:18577 ||| .
Similarly ||| S:18577 E:18586 ||| RB
,  ||| S:18586 E:18588 ||| ,
a  ||| S:18588 E:18590 ||| DT
prophylactically  ||| S:18590 E:18607 ||| JJ
effective  ||| S:18607 E:18617 ||| JJ
amount  ||| S:18617 E:18624 ||| NN
is  ||| S:18624 E:18627 ||| VBZ
a  ||| S:18627 E:18629 ||| DT
dose  ||| S:18629 E:18634 ||| NN
that  ||| S:18634 E:18639 ||| WDT
prevents  ||| S:18639 E:18648 ||| VBZ
exposed  ||| S:18648 E:18656 ||| VBN
individuals  ||| S:18656 E:18668 ||| NNS
from  ||| S:18668 E:18673 ||| IN
developing  ||| S:18673 E:18684 ||| VBG
these  ||| S:18684 E:18690 ||| DT
symptoms ||| S:18690 E:18698 ||| NNS
.  ||| S:18698 E:18702 ||| .
The  ||| S:18702 E:18706 ||| DT
following  ||| S:18706 E:18716 ||| JJ
examples  ||| S:18716 E:18725 ||| NNS
illustrate  ||| S:18725 E:18736 ||| VBP
specific  ||| S:18736 E:18745 ||| JJ
embodiments  ||| S:18745 E:18757 ||| NN
of  ||| S:18757 E:18760 ||| IN
the  ||| S:18760 E:18764 ||| DT
invention ||| S:18764 E:18773 ||| NN
.  ||| S:18773 E:18777 ||| .
Humanization  ||| S:18777 E:18790 ||| NNP
of  ||| S:18790 E:18793 ||| IN
the  ||| S:18793 E:18797 ||| DT
Anti-Stx  ||| S:18797 E:18806 ||| JJ
I  ||| S:18806 E:18808 ||| PRP
Antibody  ||| S:18808 E:18817 ||| FW
13C4  ||| S:18817 E:18824 ||| FW
The  ||| S:18824 E:18828 ||| DT
following  ||| S:18828 E:18838 ||| JJ
examples  ||| S:18838 E:18847 ||| NNS
1-3  ||| S:18847 E:18851 ||| VBP
relate  ||| S:18851 E:18858 ||| VBN
to  ||| S:18858 E:18861 ||| TO
anti-StxI  ||| S:18861 E:18871 ||| JJ
antibody  ||| S:18871 E:18880 ||| NN
13C4  ||| S:18880 E:18885 ||| NN
and  ||| S:18885 E:18889 ||| CC
its  ||| S:18889 E:18893 ||| PRP$
humanized  ||| S:18893 E:18903 ||| JJ
counterpart  ||| S:18903 E:18915 ||| NN
H13C4 ||| S:18915 E:18920 ||| NN
.  ||| S:18920 E:18923 ||| .
The  ||| S:18978 E:18982 ||| DT
hybridoma  ||| S:18982 E:18992 ||| JJ
cell  ||| S:18992 E:18997 ||| NN
producing  ||| S:18997 E:19007 ||| VBG
the  ||| S:19007 E:19011 ||| DT
& ||| S:19011 E:19012 ||| CC
# ||| S:19012 E:19013 ||| #
x201c ||| S:19013 E:19018 ||| CD
; ||| S:19018 E:19019 ||| :
13C4 ||| S:19019 E:19023 ||| CD
& ||| S:19023 E:19024 ||| CC
# ||| S:19024 E:19025 ||| #
x201d ||| S:19025 E:19030 ||| CD
;  ||| S:19030 E:19032 ||| :
antibody  ||| S:19032 E:19041 ||| NN
( ||| S:19041 E:19042 ||| -LRB-
Anti-Stx  ||| S:19042 E:19051 ||| NNP
1 ||| S:19051 E:19052 ||| CD
)  ||| S:19052 E:19054 ||| -RRB-
was  ||| S:19054 E:19058 ||| VBD
deposited  ||| S:19058 E:19068 ||| VBN
on  ||| S:19068 E:19071 ||| IN
Dec.  ||| S:19071 E:19076 ||| NNP
2 ||| S:19076 E:19077 ||| CD
,  ||| S:19077 E:19079 ||| ,
1987 ||| S:19079 E:19083 ||| CD
,  ||| S:19083 E:19085 ||| ,
at  ||| S:19085 E:19088 ||| IN
the  ||| S:19088 E:19092 ||| DT
American  ||| S:19092 E:19101 ||| NNP
Type  ||| S:19101 E:19106 ||| NNP
Culture  ||| S:19106 E:19114 ||| NNP
Collection ||| S:19114 E:19124 ||| NNP
,  ||| S:19124 E:19126 ||| ,
10801  ||| S:19126 E:19132 ||| CD
University  ||| S:19132 E:19143 ||| NNP
Boulevard ||| S:19143 E:19152 ||| NNP
,  ||| S:19152 E:19154 ||| ,
Manassas ||| S:19154 E:19162 ||| NNP
,  ||| S:19162 E:19164 ||| ,
Va. ||| S:19164 E:19167 ||| NNP
,  ||| S:19167 E:19169 ||| ,
20110-2209 ||| S:19169 E:19179 ||| NNP
,  ||| S:19179 E:19181 ||| ,
under  ||| S:19181 E:19187 ||| IN
Accession  ||| S:19187 E:19197 ||| NNP
No ||| S:19197 E:19199 ||| NNP
.  ||| S:19199 E:19201 ||| .
CRL  ||| S:19201 E:19205 ||| NNP
1794 ||| S:19205 E:19209 ||| CD
,  ||| S:19209 E:19211 ||| ,
and  ||| S:19211 E:19215 ||| CC
can  ||| S:19215 E:19219 ||| MD
be  ||| S:19219 E:19222 ||| VB
obtained  ||| S:19222 E:19231 ||| VBN
from  ||| S:19231 E:19236 ||| IN
the  ||| S:19236 E:19240 ||| DT
ATCC ||| S:19240 E:19244 ||| NNP
,  ||| S:19244 E:19246 ||| ,
or ||| S:19246 E:19248 ||| CC
,  ||| S:19248 E:19250 ||| ,
as  ||| S:19250 E:19253 ||| RB
here ||| S:19253 E:19257 ||| RB
,  ||| S:19257 E:19259 ||| ,
from  ||| S:19259 E:19264 ||| IN
Dr.  ||| S:19264 E:19268 ||| NNP
Alison  ||| S:19268 E:19275 ||| NNP
O ||| S:19275 E:19276 ||| NNP
' ||| S:19276 E:19277 ||| POS
Brien  ||| S:19277 E:19283 ||| NNP
( ||| S:19283 E:19284 ||| -LRB-
for  ||| S:19284 E:19288 ||| IN
details  ||| S:19288 E:19296 ||| NNS
of  ||| S:19296 E:19299 ||| IN
hybridoma  ||| S:19299 E:19309 ||| JJ
preparation ||| S:19309 E:19320 ||| NN
,  ||| S:19320 E:19322 ||| ,
see  ||| S:19322 E:19326 ||| VB
Strockbine ||| S:19326 E:19336 ||| NNP
,  ||| S:19336 E:19338 ||| ,
N.  ||| S:19338 E:19341 ||| NNP
A.  ||| S:19341 E:19344 ||| NNP
et  ||| S:19344 E:19347 ||| NNP
al. ||| S:19347 E:19350 ||| NNP
,  ||| S:19350 E:19352 ||| ,
Infection  ||| S:19352 E:19362 ||| NNP
and  ||| S:19362 E:19366 ||| CC
Immunity ||| S:19366 E:19374 ||| NNP
,  ||| S:19374 E:19376 ||| ,
50 ||| S:19376 E:19378 ||| CD
: ||| S:19378 E:19379 ||| :
695-700  ||| S:19379 E:19387 ||| CD
( ||| S:19387 E:19388 ||| -LRB-
1985 ||| S:19388 E:19392 ||| CD
) ||| S:19392 E:19393 ||| -RRB-
) ||| S:19393 E:19394 ||| -RRB-
.  ||| S:19394 E:19396 ||| .
A  ||| S:19396 E:19398 ||| DT
vial  ||| S:19398 E:19403 ||| NN
of  ||| S:19403 E:19406 ||| IN
cells  ||| S:19406 E:19412 ||| NNS
was  ||| S:19412 E:19416 ||| VBD
thawed  ||| S:19416 E:19423 ||| JJ
and  ||| S:19423 E:19427 ||| CC
resuspended  ||| S:19427 E:19439 ||| NN
in  ||| S:19439 E:19442 ||| IN
IMDM  ||| S:19442 E:19447 ||| NNP
( ||| S:19447 E:19448 ||| -LRB-
Mediatech ||| S:19448 E:19457 ||| NNP
)  ||| S:19457 E:19459 ||| -RRB-
complete  ||| S:19459 E:19468 ||| JJ
media  ||| S:19468 E:19474 ||| NNS
supplemented  ||| S:19474 E:19487 ||| VBN
with  ||| S:19487 E:19492 ||| IN
10 ||| S:19492 E:19494 ||| CD
%  ||| S:19494 E:19496 ||| NN
FBS  ||| S:19496 E:19500 ||| NNP
( ||| S:19500 E:19501 ||| -LRB-
Irvine ||| S:19501 E:19507 ||| NNP
) ||| S:19507 E:19508 ||| -RRB-
.  ||| S:19508 E:19512 ||| .
Total  ||| S:19512 E:19518 ||| JJ
RNA  ||| S:19518 E:19522 ||| NNP
was  ||| S:19522 E:19526 ||| VBD
isolated  ||| S:19526 E:19535 ||| VBN
from  ||| S:19535 E:19540 ||| IN
1 ||| S:19540 E:19541 ||| CD
& ||| S:19541 E:19542 ||| CC
# ||| S:19542 E:19543 ||| #
xd7 ||| S:19543 E:19546 ||| CD
; ||| S:19546 E:19547 ||| :
107  ||| S:19547 E:19551 ||| CD
& ||| S:19551 E:19552 ||| CC
# ||| S:19552 E:19553 ||| #
x201c ||| S:19553 E:19558 ||| CD
; ||| S:19558 E:19559 ||| :
13C4 ||| S:19559 E:19563 ||| CD
& ||| S:19563 E:19564 ||| CC
# ||| S:19564 E:19565 ||| #
x201d ||| S:19565 E:19570 ||| CD
;  ||| S:19570 E:19572 ||| :
cells  ||| S:19572 E:19578 ||| NNS
using  ||| S:19578 E:19584 ||| VBG
the  ||| S:19584 E:19588 ||| DT
Midi  ||| S:19588 E:19593 ||| NNP
RNA  ||| S:19593 E:19597 ||| NNP
Isolation  ||| S:19597 E:19607 ||| NNP
kit  ||| S:19607 E:19611 ||| NN
( ||| S:19611 E:19612 ||| -LRB-
Qiagen ||| S:19612 E:19618 ||| NNP
)  ||| S:19618 E:19620 ||| -RRB-
following  ||| S:19620 E:19630 ||| VBG
the  ||| S:19630 E:19634 ||| DT
manufacturer ||| S:19634 E:19646 ||| NN
's  ||| S:19646 E:19649 ||| POS
procedure ||| S:19649 E:19658 ||| NN
.  ||| S:19658 E:19660 ||| .
The  ||| S:19660 E:19664 ||| DT
RNA  ||| S:19664 E:19668 ||| NNP
was  ||| S:19668 E:19672 ||| VBD
dissolved  ||| S:19672 E:19682 ||| VBN
in  ||| S:19682 E:19685 ||| IN
10  ||| S:19685 E:19688 ||| CD
mM  ||| S:19688 E:19691 ||| JJ
Tris ||| S:19691 E:19695 ||| NNP
,  ||| S:19695 E:19697 ||| ,
0.1  ||| S:19697 E:19701 ||| CD
mM  ||| S:19701 E:19704 ||| JJ
EDTA  ||| S:19704 E:19709 ||| NNP
( ||| S:19709 E:19710 ||| -LRB-
pH  ||| S:19710 E:19713 ||| NNP
8.4 ||| S:19713 E:19716 ||| CD
)  ||| S:19716 E:19718 ||| -RRB-
containing  ||| S:19718 E:19729 ||| VBG
0.03  ||| S:19729 E:19734 ||| CD
U ||| S:19734 E:19735 ||| NNP
/ ||| S:19735 E:19736 ||| NNP
& ||| S:19736 E:19737 ||| CC
# ||| S:19737 E:19738 ||| #
x3bc ||| S:19738 E:19742 ||| CD
; ||| S:19742 E:19743 ||| :
g  ||| S:19743 E:19745 ||| JJ
Prime  ||| S:19745 E:19751 ||| NNP
RNase  ||| S:19751 E:19757 ||| NNP
Inhibitor  ||| S:19757 E:19767 ||| NNP
( ||| S:19767 E:19768 ||| -LRB-
5 ||| S:19768 E:19769 ||| CD
& ||| S:19769 E:19770 ||| CC
# ||| S:19770 E:19771 ||| #
x2032 ||| S:19771 E:19776 ||| CD
; ||| S:19776 E:19777 ||| :
-3 ||| S:19777 E:19779 ||| CD
& ||| S:19779 E:19780 ||| CC
# ||| S:19780 E:19781 ||| #
x2032 ||| S:19781 E:19786 ||| CD
; ||| S:19786 E:19787 ||| CD
)  ||| S:19787 E:19789 ||| -RRB-
to  ||| S:19789 E:19792 ||| TO
a  ||| S:19792 E:19794 ||| DT
final  ||| S:19794 E:19800 ||| JJ
concentration  ||| S:19800 E:19814 ||| NN
of  ||| S:19814 E:19817 ||| IN
0.25  ||| S:19817 E:19822 ||| CD
& ||| S:19822 E:19823 ||| CC
# ||| S:19823 E:19824 ||| #
x3bc ||| S:19824 E:19828 ||| CD
; ||| S:19828 E:19829 ||| :
g ||| S:19829 E:19830 ||| CD
/ ||| S:19830 E:19831 ||| CD
& ||| S:19831 E:19832 ||| CC
# ||| S:19832 E:19833 ||| #
x3bc ||| S:19833 E:19837 ||| CD
; ||| S:19837 E:19838 ||| :
l ||| S:19838 E:19839 ||| CD
.  ||| S:19839 E:19843 ||| .
FIG.  ||| S:19843 E:19848 ||| CD
1  ||| S:19848 E:19850 ||| CD
shows  ||| S:19850 E:19856 ||| NNS
the  ||| S:19856 E:19860 ||| DT
strategy  ||| S:19860 E:19869 ||| NN
for  ||| S:19869 E:19873 ||| IN
cloning  ||| S:19873 E:19881 ||| VBG
the  ||| S:19881 E:19885 ||| DT
variable  ||| S:19885 E:19894 ||| JJ
region  ||| S:19894 E:19901 ||| NN
gene  ||| S:19901 E:19906 ||| NN
fragments  ||| S:19906 E:19916 ||| NNS
and  ||| S:19916 E:19920 ||| CC
FIG.  ||| S:19920 E:19925 ||| CD
2  ||| S:19925 E:19927 ||| CD
lists  ||| S:19927 E:19933 ||| NNS
the  ||| S:19933 E:19937 ||| DT
oligonucleotide  ||| S:19937 E:19953 ||| JJ
primers  ||| S:19953 E:19961 ||| NNS
used ||| S:19961 E:19965 ||| VBN
.  ||| S:19965 E:19967 ||| .
The  ||| S:19967 E:19971 ||| DT
& ||| S:19971 E:19972 ||| CC
# ||| S:19972 E:19973 ||| #
x201c ||| S:19973 E:19978 ||| CD
; ||| S:19978 E:19979 ||| :
13C4 ||| S:19979 E:19983 ||| CD
& ||| S:19983 E:19984 ||| CC
# ||| S:19984 E:19985 ||| #
x201d ||| S:19985 E:19990 ||| CD
;  ||| S:19990 E:19992 ||| :
total  ||| S:19992 E:19998 ||| JJ
RNA  ||| S:19998 E:20002 ||| NNP
( ||| S:20002 E:20003 ||| -LRB-
2  ||| S:20003 E:20005 ||| CD
& ||| S:20005 E:20006 ||| CC
# ||| S:20006 E:20007 ||| #
x3bc ||| S:20007 E:20011 ||| CD
; ||| S:20011 E:20012 ||| :
g ||| S:20012 E:20013 ||| LS
)  ||| S:20013 E:20015 ||| -RRB-
was  ||| S:20015 E:20019 ||| VBD
converted  ||| S:20019 E:20029 ||| VBN
to  ||| S:20029 E:20032 ||| TO
cDNA  ||| S:20032 E:20037 ||| JJ
by  ||| S:20037 E:20040 ||| IN
using  ||| S:20040 E:20046 ||| VBG
Superscript  ||| S:20046 E:20058 ||| NNP
1l-MMLV  ||| S:20058 E:20066 ||| NNP
Reverse  ||| S:20066 E:20074 ||| NNP
Transcriptase  ||| S:20074 E:20088 ||| NNP
( ||| S:20088 E:20089 ||| -LRB-
Life  ||| S:20089 E:20094 ||| NNP
Technologies ||| S:20094 E:20106 ||| NNPS
)  ||| S:20106 E:20108 ||| -RRB-
and  ||| S:20108 E:20112 ||| CC
mouse  ||| S:20112 E:20118 ||| NN
kappa  ||| S:20118 E:20124 ||| NNS
( ||| S:20124 E:20125 ||| -LRB-
oKA57 ||| S:20125 E:20130 ||| NNP
,  ||| S:20130 E:20132 ||| ,
SEQ  ||| S:20132 E:20136 ||| UH
ID  ||| S:20136 E:20139 ||| UH
NO ||| S:20139 E:20141 ||| UH
: ||| S:20141 E:20142 ||| :
57 ||| S:20142 E:20144 ||| CD
)  ||| S:20144 E:20146 ||| -RRB-
and  ||| S:20146 E:20150 ||| CC
mouse  ||| S:20150 E:20156 ||| CD
CH1  ||| S:20156 E:20160 ||| CD
( ||| S:20160 E:20161 ||| -LRB-
JS300 ||| S:20161 E:20166 ||| NNP
,  ||| S:20166 E:20168 ||| ,
SEQ  ||| S:20168 E:20172 ||| UH
ID  ||| S:20172 E:20175 ||| UH
NO ||| S:20175 E:20177 ||| UH
:  ||| S:20177 E:20179 ||| :
6 ||| S:20179 E:20180 ||| CD
)  ||| S:20180 E:20182 ||| -RRB-
specific  ||| S:20182 E:20191 ||| JJ
priming ||| S:20191 E:20198 ||| NN
,  ||| S:20198 E:20200 ||| ,
according  ||| S:20200 E:20210 ||| VBG
to  ||| S:20210 E:20213 ||| TO
the  ||| S:20213 E:20217 ||| DT
manufacturer ||| S:20217 E:20229 ||| NN
's  ||| S:20229 E:20232 ||| POS
procedures ||| S:20232 E:20242 ||| NNS
.  ||| S:20242 E:20244 ||| .
The  ||| S:20244 E:20248 ||| DT
first  ||| S:20248 E:20254 ||| JJ
strand  ||| S:20254 E:20261 ||| JJ
cDNA  ||| S:20261 E:20266 ||| JJ
synthesis  ||| S:20266 E:20276 ||| NN
products  ||| S:20276 E:20285 ||| NNS
were  ||| S:20285 E:20290 ||| VBD
then  ||| S:20290 E:20295 ||| RB
purified  ||| S:20295 E:20304 ||| VBP
using  ||| S:20304 E:20310 ||| VBG
a  ||| S:20310 E:20312 ||| DT
membrane  ||| S:20312 E:20321 ||| JJ
concentrator  ||| S:20321 E:20334 ||| JJ
device  ||| S:20334 E:20341 ||| NN
( ||| S:20341 E:20342 ||| -LRB-
Amicon  ||| S:20342 E:20349 ||| NNP
Centricon  ||| S:20349 E:20359 ||| NNP
30  ||| S:20359 E:20362 ||| CD
or  ||| S:20362 E:20365 ||| CC
Millipore  ||| S:20365 E:20375 ||| NNP
UltraFree  ||| S:20375 E:20385 ||| NNP
15 ||| S:20385 E:20387 ||| CD
) ||| S:20387 E:20388 ||| -RRB-
.  ||| S:20388 E:20390 ||| .
Of  ||| S:20390 E:20393 ||| IN
the  ||| S:20393 E:20397 ||| DT
cDNA  ||| S:20397 E:20402 ||| JJ
recovered ||| S:20402 E:20411 ||| NN
,  ||| S:20411 E:20413 ||| ,
3  ||| S:20413 E:20415 ||| CD
& ||| S:20415 E:20416 ||| CC
# ||| S:20416 E:20417 ||| #
x3bc ||| S:20417 E:20421 ||| CD
; ||| S:20421 E:20422 ||| :
l  ||| S:20422 E:20424 ||| NNS
was  ||| S:20424 E:20428 ||| VBD
used  ||| S:20428 E:20433 ||| VBN
as  ||| S:20433 E:20436 ||| IN
template  ||| S:20436 E:20445 ||| JJ
DNA  ||| S:20445 E:20449 ||| NN
for  ||| S:20449 E:20453 ||| IN
PCR ||| S:20453 E:20456 ||| NNP
.  ||| S:20456 E:20458 ||| .
Typical  ||| S:20458 E:20466 ||| JJ
PCR  ||| S:20466 E:20470 ||| NNP
amplification  ||| S:20470 E:20484 ||| NN
reactions  ||| S:20484 E:20494 ||| NNS
( ||| S:20494 E:20495 ||| -LRB-
100  ||| S:20495 E:20499 ||| CD
& ||| S:20499 E:20500 ||| CC
# ||| S:20500 E:20501 ||| #
x3bc ||| S:20501 E:20505 ||| CD
; ||| S:20505 E:20506 ||| :
l  ||| S:20506 E:20508 ||| LS
)  ||| S:20508 E:20510 ||| -RRB-
contained  ||| S:20510 E:20520 ||| VBD
template  ||| S:20520 E:20529 ||| JJ
DNA ||| S:20529 E:20532 ||| NN
,  ||| S:20532 E:20534 ||| ,
50  ||| S:20534 E:20537 ||| CD
pmoles  ||| S:20537 E:20544 ||| NN
of  ||| S:20544 E:20547 ||| IN
the  ||| S:20547 E:20551 ||| DT
appropriate  ||| S:20551 E:20563 ||| JJ
primers  ||| S:20563 E:20571 ||| NNS
( ||| S:20571 E:20572 ||| -LRB-
JSS9 ||| S:20572 E:20576 ||| NNP
,  ||| S:20576 E:20578 ||| ,
JSS10 ||| S:20578 E:20583 ||| NNP
,  ||| S:20583 E:20585 ||| ,
JSS11 ||| S:20585 E:20590 ||| NNP
,  ||| S:20590 E:20592 ||| ,
JSS12 ||| S:20592 E:20597 ||| NNP
,  ||| S:20597 E:20599 ||| ,
JS153  ||| S:20599 E:20605 ||| NNP
& ||| S:20605 E:20606 ||| CC
# ||| S:20606 E:20607 ||| #
x26 ||| S:20607 E:20610 ||| CD
;  ||| S:20610 E:20612 ||| :
JSS154 ||| S:20612 E:20618 ||| CD
& ||| S:20618 E:20619 ||| CC
# ||| S:20619 E:20620 ||| #
x2014 ||| S:20620 E:20625 ||| CD
; ||| S:20625 E:20626 ||| :
SEQ  ||| S:20626 E:20630 ||| UH
ID  ||| S:20630 E:20633 ||| UH
NO ||| S:20633 E:20635 ||| UH
: ||| S:20635 E:20636 ||| :
9-12  ||| S:20636 E:20641 ||| CD
for  ||| S:20641 E:20645 ||| IN
light  ||| S:20645 E:20651 ||| JJ
chains ||| S:20651 E:20657 ||| NNS
;  ||| S:20657 E:20659 ||| :
JSS1 ||| S:20659 E:20663 ||| CD
,  ||| S:20663 E:20665 ||| ,
JSS2 ||| S:20665 E:20669 ||| NNP
,  ||| S:20669 E:20671 ||| ,
JSS3 ||| S:20671 E:20675 ||| NNP
,  ||| S:20675 E:20677 ||| ,
JSS4 ||| S:20677 E:20681 ||| NNP
,  ||| S:20681 E:20683 ||| ,
JSS8  ||| S:20683 E:20688 ||| NNP
and  ||| S:20688 E:20692 ||| CC
oKA-143 ||| S:20692 E:20699 ||| NNP
& ||| S:20699 E:20700 ||| CC
# ||| S:20700 E:20701 ||| #
x2014 ||| S:20701 E:20706 ||| CD
; ||| S:20706 E:20707 ||| :
SEQ  ||| S:20707 E:20711 ||| UH
ID  ||| S:20711 E:20714 ||| UH
NO ||| S:20714 E:20716 ||| UH
: ||| S:20716 E:20717 ||| :
1-5  ||| S:20717 E:20721 ||| CD
and  ||| S:20721 E:20725 ||| CC
SEQ  ||| S:20725 E:20729 ||| UH
ID  ||| S:20729 E:20732 ||| UH
NO ||| S:20732 E:20734 ||| UH
: ||| S:20734 E:20735 ||| :
15  ||| S:20735 E:20738 ||| CD
for  ||| S:20738 E:20742 ||| IN
heavy  ||| S:20742 E:20748 ||| JJ
chains ||| S:20748 E:20754 ||| NNS
) ||| S:20754 E:20755 ||| -RRB-
,  ||| S:20755 E:20757 ||| ,
2.5  ||| S:20757 E:20761 ||| CD
units  ||| S:20761 E:20767 ||| NNS
of  ||| S:20767 E:20770 ||| IN
ExTaq  ||| S:20770 E:20776 ||| JJ
polymerase  ||| S:20776 E:20787 ||| NNS
( ||| S:20787 E:20788 ||| -LRB-
PanVera ||| S:20788 E:20795 ||| NNP
) ||| S:20795 E:20796 ||| -RRB-
,  ||| S:20796 E:20798 ||| ,
1 ||| S:20798 E:20799 ||| CD
& ||| S:20799 E:20800 ||| CC
# ||| S:20800 E:20801 ||| #
xd7 ||| S:20801 E:20804 ||| CD
; ||| S:20804 E:20805 ||| :
ExTaq  ||| S:20805 E:20811 ||| JJ
reaction  ||| S:20811 E:20820 ||| NN
buffer ||| S:20820 E:20826 ||| NN
,  ||| S:20826 E:20828 ||| ,
200  ||| S:20828 E:20832 ||| CD
& ||| S:20832 E:20833 ||| CC
# ||| S:20833 E:20834 ||| #
x3bc ||| S:20834 E:20838 ||| CD
; ||| S:20838 E:20839 ||| :
M  ||| S:20839 E:20841 ||| NNP
dNTP ||| S:20841 E:20845 ||| NNP
,  ||| S:20845 E:20847 ||| ,
and  ||| S:20847 E:20851 ||| CC
2  ||| S:20851 E:20853 ||| CD
mM  ||| S:20853 E:20856 ||| JJ
MgCl2 ||| S:20856 E:20861 ||| NN
.  ||| S:20861 E:20863 ||| .
Each  ||| S:20863 E:20868 ||| DT
of  ||| S:20868 E:20871 ||| IN
the  ||| S:20871 E:20875 ||| DT
templates  ||| S:20875 E:20885 ||| NN
was  ||| S:20885 E:20889 ||| VBD
denatured  ||| S:20889 E:20899 ||| VBN
by  ||| S:20899 E:20902 ||| IN
an  ||| S:20902 E:20905 ||| DT
initial  ||| S:20905 E:20913 ||| JJ
incubation  ||| S:20913 E:20924 ||| NN
at  ||| S:20924 E:20927 ||| IN
96 ||| S:20927 E:20929 ||| CD
& ||| S:20929 E:20930 ||| CC
# ||| S:20930 E:20931 ||| #
xb0 ||| S:20931 E:20934 ||| CD
;  ||| S:20934 E:20936 ||| :
C.  ||| S:20936 E:20939 ||| NNP
for  ||| S:20939 E:20943 ||| IN
1  ||| S:20943 E:20945 ||| CD
min ||| S:20945 E:20948 ||| NNS
.  ||| S:20948 E:20950 ||| .
The  ||| S:20950 E:20954 ||| DT
heavy  ||| S:20954 E:20960 ||| JJ
chain  ||| S:20960 E:20966 ||| NN
products  ||| S:20966 E:20975 ||| NNS
were  ||| S:20975 E:20980 ||| VBD
amplified  ||| S:20980 E:20990 ||| VBN
by  ||| S:20990 E:20993 ||| IN
40  ||| S:20993 E:20996 ||| CD
or  ||| S:20996 E:20999 ||| CC
50  ||| S:20999 E:21002 ||| CD
thermal  ||| S:21002 E:21010 ||| JJ
cycles  ||| S:21010 E:21017 ||| NNS
of  ||| S:21017 E:21020 ||| IN
59  ||| S:21020 E:21023 ||| CD
to  ||| S:21023 E:21026 ||| TO
72 ||| S:21026 E:21028 ||| CD
& ||| S:21028 E:21029 ||| CC
# ||| S:21029 E:21030 ||| #
xb0 ||| S:21030 E:21033 ||| CD
;  ||| S:21033 E:21035 ||| :
C.  ||| S:21035 E:21038 ||| NNP
for  ||| S:21038 E:21042 ||| IN
30  ||| S:21042 E:21045 ||| CD
sec. ||| S:21045 E:21049 ||| CD
,  ||| S:21049 E:21051 ||| ,
72 ||| S:21051 E:21053 ||| CD
& ||| S:21053 E:21054 ||| CC
# ||| S:21054 E:21055 ||| #
xb0 ||| S:21055 E:21058 ||| CD
;  ||| S:21058 E:21060 ||| :
C.  ||| S:21060 E:21063 ||| NNP
for  ||| S:21063 E:21067 ||| IN
30  ||| S:21067 E:21070 ||| CD
sec. ||| S:21070 E:21074 ||| CD
,  ||| S:21074 E:21076 ||| ,
then  ||| S:21076 E:21081 ||| RB
96 ||| S:21081 E:21083 ||| CD
& ||| S:21083 E:21084 ||| CC
# ||| S:21084 E:21085 ||| #
xb0 ||| S:21085 E:21088 ||| CD
;  ||| S:21088 E:21090 ||| :
C.  ||| S:21090 E:21093 ||| NNP
for  ||| S:21093 E:21097 ||| IN
1  ||| S:21097 E:21099 ||| CD
min.  ||| S:21099 E:21104 ||| CD
and  ||| S:21104 E:21108 ||| CC
a  ||| S:21108 E:21110 ||| DT
final  ||| S:21110 E:21116 ||| JJ
extension  ||| S:21116 E:21126 ||| NN
step  ||| S:21126 E:21131 ||| NN
at  ||| S:21131 E:21134 ||| IN
72 ||| S:21134 E:21136 ||| CD
& ||| S:21136 E:21137 ||| CC
# ||| S:21137 E:21138 ||| #
xb0 ||| S:21138 E:21141 ||| CD
;  ||| S:21141 E:21143 ||| :
C.  ||| S:21143 E:21146 ||| NNP
for  ||| S:21146 E:21150 ||| IN
5  ||| S:21150 E:21152 ||| CD
min ||| S:21152 E:21155 ||| NNS
.  ||| S:21155 E:21157 ||| .
The  ||| S:21157 E:21161 ||| DT
light  ||| S:21161 E:21167 ||| JJ
chain  ||| S:21167 E:21173 ||| NN
products  ||| S:21173 E:21182 ||| NNS
were  ||| S:21182 E:21187 ||| VBD
amplified  ||| S:21187 E:21197 ||| VBN
by  ||| S:21197 E:21200 ||| IN
6  ||| S:21200 E:21202 ||| CD
thermal  ||| S:21202 E:21210 ||| JJ
cycles  ||| S:21210 E:21217 ||| NNS
of  ||| S:21217 E:21220 ||| IN
46 ||| S:21220 E:21222 ||| CD
,  ||| S:21222 E:21224 ||| ,
48  ||| S:21224 E:21227 ||| CD
or  ||| S:21227 E:21230 ||| CC
54 ||| S:21230 E:21232 ||| CD
& ||| S:21232 E:21233 ||| CC
# ||| S:21233 E:21234 ||| #
xb0 ||| S:21234 E:21237 ||| CD
;  ||| S:21237 E:21239 ||| :
C.  ||| S:21239 E:21242 ||| NNP
for  ||| S:21242 E:21246 ||| IN
30  ||| S:21246 E:21249 ||| CD
sec. ||| S:21249 E:21253 ||| CD
,  ||| S:21253 E:21255 ||| ,
72 ||| S:21255 E:21257 ||| CD
& ||| S:21257 E:21258 ||| CC
# ||| S:21258 E:21259 ||| #
xb0 ||| S:21259 E:21262 ||| CD
;  ||| S:21262 E:21264 ||| :
C.  ||| S:21264 E:21267 ||| NNP
for  ||| S:21267 E:21271 ||| IN
30  ||| S:21271 E:21274 ||| CD
sec. ||| S:21274 E:21278 ||| CD
,  ||| S:21278 E:21280 ||| ,
then  ||| S:21280 E:21285 ||| RB
96 ||| S:21285 E:21287 ||| CD
& ||| S:21287 E:21288 ||| CC
# ||| S:21288 E:21289 ||| #
xb0 ||| S:21289 E:21292 ||| CD
;  ||| S:21292 E:21294 ||| :
C.  ||| S:21294 E:21297 ||| NNP
for  ||| S:21297 E:21301 ||| IN
1  ||| S:21301 E:21303 ||| CD
min  ||| S:21303 E:21307 ||| NNS
followed  ||| S:21307 E:21316 ||| VBN
by  ||| S:21316 E:21319 ||| IN
35  ||| S:21319 E:21322 ||| CD
step  ||| S:21322 E:21327 ||| NN
cycles  ||| S:21327 E:21334 ||| NNS
of  ||| S:21334 E:21337 ||| IN
60 ||| S:21337 E:21339 ||| CD
& ||| S:21339 E:21340 ||| CC
# ||| S:21340 E:21341 ||| #
xb0 ||| S:21341 E:21344 ||| CD
;  ||| S:21344 E:21346 ||| :
C.  ||| S:21346 E:21349 ||| NNP
for  ||| S:21349 E:21353 ||| IN
1  ||| S:21353 E:21355 ||| CD
min ||| S:21355 E:21358 ||| NN
,  ||| S:21358 E:21360 ||| ,
then  ||| S:21360 E:21365 ||| RB
96 ||| S:21365 E:21367 ||| CD
& ||| S:21367 E:21368 ||| CC
# ||| S:21368 E:21369 ||| #
xb0 ||| S:21369 E:21372 ||| CD
;  ||| S:21372 E:21374 ||| :
C.  ||| S:21374 E:21377 ||| NNP
for  ||| S:21377 E:21381 ||| IN
1  ||| S:21381 E:21383 ||| CD
min.  ||| S:21383 E:21388 ||| CD
and  ||| S:21388 E:21392 ||| CC
a  ||| S:21392 E:21394 ||| DT
final  ||| S:21394 E:21400 ||| JJ
extension  ||| S:21400 E:21410 ||| NN
step  ||| S:21410 E:21415 ||| NN
at  ||| S:21415 E:21418 ||| IN
72 ||| S:21418 E:21420 ||| CD
& ||| S:21420 E:21421 ||| CC
# ||| S:21421 E:21422 ||| #
xb0 ||| S:21422 E:21425 ||| CD
;  ||| S:21425 E:21427 ||| :
C.  ||| S:21427 E:21430 ||| NNP
for  ||| S:21430 E:21434 ||| IN
5  ||| S:21434 E:21436 ||| CD
min ||| S:21436 E:21439 ||| NNS
.  ||| S:21439 E:21441 ||| .
The  ||| S:21441 E:21445 ||| DT
PCR  ||| S:21445 E:21449 ||| NNP
products  ||| S:21449 E:21458 ||| NNS
from  ||| S:21458 E:21463 ||| IN
the  ||| S:21463 E:21467 ||| DT
successful  ||| S:21467 E:21478 ||| JJ
reactions  ||| S:21478 E:21488 ||| NNS
were  ||| S:21488 E:21493 ||| VBD
purified  ||| S:21493 E:21502 ||| VBN
using  ||| S:21502 E:21508 ||| VBG
the  ||| S:21508 E:21512 ||| DT
Wizard  ||| S:21512 E:21519 ||| NNP
PCR  ||| S:21519 E:21523 ||| NNP
Purification  ||| S:21523 E:21536 ||| NNP
system  ||| S:21536 E:21543 ||| NN
( ||| S:21543 E:21544 ||| -LRB-
Promega ||| S:21544 E:21551 ||| NNP
)  ||| S:21551 E:21553 ||| -RRB-
as  ||| S:21553 E:21556 ||| IN
per  ||| S:21556 E:21560 ||| IN
the  ||| S:21560 E:21564 ||| DT
manufacturer ||| S:21564 E:21576 ||| NN
's  ||| S:21576 E:21579 ||| POS
procedure ||| S:21579 E:21588 ||| NN
.  ||| S:21588 E:21592 ||| .
The  ||| S:21592 E:21596 ||| DT
heavy  ||| S:21596 E:21602 ||| JJ
chain  ||| S:21602 E:21608 ||| NN
and  ||| S:21608 E:21612 ||| CC
light  ||| S:21612 E:21618 ||| JJ
chain  ||| S:21618 E:21624 ||| NN
PCR  ||| S:21624 E:21628 ||| NN
products  ||| S:21628 E:21637 ||| NNS
( ||| S:21637 E:21638 ||| -LRB-
approximately  ||| S:21638 E:21652 ||| RB
400  ||| S:21652 E:21656 ||| CD
bp ||| S:21656 E:21658 ||| CD
)  ||| S:21658 E:21660 ||| -RRB-
were  ||| S:21660 E:21665 ||| VBD
then  ||| S:21665 E:21670 ||| RB
cloned  ||| S:21670 E:21677 ||| VBN
into  ||| S:21677 E:21682 ||| IN
a  ||| S:21682 E:21684 ||| DT
bacterial  ||| S:21684 E:21694 ||| JJ
vector  ||| S:21694 E:21701 ||| NN
for  ||| S:21701 E:21705 ||| IN
DNA  ||| S:21705 E:21709 ||| NNP
sequence  ||| S:21709 E:21718 ||| NN
determination ||| S:21718 E:21731 ||| NN
.  ||| S:21731 E:21733 ||| .
Ligations  ||| S:21733 E:21743 ||| NNP
of  ||| S:21743 E:21746 ||| IN
the  ||| S:21746 E:21750 ||| DT
PCR  ||| S:21750 E:21754 ||| NNP
fragments  ||| S:21754 E:21764 ||| NNS
were  ||| S:21764 E:21769 ||| VBD
carried  ||| S:21769 E:21777 ||| VBN
out  ||| S:21777 E:21781 ||| RP
into  ||| S:21781 E:21786 ||| IN
the  ||| S:21786 E:21790 ||| DT
pCR-2.1  ||| S:21790 E:21798 ||| JJ
T ||| S:21798 E:21799 ||| NN
/ ||| S:21799 E:21800 ||| VBZ
A  ||| S:21800 E:21802 ||| DT
style  ||| S:21802 E:21808 ||| NN
cloning  ||| S:21808 E:21816 ||| NN
vector  ||| S:21816 E:21823 ||| NN
( ||| S:21823 E:21824 ||| -LRB-
Invitrogen ||| S:21824 E:21834 ||| NNP
)  ||| S:21834 E:21836 ||| -RRB-
following  ||| S:21836 E:21846 ||| VBG
the  ||| S:21846 E:21850 ||| DT
manufacturer ||| S:21850 E:21862 ||| NN
's  ||| S:21862 E:21865 ||| POS
procedures  ||| S:21865 E:21876 ||| NNS
using  ||| S:21876 E:21882 ||| VBG
1 ||| S:21882 E:21883 ||| CD
: ||| S:21883 E:21884 ||| :
1 ||| S:21884 E:21885 ||| CD
,  ||| S:21885 E:21887 ||| ,
3 ||| S:21887 E:21888 ||| LS
: ||| S:21888 E:21889 ||| :
1  ||| S:21889 E:21891 ||| CD
and  ||| S:21891 E:21895 ||| CC
5 ||| S:21895 E:21896 ||| CD
: ||| S:21896 E:21897 ||| :
1  ||| S:21897 E:21899 ||| CD
insert  ||| S:21899 E:21906 ||| NN
to  ||| S:21906 E:21909 ||| TO
vector  ||| S:21909 E:21916 ||| VB
molar  ||| S:21916 E:21922 ||| JJ
ratios ||| S:21922 E:21928 ||| NNS
.  ||| S:21928 E:21930 ||| .
One  ||| S:21930 E:21934 ||| CD
half  ||| S:21934 E:21939 ||| NN
of  ||| S:21939 E:21942 ||| IN
each  ||| S:21942 E:21947 ||| DT
of  ||| S:21947 E:21950 ||| IN
the  ||| S:21950 E:21954 ||| DT
ligation  ||| S:21954 E:21963 ||| JJ
reactions  ||| S:21963 E:21973 ||| NNS
was  ||| S:21973 E:21977 ||| VBD
used  ||| S:21977 E:21982 ||| VBN
to  ||| S:21982 E:21985 ||| TO
transform  ||| S:21985 E:21995 ||| VB
competent  ||| S:21995 E:22005 ||| JJ
XL1  ||| S:22005 E:22009 ||| NNP
Blue  ||| S:22009 E:22014 ||| NNP
cells ||| S:22014 E:22019 ||| NNS
.  ||| S:22019 E:22023 ||| .
Heavy  ||| S:22023 E:22029 ||| JJ
chain  ||| S:22029 E:22035 ||| NN
plasmid  ||| S:22035 E:22043 ||| NNS
clones  ||| S:22043 E:22050 ||| VBP
containing  ||| S:22050 E:22061 ||| VBG
DNA  ||| S:22061 E:22065 ||| NN
inserts  ||| S:22065 E:22073 ||| NNS
were  ||| S:22073 E:22078 ||| VBD
identified  ||| S:22078 E:22089 ||| VBN
using  ||| S:22089 E:22095 ||| VBG
diagnostic  ||| S:22095 E:22106 ||| JJ
restriction  ||| S:22106 E:22118 ||| NN
enzyme  ||| S:22118 E:22125 ||| NN
digests  ||| S:22125 E:22133 ||| NN
with  ||| S:22133 E:22138 ||| IN
EcoRI  ||| S:22138 E:22144 ||| NNP
( ||| S:22144 E:22145 ||| -LRB-
New  ||| S:22145 E:22149 ||| NNP
England  ||| S:22149 E:22157 ||| NNP
Biolabs ||| S:22157 E:22164 ||| NNP
) ||| S:22164 E:22165 ||| -RRB-
.  ||| S:22165 E:22167 ||| .
The  ||| S:22167 E:22171 ||| DT
DNA  ||| S:22171 E:22175 ||| NN
sequence  ||| S:22175 E:22184 ||| NN
of  ||| S:22184 E:22187 ||| IN
plasmids  ||| S:22187 E:22196 ||| NNS
( ||| S:22196 E:22197 ||| -LRB-
tKMC217B ||| S:22197 E:22205 ||| NNP
)  ||| S:22205 E:22207 ||| -RRB-
containing  ||| S:22207 E:22218 ||| VBG
inserts  ||| S:22218 E:22226 ||| NNS
of  ||| S:22226 E:22229 ||| IN
the  ||| S:22229 E:22233 ||| DT
appropriate  ||| S:22233 E:22245 ||| JJ
size  ||| S:22245 E:22250 ||| NN
( ||| S:22250 E:22251 ||| -LRB-
400  ||| S:22251 E:22255 ||| CD
bp ||| S:22255 E:22257 ||| CD
)  ||| S:22257 E:22259 ||| -RRB-
were  ||| S:22259 E:22264 ||| VBD
then  ||| S:22264 E:22269 ||| RB
determined ||| S:22269 E:22279 ||| VBN
.  ||| S:22279 E:22281 ||| .
The  ||| S:22281 E:22285 ||| DT
final  ||| S:22285 E:22291 ||| JJ
consensus  ||| S:22291 E:22301 ||| NN
DNA  ||| S:22301 E:22305 ||| NN
sequence  ||| S:22305 E:22314 ||| NN
of  ||| S:22314 E:22317 ||| IN
the  ||| S:22317 E:22321 ||| DT
heavy  ||| S:22321 E:22327 ||| JJ
chain  ||| S:22327 E:22333 ||| NN
variable  ||| S:22333 E:22342 ||| NN
regions  ||| S:22342 E:22350 ||| NNS
is  ||| S:22350 E:22353 ||| VBZ
shown  ||| S:22353 E:22359 ||| VBN
in  ||| S:22359 E:22362 ||| IN
FIG.  ||| S:22362 E:22367 ||| CD
3 ||| S:22367 E:22368 ||| CD
.  ||| S:22368 E:22372 ||| .
The  ||| S:22372 E:22376 ||| DT
light  ||| S:22376 E:22382 ||| JJ
chain  ||| S:22382 E:22388 ||| NN
PCR  ||| S:22388 E:22392 ||| NN
products  ||| S:22392 E:22401 ||| NNS
were  ||| S:22401 E:22406 ||| VBD
identified  ||| S:22406 E:22417 ||| VBN
differently ||| S:22417 E:22428 ||| RB
.  ||| S:22428 E:22430 ||| .
The  ||| S:22430 E:22434 ||| DT
hybridoma  ||| S:22434 E:22444 ||| JJ
cell  ||| S:22444 E:22449 ||| NN
line  ||| S:22449 E:22454 ||| NN
that  ||| S:22454 E:22459 ||| WDT
expresses  ||| S:22459 E:22469 ||| VBZ
the  ||| S:22469 E:22473 ||| DT
& ||| S:22473 E:22474 ||| CC
# ||| S:22474 E:22475 ||| #
x201c ||| S:22475 E:22480 ||| CD
; ||| S:22480 E:22481 ||| :
13C4 ||| S:22481 E:22485 ||| CD
& ||| S:22485 E:22486 ||| CC
# ||| S:22486 E:22487 ||| #
x201d ||| S:22487 E:22492 ||| CD
;  ||| S:22492 E:22494 ||| :
antibody  ||| S:22494 E:22503 ||| NN
was  ||| S:22503 E:22507 ||| VBD
made  ||| S:22507 E:22512 ||| VBN
by  ||| S:22512 E:22515 ||| IN
fusing  ||| S:22515 E:22522 ||| JJ
mouse  ||| S:22522 E:22528 ||| NN
splenocytes  ||| S:22528 E:22540 ||| NN
with  ||| S:22540 E:22545 ||| IN
the  ||| S:22545 E:22549 ||| DT
SP2 ||| S:22549 E:22552 ||| CD
/ ||| S:22552 E:22553 ||| CD
0  ||| S:22553 E:22555 ||| CD
myeloma  ||| S:22555 E:22563 ||| JJ
cell  ||| S:22563 E:22568 ||| NN
line ||| S:22568 E:22572 ||| NN
.  ||| S:22572 E:22574 ||| .
The  ||| S:22574 E:22578 ||| DT
SP2 ||| S:22578 E:22581 ||| CD
/ ||| S:22581 E:22582 ||| CD
0  ||| S:22582 E:22584 ||| CD
cell  ||| S:22584 E:22589 ||| NN
line  ||| S:22589 E:22594 ||| NN
transcribes  ||| S:22594 E:22606 ||| VBD
a  ||| S:22606 E:22608 ||| DT
pseudogene  ||| S:22608 E:22619 ||| NN
for  ||| S:22619 E:22623 ||| IN
the  ||| S:22623 E:22627 ||| DT
kappa  ||| S:22627 E:22633 ||| JJ
light  ||| S:22633 E:22639 ||| JJ
chain ||| S:22639 E:22644 ||| NN
.  ||| S:22644 E:22646 ||| .
The  ||| S:22646 E:22650 ||| DT
pseudogene  ||| S:22650 E:22661 ||| JJ
transcript ||| S:22661 E:22671 ||| NN
,  ||| S:22671 E:22673 ||| ,
when  ||| S:22673 E:22678 ||| WRB
converted  ||| S:22678 E:22688 ||| VBN
to  ||| S:22688 E:22691 ||| TO
cDNA  ||| S:22691 E:22696 ||| JJ
by  ||| S:22696 E:22699 ||| IN
RT-PCR ||| S:22699 E:22705 ||| NNP
,  ||| S:22705 E:22707 ||| ,
contains  ||| S:22707 E:22716 ||| VBZ
an  ||| S:22716 E:22719 ||| DT
AflIII  ||| S:22719 E:22726 ||| JJ
restriction  ||| S:22726 E:22738 ||| NN
site ||| S:22738 E:22742 ||| NN
.  ||| S:22742 E:22744 ||| .
Light  ||| S:22744 E:22750 ||| JJ
chain  ||| S:22750 E:22756 ||| NN
candidate  ||| S:22756 E:22766 ||| NN
clones  ||| S:22766 E:22773 ||| NNS
( ||| S:22773 E:22774 ||| -LRB-
tKMC226  ||| S:22774 E:22782 ||| NNP
& ||| S:22782 E:22783 ||| CC
# ||| S:22783 E:22784 ||| #
x26 ||| S:22784 E:22787 ||| CD
;  ||| S:22787 E:22789 ||| :
227 ||| S:22789 E:22792 ||| CD
)  ||| S:22792 E:22794 ||| -RRB-
were  ||| S:22794 E:22799 ||| VBD
digested  ||| S:22799 E:22808 ||| VBN
with  ||| S:22808 E:22813 ||| IN
AflIII  ||| S:22813 E:22820 ||| NNP
( ||| S:22820 E:22821 ||| -LRB-
New  ||| S:22821 E:22825 ||| NNP
England  ||| S:22825 E:22833 ||| NNP
Biolabs ||| S:22833 E:22840 ||| NNP
)  ||| S:22840 E:22842 ||| -RRB-
using  ||| S:22842 E:22848 ||| VBG
the  ||| S:22848 E:22852 ||| DT
manufacturer ||| S:22852 E:22864 ||| NN
's  ||| S:22864 E:22867 ||| POS
procedures  ||| S:22867 E:22878 ||| NNS
to  ||| S:22878 E:22881 ||| TO
identify  ||| S:22881 E:22890 ||| VB
clones  ||| S:22890 E:22897 ||| NNS
containing  ||| S:22897 E:22908 ||| VBG
inserts  ||| S:22908 E:22916 ||| NNS
of  ||| S:22916 E:22919 ||| IN
the  ||| S:22919 E:22923 ||| DT
appropriate  ||| S:22923 E:22935 ||| JJ
size  ||| S:22935 E:22940 ||| NN
( ||| S:22940 E:22941 ||| -LRB-
403  ||| S:22941 E:22945 ||| CD
bp ||| S:22945 E:22947 ||| NNS
;  ||| S:22947 E:22949 ||| :
no  ||| S:22949 E:22952 ||| DT
AflIII  ||| S:22952 E:22959 ||| JJ
site  ||| S:22959 E:22964 ||| NN
is  ||| S:22964 E:22967 ||| VBZ
present  ||| S:22967 E:22975 ||| JJ
in  ||| S:22975 E:22978 ||| IN
these  ||| S:22978 E:22984 ||| DT
products ||| S:22984 E:22992 ||| NNS
) ||| S:22992 E:22993 ||| -RRB-
.  ||| S:22993 E:22995 ||| .
The  ||| S:22995 E:22999 ||| DT
final  ||| S:22999 E:23005 ||| JJ
consensus  ||| S:23005 E:23015 ||| NN
DNA  ||| S:23015 E:23019 ||| NN
sequence  ||| S:23019 E:23028 ||| NN
of  ||| S:23028 E:23031 ||| IN
the  ||| S:23031 E:23035 ||| DT
light  ||| S:23035 E:23041 ||| JJ
chain  ||| S:23041 E:23047 ||| NN
variable  ||| S:23047 E:23056 ||| NN
regions  ||| S:23056 E:23064 ||| NNS
is  ||| S:23064 E:23067 ||| VBZ
shown  ||| S:23067 E:23073 ||| VBN
in  ||| S:23073 E:23076 ||| IN
FIG.  ||| S:23076 E:23081 ||| CD
3  ||| S:23081 E:23083 ||| CD
with  ||| S:23083 E:23088 ||| IN
the  ||| S:23088 E:23092 ||| DT
CDRs  ||| S:23092 E:23097 ||| NN
indicated  ||| S:23097 E:23107 ||| VBD
by  ||| S:23107 E:23110 ||| IN
underlining ||| S:23110 E:23121 ||| NN
.  ||| S:23121 E:23124 ||| .
The  ||| S:23184 E:23188 ||| DT
heavy  ||| S:23188 E:23194 ||| JJ
and  ||| S:23194 E:23198 ||| CC
light  ||| S:23198 E:23204 ||| JJ
chain  ||| S:23204 E:23210 ||| NN
variable  ||| S:23210 E:23219 ||| NN
regions  ||| S:23219 E:23227 ||| NNS
were  ||| S:23227 E:23232 ||| VBD
then  ||| S:23232 E:23237 ||| RB
subcloned  ||| S:23237 E:23247 ||| VBN
into  ||| S:23247 E:23252 ||| IN
mammalian  ||| S:23252 E:23262 ||| JJ
expression  ||| S:23262 E:23273 ||| NN
plasmid  ||| S:23273 E:23281 ||| NN
vectors  ||| S:23281 E:23289 ||| NN
for  ||| S:23289 E:23293 ||| IN
the  ||| S:23293 E:23297 ||| DT
production  ||| S:23297 E:23308 ||| NN
of  ||| S:23308 E:23311 ||| IN
recombinant  ||| S:23311 E:23323 ||| FW
chimeric  ||| S:23323 E:23332 ||| FW
mouse ||| S:23332 E:23337 ||| FW
/ ||| S:23337 E:23338 ||| FW
human  ||| S:23338 E:23344 ||| FW
antibody  ||| S:23344 E:23353 ||| FW
molecules ||| S:23353 E:23362 ||| FW
.  ||| S:23362 E:23364 ||| .
The  ||| S:23364 E:23368 ||| DT
vectors  ||| S:23368 E:23376 ||| JJ
result  ||| S:23376 E:23383 ||| NN
in  ||| S:23383 E:23386 ||| IN
the  ||| S:23386 E:23390 ||| DT
production  ||| S:23390 E:23401 ||| NN
of  ||| S:23401 E:23404 ||| IN
recombinant  ||| S:23404 E:23416 ||| JJ
antibody  ||| S:23416 E:23425 ||| NN
molecules  ||| S:23425 E:23435 ||| NNS
under  ||| S:23435 E:23441 ||| IN
the  ||| S:23441 E:23445 ||| DT
control  ||| S:23445 E:23453 ||| NN
of  ||| S:23453 E:23456 ||| IN
CMV  ||| S:23456 E:23460 ||| NNP
transcriptional  ||| S:23460 E:23476 ||| NN
promoters ||| S:23476 E:23485 ||| NNS
.  ||| S:23485 E:23487 ||| .
The  ||| S:23487 E:23491 ||| DT
heavy  ||| S:23491 E:23497 ||| JJ
chain  ||| S:23497 E:23503 ||| NN
molecules  ||| S:23503 E:23513 ||| NNS
are  ||| S:23513 E:23517 ||| VBP
direct  ||| S:23517 E:23524 ||| JJ
cDNA  ||| S:23524 E:23529 ||| JJ
constructs  ||| S:23529 E:23540 ||| NN
that  ||| S:23540 E:23545 ||| IN
fuse  ||| S:23545 E:23550 ||| VBG
the  ||| S:23550 E:23554 ||| DT
variable  ||| S:23554 E:23563 ||| JJ
region  ||| S:23563 E:23570 ||| NN
sequence  ||| S:23570 E:23579 ||| NN
directly  ||| S:23579 E:23588 ||| RB
into  ||| S:23588 E:23593 ||| IN
the  ||| S:23593 E:23597 ||| DT
human  ||| S:23597 E:23603 ||| JJ
IgG1  ||| S:23603 E:23608 ||| CD
constant  ||| S:23608 E:23617 ||| JJ
domain ||| S:23617 E:23623 ||| NN
.  ||| S:23623 E:23625 ||| .
The  ||| S:23625 E:23629 ||| DT
light  ||| S:23629 E:23635 ||| JJ
chain  ||| S:23635 E:23641 ||| NN
molecules ||| S:23641 E:23650 ||| NNS
,  ||| S:23650 E:23652 ||| ,
on  ||| S:23652 E:23655 ||| IN
the  ||| S:23655 E:23659 ||| DT
other  ||| S:23659 E:23665 ||| JJ
hand ||| S:23665 E:23669 ||| NN
,  ||| S:23669 E:23671 ||| ,
have  ||| S:23671 E:23676 ||| VBP
a  ||| S:23676 E:23678 ||| DT
mouse  ||| S:23678 E:23684 ||| NN
kappa  ||| S:23684 E:23690 ||| VBZ
intron  ||| S:23690 E:23697 ||| JJ
region  ||| S:23697 E:23704 ||| NN
3 ||| S:23704 E:23705 ||| CD
& ||| S:23705 E:23706 ||| CC
# ||| S:23706 E:23707 ||| #
x2032 ||| S:23707 E:23712 ||| CD
;  ||| S:23712 E:23714 ||| :
of  ||| S:23714 E:23717 ||| IN
the  ||| S:23717 E:23721 ||| DT
variable  ||| S:23721 E:23730 ||| JJ
region  ||| S:23730 E:23737 ||| NN
coding  ||| S:23737 E:23744 ||| NN
fragment ||| S:23744 E:23752 ||| NN
.  ||| S:23752 E:23754 ||| .
After  ||| S:23754 E:23760 ||| IN
splicing ||| S:23760 E:23768 ||| NN
,  ||| S:23768 E:23770 ||| ,
the  ||| S:23770 E:23774 ||| DT
variable  ||| S:23774 E:23783 ||| JJ
region  ||| S:23783 E:23790 ||| NN
becomes  ||| S:23790 E:23798 ||| VBZ
fused  ||| S:23798 E:23804 ||| VBN
to  ||| S:23804 E:23807 ||| TO
a  ||| S:23807 E:23809 ||| DT
human  ||| S:23809 E:23815 ||| JJ
kappa  ||| S:23815 E:23821 ||| JJ
constant  ||| S:23821 E:23830 ||| JJ
region  ||| S:23830 E:23837 ||| NN
exon  ||| S:23837 E:23842 ||| NNS
( ||| S:23842 E:23843 ||| -LRB-
FIG.  ||| S:23843 E:23848 ||| CD
4 ||| S:23848 E:23849 ||| CD
) ||| S:23849 E:23850 ||| -RRB-
.  ||| S:23850 E:23852 ||| .
The  ||| S:23852 E:23856 ||| DT
selectable  ||| S:23856 E:23867 ||| JJ
marker  ||| S:23867 E:23874 ||| NN
for  ||| S:23874 E:23878 ||| IN
the  ||| S:23878 E:23882 ||| DT
vector  ||| S:23882 E:23889 ||| NN
in  ||| S:23889 E:23892 ||| IN
mammalian  ||| S:23892 E:23902 ||| JJ
cells  ||| S:23902 E:23908 ||| NNS
is  ||| S:23908 E:23911 ||| VBZ
aminoglycoside  ||| S:23911 E:23926 ||| JJ
phosphotransferase  ||| S:23926 E:23945 ||| NNS
( ||| S:23945 E:23946 ||| -LRB-
neo ||| S:23946 E:23949 ||| LS
) ||| S:23949 E:23950 ||| -RRB-
,  ||| S:23950 E:23952 ||| ,
using  ||| S:23952 E:23958 ||| VBG
the  ||| S:23958 E:23962 ||| DT
drug  ||| S:23962 E:23967 ||| NN
G418  ||| S:23967 E:23972 ||| NNP
( ||| S:23972 E:23973 ||| -LRB-
CellTech ||| S:23973 E:23981 ||| NNP
) ||| S:23981 E:23982 ||| -RRB-
.  ||| S:23982 E:23986 ||| .
A.  ||| S:23986 E:23989 ||| NNP
Creation  ||| S:23989 E:23998 ||| NNP
of  ||| S:23998 E:24001 ||| IN
the  ||| S:24001 E:24005 ||| DT
Expression  ||| S:24005 E:24016 ||| NNP
Vectors  ||| S:24016 E:24026 ||| NNPS
To  ||| S:24026 E:24029 ||| TO
create  ||| S:24029 E:24036 ||| VB
the  ||| S:24036 E:24040 ||| DT
heavy  ||| S:24040 E:24046 ||| JJ
and  ||| S:24046 E:24050 ||| CC
light  ||| S:24050 E:24056 ||| JJ
chain  ||| S:24056 E:24062 ||| NN
expression  ||| S:24062 E:24073 ||| NN
vectors  ||| S:24073 E:24081 ||| VBZ
required  ||| S:24081 E:24090 ||| VBN
DNA  ||| S:24090 E:24094 ||| NN
fragment  ||| S:24094 E:24103 ||| NN
ligations  ||| S:24103 E:24113 ||| NNS
and  ||| S:24113 E:24117 ||| CC
site  ||| S:24117 E:24122 ||| NN
directed  ||| S:24122 E:24131 ||| VBD
mutagenesis  ||| S:24131 E:24143 ||| JJ
steps ||| S:24143 E:24148 ||| NNS
.  ||| S:24148 E:24150 ||| .
The  ||| S:24150 E:24154 ||| DT
result  ||| S:24154 E:24161 ||| NN
was  ||| S:24161 E:24165 ||| VBD
vectors  ||| S:24165 E:24173 ||| NNS
that  ||| S:24173 E:24178 ||| WDT
express  ||| S:24178 E:24186 ||| VBP
both  ||| S:24186 E:24191 ||| DT
antibody  ||| S:24191 E:24200 ||| NN
chains  ||| S:24200 E:24207 ||| NNS
with  ||| S:24207 E:24212 ||| IN
CMV  ||| S:24212 E:24216 ||| NNP
promoter  ||| S:24216 E:24225 ||| VBD
driven  ||| S:24225 E:24232 ||| VBN
transcription ||| S:24232 E:24245 ||| NN
.  ||| S:24245 E:24247 ||| .
Neomycin  ||| S:24247 E:24256 ||| JJ
resistance  ||| S:24256 E:24267 ||| NN
serves  ||| S:24267 E:24274 ||| VBZ
as  ||| S:24274 E:24277 ||| IN
a  ||| S:24277 E:24279 ||| DT
dominant  ||| S:24279 E:24288 ||| JJ
selectable  ||| S:24288 E:24299 ||| JJ
marker  ||| S:24299 E:24306 ||| NN
for  ||| S:24306 E:24310 ||| IN
transfection  ||| S:24310 E:24323 ||| NN
of  ||| S:24323 E:24326 ||| IN
mammalian  ||| S:24326 E:24336 ||| JJ
cells ||| S:24336 E:24341 ||| NNS
.  ||| S:24341 E:24343 ||| .
In  ||| S:24343 E:24346 ||| IN
addition ||| S:24346 E:24354 ||| NN
,  ||| S:24354 E:24356 ||| ,
these  ||| S:24356 E:24362 ||| DT
vectors  ||| S:24362 E:24370 ||| NNS
have  ||| S:24370 E:24375 ||| VBP
been  ||| S:24375 E:24380 ||| VBN
designed  ||| S:24380 E:24389 ||| VBN
to  ||| S:24389 E:24392 ||| TO
allow  ||| S:24392 E:24398 ||| VB
convenient  ||| S:24398 E:24409 ||| JJ
cloning  ||| S:24409 E:24417 ||| NN
of  ||| S:24417 E:24420 ||| IN
any  ||| S:24420 E:24424 ||| DT
light  ||| S:24424 E:24430 ||| JJ
chain  ||| S:24430 E:24436 ||| NN
variable  ||| S:24436 E:24445 ||| NN
region  ||| S:24445 E:24452 ||| NN
as  ||| S:24452 E:24455 ||| IN
EcoRV ||| S:24455 E:24460 ||| JJ
/ ||| S:24460 E:24461 ||| CD
BstBI  ||| S:24461 E:24467 ||| JJ
fragment ||| S:24467 E:24475 ||| NN
,  ||| S:24475 E:24477 ||| ,
any  ||| S:24477 E:24481 ||| DT
heavy  ||| S:24481 E:24487 ||| JJ
chain  ||| S:24487 E:24493 ||| NN
variable  ||| S:24493 E:24502 ||| NN
region  ||| S:24502 E:24509 ||| NN
as  ||| S:24509 E:24512 ||| IN
a  ||| S:24512 E:24514 ||| DT
NruI ||| S:24514 E:24518 ||| JJ
/ ||| S:24518 E:24519 ||| CD
EcoRI  ||| S:24519 E:24525 ||| JJ
fragment ||| S:24525 E:24533 ||| NN
,  ||| S:24533 E:24535 ||| ,
and  ||| S:24535 E:24539 ||| CC
any  ||| S:24539 E:24543 ||| DT
heavy  ||| S:24543 E:24549 ||| JJ
chain  ||| S:24549 E:24555 ||| NN
constant  ||| S:24555 E:24564 ||| JJ
domain  ||| S:24564 E:24571 ||| NN
as  ||| S:24571 E:24574 ||| IN
an  ||| S:24574 E:24577 ||| DT
EcoRI ||| S:24577 E:24582 ||| JJ
/ ||| S:24582 E:24583 ||| CD
NotI  ||| S:24583 E:24588 ||| JJ
fragment ||| S:24588 E:24596 ||| NN
.  ||| S:24596 E:24598 ||| .
These  ||| S:24598 E:24604 ||| DT
restriction  ||| S:24604 E:24616 ||| NN
sites  ||| S:24616 E:24622 ||| NNS
were  ||| S:24622 E:24627 ||| VBD
chosen  ||| S:24627 E:24634 ||| VBN
because  ||| S:24634 E:24642 ||| IN
they  ||| S:24642 E:24647 ||| PRP
occur  ||| S:24647 E:24653 ||| VBP
rarely  ||| S:24653 E:24660 ||| RB
( ||| S:24660 E:24661 ||| -LRB-
if  ||| S:24661 E:24664 ||| IN
ever ||| S:24664 E:24668 ||| RB
)  ||| S:24668 E:24670 ||| -RRB-
in  ||| S:24670 E:24673 ||| IN
human  ||| S:24673 E:24679 ||| JJ
and  ||| S:24679 E:24683 ||| CC
mouse  ||| S:24683 E:24689 ||| JJ
variable  ||| S:24689 E:24698 ||| JJ
regions ||| S:24698 E:24705 ||| NNS
.  ||| S:24705 E:24707 ||| .
There  ||| S:24707 E:24713 ||| EX
is  ||| S:24713 E:24716 ||| VBZ
a  ||| S:24716 E:24718 ||| DT
mouse  ||| S:24718 E:24724 ||| NN
J  ||| S:24724 E:24726 ||| NNP
region ||| S:24726 E:24732 ||| FW
/ ||| S:24732 E:24733 ||| FW
kappa  ||| S:24733 E:24739 ||| FW
intron  ||| S:24739 E:24746 ||| FW
fragment  ||| S:24746 E:24755 ||| FW
fused  ||| S:24755 E:24761 ||| FW
to  ||| S:24761 E:24764 ||| TO
a  ||| S:24764 E:24766 ||| DT
human  ||| S:24766 E:24772 ||| JJ
kappa  ||| S:24772 E:24778 ||| NNS
exon  ||| S:24778 E:24783 ||| VBP
so  ||| S:24783 E:24786 ||| RB
that  ||| S:24786 E:24791 ||| IN
after  ||| S:24791 E:24797 ||| IN
post-transcriptional  ||| S:24797 E:24818 ||| JJ
splicing  ||| S:24818 E:24827 ||| NNS
a  ||| S:24827 E:24829 ||| DT
mouse  ||| S:24829 E:24835 ||| JJ
human  ||| S:24835 E:24841 ||| JJ
chimeric  ||| S:24841 E:24850 ||| NNS
kappa  ||| S:24850 E:24856 ||| VBP
light  ||| S:24856 E:24862 ||| JJ
chain  ||| S:24862 E:24868 ||| NN
is  ||| S:24868 E:24871 ||| VBZ
produced ||| S:24871 E:24879 ||| VBN
.  ||| S:24879 E:24881 ||| .
Lastly ||| S:24881 E:24887 ||| NNP
,  ||| S:24887 E:24889 ||| ,
the  ||| S:24889 E:24893 ||| DT
vectors  ||| S:24893 E:24901 ||| NN
were  ||| S:24901 E:24906 ||| VBD
designed  ||| S:24906 E:24915 ||| VBN
to  ||| S:24915 E:24918 ||| TO
facilitate  ||| S:24918 E:24929 ||| VB
excision  ||| S:24929 E:24938 ||| NN
( ||| S:24938 E:24939 ||| -LRB-
BglII ||| S:24939 E:24944 ||| NNP
/ ||| S:24944 E:24945 ||| NNP
NheI ||| S:24945 E:24949 ||| NNP
)  ||| S:24949 E:24951 ||| -RRB-
of  ||| S:24951 E:24954 ||| IN
a  ||| S:24954 E:24956 ||| DT
whole  ||| S:24956 E:24962 ||| JJ
antibody  ||| S:24962 E:24971 ||| NN
expression  ||| S:24971 E:24982 ||| NN
cassette  ||| S:24982 E:24991 ||| NN
from  ||| S:24991 E:24996 ||| IN
one  ||| S:24996 E:25000 ||| CD
vector  ||| S:25000 E:25007 ||| NN
to  ||| S:25007 E:25010 ||| TO
be  ||| S:25010 E:25013 ||| VB
ligated  ||| S:25013 E:25021 ||| VBN
into  ||| S:25021 E:25026 ||| IN
a  ||| S:25026 E:25028 ||| DT
second  ||| S:25028 E:25035 ||| JJ
vector  ||| S:25035 E:25042 ||| NN
cut  ||| S:25042 E:25046 ||| NN
with  ||| S:25046 E:25051 ||| IN
BamHI ||| S:25051 E:25056 ||| NNP
/ ||| S:25056 E:25057 ||| NNP
NheI ||| S:25057 E:25061 ||| NNP
,  ||| S:25061 E:25063 ||| ,
creating  ||| S:25063 E:25072 ||| VBG
an  ||| S:25072 E:25075 ||| DT
expression  ||| S:25075 E:25086 ||| NN
vector  ||| S:25086 E:25093 ||| NN
with  ||| S:25093 E:25098 ||| IN
the  ||| S:25098 E:25102 ||| DT
apparatus  ||| S:25102 E:25112 ||| NN
for  ||| S:25112 E:25116 ||| IN
both  ||| S:25116 E:25121 ||| DT
chains ||| S:25121 E:25127 ||| NNS
.  ||| S:25127 E:25131 ||| .
The  ||| S:25131 E:25135 ||| DT
backbone  ||| S:25135 E:25144 ||| NN
of  ||| S:25144 E:25147 ||| IN
the  ||| S:25147 E:25151 ||| DT
vector  ||| S:25151 E:25158 ||| NN
was  ||| S:25158 E:25162 ||| VBD
the  ||| S:25162 E:25166 ||| DT
plasmid  ||| S:25166 E:25174 ||| JJ
pCDNA3  ||| S:25174 E:25181 ||| NNP
( ||| S:25181 E:25182 ||| -LRB-
Invitrogen ||| S:25182 E:25192 ||| NNP
) ||| S:25192 E:25193 ||| -RRB-
.  ||| S:25193 E:25195 ||| .
This  ||| S:25195 E:25200 ||| DT
plasmid  ||| S:25200 E:25208 ||| NN
was  ||| S:25208 E:25212 ||| VBD
cut  ||| S:25212 E:25216 ||| VBN
with  ||| S:25216 E:25221 ||| IN
HindIII ||| S:25221 E:25228 ||| NNP
/ ||| S:25228 E:25229 ||| NNP
XhoI  ||| S:25229 E:25234 ||| NNP
and  ||| S:25234 E:25238 ||| CC
a  ||| S:25238 E:25240 ||| DT
& ||| S:25240 E:25241 ||| CC
# ||| S:25241 E:25242 ||| #
x201c ||| S:25242 E:25247 ||| CD
; ||| S:25247 E:25248 ||| :
light  ||| S:25248 E:25254 ||| JJ
chain  ||| S:25254 E:25260 ||| NN
polylinker ||| S:25260 E:25270 ||| NNS
& ||| S:25270 E:25271 ||| CC
# ||| S:25271 E:25272 ||| #
x201d ||| S:25272 E:25277 ||| CD
;  ||| S:25277 E:25279 ||| :
DNA  ||| S:25279 E:25283 ||| NNP
fragment  ||| S:25283 E:25292 ||| NN
was  ||| S:25292 E:25296 ||| VBD
inserted  ||| S:25296 E:25305 ||| VBN
to  ||| S:25305 E:25308 ||| TO
create  ||| S:25308 E:25315 ||| VB
the  ||| S:25315 E:25319 ||| DT
starting  ||| S:25319 E:25328 ||| VBG
& ||| S:25328 E:25329 ||| CC
# ||| S:25329 E:25330 ||| #
x201c ||| S:25330 E:25335 ||| CD
; ||| S:25335 E:25336 ||| :
light  ||| S:25336 E:25342 ||| JJ
chain  ||| S:25342 E:25348 ||| NN
vector ||| S:25348 E:25354 ||| NN
& ||| S:25354 E:25355 ||| CC
# ||| S:25355 E:25356 ||| #
x201d ||| S:25356 E:25361 ||| CD
;  ||| S:25361 E:25363 ||| :
pCDNA3.LCPL  ||| S:25363 E:25375 ||| CD
( ||| S:25375 E:25376 ||| -LRB-
see  ||| S:25376 E:25380 ||| VB
FIG.  ||| S:25380 E:25385 ||| CD
12 ||| S:25385 E:25387 ||| CD
) ||| S:25387 E:25388 ||| -RRB-
.  ||| S:25388 E:25390 ||| .
This  ||| S:25390 E:25395 ||| DT
linker  ||| S:25395 E:25402 ||| NN
contained  ||| S:25402 E:25412 ||| VBD
the  ||| S:25412 E:25416 ||| DT
restriction  ||| S:25416 E:25428 ||| NN
sites  ||| S:25428 E:25434 ||| NNS
HindIII ||| S:25434 E:25441 ||| JJ
,  ||| S:25441 E:25443 ||| ,
KpnI ||| S:25443 E:25447 ||| NNP
,  ||| S:25447 E:25449 ||| ,
ClaI ||| S:25449 E:25453 ||| NNP
,  ||| S:25453 E:25455 ||| ,
PmlI ||| S:25455 E:25459 ||| NNP
,  ||| S:25459 E:25461 ||| ,
EcoRV ||| S:25461 E:25466 ||| NNP
,  ||| S:25466 E:25468 ||| ,
XmaI ||| S:25468 E:25472 ||| NNP
,  ||| S:25472 E:25474 ||| ,
BamHI  ||| S:25474 E:25480 ||| JJ
and  ||| S:25480 E:25484 ||| CC
XhoI  ||| S:25484 E:25489 ||| JJ
to  ||| S:25489 E:25492 ||| TO
facilitate  ||| S:25492 E:25503 ||| VB
subsequent  ||| S:25503 E:25514 ||| JJ
cloning  ||| S:25514 E:25522 ||| JJ
steps ||| S:25522 E:25527 ||| NNS
.  ||| S:25527 E:25529 ||| .
A  ||| S:25529 E:25531 ||| DT
SmaII ||| S:25531 E:25536 ||| JJ
/ ||| S:25536 E:25537 ||| NNP
BclI  ||| S:25537 E:25542 ||| NNP
DNA  ||| S:25542 E:25546 ||| NNP
fragment  ||| S:25546 E:25555 ||| VBZ
containing  ||| S:25555 E:25566 ||| VBG
a  ||| S:25566 E:25568 ||| DT
light  ||| S:25568 E:25574 ||| JJ
chain  ||| S:25574 E:25580 ||| NN
leader ||| S:25580 E:25586 ||| NN
,  ||| S:25586 E:25588 ||| ,
mouse  ||| S:25588 E:25594 ||| JJ
anti-CKMB  ||| S:25594 E:25604 ||| JJ
kappa  ||| S:25604 E:25610 ||| JJ
light  ||| S:25610 E:25616 ||| JJ
chain  ||| S:25616 E:25622 ||| NN
genomic  ||| S:25622 E:25630 ||| NN
fragment ||| S:25630 E:25638 ||| NN
,  ||| S:25638 E:25640 ||| ,
and  ||| S:25640 E:25644 ||| CC
3 ||| S:25644 E:25645 ||| CD
& ||| S:25645 E:25646 ||| CC
# ||| S:25646 E:25647 ||| #
x2032 ||| S:25647 E:25652 ||| CD
;  ||| S:25652 E:25654 ||| :
UTR  ||| S:25654 E:25658 ||| NNP
was  ||| S:25658 E:25662 ||| VBD
cloned  ||| S:25662 E:25669 ||| VBN
into  ||| S:25669 E:25674 ||| IN
the  ||| S:25674 E:25678 ||| DT
EcoRV ||| S:25678 E:25683 ||| JJ
/ ||| S:25683 E:25684 ||| CD
BamHI  ||| S:25684 E:25690 ||| JJ
sites  ||| S:25690 E:25696 ||| NNS
of  ||| S:25696 E:25699 ||| IN
pCDNA3.LCPL ||| S:25699 E:25710 ||| CD
.  ||| S:25710 E:25712 ||| .
The  ||| S:25712 E:25716 ||| DT
mouse  ||| S:25716 E:25722 ||| NN
kappa  ||| S:25722 E:25728 ||| NN
intron ||| S:25728 E:25734 ||| NN
,  ||| S:25734 E:25736 ||| ,
exon ||| S:25736 E:25740 ||| NN
,  ||| S:25740 E:25742 ||| ,
and  ||| S:25742 E:25746 ||| CC
3 ||| S:25746 E:25747 ||| CD
& ||| S:25747 E:25748 ||| CC
# ||| S:25748 E:25749 ||| #
x2032 ||| S:25749 E:25754 ||| CD
;  ||| S:25754 E:25756 ||| :
UTR  ||| S:25756 E:25760 ||| NNP
in  ||| S:25760 E:25763 ||| IN
this  ||| S:25763 E:25768 ||| DT
fragment  ||| S:25768 E:25777 ||| NN
was  ||| S:25777 E:25781 ||| VBD
derived  ||| S:25781 E:25789 ||| VBN
from  ||| S:25789 E:25794 ||| IN
LCPXK2  ||| S:25794 E:25801 ||| NNP
received  ||| S:25801 E:25810 ||| VBD
from  ||| S:25810 E:25815 ||| IN
Dr.  ||| S:25815 E:25819 ||| NNP
Richard  ||| S:25819 E:25827 ||| NNP
Near  ||| S:25827 E:25832 ||| NNP
( ||| S:25832 E:25833 ||| -LRB-
Near ||| S:25833 E:25837 ||| NNP
,  ||| S:25837 E:25839 ||| ,
R.  ||| S:25839 E:25842 ||| NNP
I.  ||| S:25842 E:25845 ||| NNP
et  ||| S:25845 E:25848 ||| NNP
al. ||| S:25848 E:25851 ||| NNP
,  ||| S:25851 E:25853 ||| ,
1990 ||| S:25853 E:25857 ||| CD
,  ||| S:25857 E:25859 ||| ,
Mol ||| S:25859 E:25862 ||| NNP
.  ||| S:25862 E:25864 ||| .
Immunol.  ||| S:25864 E:25873 ||| CD
27 ||| S:25873 E:25875 ||| CD
: ||| S:25875 E:25876 ||| :
901-909 ||| S:25876 E:25883 ||| CD
) ||| S:25883 E:25884 ||| -RRB-
.  ||| S:25884 E:25886 ||| .
Mutagenesis  ||| S:25886 E:25898 ||| NNP
was  ||| S:25898 E:25902 ||| VBD
then  ||| S:25902 E:25907 ||| RB
performed  ||| S:25907 E:25917 ||| VBN
to  ||| S:25917 E:25920 ||| TO
eliminate  ||| S:25920 E:25930 ||| VB
an  ||| S:25930 E:25933 ||| DT
NruI  ||| S:25933 E:25938 ||| JJ
( ||| S:25938 E:25939 ||| -LRB-
209 ||| S:25939 E:25942 ||| LS
) ||| S:25942 E:25943 ||| -RRB-
,  ||| S:25943 E:25945 ||| ,
MluI  ||| S:25945 E:25950 ||| NNP
( ||| S:25950 E:25951 ||| -LRB-
229 ||| S:25951 E:25954 ||| CD
) ||| S:25954 E:25955 ||| -RRB-
,  ||| S:25955 E:25957 ||| ,
and  ||| S:25957 E:25961 ||| CC
BstBI  ||| S:25961 E:25967 ||| NNP
( ||| S:25967 E:25968 ||| -LRB-
2962 ||| S:25968 E:25972 ||| CD
)  ||| S:25972 E:25974 ||| -RRB-
and  ||| S:25974 E:25978 ||| CC
to  ||| S:25978 E:25981 ||| TO
introduce  ||| S:25981 E:25991 ||| VB
an  ||| S:25991 E:25994 ||| DT
NheI  ||| S:25994 E:25999 ||| JJ
( ||| S:25999 E:26000 ||| -LRB-
1229 ||| S:26000 E:26004 ||| CD
)  ||| S:26004 E:26006 ||| -RRB-
and  ||| S:26006 E:26010 ||| CC
a  ||| S:26010 E:26012 ||| DT
BamHI  ||| S:26012 E:26018 ||| JJ
( ||| S:26018 E:26019 ||| -LRB-
1214 ||| S:26019 E:26023 ||| CD
)  ||| S:26023 E:26025 ||| -RRB-
site  ||| S:26025 E:26030 ||| NN
to  ||| S:26030 E:26033 ||| TO
create  ||| S:26033 E:26040 ||| VB
the  ||| S:26040 E:26044 ||| DT
plasmid  ||| S:26044 E:26052 ||| JJ
pCDNA3mut.LCPL.LCVK  ||| S:26052 E:26072 ||| NNP
( ||| S:26072 E:26073 ||| -LRB-
see  ||| S:26073 E:26077 ||| VB
FIG.  ||| S:26077 E:26082 ||| CD
12 ||| S:26082 E:26084 ||| CD
) ||| S:26084 E:26085 ||| -RRB-
.  ||| S:26085 E:26089 ||| .
A  ||| S:26089 E:26091 ||| DT
second  ||| S:26091 E:26098 ||| JJ
& ||| S:26098 E:26099 ||| CC
# ||| S:26099 E:26100 ||| #
x201c ||| S:26100 E:26105 ||| CD
; ||| S:26105 E:26106 ||| :
heavy  ||| S:26106 E:26112 ||| JJ
chain  ||| S:26112 E:26118 ||| NN
vector ||| S:26118 E:26124 ||| NN
& ||| S:26124 E:26125 ||| CC
# ||| S:26125 E:26126 ||| #
x201d ||| S:26126 E:26131 ||| CD
;  ||| S:26131 E:26133 ||| :
pCDNA3mut.HCPL  ||| S:26133 E:26148 ||| NNP
was  ||| S:26148 E:26152 ||| VBD
constructed  ||| S:26152 E:26164 ||| VBN
from  ||| S:26164 E:26169 ||| IN
the  ||| S:26169 E:26173 ||| DT
pCDNA3mut.LCPL.LCVK  ||| S:26173 E:26193 ||| JJ
plasmid  ||| S:26193 E:26201 ||| NN
by  ||| S:26201 E:26204 ||| IN
replacing  ||| S:26204 E:26214 ||| VBG
the  ||| S:26214 E:26218 ||| DT
light  ||| S:26218 E:26224 ||| JJ
chain  ||| S:26224 E:26230 ||| NN
expression  ||| S:26230 E:26241 ||| NN
region  ||| S:26241 E:26248 ||| NN
( ||| S:26248 E:26249 ||| -LRB-
HindIII ||| S:26249 E:26256 ||| NNP
/ ||| S:26256 E:26257 ||| NNP
XhoI ||| S:26257 E:26261 ||| NNP
)  ||| S:26261 E:26263 ||| -RRB-
with  ||| S:26263 E:26268 ||| IN
a  ||| S:26268 E:26270 ||| DT
& ||| S:26270 E:26271 ||| CC
# ||| S:26271 E:26272 ||| #
x201c ||| S:26272 E:26277 ||| CD
; ||| S:26277 E:26278 ||| :
heavy  ||| S:26278 E:26284 ||| JJ
chain  ||| S:26284 E:26290 ||| NN
polylinker ||| S:26290 E:26300 ||| NNS
& ||| S:26300 E:26301 ||| CC
# ||| S:26301 E:26302 ||| #
x201d ||| S:26302 E:26307 ||| CD
;  ||| S:26307 E:26309 ||| :
consisting  ||| S:26309 E:26320 ||| VBG
of  ||| S:26320 E:26323 ||| IN
restriction  ||| S:26323 E:26335 ||| NN
sites  ||| S:26335 E:26341 ||| NNS
HpaI ||| S:26341 E:26345 ||| JJ
,  ||| S:26345 E:26347 ||| ,
BspEI ||| S:26347 E:26352 ||| NNP
,  ||| S:26352 E:26354 ||| ,
EcoRV ||| S:26354 E:26359 ||| NNP
,  ||| S:26359 E:26361 ||| ,
KpnI ||| S:26361 E:26365 ||| NNP
,  ||| S:26365 E:26367 ||| ,
and  ||| S:26367 E:26371 ||| CC
Xhol ||| S:26371 E:26375 ||| NNP
.  ||| S:26375 E:26377 ||| .
This  ||| S:26377 E:26382 ||| DT
plasmid  ||| S:26382 E:26390 ||| NN
was  ||| S:26390 E:26394 ||| VBD
digested  ||| S:26394 E:26403 ||| VBN
with  ||| S:26403 E:26408 ||| IN
EcorRV  ||| S:26408 E:26415 ||| JJ
and  ||| S:26415 E:26419 ||| CC
KpnI ||| S:26419 E:26423 ||| JJ
.  ||| S:26423 E:26425 ||| .
A  ||| S:26425 E:26427 ||| DT
SmaI ||| S:26427 E:26431 ||| JJ
/ ||| S:26431 E:26432 ||| CD
KpnI  ||| S:26432 E:26437 ||| JJ
digested  ||| S:26437 E:26446 ||| JJ
DNA  ||| S:26446 E:26450 ||| NN
fragment  ||| S:26450 E:26459 ||| NN
containing  ||| S:26459 E:26470 ||| VBG
a  ||| S:26470 E:26472 ||| DT
heavy  ||| S:26472 E:26478 ||| JJ
chain  ||| S:26478 E:26484 ||| NN
leader  ||| S:26484 E:26491 ||| NN
and  ||| S:26491 E:26495 ||| CC
an  ||| S:26495 E:26498 ||| DT
anti-CKMB  ||| S:26498 E:26508 ||| JJ
IgG2b  ||| S:26508 E:26514 ||| CD
mouse  ||| S:26514 E:26520 ||| NN
heavy  ||| S:26520 E:26526 ||| JJ
chain  ||| S:26526 E:26532 ||| NN
genomic  ||| S:26532 E:26540 ||| NN
fragment  ||| S:26540 E:26549 ||| NN
was  ||| S:26549 E:26553 ||| VBD
then  ||| S:26553 E:26558 ||| RB
ligated  ||| S:26558 E:26566 ||| VBN
into  ||| S:26566 E:26571 ||| IN
the  ||| S:26571 E:26575 ||| DT
EcoRV ||| S:26575 E:26580 ||| JJ
/ ||| S:26580 E:26581 ||| FW
KpnI  ||| S:26581 E:26586 ||| FW
digested  ||| S:26586 E:26595 ||| FW
plasmid ||| S:26595 E:26602 ||| FW
.  ||| S:26602 E:26604 ||| .
A  ||| S:26604 E:26606 ||| DT
KpnI ||| S:26606 E:26610 ||| JJ
/ ||| S:26610 E:26611 ||| CD
SalI  ||| S:26611 E:26616 ||| JJ
oligonucleotide  ||| S:26616 E:26632 ||| NNS
fragment  ||| S:26632 E:26641 ||| VBP
containing  ||| S:26641 E:26652 ||| VBG
a  ||| S:26652 E:26654 ||| DT
3 ||| S:26654 E:26655 ||| CD
& ||| S:26655 E:26656 ||| CC
# ||| S:26656 E:26657 ||| #
x2032 ||| S:26657 E:26662 ||| CD
;  ||| S:26662 E:26664 ||| :
UTR  ||| S:26664 E:26668 ||| NNP
and  ||| S:26668 E:26672 ||| CC
a  ||| S:26672 E:26674 ||| DT
NotI  ||| S:26674 E:26679 ||| JJ
upstream  ||| S:26679 E:26688 ||| NN
of  ||| S:26688 E:26691 ||| IN
the  ||| S:26691 E:26695 ||| DT
SalI  ||| S:26695 E:26700 ||| JJ
site  ||| S:26700 E:26705 ||| NN
was  ||| S:26705 E:26709 ||| VBD
subsequently  ||| S:26709 E:26722 ||| RB
cloned  ||| S:26722 E:26729 ||| VBN
into  ||| S:26729 E:26734 ||| IN
the  ||| S:26734 E:26738 ||| DT
KpnI ||| S:26738 E:26742 ||| JJ
/ ||| S:26742 E:26743 ||| FW
XhoI  ||| S:26743 E:26748 ||| FW
digested  ||| S:26748 E:26757 ||| FW
plasmid ||| S:26757 E:26764 ||| FW
,  ||| S:26764 E:26766 ||| ,
( ||| S:26766 E:26767 ||| -LRB-
knocking  ||| S:26767 E:26776 ||| VBG
out  ||| S:26776 E:26780 ||| RP
the  ||| S:26780 E:26784 ||| DT
XhoI  ||| S:26784 E:26789 ||| JJ
site ||| S:26789 E:26793 ||| NN
) ||| S:26793 E:26794 ||| -RRB-
,  ||| S:26794 E:26796 ||| ,
to  ||| S:26796 E:26799 ||| TO
create  ||| S:26799 E:26806 ||| VB
the  ||| S:26806 E:26810 ||| DT
plasmid  ||| S:26810 E:26818 ||| JJ
pCDNA3mut.HCPL.HCV2b  ||| S:26818 E:26839 ||| NNP
( ||| S:26839 E:26840 ||| -LRB-
see  ||| S:26840 E:26844 ||| VB
FIG.  ||| S:26844 E:26849 ||| CD
13 ||| S:26849 E:26851 ||| CD
) ||| S:26851 E:26852 ||| -RRB-
.  ||| S:26852 E:26856 ||| .
A  ||| S:26856 E:26858 ||| DT
human  ||| S:26858 E:26864 ||| JJ
kappa  ||| S:26864 E:26870 ||| JJ
light  ||| S:26870 E:26876 ||| JJ
chain  ||| S:26876 E:26882 ||| NN
constant  ||| S:26882 E:26891 ||| JJ
domain  ||| S:26891 E:26898 ||| NN
was  ||| S:26898 E:26902 ||| VBD
then  ||| S:26902 E:26907 ||| RB
cloned  ||| S:26907 E:26914 ||| VBN
into  ||| S:26914 E:26919 ||| IN
pCDNA3mut.LCPL.LCVK  ||| S:26919 E:26939 ||| CD
as  ||| S:26939 E:26942 ||| IN
a  ||| S:26942 E:26944 ||| DT
EcoNI ||| S:26944 E:26949 ||| JJ
/ ||| S:26949 E:26950 ||| CD
XhoI  ||| S:26950 E:26955 ||| JJ
fragment  ||| S:26955 E:26964 ||| NN
generating  ||| S:26964 E:26975 ||| VBG
the  ||| S:26975 E:26979 ||| DT
plasmid  ||| S:26979 E:26987 ||| JJ
tKMC180C2 ||| S:26987 E:26996 ||| NN
.  ||| S:26996 E:26998 ||| .
A  ||| S:26998 E:27000 ||| DT
human  ||| S:27000 E:27006 ||| JJ
IgG1  ||| S:27006 E:27011 ||| CD
constant  ||| S:27011 E:27020 ||| JJ
domain  ||| S:27020 E:27027 ||| NN
was  ||| S:27027 E:27031 ||| VBD
cloned  ||| S:27031 E:27038 ||| VBN
into  ||| S:27038 E:27043 ||| IN
pSUN10  ||| S:27043 E:27050 ||| CD
as  ||| S:27050 E:27053 ||| IN
a  ||| S:27053 E:27055 ||| DT
EcoRI ||| S:27055 E:27060 ||| JJ
/ ||| S:27060 E:27061 ||| CD
NotI  ||| S:27061 E:27066 ||| JJ
fragment  ||| S:27066 E:27075 ||| NN
creating  ||| S:27075 E:27084 ||| VBG
the  ||| S:27084 E:27088 ||| DT
plasmid  ||| S:27088 E:27096 ||| JJ
pJRS313 ||| S:27096 E:27103 ||| NN
.  ||| S:27103 E:27105 ||| .
The  ||| S:27105 E:27109 ||| DT
variable  ||| S:27109 E:27118 ||| JJ
regions  ||| S:27118 E:27126 ||| NNS
of  ||| S:27126 E:27129 ||| IN
13C4  ||| S:27129 E:27134 ||| NNP
were  ||| S:27134 E:27139 ||| VBD
cloned  ||| S:27139 E:27146 ||| VBN
into  ||| S:27146 E:27151 ||| IN
these  ||| S:27151 E:27157 ||| DT
two  ||| S:27157 E:27161 ||| CD
vectors  ||| S:27161 E:27169 ||| NNS
( ||| S:27169 E:27170 ||| -LRB-
as  ||| S:27170 E:27173 ||| RB
described  ||| S:27173 E:27183 ||| VBN
above ||| S:27183 E:27188 ||| IN
) ||| S:27188 E:27189 ||| -RRB-
.  ||| S:27189 E:27191 ||| .
A  ||| S:27191 E:27193 ||| DT
BglII ||| S:27193 E:27198 ||| JJ
/ ||| S:27198 E:27199 ||| CD
NheI  ||| S:27199 E:27204 ||| JJ
fragment  ||| S:27204 E:27213 ||| NN
from  ||| S:27213 E:27218 ||| IN
the  ||| S:27218 E:27222 ||| DT
human  ||| S:27222 E:27228 ||| JJ
heavy  ||| S:27228 E:27234 ||| JJ
chain  ||| S:27234 E:27240 ||| NN
vector  ||| S:27240 E:27247 ||| NN
tKMC229C  ||| S:27247 E:27256 ||| NN
was  ||| S:27256 E:27260 ||| VBD
then  ||| S:27260 E:27265 ||| RB
cloned  ||| S:27265 E:27272 ||| VBN
into  ||| S:27272 E:27277 ||| IN
the  ||| S:27277 E:27281 ||| DT
human  ||| S:27281 E:27287 ||| JJ
light  ||| S:27287 E:27293 ||| JJ
chain  ||| S:27293 E:27299 ||| NN
vector  ||| S:27299 E:27306 ||| NN
tKMC231D  ||| S:27306 E:27315 ||| RB
cut  ||| S:27315 E:27319 ||| VB
BamHI ||| S:27319 E:27324 ||| JJ
/ ||| S:27324 E:27325 ||| CD
NheI  ||| S:27325 E:27330 ||| JJ
to  ||| S:27330 E:27333 ||| TO
create  ||| S:27333 E:27340 ||| VB
tKMC249A  ||| S:27340 E:27349 ||| NNP
( ||| S:27349 E:27350 ||| -LRB-
see  ||| S:27350 E:27354 ||| VB
FIG.  ||| S:27354 E:27359 ||| CD
4 ||| S:27359 E:27360 ||| CD
) ||| S:27360 E:27361 ||| -RRB-
.  ||| S:27361 E:27365 ||| .
B.  ||| S:27365 E:27368 ||| NNP
Subcloning  ||| S:27368 E:27379 ||| NNP
the  ||| S:27379 E:27383 ||| DT
Variable  ||| S:27383 E:27392 ||| NNP
Regions  ||| S:27392 E:27400 ||| NNP
into  ||| S:27400 E:27405 ||| IN
the  ||| S:27405 E:27409 ||| DT
Expression  ||| S:27409 E:27420 ||| NNP
Vectors  ||| S:27420 E:27430 ||| NNPS
The  ||| S:27430 E:27434 ||| DT
variable  ||| S:27434 E:27443 ||| JJ
region  ||| S:27443 E:27450 ||| NN
gene  ||| S:27450 E:27455 ||| NN
fragments  ||| S:27455 E:27465 ||| NNS
were  ||| S:27465 E:27470 ||| VBD
re-amplified  ||| S:27470 E:27483 ||| JJ
by  ||| S:27483 E:27486 ||| IN
PCR  ||| S:27486 E:27490 ||| NNP
using  ||| S:27490 E:27496 ||| VBG
primers  ||| S:27496 E:27504 ||| NNS
that  ||| S:27504 E:27509 ||| WDT
adapted  ||| S:27509 E:27517 ||| VBD
the  ||| S:27517 E:27521 ||| DT
fragments  ||| S:27521 E:27531 ||| NN
for  ||| S:27531 E:27535 ||| IN
cloning  ||| S:27535 E:27543 ||| NN
into  ||| S:27543 E:27548 ||| IN
the  ||| S:27548 E:27552 ||| DT
expression  ||| S:27552 E:27563 ||| NN
vectors  ||| S:27563 E:27571 ||| NNS
( ||| S:27571 E:27572 ||| -LRB-
see  ||| S:27572 E:27576 ||| VB
FIGS.  ||| S:27576 E:27582 ||| CD
2  ||| S:27582 E:27584 ||| CD
and  ||| S:27584 E:27588 ||| CC
4 ||| S:27588 E:27589 ||| LS
) ||| S:27589 E:27590 ||| -RRB-
.  ||| S:27590 E:27592 ||| .
The  ||| S:27592 E:27596 ||| DT
heavy  ||| S:27596 E:27602 ||| JJ
chain  ||| S:27602 E:27608 ||| NN
front  ||| S:27608 E:27614 ||| NN
primer  ||| S:27614 E:27621 ||| NNS
( ||| S:27621 E:27622 ||| -LRB-
oKA143 ||| S:27622 E:27628 ||| NNP
,  ||| S:27628 E:27630 ||| ,
SEQ  ||| S:27630 E:27634 ||| UH
ID  ||| S:27634 E:27637 ||| UH
NO ||| S:27637 E:27639 ||| UH
: ||| S:27639 E:27640 ||| :
15 ||| S:27640 E:27642 ||| CD
)  ||| S:27642 E:27644 ||| -RRB-
includes  ||| S:27644 E:27653 ||| VBZ
a  ||| S:27653 E:27655 ||| DT
5 ||| S:27655 E:27656 ||| CD
& ||| S:27656 E:27657 ||| CC
# ||| S:27657 E:27658 ||| #
x2032 ||| S:27658 E:27663 ||| CD
;  ||| S:27663 E:27665 ||| :
tail  ||| S:27665 E:27670 ||| NN
that  ||| S:27670 E:27675 ||| IN
encodes  ||| S:27675 E:27683 ||| VBG
the  ||| S:27683 E:27687 ||| DT
C-terminus  ||| S:27687 E:27698 ||| JJ
of  ||| S:27698 E:27701 ||| IN
the  ||| S:27701 E:27705 ||| DT
heavy  ||| S:27705 E:27711 ||| JJ
chain  ||| S:27711 E:27717 ||| NN
leader  ||| S:27717 E:27724 ||| NN
and  ||| S:27724 E:27728 ||| CC
an  ||| S:27728 E:27731 ||| DT
NruI  ||| S:27731 E:27736 ||| JJ
restriction  ||| S:27736 E:27748 ||| NN
site  ||| S:27748 E:27753 ||| NN
for  ||| S:27753 E:27757 ||| IN
cloning ||| S:27757 E:27764 ||| NN
,  ||| S:27764 E:27766 ||| ,
while  ||| S:27766 E:27772 ||| IN
the  ||| S:27772 E:27776 ||| DT
heavy  ||| S:27776 E:27782 ||| JJ
chain  ||| S:27782 E:27788 ||| NN
reverse  ||| S:27788 E:27796 ||| NN
primer  ||| S:27796 E:27803 ||| NNS
( ||| S:27803 E:27804 ||| -LRB-
oKA144 ||| S:27804 E:27810 ||| NNP
,  ||| S:27810 E:27812 ||| ,
SEQ  ||| S:27812 E:27816 ||| UH
ID  ||| S:27816 E:27819 ||| UH
NO ||| S:27819 E:27821 ||| UH
: ||| S:27821 E:27822 ||| :
14 ||| S:27822 E:27824 ||| CD
)  ||| S:27824 E:27826 ||| -RRB-
adds  ||| S:27826 E:27831 ||| VBZ
a  ||| S:27831 E:27833 ||| DT
3 ||| S:27833 E:27834 ||| CD
& ||| S:27834 E:27835 ||| CC
# ||| S:27835 E:27836 ||| #
x2032 ||| S:27836 E:27841 ||| CD
;  ||| S:27841 E:27843 ||| :
EcoRI  ||| S:27843 E:27849 ||| JJ
restriction  ||| S:27849 E:27861 ||| NN
site  ||| S:27861 E:27866 ||| NN
for  ||| S:27866 E:27870 ||| IN
cloning ||| S:27870 E:27877 ||| NN
.  ||| S:27877 E:27879 ||| .
The  ||| S:27879 E:27883 ||| DT
light  ||| S:27883 E:27889 ||| JJ
chain  ||| S:27889 E:27895 ||| NN
front  ||| S:27895 E:27901 ||| NN
primer  ||| S:27901 E:27908 ||| NNS
( ||| S:27908 E:27909 ||| -LRB-
oKA145 ||| S:27909 E:27915 ||| NNP
,  ||| S:27915 E:27917 ||| ,
SEQ  ||| S:27917 E:27921 ||| UH
ID  ||| S:27921 E:27924 ||| UH
NO ||| S:27924 E:27926 ||| UH
: ||| S:27926 E:27927 ||| :
16 ||| S:27927 E:27929 ||| CD
)  ||| S:27929 E:27931 ||| -RRB-
introduces  ||| S:27931 E:27942 ||| VBZ
an  ||| S:27942 E:27945 ||| DT
EcoRV  ||| S:27945 E:27951 ||| JJ
restriction  ||| S:27951 E:27963 ||| NN
site  ||| S:27963 E:27968 ||| NN
at  ||| S:27968 E:27971 ||| IN
the  ||| S:27971 E:27975 ||| DT
N-terminus  ||| S:27975 E:27986 ||| JJ
of  ||| S:27986 E:27989 ||| IN
the  ||| S:27989 E:27993 ||| DT
light  ||| S:27993 E:27999 ||| JJ
chain  ||| S:27999 E:28005 ||| NN
variable  ||| S:28005 E:28014 ||| NN
region  ||| S:28014 E:28021 ||| NN
for  ||| S:28021 E:28025 ||| IN
cloning ||| S:28025 E:28032 ||| NN
,  ||| S:28032 E:28034 ||| ,
while  ||| S:28034 E:28040 ||| IN
the  ||| S:28040 E:28044 ||| DT
light  ||| S:28044 E:28050 ||| JJ
chain  ||| S:28050 E:28056 ||| NN
reverse  ||| S:28056 E:28064 ||| NN
primer  ||| S:28064 E:28071 ||| NNS
( ||| S:28071 E:28072 ||| -LRB-
oKA146 ||| S:28072 E:28078 ||| NNP
,  ||| S:28078 E:28080 ||| ,
SEQ  ||| S:28080 E:28084 ||| UH
ID  ||| S:28084 E:28087 ||| UH
NO ||| S:28087 E:28089 ||| UH
: ||| S:28089 E:28090 ||| :
17 ||| S:28090 E:28092 ||| CD
)  ||| S:28092 E:28094 ||| -RRB-
adds  ||| S:28094 E:28099 ||| VBZ
a  ||| S:28099 E:28101 ||| DT
3 ||| S:28101 E:28102 ||| CD
& ||| S:28102 E:28103 ||| CC
# ||| S:28103 E:28104 ||| #
x2032 ||| S:28104 E:28109 ||| CD
;  ||| S:28109 E:28111 ||| :
DNA  ||| S:28111 E:28115 ||| NNP
sequence  ||| S:28115 E:28124 ||| NN
for  ||| S:28124 E:28128 ||| IN
the  ||| S:28128 E:28132 ||| DT
joining  ||| S:28132 E:28140 ||| VBG
region-kappa  ||| S:28140 E:28153 ||| JJ
exon  ||| S:28153 E:28158 ||| JJ
splice  ||| S:28158 E:28165 ||| NNS
junction  ||| S:28165 E:28174 ||| VBP
followed  ||| S:28174 E:28183 ||| VBN
by  ||| S:28183 E:28186 ||| IN
a  ||| S:28186 E:28188 ||| DT
BstBI  ||| S:28188 E:28194 ||| JJ
restriction  ||| S:28194 E:28206 ||| NN
site  ||| S:28206 E:28211 ||| NN
for  ||| S:28211 E:28215 ||| IN
cloning ||| S:28215 E:28222 ||| NN
.  ||| S:28222 E:28226 ||| .
PCR  ||| S:28226 E:28230 ||| NNP
reactions  ||| S:28230 E:28240 ||| NNS
were  ||| S:28240 E:28245 ||| VBD
performed  ||| S:28245 E:28255 ||| VBN
with  ||| S:28255 E:28260 ||| IN
reagents  ||| S:28260 E:28269 ||| VBG
as  ||| S:28269 E:28272 ||| RB
described  ||| S:28272 E:28282 ||| VBN
above  ||| S:28282 E:28288 ||| IN
and  ||| S:28288 E:28292 ||| CC
with  ||| S:28292 E:28297 ||| IN
templates  ||| S:28297 E:28307 ||| NN
of  ||| S:28307 E:28310 ||| IN
1-2  ||| S:28310 E:28314 ||| CD
ng  ||| S:28314 E:28317 ||| NN
of  ||| S:28317 E:28320 ||| IN
PvuI  ||| S:28320 E:28325 ||| NNP
( ||| S:28325 E:28326 ||| -LRB-
New  ||| S:28326 E:28330 ||| NNP
England  ||| S:28330 E:28338 ||| NNP
Biolabs ||| S:28338 E:28345 ||| NNP
)  ||| S:28345 E:28347 ||| -RRB-
digested  ||| S:28347 E:28356 ||| JJ
plasmid ||| S:28356 E:28363 ||| NN
;  ||| S:28363 E:28365 ||| :
each  ||| S:28365 E:28370 ||| DT
of  ||| S:28370 E:28373 ||| IN
these  ||| S:28373 E:28379 ||| DT
templates  ||| S:28379 E:28389 ||| NN
was  ||| S:28389 E:28393 ||| VBD
denatured  ||| S:28393 E:28403 ||| VBN
by  ||| S:28403 E:28406 ||| IN
an  ||| S:28406 E:28409 ||| DT
initial  ||| S:28409 E:28417 ||| JJ
one  ||| S:28417 E:28421 ||| CD
minute  ||| S:28421 E:28428 ||| NN
incubation  ||| S:28428 E:28439 ||| NN
at  ||| S:28439 E:28442 ||| IN
96 ||| S:28442 E:28444 ||| CD
& ||| S:28444 E:28445 ||| CC
# ||| S:28445 E:28446 ||| #
xb0 ||| S:28446 E:28449 ||| CD
;  ||| S:28449 E:28451 ||| :
C.  ||| S:28451 E:28454 ||| NNP
The  ||| S:28454 E:28458 ||| DT
heavy  ||| S:28458 E:28464 ||| JJ
chain  ||| S:28464 E:28470 ||| NN
products  ||| S:28470 E:28479 ||| NNS
were  ||| S:28479 E:28484 ||| VBD
amplified  ||| S:28484 E:28494 ||| VBN
by  ||| S:28494 E:28497 ||| IN
35  ||| S:28497 E:28500 ||| CD
thermal  ||| S:28500 E:28508 ||| JJ
cycles  ||| S:28508 E:28515 ||| NNS
of  ||| S:28515 E:28518 ||| IN
55  ||| S:28518 E:28521 ||| CD
or  ||| S:28521 E:28524 ||| CC
60 ||| S:28524 E:28526 ||| CD
& ||| S:28526 E:28527 ||| CC
# ||| S:28527 E:28528 ||| #
xb0 ||| S:28528 E:28531 ||| CD
;  ||| S:28531 E:28533 ||| :
C.  ||| S:28533 E:28536 ||| NNP
for  ||| S:28536 E:28540 ||| IN
30  ||| S:28540 E:28543 ||| CD
sec. ||| S:28543 E:28547 ||| CD
,  ||| S:28547 E:28549 ||| ,
72 ||| S:28549 E:28551 ||| CD
& ||| S:28551 E:28552 ||| CC
# ||| S:28552 E:28553 ||| #
xb0 ||| S:28553 E:28556 ||| CD
;  ||| S:28556 E:28558 ||| :
C.  ||| S:28558 E:28561 ||| NNP
for  ||| S:28561 E:28565 ||| IN
30  ||| S:28565 E:28568 ||| CD
sec. ||| S:28568 E:28572 ||| CD
,  ||| S:28572 E:28574 ||| ,
then  ||| S:28574 E:28579 ||| RB
96 ||| S:28579 E:28581 ||| CD
& ||| S:28581 E:28582 ||| CC
# ||| S:28582 E:28583 ||| #
xb0 ||| S:28583 E:28586 ||| CD
;  ||| S:28586 E:28588 ||| :
C.  ||| S:28588 E:28591 ||| NNP
for  ||| S:28591 E:28595 ||| IN
1  ||| S:28595 E:28597 ||| CD
min  ||| S:28597 E:28601 ||| NNS
and  ||| S:28601 E:28605 ||| CC
a  ||| S:28605 E:28607 ||| DT
final  ||| S:28607 E:28613 ||| JJ
extension  ||| S:28613 E:28623 ||| NN
step  ||| S:28623 E:28628 ||| NN
at  ||| S:28628 E:28631 ||| IN
72 ||| S:28631 E:28633 ||| CD
& ||| S:28633 E:28634 ||| CC
# ||| S:28634 E:28635 ||| #
xb0 ||| S:28635 E:28638 ||| CD
;  ||| S:28638 E:28640 ||| :
C.  ||| S:28640 E:28643 ||| NNP
for  ||| S:28643 E:28647 ||| IN
5  ||| S:28647 E:28649 ||| CD
min ||| S:28649 E:28652 ||| NNS
.  ||| S:28652 E:28654 ||| .
The  ||| S:28654 E:28658 ||| DT
light  ||| S:28658 E:28664 ||| JJ
chain  ||| S:28664 E:28670 ||| NN
products  ||| S:28670 E:28679 ||| NNS
were  ||| S:28679 E:28684 ||| VBD
amplified  ||| S:28684 E:28694 ||| VBN
by  ||| S:28694 E:28697 ||| IN
8  ||| S:28697 E:28699 ||| CD
thermal  ||| S:28699 E:28707 ||| JJ
cycles  ||| S:28707 E:28714 ||| NNS
of  ||| S:28714 E:28717 ||| IN
55  ||| S:28717 E:28720 ||| CD
or  ||| S:28720 E:28723 ||| CC
60 ||| S:28723 E:28725 ||| CD
& ||| S:28725 E:28726 ||| CC
# ||| S:28726 E:28727 ||| #
xb0 ||| S:28727 E:28730 ||| CD
;  ||| S:28730 E:28732 ||| :
C.  ||| S:28732 E:28735 ||| NNP
for  ||| S:28735 E:28739 ||| IN
30  ||| S:28739 E:28742 ||| CD
sec. ||| S:28742 E:28746 ||| CD
,  ||| S:28746 E:28748 ||| ,
72 ||| S:28748 E:28750 ||| CD
& ||| S:28750 E:28751 ||| CC
# ||| S:28751 E:28752 ||| #
xb0 ||| S:28752 E:28755 ||| CD
;  ||| S:28755 E:28757 ||| :
C.  ||| S:28757 E:28760 ||| NNP
for  ||| S:28760 E:28764 ||| IN
30  ||| S:28764 E:28767 ||| CD
sec. ||| S:28767 E:28771 ||| CD
,  ||| S:28771 E:28773 ||| ,
then  ||| S:28773 E:28778 ||| RB
96 ||| S:28778 E:28780 ||| CD
& ||| S:28780 E:28781 ||| CC
# ||| S:28781 E:28782 ||| #
xb0 ||| S:28782 E:28785 ||| CD
;  ||| S:28785 E:28787 ||| :
C.  ||| S:28787 E:28790 ||| NNP
for  ||| S:28790 E:28794 ||| IN
1  ||| S:28794 E:28796 ||| CD
min  ||| S:28796 E:28800 ||| NNS
followed  ||| S:28800 E:28809 ||| VBN
by  ||| S:28809 E:28812 ||| IN
30  ||| S:28812 E:28815 ||| CD
step  ||| S:28815 E:28820 ||| NN
cycles  ||| S:28820 E:28827 ||| NNS
of  ||| S:28827 E:28830 ||| IN
60 ||| S:28830 E:28832 ||| CD
& ||| S:28832 E:28833 ||| CC
# ||| S:28833 E:28834 ||| #
xb0 ||| S:28834 E:28837 ||| CD
;  ||| S:28837 E:28839 ||| :
C.  ||| S:28839 E:28842 ||| NNP
for  ||| S:28842 E:28846 ||| IN
1  ||| S:28846 E:28848 ||| CD
min ||| S:28848 E:28851 ||| NN
,  ||| S:28851 E:28853 ||| ,
then  ||| S:28853 E:28858 ||| RB
96 ||| S:28858 E:28860 ||| CD
& ||| S:28860 E:28861 ||| CC
# ||| S:28861 E:28862 ||| #
xb0 ||| S:28862 E:28865 ||| CD
;  ||| S:28865 E:28867 ||| :
C.  ||| S:28867 E:28870 ||| NNP
for  ||| S:28870 E:28874 ||| IN
1  ||| S:28874 E:28876 ||| CD
min ||| S:28876 E:28879 ||| NN
,  ||| S:28879 E:28881 ||| ,
and  ||| S:28881 E:28885 ||| CC
a  ||| S:28885 E:28887 ||| DT
final  ||| S:28887 E:28893 ||| JJ
extension  ||| S:28893 E:28903 ||| NN
step  ||| S:28903 E:28908 ||| NN
at  ||| S:28908 E:28911 ||| IN
72 ||| S:28911 E:28913 ||| CD
& ||| S:28913 E:28914 ||| CC
# ||| S:28914 E:28915 ||| #
xb0 ||| S:28915 E:28918 ||| CD
;  ||| S:28918 E:28920 ||| :
C.  ||| S:28920 E:28923 ||| NNP
for  ||| S:28923 E:28927 ||| IN
5  ||| S:28927 E:28929 ||| CD
min ||| S:28929 E:28932 ||| NNS
.  ||| S:28932 E:28936 ||| .
The  ||| S:28936 E:28940 ||| DT
13C4  ||| S:28940 E:28945 ||| JJ
heavy  ||| S:28945 E:28951 ||| JJ
chain  ||| S:28951 E:28957 ||| NN
PCR  ||| S:28957 E:28961 ||| NNP
product  ||| S:28961 E:28969 ||| NN
( ||| S:28969 E:28970 ||| -LRB-
approximately  ||| S:28970 E:28984 ||| RB
400  ||| S:28984 E:28988 ||| CD
bp ||| S:28988 E:28990 ||| CD
)  ||| S:28990 E:28992 ||| -RRB-
was  ||| S:28992 E:28996 ||| VBD
purified  ||| S:28996 E:29005 ||| VBN
using  ||| S:29005 E:29011 ||| VBG
Qiaquick  ||| S:29011 E:29020 ||| NNP
PCR  ||| S:29020 E:29024 ||| NNP
Purification  ||| S:29024 E:29037 ||| NNP
columns  ||| S:29037 E:29045 ||| NNS
( ||| S:29045 E:29046 ||| -LRB-
Qiagen ||| S:29046 E:29052 ||| NNP
)  ||| S:29052 E:29054 ||| -RRB-
as  ||| S:29054 E:29057 ||| RB
described  ||| S:29057 E:29067 ||| VBN
by  ||| S:29067 E:29070 ||| IN
the  ||| S:29070 E:29074 ||| DT
manufacturer ||| S:29074 E:29086 ||| NN
's  ||| S:29086 E:29089 ||| POS
instructions  ||| S:29089 E:29102 ||| NNS
and  ||| S:29102 E:29106 ||| CC
subsequently  ||| S:29106 E:29119 ||| RB
digested  ||| S:29119 E:29128 ||| VBN
with  ||| S:29128 E:29133 ||| IN
NruI  ||| S:29133 E:29138 ||| JJ
and  ||| S:29138 E:29142 ||| CC
EcoRI  ||| S:29142 E:29148 ||| NNP
( ||| S:29148 E:29149 ||| -LRB-
New  ||| S:29149 E:29153 ||| NNP
England  ||| S:29153 E:29161 ||| NNP
Biolabs ||| S:29161 E:29168 ||| NNP
) ||| S:29168 E:29169 ||| -RRB-
.  ||| S:29169 E:29171 ||| .
The  ||| S:29171 E:29175 ||| DT
digested  ||| S:29175 E:29184 ||| JJ
PCR  ||| S:29184 E:29188 ||| NN
products  ||| S:29188 E:29197 ||| NNS
were  ||| S:29197 E:29202 ||| VBD
purified  ||| S:29202 E:29211 ||| VBN
using  ||| S:29211 E:29217 ||| VBG
the  ||| S:29217 E:29221 ||| DT
Wizard  ||| S:29221 E:29228 ||| NNP
PCR  ||| S:29228 E:29232 ||| NNP
Purification  ||| S:29232 E:29245 ||| NNP
system  ||| S:29245 E:29252 ||| NN
( ||| S:29252 E:29253 ||| -LRB-
Promega ||| S:29253 E:29260 ||| NNP
)  ||| S:29260 E:29262 ||| -RRB-
as  ||| S:29262 E:29265 ||| IN
per  ||| S:29265 E:29269 ||| IN
manufacturer ||| S:29269 E:29281 ||| NN
's  ||| S:29281 E:29284 ||| POS
procedure  ||| S:29284 E:29294 ||| NN
and  ||| S:29294 E:29298 ||| CC
ligated  ||| S:29298 E:29306 ||| NN
into  ||| S:29306 E:29311 ||| IN
NruI ||| S:29311 E:29315 ||| JJ
/ ||| S:29315 E:29316 ||| CD
EcoRI  ||| S:29316 E:29322 ||| JJ
digested  ||| S:29322 E:29331 ||| NN
and  ||| S:29331 E:29335 ||| CC
gel-purified  ||| S:29335 E:29348 ||| NNP
pJRS3I3 ||| S:29348 E:29355 ||| NNP
,  ||| S:29355 E:29357 ||| ,
resulting  ||| S:29357 E:29367 ||| VBG
in  ||| S:29367 E:29370 ||| IN
plasmid  ||| S:29370 E:29378 ||| CD
tKMC229C  ||| S:29378 E:29387 ||| CD
( ||| S:29387 E:29388 ||| -LRB-
see  ||| S:29388 E:29392 ||| VB
FIG.  ||| S:29392 E:29397 ||| CD
4 ||| S:29397 E:29398 ||| CD
) ||| S:29398 E:29399 ||| -RRB-
.  ||| S:29399 E:29401 ||| .
The  ||| S:29401 E:29405 ||| DT
final  ||| S:29405 E:29411 ||| JJ
consensus  ||| S:29411 E:29421 ||| NN
DNA  ||| S:29421 E:29425 ||| NN
sequence  ||| S:29425 E:29434 ||| NN
of  ||| S:29434 E:29437 ||| IN
the  ||| S:29437 E:29441 ||| DT
heavy  ||| S:29441 E:29447 ||| JJ
chain  ||| S:29447 E:29453 ||| NN
variable  ||| S:29453 E:29462 ||| NN
region  ||| S:29462 E:29469 ||| NN
and  ||| S:29469 E:29473 ||| CC
proper  ||| S:29473 E:29480 ||| JJ
splicing  ||| S:29480 E:29489 ||| NN
of  ||| S:29489 E:29492 ||| IN
the  ||| S:29492 E:29496 ||| DT
restriction  ||| S:29496 E:29508 ||| NN
sites  ||| S:29508 E:29514 ||| NNS
were  ||| S:29514 E:29519 ||| VBD
confirmed  ||| S:29519 E:29529 ||| VBN
in  ||| S:29529 E:29532 ||| IN
this  ||| S:29532 E:29537 ||| DT
construct ||| S:29537 E:29546 ||| NN
.  ||| S:29546 E:29550 ||| .
The  ||| S:29550 E:29554 ||| DT
13C4  ||| S:29554 E:29559 ||| JJ
light  ||| S:29559 E:29565 ||| JJ
chain  ||| S:29565 E:29571 ||| NN
PCR  ||| S:29571 E:29575 ||| NNP
product  ||| S:29575 E:29583 ||| NN
( ||| S:29583 E:29584 ||| -LRB-
approximately  ||| S:29584 E:29598 ||| RB
350  ||| S:29598 E:29602 ||| CD
bp ||| S:29602 E:29604 ||| CD
)  ||| S:29604 E:29606 ||| -RRB-
was  ||| S:29606 E:29610 ||| VBD
purified  ||| S:29610 E:29619 ||| VBN
using  ||| S:29619 E:29625 ||| VBG
Qiaquick  ||| S:29625 E:29634 ||| NNP
PCR  ||| S:29634 E:29638 ||| NNP
Purification  ||| S:29638 E:29651 ||| NNP
columns  ||| S:29651 E:29659 ||| NNS
( ||| S:29659 E:29660 ||| -LRB-
Qiagen ||| S:29660 E:29666 ||| NNP
)  ||| S:29666 E:29668 ||| -RRB-
as  ||| S:29668 E:29671 ||| RB
described  ||| S:29671 E:29681 ||| VBN
by  ||| S:29681 E:29684 ||| IN
the  ||| S:29684 E:29688 ||| DT
manufacturer ||| S:29688 E:29700 ||| NN
's  ||| S:29700 E:29703 ||| POS
instructions  ||| S:29703 E:29716 ||| NNS
and  ||| S:29716 E:29720 ||| CC
subsequently  ||| S:29720 E:29733 ||| RB
digested  ||| S:29733 E:29742 ||| VBN
with  ||| S:29742 E:29747 ||| IN
EcoRV  ||| S:29747 E:29753 ||| JJ
and  ||| S:29753 E:29757 ||| CC
BstBI  ||| S:29757 E:29763 ||| NNP
( ||| S:29763 E:29764 ||| -LRB-
New  ||| S:29764 E:29768 ||| NNP
England  ||| S:29768 E:29776 ||| NNP
Biolabs ||| S:29776 E:29783 ||| NNP
) ||| S:29783 E:29784 ||| -RRB-
.  ||| S:29784 E:29786 ||| .
The  ||| S:29786 E:29790 ||| DT
digested  ||| S:29790 E:29799 ||| JJ
PCR  ||| S:29799 E:29803 ||| NN
products  ||| S:29803 E:29812 ||| NNS
were  ||| S:29812 E:29817 ||| VBD
purified  ||| S:29817 E:29826 ||| VBN
using  ||| S:29826 E:29832 ||| VBG
Qiaquick  ||| S:29832 E:29841 ||| NNP
PCR  ||| S:29841 E:29845 ||| NNP
Purification  ||| S:29845 E:29858 ||| NNP
columns  ||| S:29858 E:29866 ||| NNS
( ||| S:29866 E:29867 ||| -LRB-
Qiagen ||| S:29867 E:29873 ||| NNP
)  ||| S:29873 E:29875 ||| -RRB-
as  ||| S:29875 E:29878 ||| IN
per  ||| S:29878 E:29882 ||| IN
manufacturer ||| S:29882 E:29894 ||| NN
's  ||| S:29894 E:29897 ||| POS
procedure  ||| S:29897 E:29907 ||| NN
and  ||| S:29907 E:29911 ||| CC
ligated  ||| S:29911 E:29919 ||| NN
into  ||| S:29919 E:29924 ||| IN
EcoRV ||| S:29924 E:29929 ||| JJ
/ ||| S:29929 E:29930 ||| CD
BstBI  ||| S:29930 E:29936 ||| JJ
digested  ||| S:29936 E:29945 ||| NN
and  ||| S:29945 E:29949 ||| CC
gel-purified  ||| S:29949 E:29962 ||| NNP
tKMC180C2  ||| S:29962 E:29972 ||| NNP
( ||| S:29972 E:29973 ||| -LRB-
as  ||| S:29973 E:29976 ||| RB
described  ||| S:29976 E:29986 ||| VBN
above ||| S:29986 E:29991 ||| IN
) ||| S:29991 E:29992 ||| -RRB-
,  ||| S:29992 E:29994 ||| ,
resulting  ||| S:29994 E:30004 ||| VBG
in  ||| S:30004 E:30007 ||| IN
plasmid  ||| S:30007 E:30015 ||| CD
tKMC231D  ||| S:30015 E:30024 ||| CD
( ||| S:30024 E:30025 ||| -LRB-
see  ||| S:30025 E:30029 ||| VB
FIG.  ||| S:30029 E:30034 ||| CD
4 ||| S:30034 E:30035 ||| CD
) ||| S:30035 E:30036 ||| -RRB-
.  ||| S:30036 E:30038 ||| .
The  ||| S:30038 E:30042 ||| DT
final  ||| S:30042 E:30048 ||| JJ
consensus  ||| S:30048 E:30058 ||| NN
DNA  ||| S:30058 E:30062 ||| NN
sequence  ||| S:30062 E:30071 ||| NN
of  ||| S:30071 E:30074 ||| IN
the  ||| S:30074 E:30078 ||| DT
light  ||| S:30078 E:30084 ||| JJ
chain  ||| S:30084 E:30090 ||| NN
variable  ||| S:30090 E:30099 ||| NN
region  ||| S:30099 E:30106 ||| NN
and  ||| S:30106 E:30110 ||| CC
proper  ||| S:30110 E:30117 ||| JJ
splicing  ||| S:30117 E:30126 ||| NN
of  ||| S:30126 E:30129 ||| IN
the  ||| S:30129 E:30133 ||| DT
restriction  ||| S:30133 E:30145 ||| NN
sites  ||| S:30145 E:30151 ||| NNS
were  ||| S:30151 E:30156 ||| VBD
confirmed  ||| S:30156 E:30166 ||| VBN
in  ||| S:30166 E:30169 ||| IN
this  ||| S:30169 E:30174 ||| DT
construct ||| S:30174 E:30183 ||| NN
.  ||| S:30183 E:30186 ||| .
A.  ||| S:30267 E:30270 ||| NNP
Transfection  ||| S:30270 E:30283 ||| NNP
of  ||| S:30283 E:30286 ||| IN
NSO  ||| S:30286 E:30290 ||| NNP
Cells  ||| S:30290 E:30298 ||| NNPS
The  ||| S:30298 E:30302 ||| DT
plasmid  ||| S:30302 E:30310 ||| JJ
tKMC249A  ||| S:30310 E:30319 ||| NN
was  ||| S:30319 E:30323 ||| VBD
transfected  ||| S:30323 E:30335 ||| VBN
into  ||| S:30335 E:30340 ||| IN
NSO  ||| S:30340 E:30344 ||| NNP
cells  ||| S:30344 E:30350 ||| NNS
( ||| S:30350 E:30351 ||| -LRB-
Baxter  ||| S:30351 E:30358 ||| NNP
International ||| S:30358 E:30371 ||| NNP
,  ||| S:30371 E:30373 ||| ,
Inc. ||| S:30373 E:30377 ||| NNP
,  ||| S:30377 E:30379 ||| ,
Durante ||| S:30379 E:30386 ||| NNP
,  ||| S:30386 E:30388 ||| ,
Calif. ||| S:30388 E:30394 ||| NNP
)  ||| S:30394 E:30396 ||| -RRB-
using  ||| S:30396 E:30402 ||| VBG
electroporation  ||| S:30402 E:30418 ||| NN
after  ||| S:30418 E:30424 ||| IN
linearization  ||| S:30424 E:30438 ||| NN
with  ||| S:30438 E:30443 ||| IN
PvuI  ||| S:30443 E:30448 ||| NNP
( ||| S:30448 E:30449 ||| -LRB-
New  ||| S:30449 E:30453 ||| NNP
England  ||| S:30453 E:30461 ||| NNP
Biolabs ||| S:30461 E:30468 ||| NNP
) ||| S:30468 E:30469 ||| -RRB-
.  ||| S:30469 E:30471 ||| .
40  ||| S:30471 E:30474 ||| CD
micrograms  ||| S:30474 E:30485 ||| NN
of  ||| S:30485 E:30488 ||| IN
the  ||| S:30488 E:30492 ||| DT
digested  ||| S:30492 E:30501 ||| JJ
plasmid  ||| S:30501 E:30509 ||| NN
was  ||| S:30509 E:30513 ||| VBD
mixed  ||| S:30513 E:30519 ||| VBN
with  ||| S:30519 E:30524 ||| IN
1 ||| S:30524 E:30525 ||| CD
& ||| S:30525 E:30526 ||| CC
# ||| S:30526 E:30527 ||| #
xd7 ||| S:30527 E:30530 ||| CD
; ||| S:30530 E:30531 ||| :
107  ||| S:30531 E:30535 ||| CD
cells  ||| S:30535 E:30541 ||| NNS
in  ||| S:30541 E:30544 ||| IN
a  ||| S:30544 E:30546 ||| DT
total  ||| S:30546 E:30552 ||| JJ
volume  ||| S:30552 E:30559 ||| NN
of  ||| S:30559 E:30562 ||| IN
800  ||| S:30562 E:30566 ||| CD
microliters  ||| S:30566 E:30578 ||| NN
in  ||| S:30578 E:30581 ||| IN
a  ||| S:30581 E:30583 ||| DT
0.4  ||| S:30583 E:30587 ||| CD
centimeter  ||| S:30587 E:30598 ||| CD
cuvette  ||| S:30598 E:30606 ||| NNS
and  ||| S:30606 E:30610 ||| CC
subjected  ||| S:30610 E:30620 ||| VBN
to  ||| S:30620 E:30623 ||| TO
a  ||| S:30623 E:30625 ||| DT
pulse  ||| S:30625 E:30631 ||| NN
of  ||| S:30631 E:30634 ||| IN
250  ||| S:30634 E:30638 ||| CD
mA ||| S:30638 E:30640 ||| NN
,  ||| S:30640 E:30642 ||| ,
960  ||| S:30642 E:30646 ||| CD
& ||| S:30646 E:30647 ||| CC
# ||| S:30647 E:30648 ||| #
x3bc ||| S:30648 E:30652 ||| CD
; ||| S:30652 E:30653 ||| :
F ||| S:30653 E:30654 ||| NN
.  ||| S:30654 E:30656 ||| .
The  ||| S:30656 E:30660 ||| DT
cells  ||| S:30660 E:30666 ||| NNS
were  ||| S:30666 E:30671 ||| VBD
plated  ||| S:30671 E:30678 ||| VBN
out  ||| S:30678 E:30682 ||| RP
after  ||| S:30682 E:30688 ||| IN
24  ||| S:30688 E:30691 ||| CD
hours  ||| S:30691 E:30697 ||| NNS
into  ||| S:30697 E:30702 ||| IN
96-well  ||| S:30702 E:30710 ||| CD
tissue  ||| S:30710 E:30717 ||| NN
culture  ||| S:30717 E:30725 ||| NN
plates ||| S:30725 E:30731 ||| NN
,  ||| S:30731 E:30733 ||| ,
6  ||| S:30733 E:30735 ||| CD
plates  ||| S:30735 E:30742 ||| NN
with  ||| S:30742 E:30747 ||| IN
200  ||| S:30747 E:30751 ||| CD
& ||| S:30751 E:30752 ||| CC
# ||| S:30752 E:30753 ||| #
x3bc ||| S:30753 E:30757 ||| CD
; ||| S:30757 E:30758 ||| :
l ||| S:30758 E:30759 ||| CD
/ ||| S:30759 E:30760 ||| CD
well ||| S:30760 E:30764 ||| RB
,  ||| S:30764 E:30766 ||| ,
and  ||| S:30766 E:30770 ||| CC
incubated  ||| S:30770 E:30780 ||| NN
at  ||| S:30780 E:30783 ||| IN
37 ||| S:30783 E:30785 ||| CD
& ||| S:30785 E:30786 ||| CC
# ||| S:30786 E:30787 ||| #
xb0 ||| S:30787 E:30790 ||| CD
;  ||| S:30790 E:30792 ||| :
C.  ||| S:30792 E:30795 ||| NNP
and  ||| S:30795 E:30799 ||| CC
10 ||| S:30799 E:30801 ||| CD
%  ||| S:30801 E:30803 ||| NN
CO2 ||| S:30803 E:30806 ||| NN
.  ||| S:30806 E:30808 ||| .
As  ||| S:30808 E:30811 ||| IN
colonies  ||| S:30811 E:30820 ||| NNS
appeared ||| S:30820 E:30828 ||| VBD
,  ||| S:30828 E:30830 ||| ,
the  ||| S:30830 E:30834 ||| DT
supernatants  ||| S:30834 E:30847 ||| NN
were  ||| S:30847 E:30852 ||| VBD
assayed  ||| S:30852 E:30860 ||| VBN
for  ||| S:30860 E:30864 ||| IN
the  ||| S:30864 E:30868 ||| DT
production  ||| S:30868 E:30879 ||| NN
of  ||| S:30879 E:30882 ||| IN
& ||| S:30882 E:30883 ||| CC
# ||| S:30883 E:30884 ||| #
x201c ||| S:30884 E:30889 ||| CD
; ||| S:30889 E:30890 ||| :
humanized ||| S:30890 E:30899 ||| NNS
& ||| S:30899 E:30900 ||| CC
# ||| S:30900 E:30901 ||| #
x201d ||| S:30901 E:30906 ||| CD
;  ||| S:30906 E:30908 ||| :
antibody  ||| S:30908 E:30917 ||| NN
and  ||| S:30917 E:30921 ||| CC
for  ||| S:30921 E:30925 ||| IN
the  ||| S:30925 E:30929 ||| DT
capability  ||| S:30929 E:30940 ||| NN
of  ||| S:30940 E:30943 ||| IN
the  ||| S:30943 E:30947 ||| DT
expressed  ||| S:30947 E:30957 ||| JJ
antibody  ||| S:30957 E:30966 ||| NN
to  ||| S:30966 E:30969 ||| TO
bind  ||| S:30969 E:30974 ||| VB
to  ||| S:30974 E:30977 ||| TO
Stx1 ||| S:30977 E:30981 ||| CD
.  ||| S:30981 E:30985 ||| .
B.  ||| S:30985 E:30988 ||| NNP
Assay  ||| S:30988 E:30994 ||| NNP
for  ||| S:30994 E:30998 ||| IN
Antibody  ||| S:30998 E:31007 ||| NNP
Production  ||| S:31007 E:31020 ||| NNPS
Antibody  ||| S:31020 E:31029 ||| NN
production  ||| S:31029 E:31040 ||| NN
and  ||| S:31040 E:31044 ||| CC
activity  ||| S:31044 E:31053 ||| NN
assays  ||| S:31053 E:31060 ||| NN
for  ||| S:31060 E:31064 ||| IN
the  ||| S:31064 E:31068 ||| DT
stable  ||| S:31068 E:31075 ||| JJ
transfectants  ||| S:31075 E:31089 ||| NN
were  ||| S:31089 E:31094 ||| VBD
performed  ||| S:31094 E:31104 ||| VBN
as  ||| S:31104 E:31107 ||| RB
described  ||| S:31107 E:31117 ||| VBN
below ||| S:31117 E:31122 ||| RB
.  ||| S:31122 E:31124 ||| .
These  ||| S:31124 E:31130 ||| DT
assays  ||| S:31130 E:31137 ||| JJ
demonstrate  ||| S:31137 E:31149 ||| NN
that  ||| S:31149 E:31154 ||| IN
the  ||| S:31154 E:31158 ||| DT
transfection  ||| S:31158 E:31171 ||| NN
of  ||| S:31171 E:31174 ||| IN
cells  ||| S:31174 E:31180 ||| NNS
with  ||| S:31180 E:31185 ||| IN
this  ||| S:31185 E:31190 ||| DT
plasmid  ||| S:31190 E:31198 ||| JJ
construct  ||| S:31198 E:31208 ||| NN
can  ||| S:31208 E:31212 ||| MD
result  ||| S:31212 E:31219 ||| VB
in  ||| S:31219 E:31222 ||| IN
the  ||| S:31222 E:31226 ||| DT
production  ||| S:31226 E:31237 ||| NN
of  ||| S:31237 E:31240 ||| IN
a  ||| S:31240 E:31242 ||| DT
stable  ||| S:31242 E:31249 ||| JJ
cell  ||| S:31249 E:31254 ||| NN
line  ||| S:31254 E:31259 ||| NN
that  ||| S:31259 E:31264 ||| WDT
produces  ||| S:31264 E:31273 ||| VBZ
a  ||| S:31273 E:31275 ||| DT
humanized  ||| S:31275 E:31285 ||| JJ
chimeric  ||| S:31285 E:31294 ||| JJ
version  ||| S:31294 E:31302 ||| NN
of  ||| S:31302 E:31305 ||| IN
the  ||| S:31305 E:31309 ||| DT
13C4  ||| S:31309 E:31314 ||| FW
mouse  ||| S:31314 E:31320 ||| FW
hybridoma  ||| S:31320 E:31330 ||| FW
antibody  ||| S:31330 E:31339 ||| FW
( ||| S:31339 E:31340 ||| -LRB-
designated  ||| S:31340 E:31351 ||| VBN
H13C4 ||| S:31351 E:31356 ||| CD
) ||| S:31356 E:31357 ||| -RRB-
.  ||| S:31357 E:31361 ||| .
Antibody  ||| S:31361 E:31370 ||| NN
production  ||| S:31370 E:31381 ||| NN
ELISA  ||| S:31381 E:31387 ||| NNP
assays  ||| S:31387 E:31394 ||| NN
were  ||| S:31394 E:31399 ||| VBD
performed  ||| S:31399 E:31409 ||| VBN
in  ||| S:31409 E:31412 ||| IN
8-well  ||| S:31412 E:31419 ||| CD
strips  ||| S:31419 E:31426 ||| NNS
from  ||| S:31426 E:31431 ||| IN
96-well  ||| S:31431 E:31439 ||| FW
microtiter  ||| S:31439 E:31450 ||| FW
plates  ||| S:31450 E:31457 ||| FW
( ||| S:31457 E:31458 ||| -LRB-
Maxisorp  ||| S:31458 E:31467 ||| NNP
F8 ||| S:31467 E:31469 ||| NNP
;  ||| S:31469 E:31471 ||| :
Nunc ||| S:31471 E:31475 ||| NNP
,  ||| S:31475 E:31477 ||| ,
Inc. ||| S:31477 E:31481 ||| NNP
)  ||| S:31481 E:31483 ||| -RRB-
coated  ||| S:31483 E:31490 ||| VBN
at  ||| S:31490 E:31493 ||| IN
a  ||| S:31493 E:31495 ||| DT
1 ||| S:31495 E:31496 ||| CD
: ||| S:31496 E:31497 ||| :
500  ||| S:31497 E:31501 ||| CD
dilution  ||| S:31501 E:31510 ||| NN
with  ||| S:31510 E:31515 ||| IN
Goat  ||| S:31515 E:31520 ||| NNP
anti-Human  ||| S:31520 E:31531 ||| JJ
IgG  ||| S:31531 E:31535 ||| JJ
antibody  ||| S:31535 E:31544 ||| NN
( ||| S:31544 E:31545 ||| -LRB-
Pierce  ||| S:31545 E:31552 ||| NNP
or  ||| S:31552 E:31555 ||| CC
Biodesign  ||| S:31555 E:31565 ||| NNP
International ||| S:31565 E:31578 ||| NNP
)  ||| S:31578 E:31580 ||| -RRB-
using  ||| S:31580 E:31586 ||| VBG
a  ||| S:31586 E:31588 ||| DT
Tris-HCl  ||| S:31588 E:31597 ||| JJ
coating  ||| S:31597 E:31605 ||| NN
buffer ||| S:31605 E:31611 ||| NN
,  ||| S:31611 E:31613 ||| ,
pH  ||| S:31613 E:31616 ||| JJ
8.5 ||| S:31616 E:31619 ||| CD
.  ||| S:31619 E:31621 ||| .
The  ||| S:31621 E:31625 ||| DT
plates  ||| S:31625 E:31632 ||| NN
were  ||| S:31632 E:31637 ||| VBD
covered  ||| S:31637 E:31645 ||| VBN
and  ||| S:31645 E:31649 ||| CC
incubated  ||| S:31649 E:31659 ||| JJ
overnight  ||| S:31659 E:31669 ||| JJ
at  ||| S:31669 E:31672 ||| IN
4 ||| S:31672 E:31673 ||| CD
& ||| S:31673 E:31674 ||| CC
# ||| S:31674 E:31675 ||| #
xb0 ||| S:31675 E:31678 ||| CD
;  ||| S:31678 E:31680 ||| :
C.  ||| S:31680 E:31683 ||| NNP
Plates  ||| S:31683 E:31690 ||| NNP
were  ||| S:31690 E:31695 ||| VBD
then  ||| S:31695 E:31700 ||| RB
washed  ||| S:31700 E:31707 ||| VBN
once  ||| S:31707 E:31712 ||| RB
with  ||| S:31712 E:31717 ||| IN
a  ||| S:31717 E:31719 ||| DT
wash  ||| S:31719 E:31724 ||| JJ
storage  ||| S:31724 E:31732 ||| NN
buffer  ||| S:31732 E:31739 ||| NN
( ||| S:31739 E:31740 ||| -LRB-
Tris-HCl ||| S:31740 E:31748 ||| NNP
/ ||| S:31748 E:31749 ||| NNP
NaCl ||| S:31749 E:31753 ||| NNP
/ ||| S:31753 E:31754 ||| CD
0.1 ||| S:31754 E:31757 ||| CD
%  ||| S:31757 E:31759 ||| NN
NaN3 ||| S:31759 E:31763 ||| CD
) ||| S:31763 E:31764 ||| -RRB-
.  ||| S:31764 E:31766 ||| .
50  ||| S:31766 E:31769 ||| CD
microliters  ||| S:31769 E:31781 ||| NN
of  ||| S:31781 E:31784 ||| IN
culture  ||| S:31784 E:31792 ||| NN
supernatant  ||| S:31792 E:31804 ||| NNS
was  ||| S:31804 E:31808 ||| VBD
then  ||| S:31808 E:31813 ||| RB
applied  ||| S:31813 E:31821 ||| VBN
to  ||| S:31821 E:31824 ||| TO
each  ||| S:31824 E:31829 ||| DT
well  ||| S:31829 E:31834 ||| NN
that  ||| S:31834 E:31839 ||| WDT
had  ||| S:31839 E:31843 ||| VBD
been  ||| S:31843 E:31848 ||| VBN
filled  ||| S:31848 E:31855 ||| VBN
previously  ||| S:31855 E:31866 ||| RB
with  ||| S:31866 E:31871 ||| IN
50  ||| S:31871 E:31874 ||| CD
microliters  ||| S:31874 E:31886 ||| NN
of  ||| S:31886 E:31889 ||| IN
a  ||| S:31889 E:31891 ||| DT
sample ||| S:31891 E:31897 ||| FW
/ ||| S:31897 E:31898 ||| FW
conjugate  ||| S:31898 E:31908 ||| FW
diluent  ||| S:31908 E:31916 ||| FW
( ||| S:31916 E:31917 ||| -LRB-
Tris-HCl ||| S:31917 E:31925 ||| FW
/ ||| S:31925 E:31926 ||| FW
NaCl ||| S:31926 E:31930 ||| FW
/ ||| S:31930 E:31931 ||| FW
gelatin ||| S:31931 E:31938 ||| FW
/ ||| S:31938 E:31939 ||| FW
Tween-20 ||| S:31939 E:31947 ||| FW
) ||| S:31947 E:31948 ||| -RRB-
.  ||| S:31948 E:31950 ||| .
The  ||| S:31950 E:31954 ||| DT
plates  ||| S:31954 E:31961 ||| NN
were  ||| S:31961 E:31966 ||| VBD
allowed  ||| S:31966 E:31974 ||| VBN
to  ||| S:31974 E:31977 ||| TO
incubate  ||| S:31977 E:31986 ||| VB
for  ||| S:31986 E:31990 ||| IN
30  ||| S:31990 E:31993 ||| CD
to  ||| S:31993 E:31996 ||| TO
60  ||| S:31996 E:31999 ||| CD
minutes  ||| S:31999 E:32007 ||| NNS
on  ||| S:32007 E:32010 ||| IN
a  ||| S:32010 E:32012 ||| DT
rotator  ||| S:32012 E:32020 ||| NN
at  ||| S:32020 E:32023 ||| IN
room  ||| S:32023 E:32028 ||| NN
temperature ||| S:32028 E:32039 ||| NN
.  ||| S:32039 E:32041 ||| .
They  ||| S:32041 E:32046 ||| PRP
were  ||| S:32046 E:32051 ||| VBD
then  ||| S:32051 E:32056 ||| RB
washed  ||| S:32056 E:32063 ||| VBD
three  ||| S:32063 E:32069 ||| CD
times  ||| S:32069 E:32075 ||| NNS
with  ||| S:32075 E:32080 ||| IN
a  ||| S:32080 E:32082 ||| DT
wash  ||| S:32082 E:32087 ||| JJ
solution  ||| S:32087 E:32096 ||| NN
( ||| S:32096 E:32097 ||| -LRB-
imidazole ||| S:32097 E:32106 ||| FW
/ ||| S:32106 E:32107 ||| FW
NaCl ||| S:32107 E:32111 ||| FW
/ ||| S:32111 E:32112 ||| FW
Tween-20 ||| S:32112 E:32120 ||| FW
) ||| S:32120 E:32121 ||| -RRB-
.  ||| S:32121 E:32123 ||| .
A  ||| S:32123 E:32125 ||| DT
goat  ||| S:32125 E:32130 ||| JJ
anti-human  ||| S:32130 E:32141 ||| JJ
kappa-HRP  ||| S:32141 E:32151 ||| NN
( ||| S:32151 E:32152 ||| -LRB-
Southern  ||| S:32152 E:32161 ||| NNP
Biotechnologies ||| S:32161 E:32176 ||| NNP
)  ||| S:32176 E:32178 ||| -RRB-
conjugate  ||| S:32178 E:32188 ||| NN
was  ||| S:32188 E:32192 ||| VBD
diluted  ||| S:32192 E:32200 ||| VBN
1 ||| S:32200 E:32201 ||| CD
: ||| S:32201 E:32202 ||| :
250  ||| S:32202 E:32206 ||| CD
in  ||| S:32206 E:32209 ||| IN
the  ||| S:32209 E:32213 ||| DT
sample ||| S:32213 E:32219 ||| FW
/ ||| S:32219 E:32220 ||| FW
conjugate  ||| S:32220 E:32230 ||| FW
diluent  ||| S:32230 E:32238 ||| FW
and  ||| S:32238 E:32242 ||| CC
100  ||| S:32242 E:32246 ||| CD
microliters  ||| S:32246 E:32258 ||| NNS
was  ||| S:32258 E:32262 ||| VBD
added  ||| S:32262 E:32268 ||| VBN
to  ||| S:32268 E:32271 ||| TO
the  ||| S:32271 E:32275 ||| DT
wells ||| S:32275 E:32280 ||| NNS
.  ||| S:32280 E:32282 ||| .
The  ||| S:32282 E:32286 ||| DT
plates  ||| S:32286 E:32293 ||| NN
were  ||| S:32293 E:32298 ||| VBD
incubated  ||| S:32298 E:32308 ||| VBN
on  ||| S:32308 E:32311 ||| IN
a  ||| S:32311 E:32313 ||| DT
rotator  ||| S:32313 E:32321 ||| NN
for  ||| S:32321 E:32325 ||| IN
30  ||| S:32325 E:32328 ||| CD
to  ||| S:32328 E:32331 ||| TO
60  ||| S:32331 E:32334 ||| CD
minutes  ||| S:32334 E:32342 ||| NNS
at  ||| S:32342 E:32345 ||| IN
room  ||| S:32345 E:32350 ||| NN
temperature ||| S:32350 E:32361 ||| NN
.  ||| S:32361 E:32363 ||| .
They  ||| S:32363 E:32368 ||| PRP
were  ||| S:32368 E:32373 ||| VBD
washed  ||| S:32373 E:32380 ||| VBN
6  ||| S:32380 E:32382 ||| CD
times  ||| S:32382 E:32388 ||| NNS
using  ||| S:32388 E:32394 ||| VBG
the  ||| S:32394 E:32398 ||| DT
wash  ||| S:32398 E:32403 ||| JJ
buffer ||| S:32403 E:32409 ||| NN
,  ||| S:32409 E:32411 ||| ,
and  ||| S:32411 E:32415 ||| CC
then  ||| S:32415 E:32420 ||| RB
incubated  ||| S:32420 E:32430 ||| VBN
with  ||| S:32430 E:32435 ||| IN
100  ||| S:32435 E:32439 ||| CD
& ||| S:32439 E:32440 ||| CC
# ||| S:32440 E:32441 ||| #
x3bc ||| S:32441 E:32445 ||| CD
; ||| S:32445 E:32446 ||| :
L ||| S:32446 E:32447 ||| NNP
/ ||| S:32447 E:32448 ||| NNP
well  ||| S:32448 E:32453 ||| RB
of  ||| S:32453 E:32456 ||| IN
ABTS  ||| S:32456 E:32461 ||| NNP
developing  ||| S:32461 E:32472 ||| VBG
substrate  ||| S:32472 E:32482 ||| NNS
( ||| S:32482 E:32483 ||| -LRB-
Kirkgaard  ||| S:32483 E:32493 ||| NNP
& ||| S:32493 E:32494 ||| CC
# ||| S:32494 E:32495 ||| #
x26 ||| S:32495 E:32498 ||| CD
;  ||| S:32498 E:32500 ||| :
Perry  ||| S:32500 E:32506 ||| NNP
Laboratories ||| S:32506 E:32518 ||| NNPS
)  ||| S:32518 E:32520 ||| -RRB-
for  ||| S:32520 E:32524 ||| IN
8  ||| S:32524 E:32526 ||| CD
minutes  ||| S:32526 E:32534 ||| NNS
at  ||| S:32534 E:32537 ||| IN
room  ||| S:32537 E:32542 ||| NN
temperature ||| S:32542 E:32553 ||| NN
.  ||| S:32553 E:32555 ||| .
The  ||| S:32555 E:32559 ||| DT
reaction  ||| S:32559 E:32568 ||| NN
was  ||| S:32568 E:32572 ||| VBD
stopped  ||| S:32572 E:32580 ||| VBN
with  ||| S:32580 E:32585 ||| IN
100  ||| S:32585 E:32589 ||| CD
& ||| S:32589 E:32590 ||| CC
# ||| S:32590 E:32591 ||| #
x3bc ||| S:32591 E:32595 ||| CD
; ||| S:32595 E:32596 ||| :
L ||| S:32596 E:32597 ||| NNP
/ ||| S:32597 E:32598 ||| NNP
well  ||| S:32598 E:32603 ||| RB
of  ||| S:32603 E:32606 ||| IN
diluted  ||| S:32606 E:32614 ||| JJ
Quench  ||| S:32614 E:32621 ||| JJ
buffer  ||| S:32621 E:32628 ||| NN
( ||| S:32628 E:32629 ||| -LRB-
Kirkgaard  ||| S:32629 E:32639 ||| NNP
& ||| S:32639 E:32640 ||| CC
# ||| S:32640 E:32641 ||| #
x26 ||| S:32641 E:32644 ||| CD
;  ||| S:32644 E:32646 ||| :
Perry  ||| S:32646 E:32652 ||| NNP
Laboratories ||| S:32652 E:32664 ||| NNPS
) ||| S:32664 E:32665 ||| -RRB-
.  ||| S:32665 E:32667 ||| .
The  ||| S:32667 E:32671 ||| DT
absorbance  ||| S:32671 E:32682 ||| JJ
value  ||| S:32682 E:32688 ||| NN
at  ||| S:32688 E:32691 ||| IN
405  ||| S:32691 E:32695 ||| CD
nm  ||| S:32695 E:32698 ||| NNS
was  ||| S:32698 E:32702 ||| VBD
determined  ||| S:32702 E:32713 ||| VBN
using  ||| S:32713 E:32719 ||| VBG
an  ||| S:32719 E:32722 ||| DT
automated  ||| S:32722 E:32732 ||| FW
microtiter  ||| S:32732 E:32743 ||| FW
plate  ||| S:32743 E:32749 ||| FW
ELISA  ||| S:32749 E:32755 ||| FW
reader  ||| S:32755 E:32762 ||| FW
( ||| S:32762 E:32763 ||| -LRB-
Ceres  ||| S:32763 E:32769 ||| NNP
UV900HI ||| S:32769 E:32776 ||| NNP
,  ||| S:32776 E:32778 ||| ,
Bioteck ||| S:32778 E:32785 ||| NNP
,  ||| S:32785 E:32787 ||| ,
Winooski ||| S:32787 E:32795 ||| NNP
,  ||| S:32795 E:32797 ||| ,
Vt. ||| S:32797 E:32800 ||| NNP
) ||| S:32800 E:32801 ||| -RRB-
.  ||| S:32801 E:32803 ||| .
The  ||| S:32803 E:32807 ||| DT
controls  ||| S:32807 E:32816 ||| NNS
for  ||| S:32816 E:32820 ||| IN
the  ||| S:32820 E:32824 ||| DT
ELISA  ||| S:32824 E:32830 ||| NNP
assay  ||| S:32830 E:32836 ||| NN
were  ||| S:32836 E:32841 ||| VBD
a  ||| S:32841 E:32843 ||| DT
human  ||| S:32843 E:32849 ||| JJ
IgG1K  ||| S:32849 E:32855 ||| FW
myeloma  ||| S:32855 E:32863 ||| FW
protein  ||| S:32863 E:32871 ||| FW
( ||| S:32871 E:32872 ||| -LRB-
Biodesign  ||| S:32872 E:32882 ||| NNP
International ||| S:32882 E:32895 ||| NNP
)  ||| S:32895 E:32897 ||| -RRB-
and  ||| S:32897 E:32901 ||| CC
supernatant  ||| S:32901 E:32913 ||| VB
collected  ||| S:32913 E:32923 ||| VBN
from  ||| S:32923 E:32928 ||| IN
non-transfected  ||| S:32928 E:32944 ||| NNP
NSO  ||| S:32944 E:32948 ||| NNP
cells ||| S:32948 E:32953 ||| NNS
.  ||| S:32953 E:32955 ||| .
This  ||| S:32955 E:32960 ||| DT
assay  ||| S:32960 E:32966 ||| NN
( ||| S:32966 E:32967 ||| -LRB-
see  ||| S:32967 E:32971 ||| VB
FIG.  ||| S:32971 E:32976 ||| CD
8 ||| S:32976 E:32977 ||| CD
)  ||| S:32977 E:32979 ||| -RRB-
demonstrates  ||| S:32979 E:32992 ||| VBZ
that  ||| S:32992 E:32997 ||| IN
the  ||| S:32997 E:33001 ||| DT
transfection  ||| S:33001 E:33014 ||| NN
of  ||| S:33014 E:33017 ||| IN
cells  ||| S:33017 E:33023 ||| NNS
with  ||| S:33023 E:33028 ||| IN
this  ||| S:33028 E:33033 ||| DT
plasmid  ||| S:33033 E:33041 ||| JJ
construct  ||| S:33041 E:33051 ||| JJ
results  ||| S:33051 E:33059 ||| NNS
in  ||| S:33059 E:33062 ||| IN
the  ||| S:33062 E:33066 ||| DT
cells  ||| S:33066 E:33072 ||| NNS
producing  ||| S:33072 E:33082 ||| VBG
a  ||| S:33082 E:33084 ||| DT
molecule  ||| S:33084 E:33093 ||| NN
containing  ||| S:33093 E:33104 ||| VBG
both  ||| S:33104 E:33109 ||| DT
human  ||| S:33109 E:33115 ||| JJ
heavy  ||| S:33115 E:33121 ||| JJ
chain  ||| S:33121 E:33127 ||| NN
( ||| S:33127 E:33128 ||| -LRB-
IgG ||| S:33128 E:33131 ||| NNP
)  ||| S:33131 E:33133 ||| -RRB-
and  ||| S:33133 E:33137 ||| CC
light  ||| S:33137 E:33143 ||| JJ
chain  ||| S:33143 E:33149 ||| NN
( ||| S:33149 E:33150 ||| -LRB-
kappa ||| S:33150 E:33155 ||| LS
)  ||| S:33155 E:33157 ||| -RRB-
domains ||| S:33157 E:33164 ||| NN
.  ||| S:33164 E:33168 ||| .
The  ||| S:33168 E:33172 ||| DT
supernatants  ||| S:33172 E:33185 ||| NN
were  ||| S:33185 E:33190 ||| VBD
then  ||| S:33190 E:33195 ||| RB
assayed  ||| S:33195 E:33203 ||| VBN
for  ||| S:33203 E:33207 ||| IN
the  ||| S:33207 E:33211 ||| DT
ability  ||| S:33211 E:33219 ||| NN
of  ||| S:33219 E:33222 ||| IN
the  ||| S:33222 E:33226 ||| DT
expressed  ||| S:33226 E:33236 ||| JJ
antibodies  ||| S:33236 E:33247 ||| NNS
to  ||| S:33247 E:33250 ||| TO
bind  ||| S:33250 E:33255 ||| VB
to  ||| S:33255 E:33258 ||| TO
Stx1  ||| S:33258 E:33263 ||| CD
protein  ||| S:33263 E:33271 ||| NN
by  ||| S:33271 E:33274 ||| IN
ELISA ||| S:33274 E:33279 ||| NNP
.  ||| S:33279 E:33281 ||| .
The  ||| S:33281 E:33285 ||| DT
activity  ||| S:33285 E:33294 ||| NN
assays  ||| S:33294 E:33301 ||| NNS
were  ||| S:33301 E:33306 ||| VBD
preformed  ||| S:33306 E:33316 ||| VBN
in  ||| S:33316 E:33319 ||| IN
8-well  ||| S:33319 E:33326 ||| CD
strips  ||| S:33326 E:33333 ||| NNS
from  ||| S:33333 E:33338 ||| IN
96-well  ||| S:33338 E:33346 ||| FW
microtiter  ||| S:33346 E:33357 ||| FW
plates  ||| S:33357 E:33364 ||| FW
( ||| S:33364 E:33365 ||| -LRB-
Maxisorp  ||| S:33365 E:33374 ||| NNP
F8 ||| S:33374 E:33376 ||| NNP
;  ||| S:33376 E:33378 ||| :
Nunc ||| S:33378 E:33382 ||| NNP
,  ||| S:33382 E:33384 ||| ,
Inc. ||| S:33384 E:33388 ||| NNP
)  ||| S:33388 E:33390 ||| -RRB-
coated  ||| S:33390 E:33397 ||| VBN
with  ||| S:33397 E:33402 ||| IN
approximately  ||| S:33402 E:33416 ||| RB
0.1  ||| S:33416 E:33420 ||| CD
& ||| S:33420 E:33421 ||| CC
# ||| S:33421 E:33422 ||| #
x3bc ||| S:33422 E:33426 ||| CD
; ||| S:33426 E:33427 ||| :
g ||| S:33427 E:33428 ||| CD
/ ||| S:33428 E:33429 ||| CD
well  ||| S:33429 E:33434 ||| RB
purified  ||| S:33434 E:33443 ||| JJ
Stx1  ||| S:33443 E:33448 ||| NN
received  ||| S:33448 E:33457 ||| VBD
from  ||| S:33457 E:33462 ||| IN
Alison  ||| S:33462 E:33469 ||| NNP
O ||| S:33469 E:33470 ||| NNP
' ||| S:33470 E:33471 ||| POS
Brien  ||| S:33471 E:33477 ||| NNP
( ||| S:33477 E:33478 ||| -LRB-
or  ||| S:33478 E:33481 ||| CC
obtained  ||| S:33481 E:33490 ||| VBD
as  ||| S:33490 E:33493 ||| RB
described  ||| S:33493 E:33503 ||| VBN
in  ||| S:33503 E:33506 ||| IN
Example  ||| S:33506 E:33514 ||| NNP
7 ||| S:33514 E:33515 ||| CD
) ||| S:33515 E:33516 ||| -RRB-
.  ||| S:33516 E:33518 ||| .
The  ||| S:33518 E:33522 ||| DT
plate  ||| S:33522 E:33528 ||| NN
coating  ||| S:33528 E:33536 ||| NN
and  ||| S:33536 E:33540 ||| CC
ELISA  ||| S:33540 E:33546 ||| NNP
procedure  ||| S:33546 E:33556 ||| NN
was  ||| S:33556 E:33560 ||| VBD
performed  ||| S:33560 E:33570 ||| VBN
in  ||| S:33570 E:33573 ||| IN
the  ||| S:33573 E:33577 ||| DT
same  ||| S:33577 E:33582 ||| JJ
manner  ||| S:33582 E:33589 ||| NN
as  ||| S:33589 E:33592 ||| IN
the  ||| S:33592 E:33596 ||| DT
antibody  ||| S:33596 E:33605 ||| NN
assay  ||| S:33605 E:33611 ||| NN
above  ||| S:33611 E:33617 ||| IN
with  ||| S:33617 E:33622 ||| IN
the  ||| S:33622 E:33626 ||| DT
substitution  ||| S:33626 E:33639 ||| NN
of  ||| S:33639 E:33642 ||| IN
TMB  ||| S:33642 E:33646 ||| NNP
( ||| S:33646 E:33647 ||| -LRB-
Kirkgaard  ||| S:33647 E:33657 ||| NNP
& ||| S:33657 E:33658 ||| CC
# ||| S:33658 E:33659 ||| #
x26 ||| S:33659 E:33662 ||| CD
;  ||| S:33662 E:33664 ||| :
Perry  ||| S:33664 E:33670 ||| NNP
Laboratories ||| S:33670 E:33682 ||| NNPS
)  ||| S:33682 E:33684 ||| -RRB-
for  ||| S:33684 E:33688 ||| IN
ABTS  ||| S:33688 E:33693 ||| NNP
as  ||| S:33693 E:33696 ||| IN
a  ||| S:33696 E:33698 ||| DT
developing  ||| S:33698 E:33709 ||| VBG
substrate ||| S:33709 E:33718 ||| NNS
.  ||| S:33718 E:33720 ||| .
The  ||| S:33720 E:33724 ||| DT
absorbance  ||| S:33724 E:33735 ||| JJ
value  ||| S:33735 E:33741 ||| NN
at  ||| S:33741 E:33744 ||| IN
450  ||| S:33744 E:33748 ||| CD
nm  ||| S:33748 E:33751 ||| NNS
was  ||| S:33751 E:33755 ||| VBD
determined  ||| S:33755 E:33766 ||| VBN
using  ||| S:33766 E:33772 ||| VBG
an  ||| S:33772 E:33775 ||| DT
automated  ||| S:33775 E:33785 ||| FW
microtiter  ||| S:33785 E:33796 ||| FW
plate  ||| S:33796 E:33802 ||| FW
ELISA  ||| S:33802 E:33808 ||| FW
reader  ||| S:33808 E:33815 ||| FW
( ||| S:33815 E:33816 ||| -LRB-
Ceres  ||| S:33816 E:33822 ||| NNP
UV900HI ||| S:33822 E:33829 ||| NNP
,  ||| S:33829 E:33831 ||| ,
Bioteck ||| S:33831 E:33838 ||| NNP
,  ||| S:33838 E:33840 ||| ,
Winooski ||| S:33840 E:33848 ||| NNP
,  ||| S:33848 E:33850 ||| ,
Vt. ||| S:33850 E:33853 ||| NNP
) ||| S:33853 E:33854 ||| -RRB-
.  ||| S:33854 E:33856 ||| .
As  ||| S:33856 E:33859 ||| IN
a  ||| S:33859 E:33861 ||| DT
positive  ||| S:33861 E:33870 ||| JJ
control ||| S:33870 E:33877 ||| NN
,  ||| S:33877 E:33879 ||| ,
the  ||| S:33879 E:33883 ||| DT
original  ||| S:33883 E:33892 ||| JJ
mouse  ||| S:33892 E:33898 ||| NN
monoclonal  ||| S:33898 E:33909 ||| NN
antibody  ||| S:33909 E:33918 ||| NN
13C4  ||| S:33918 E:33923 ||| NN
was  ||| S:33923 E:33927 ||| VBD
used ||| S:33927 E:33931 ||| VBN
,  ||| S:33931 E:33933 ||| ,
and  ||| S:33933 E:33937 ||| CC
assayed  ||| S:33937 E:33945 ||| NN
with  ||| S:33945 E:33950 ||| IN
a  ||| S:33950 E:33952 ||| DT
goat  ||| S:33952 E:33957 ||| JJ
anti-mouse  ||| S:33957 E:33968 ||| JJ
IgG  ||| S:33968 E:33972 ||| JJ
conjugate  ||| S:33972 E:33982 ||| NNS
( ||| S:33982 E:33983 ||| -LRB-
Jackson  ||| S:33983 E:33991 ||| NNP
Laboratories ||| S:33991 E:34003 ||| NNPS
)  ||| S:34003 E:34005 ||| -RRB-
at  ||| S:34005 E:34008 ||| IN
a  ||| S:34008 E:34010 ||| DT
1 ||| S:34010 E:34011 ||| CD
: ||| S:34011 E:34012 ||| :
2000  ||| S:34012 E:34017 ||| CD
dilution ||| S:34017 E:34025 ||| NN
.  ||| S:34025 E:34027 ||| .
This  ||| S:34027 E:34032 ||| DT
assay  ||| S:34032 E:34038 ||| NN
( ||| S:34038 E:34039 ||| -LRB-
see  ||| S:34039 E:34043 ||| VB
FIG.  ||| S:34043 E:34048 ||| CD
9 ||| S:34048 E:34049 ||| CD
)  ||| S:34049 E:34051 ||| -RRB-
demonstrates  ||| S:34051 E:34064 ||| VBZ
that  ||| S:34064 E:34069 ||| IN
the  ||| S:34069 E:34073 ||| DT
transfection  ||| S:34073 E:34086 ||| NN
of  ||| S:34086 E:34089 ||| IN
cells  ||| S:34089 E:34095 ||| NNS
with  ||| S:34095 E:34100 ||| IN
this  ||| S:34100 E:34105 ||| DT
plasmid  ||| S:34105 E:34113 ||| JJ
construct  ||| S:34113 E:34123 ||| JJ
results  ||| S:34123 E:34131 ||| NNS
in  ||| S:34131 E:34134 ||| IN
cells  ||| S:34134 E:34140 ||| NNS
producing  ||| S:34140 E:34150 ||| VBG
immunoglobulin  ||| S:34150 E:34165 ||| NN
that  ||| S:34165 E:34170 ||| IN
binds  ||| S:34170 E:34176 ||| VBG
to  ||| S:34176 E:34179 ||| TO
Stx1 ||| S:34179 E:34183 ||| CD
.  ||| S:34183 E:34185 ||| .
Neither  ||| S:34185 E:34193 ||| DT
mouse  ||| S:34193 E:34199 ||| NN
nor  ||| S:34199 E:34203 ||| CC
human  ||| S:34203 E:34209 ||| JJ
IgG  ||| S:34209 E:34213 ||| JJ
1K  ||| S:34213 E:34216 ||| NN
lacking  ||| S:34216 E:34224 ||| VBG
the  ||| S:34224 E:34228 ||| DT
anti-Stx  ||| S:34228 E:34237 ||| JJ
variable  ||| S:34237 E:34246 ||| JJ
region  ||| S:34246 E:34253 ||| NN
bound  ||| S:34253 E:34259 ||| VBN
the  ||| S:34259 E:34263 ||| DT
toxin ||| S:34263 E:34268 ||| NN
.  ||| S:34268 E:34272 ||| .
Humanization  ||| S:34272 E:34285 ||| NNP
of  ||| S:34285 E:34288 ||| IN
the  ||| S:34288 E:34292 ||| DT
EHEC  ||| S:34292 E:34297 ||| NNP
Anti-Stx2  ||| S:34297 E:34307 ||| NNP
Antibody ||| S:34307 E:34315 ||| NNP
:  ||| S:34315 E:34317 ||| :
11E10  ||| S:34317 E:34325 ||| LS
The  ||| S:34325 E:34329 ||| DT
following  ||| S:34329 E:34339 ||| JJ
examples  ||| S:34339 E:34348 ||| NNS
4-7  ||| S:34348 E:34352 ||| VBP
relate  ||| S:34352 E:34359 ||| VBN
to  ||| S:34359 E:34362 ||| TO
anti-Stx2  ||| S:34362 E:34372 ||| CD
and  ||| S:34372 E:34376 ||| CC
-Stx2  ||| S:34376 E:34382 ||| CD
variant  ||| S:34382 E:34390 ||| JJ
antibody  ||| S:34390 E:34399 ||| NN
11E10  ||| S:34399 E:34405 ||| NN
and  ||| S:34405 E:34409 ||| CC
its  ||| S:34409 E:34413 ||| PRP$
humanized  ||| S:34413 E:34423 ||| JJ
counterpart  ||| S:34423 E:34435 ||| NN
H11E10 ||| S:34435 E:34441 ||| NN
.  ||| S:34441 E:34444 ||| .
The  ||| S:34500 E:34504 ||| DT
hybridoma  ||| S:34504 E:34514 ||| JJ
cell  ||| S:34514 E:34519 ||| NN
line  ||| S:34519 E:34524 ||| NN
producing  ||| S:34524 E:34534 ||| VBG
the  ||| S:34534 E:34538 ||| DT
& ||| S:34538 E:34539 ||| CC
# ||| S:34539 E:34540 ||| #
x201c ||| S:34540 E:34545 ||| CD
; ||| S:34545 E:34546 ||| :
11  ||| S:34546 E:34549 ||| CD
E10 ||| S:34549 E:34552 ||| CD
& ||| S:34552 E:34553 ||| CC
# ||| S:34553 E:34554 ||| #
x201d ||| S:34554 E:34559 ||| CD
;  ||| S:34559 E:34561 ||| :
antibody  ||| S:34561 E:34570 ||| NN
( ||| S:34570 E:34571 ||| -LRB-
Anti-Stx2 ||| S:34571 E:34580 ||| NNP
)  ||| S:34580 E:34582 ||| -RRB-
was  ||| S:34582 E:34586 ||| VBD
deposited  ||| S:34586 E:34596 ||| VBN
on  ||| S:34596 E:34599 ||| IN
Aug.  ||| S:34599 E:34604 ||| NNP
1 ||| S:34604 E:34605 ||| CD
,  ||| S:34605 E:34607 ||| ,
1990 ||| S:34607 E:34611 ||| CD
,  ||| S:34611 E:34613 ||| ,
at  ||| S:34613 E:34616 ||| IN
the  ||| S:34616 E:34620 ||| DT
American  ||| S:34620 E:34629 ||| NNP
Type  ||| S:34629 E:34634 ||| NNP
Culture  ||| S:34634 E:34642 ||| NNP
Collection ||| S:34642 E:34652 ||| NNP
,  ||| S:34652 E:34654 ||| ,
10801  ||| S:34654 E:34660 ||| CD
University  ||| S:34660 E:34671 ||| NNP
Boulevard ||| S:34671 E:34680 ||| NNP
,  ||| S:34680 E:34682 ||| ,
Manassas ||| S:34682 E:34690 ||| NNP
,  ||| S:34690 E:34692 ||| ,
Va. ||| S:34692 E:34695 ||| NNP
,  ||| S:34695 E:34697 ||| ,
20110-2209 ||| S:34697 E:34707 ||| NNP
,  ||| S:34707 E:34709 ||| ,
under  ||| S:34709 E:34715 ||| IN
Accession  ||| S:34715 E:34725 ||| NNP
No ||| S:34725 E:34727 ||| NNP
.  ||| S:34727 E:34729 ||| .
CRL  ||| S:34729 E:34733 ||| NNP
1987 ||| S:34733 E:34737 ||| CD
,  ||| S:34737 E:34739 ||| ,
and  ||| S:34739 E:34743 ||| CC
can  ||| S:34743 E:34747 ||| MD
be  ||| S:34747 E:34750 ||| VB
obtained  ||| S:34750 E:34759 ||| VBN
from  ||| S:34759 E:34764 ||| IN
the  ||| S:34764 E:34768 ||| DT
ATCC ||| S:34768 E:34772 ||| NNP
,  ||| S:34772 E:34774 ||| ,
or ||| S:34774 E:34776 ||| CC
,  ||| S:34776 E:34778 ||| ,
as  ||| S:34778 E:34781 ||| RB
here ||| S:34781 E:34785 ||| RB
,  ||| S:34785 E:34787 ||| ,
from  ||| S:34787 E:34792 ||| IN
Dr.  ||| S:34792 E:34796 ||| NNP
Alison  ||| S:34796 E:34803 ||| NNP
O ||| S:34803 E:34804 ||| NNP
' ||| S:34804 E:34805 ||| POS
Brien  ||| S:34805 E:34811 ||| NNP
( ||| S:34811 E:34812 ||| -LRB-
for  ||| S:34812 E:34816 ||| IN
details  ||| S:34816 E:34824 ||| NNS
of  ||| S:34824 E:34827 ||| IN
hybridoma  ||| S:34827 E:34837 ||| JJ
preparation ||| S:34837 E:34848 ||| NN
,  ||| S:34848 E:34850 ||| ,
see  ||| S:34850 E:34854 ||| VB
Perera ||| S:34854 E:34860 ||| NNP
,  ||| S:34860 E:34862 ||| ,
L.  ||| S:34862 E:34865 ||| NNP
P.  ||| S:34865 E:34868 ||| NNP
et  ||| S:34868 E:34871 ||| NNP
al. ||| S:34871 E:34874 ||| NNP
,  ||| S:34874 E:34876 ||| ,
J  ||| S:34876 E:34878 ||| NNP
Clinical  ||| S:34878 E:34887 ||| NNP
Microbil. ||| S:34887 E:34896 ||| NNP
,  ||| S:34896 E:34898 ||| ,
26 ||| S:34898 E:34900 ||| CD
: ||| S:34900 E:34901 ||| :
2127-2131 ||| S:34901 E:34910 ||| CD
( ||| S:34910 E:34911 ||| -LRB-
1988 ||| S:34911 E:34915 ||| CD
) ||| S:34915 E:34916 ||| -RRB-
) ||| S:34916 E:34917 ||| -RRB-
.  ||| S:34917 E:34919 ||| .
A  ||| S:34919 E:34921 ||| DT
vial  ||| S:34921 E:34926 ||| NN
of  ||| S:34926 E:34929 ||| IN
the  ||| S:34929 E:34933 ||| DT
cell  ||| S:34933 E:34938 ||| NN
line  ||| S:34938 E:34943 ||| NN
was  ||| S:34943 E:34947 ||| VBD
thawed ||| S:34947 E:34953 ||| CD
,  ||| S:34953 E:34955 ||| ,
washed  ||| S:34955 E:34962 ||| VBN
with  ||| S:34962 E:34967 ||| IN
serum  ||| S:34967 E:34973 ||| JJ
free  ||| S:34973 E:34978 ||| JJ
medium  ||| S:34978 E:34985 ||| NN
and  ||| S:34985 E:34989 ||| CC
then  ||| S:34989 E:34994 ||| RB
resuspended  ||| S:34994 E:35006 ||| VBN
in  ||| S:35006 E:35009 ||| IN
IMDM  ||| S:35009 E:35014 ||| NNP
( ||| S:35014 E:35015 ||| -LRB-
Mediatech ||| S:35015 E:35024 ||| NNP
)  ||| S:35024 E:35026 ||| -RRB-
complete  ||| S:35026 E:35035 ||| JJ
media  ||| S:35035 E:35041 ||| NNS
supplemented  ||| S:35041 E:35054 ||| VBN
with  ||| S:35054 E:35059 ||| IN
10 ||| S:35059 E:35061 ||| CD
%  ||| S:35061 E:35063 ||| NN
FBS  ||| S:35063 E:35067 ||| NNP
( ||| S:35067 E:35068 ||| -LRB-
Irvine ||| S:35068 E:35074 ||| NNP
) ||| S:35074 E:35075 ||| -RRB-
.  ||| S:35075 E:35079 ||| .
Total  ||| S:35079 E:35085 ||| JJ
RNA  ||| S:35085 E:35089 ||| NNP
was  ||| S:35089 E:35093 ||| VBD
isolated  ||| S:35093 E:35102 ||| VBN
from  ||| S:35102 E:35107 ||| IN
1 ||| S:35107 E:35108 ||| CD
& ||| S:35108 E:35109 ||| CC
# ||| S:35109 E:35110 ||| #
xd7 ||| S:35110 E:35113 ||| CD
; ||| S:35113 E:35114 ||| :
107  ||| S:35114 E:35118 ||| CD
& ||| S:35118 E:35119 ||| CC
# ||| S:35119 E:35120 ||| #
x201c ||| S:35120 E:35125 ||| CD
; ||| S:35125 E:35126 ||| :
11E10 ||| S:35126 E:35131 ||| CD
& ||| S:35131 E:35132 ||| CC
# ||| S:35132 E:35133 ||| #
x201d ||| S:35133 E:35138 ||| CD
;  ||| S:35138 E:35140 ||| :
cells  ||| S:35140 E:35146 ||| NNS
using  ||| S:35146 E:35152 ||| VBG
the  ||| S:35152 E:35156 ||| DT
RNeasy  ||| S:35156 E:35163 ||| JJ
RNA  ||| S:35163 E:35167 ||| NNP
Isolation  ||| S:35167 E:35177 ||| NNP
kit  ||| S:35177 E:35181 ||| NN
( ||| S:35181 E:35182 ||| -LRB-
Qiagen ||| S:35182 E:35188 ||| NNP
)  ||| S:35188 E:35190 ||| -RRB-
following  ||| S:35190 E:35200 ||| VBG
the  ||| S:35200 E:35204 ||| DT
manufacturer ||| S:35204 E:35216 ||| NN
's  ||| S:35216 E:35219 ||| POS
procedure ||| S:35219 E:35228 ||| NN
.  ||| S:35228 E:35230 ||| .
The  ||| S:35230 E:35234 ||| DT
RNA  ||| S:35234 E:35238 ||| NNP
was  ||| S:35238 E:35242 ||| VBD
dissolved  ||| S:35242 E:35252 ||| VBN
in  ||| S:35252 E:35255 ||| IN
10  ||| S:35255 E:35258 ||| CD
mM  ||| S:35258 E:35261 ||| JJ
Tris ||| S:35261 E:35265 ||| NNP
,  ||| S:35265 E:35267 ||| ,
0.1  ||| S:35267 E:35271 ||| CD
mM  ||| S:35271 E:35274 ||| JJ
EDTA  ||| S:35274 E:35279 ||| NNP
( ||| S:35279 E:35280 ||| -LRB-
pH  ||| S:35280 E:35283 ||| NNP
8.4 ||| S:35283 E:35286 ||| CD
)  ||| S:35286 E:35288 ||| -RRB-
containing  ||| S:35288 E:35299 ||| VBG
0.03  ||| S:35299 E:35304 ||| CD
U ||| S:35304 E:35305 ||| NNP
/ ||| S:35305 E:35306 ||| NNP
& ||| S:35306 E:35307 ||| CC
# ||| S:35307 E:35308 ||| #
x3bc ||| S:35308 E:35312 ||| CD
; ||| S:35312 E:35313 ||| :
g  ||| S:35313 E:35315 ||| JJ
Prime  ||| S:35315 E:35321 ||| NNP
RNase  ||| S:35321 E:35327 ||| NNP
Inhibitor  ||| S:35327 E:35337 ||| NNP
( ||| S:35337 E:35338 ||| -LRB-
5 ||| S:35338 E:35339 ||| CD
& ||| S:35339 E:35340 ||| CC
# ||| S:35340 E:35341 ||| #
x2032 ||| S:35341 E:35346 ||| CD
; ||| S:35346 E:35347 ||| :
-3 ||| S:35347 E:35349 ||| CD
& ||| S:35349 E:35350 ||| CC
# ||| S:35350 E:35351 ||| #
x2032 ||| S:35351 E:35356 ||| CD
; ||| S:35356 E:35357 ||| CD
)  ||| S:35357 E:35359 ||| -RRB-
to  ||| S:35359 E:35362 ||| TO
a  ||| S:35362 E:35364 ||| DT
final  ||| S:35364 E:35370 ||| JJ
concentration  ||| S:35370 E:35384 ||| NN
of  ||| S:35384 E:35387 ||| IN
0.63  ||| S:35387 E:35392 ||| CD
& ||| S:35392 E:35393 ||| CC
# ||| S:35393 E:35394 ||| #
x3bc ||| S:35394 E:35398 ||| CD
; ||| S:35398 E:35399 ||| :
g ||| S:35399 E:35400 ||| CD
/ ||| S:35400 E:35401 ||| CD
& ||| S:35401 E:35402 ||| CC
# ||| S:35402 E:35403 ||| #
x3bc ||| S:35403 E:35407 ||| CD
; ||| S:35407 E:35408 ||| :
l ||| S:35408 E:35409 ||| CD
.  ||| S:35409 E:35413 ||| .
FIG.  ||| S:35413 E:35418 ||| CD
1  ||| S:35418 E:35420 ||| CD
shows  ||| S:35420 E:35426 ||| NNS
the  ||| S:35426 E:35430 ||| DT
strategy  ||| S:35430 E:35439 ||| NN
for  ||| S:35439 E:35443 ||| IN
cloning  ||| S:35443 E:35451 ||| VBG
the  ||| S:35451 E:35455 ||| DT
variable  ||| S:35455 E:35464 ||| JJ
region  ||| S:35464 E:35471 ||| NN
gene  ||| S:35471 E:35476 ||| NN
fragments  ||| S:35476 E:35486 ||| NNS
and  ||| S:35486 E:35490 ||| CC
FIG.  ||| S:35490 E:35495 ||| CD
5  ||| S:35495 E:35497 ||| CD
lists  ||| S:35497 E:35503 ||| NNS
the  ||| S:35503 E:35507 ||| DT
oligonucleotide  ||| S:35507 E:35523 ||| JJ
primers  ||| S:35523 E:35531 ||| NNS
used ||| S:35531 E:35535 ||| VBN
.  ||| S:35535 E:35537 ||| .
The  ||| S:35537 E:35541 ||| DT
& ||| S:35541 E:35542 ||| CC
# ||| S:35542 E:35543 ||| #
x201c ||| S:35543 E:35548 ||| CD
; ||| S:35548 E:35549 ||| :
11E10 ||| S:35549 E:35554 ||| CD
& ||| S:35554 E:35555 ||| CC
# ||| S:35555 E:35556 ||| #
x201d ||| S:35556 E:35561 ||| CD
;  ||| S:35561 E:35563 ||| :
total  ||| S:35563 E:35569 ||| JJ
RNA  ||| S:35569 E:35573 ||| NNP
( ||| S:35573 E:35574 ||| -LRB-
2.5  ||| S:35574 E:35578 ||| CD
& ||| S:35578 E:35579 ||| CC
# ||| S:35579 E:35580 ||| #
x3bc ||| S:35580 E:35584 ||| CD
; ||| S:35584 E:35585 ||| :
g ||| S:35585 E:35586 ||| LS
)  ||| S:35586 E:35588 ||| -RRB-
was  ||| S:35588 E:35592 ||| VBD
converted  ||| S:35592 E:35602 ||| VBN
to  ||| S:35602 E:35605 ||| TO
cDNA  ||| S:35605 E:35610 ||| JJ
by  ||| S:35610 E:35613 ||| IN
using  ||| S:35613 E:35619 ||| VBG
Superscript  ||| S:35619 E:35631 ||| NNP
11-MMLV  ||| S:35631 E:35639 ||| NNP
Reverse  ||| S:35639 E:35647 ||| NNP
Transcriptase  ||| S:35647 E:35661 ||| NNP
( ||| S:35661 E:35662 ||| -LRB-
Life  ||| S:35662 E:35667 ||| NNP
Technologies ||| S:35667 E:35679 ||| NNPS
)  ||| S:35679 E:35681 ||| -RRB-
according  ||| S:35681 E:35691 ||| VBG
to  ||| S:35691 E:35694 ||| TO
manufacturer ||| S:35694 E:35706 ||| NN
's  ||| S:35706 E:35709 ||| POS
procedures ||| S:35709 E:35719 ||| NNS
.  ||| S:35719 E:35721 ||| .
The  ||| S:35721 E:35725 ||| DT
mouse  ||| S:35725 E:35731 ||| NN
light  ||| S:35731 E:35737 ||| NN
chain  ||| S:35737 E:35743 ||| NN
( ||| S:35743 E:35744 ||| -LRB-
JS153 ||| S:35744 E:35749 ||| NNP
,  ||| S:35749 E:35751 ||| ,
JS154 ||| S:35751 E:35756 ||| NNP
,  ||| S:35756 E:35758 ||| ,
SEQ  ||| S:35758 E:35762 ||| UH
ID  ||| S:35762 E:35765 ||| UH
NO ||| S:35765 E:35767 ||| UH
: ||| S:35767 E:35768 ||| :
11  ||| S:35768 E:35771 ||| CD
and  ||| S:35771 E:35775 ||| CC
12 ||| S:35775 E:35777 ||| CD
)  ||| S:35777 E:35779 ||| -RRB-
and  ||| S:35779 E:35783 ||| CC
mouse  ||| S:35783 E:35789 ||| JJ
heavy  ||| S:35789 E:35795 ||| JJ
chain  ||| S:35795 E:35801 ||| NN
( ||| S:35801 E:35802 ||| -LRB-
JS300 ||| S:35802 E:35807 ||| NNP
,  ||| S:35807 E:35809 ||| ,
SEQ  ||| S:35809 E:35813 ||| UH
ID  ||| S:35813 E:35816 ||| UH
NO ||| S:35816 E:35818 ||| UH
: ||| S:35818 E:35819 ||| :
6 ||| S:35819 E:35820 ||| CD
)  ||| S:35820 E:35822 ||| -RRB-
were  ||| S:35822 E:35827 ||| VBD
used  ||| S:35827 E:35832 ||| VBN
as  ||| S:35832 E:35835 ||| IN
specific  ||| S:35835 E:35844 ||| JJ
primers ||| S:35844 E:35851 ||| NN
.  ||| S:35851 E:35853 ||| .
The  ||| S:35853 E:35857 ||| DT
first  ||| S:35857 E:35863 ||| JJ
strand  ||| S:35863 E:35870 ||| JJ
cDNA  ||| S:35870 E:35875 ||| JJ
synthesis  ||| S:35875 E:35885 ||| NN
products  ||| S:35885 E:35894 ||| NNS
were  ||| S:35894 E:35899 ||| VBD
then  ||| S:35899 E:35904 ||| RB
purified  ||| S:35904 E:35913 ||| VBP
using  ||| S:35913 E:35919 ||| VBG
a  ||| S:35919 E:35921 ||| DT
Centricon-30  ||| S:35921 E:35934 ||| JJ
concentrator  ||| S:35934 E:35947 ||| JJ
device  ||| S:35947 E:35954 ||| NN
( ||| S:35954 E:35955 ||| -LRB-
Amicon ||| S:35955 E:35961 ||| NNP
) ||| S:35961 E:35962 ||| -RRB-
.  ||| S:35962 E:35964 ||| .
Of  ||| S:35964 E:35967 ||| IN
the  ||| S:35967 E:35971 ||| DT
70  ||| S:35971 E:35974 ||| CD
& ||| S:35974 E:35975 ||| CC
# ||| S:35975 E:35976 ||| #
x3bc ||| S:35976 E:35980 ||| CD
; ||| S:35980 E:35981 ||| :
l  ||| S:35981 E:35983 ||| NN
of  ||| S:35983 E:35986 ||| IN
cDNA  ||| S:35986 E:35991 ||| JJ
recovered ||| S:35991 E:36000 ||| NN
,  ||| S:36000 E:36002 ||| ,
3.5  ||| S:36002 E:36006 ||| CD
& ||| S:36006 E:36007 ||| CC
# ||| S:36007 E:36008 ||| #
x3bc ||| S:36008 E:36012 ||| CD
; ||| S:36012 E:36013 ||| :
l  ||| S:36013 E:36015 ||| NNS
was  ||| S:36015 E:36019 ||| VBD
used  ||| S:36019 E:36024 ||| VBN
as  ||| S:36024 E:36027 ||| IN
template  ||| S:36027 E:36036 ||| JJ
DNA  ||| S:36036 E:36040 ||| NN
for  ||| S:36040 E:36044 ||| IN
PCR ||| S:36044 E:36047 ||| NNP
.  ||| S:36047 E:36049 ||| .
Typical  ||| S:36049 E:36057 ||| JJ
PCR  ||| S:36057 E:36061 ||| NNP
amplification  ||| S:36061 E:36075 ||| NN
reactions  ||| S:36075 E:36085 ||| NNS
( ||| S:36085 E:36086 ||| -LRB-
100  ||| S:36086 E:36090 ||| CD
& ||| S:36090 E:36091 ||| CC
# ||| S:36091 E:36092 ||| #
x3bc ||| S:36092 E:36096 ||| CD
; ||| S:36096 E:36097 ||| :
l ||| S:36097 E:36098 ||| LS
)  ||| S:36098 E:36100 ||| -RRB-
contained  ||| S:36100 E:36110 ||| VBD
template  ||| S:36110 E:36119 ||| JJ
DNA ||| S:36119 E:36122 ||| NN
,  ||| S:36122 E:36124 ||| ,
50  ||| S:36124 E:36127 ||| CD
pmoles  ||| S:36127 E:36134 ||| NN
of  ||| S:36134 E:36137 ||| IN
the  ||| S:36137 E:36141 ||| DT
appropriate  ||| S:36141 E:36153 ||| JJ
primers  ||| S:36153 E:36161 ||| NNS
( ||| S:36161 E:36162 ||| -LRB-
JS153 ||| S:36162 E:36167 ||| NNP
,  ||| S:36167 E:36169 ||| ,
JS154  ||| S:36169 E:36175 ||| NNP
and  ||| S:36175 E:36179 ||| CC
JS009 ||| S:36179 E:36184 ||| NNP
,  ||| S:36184 E:36186 ||| ,
JS010 ||| S:36186 E:36191 ||| NNP
,  ||| S:36191 E:36193 ||| ,
JS011 ||| S:36193 E:36198 ||| NNP
,  ||| S:36198 E:36200 ||| ,
JS012 ||| S:36200 E:36205 ||| NNP
,  ||| S:36205 E:36207 ||| ,
SEQ  ||| S:36207 E:36211 ||| UH
ID  ||| S:36211 E:36214 ||| UH
NO ||| S:36214 E:36216 ||| UH
: ||| S:36216 E:36217 ||| :
7-12  ||| S:36217 E:36222 ||| CD
for  ||| S:36222 E:36226 ||| IN
light  ||| S:36226 E:36232 ||| JJ
chains ||| S:36232 E:36238 ||| NNS
,  ||| S:36238 E:36240 ||| ,
JS160 ||| S:36240 E:36245 ||| NNP
,  ||| S:36245 E:36247 ||| ,
JS161 ||| S:36247 E:36252 ||| NNP
,  ||| S:36252 E:36254 ||| ,
JS162  ||| S:36254 E:36260 ||| NNP
and  ||| S:36260 E:36264 ||| CC
JS001 ||| S:36264 E:36269 ||| NNP
,  ||| S:36269 E:36271 ||| ,
JS002 ||| S:36271 E:36276 ||| NNP
,  ||| S:36276 E:36278 ||| ,
JS003 ||| S:36278 E:36283 ||| NNP
,  ||| S:36283 E:36285 ||| ,
JS004 ||| S:36285 E:36290 ||| NNP
,  ||| S:36290 E:36292 ||| ,
JS008 ||| S:36292 E:36297 ||| NNP
,  ||| S:36297 E:36299 ||| ,
SEQ  ||| S:36299 E:36303 ||| UH
ID  ||| S:36303 E:36306 ||| UH
NO ||| S:36306 E:36308 ||| UH
: ||| S:36308 E:36309 ||| :
28-30 ||| S:36309 E:36314 ||| CD
,  ||| S:36314 E:36316 ||| ,
SEQ  ||| S:36316 E:36320 ||| UH
ID  ||| S:36320 E:36323 ||| UH
NO ||| S:36323 E:36325 ||| UH
: ||| S:36325 E:36326 ||| :
2-5  ||| S:36326 E:36330 ||| CD
for  ||| S:36330 E:36334 ||| IN
heavy  ||| S:36334 E:36340 ||| JJ
chains ||| S:36340 E:36346 ||| NNS
) ||| S:36346 E:36347 ||| -RRB-
,  ||| S:36347 E:36349 ||| ,
2.5  ||| S:36349 E:36353 ||| CD
units  ||| S:36353 E:36359 ||| NNS
of  ||| S:36359 E:36362 ||| IN
ExTaq  ||| S:36362 E:36368 ||| JJ
polymerase  ||| S:36368 E:36379 ||| NNS
( ||| S:36379 E:36380 ||| -LRB-
PanVera ||| S:36380 E:36387 ||| NNP
) ||| S:36387 E:36388 ||| -RRB-
,  ||| S:36388 E:36390 ||| ,
1 ||| S:36390 E:36391 ||| CD
& ||| S:36391 E:36392 ||| CC
# ||| S:36392 E:36393 ||| #
xd7 ||| S:36393 E:36396 ||| CD
; ||| S:36396 E:36397 ||| :
ExTaq  ||| S:36397 E:36403 ||| JJ
reaction  ||| S:36403 E:36412 ||| NN
buffer ||| S:36412 E:36418 ||| NN
,  ||| S:36418 E:36420 ||| ,
200  ||| S:36420 E:36424 ||| CD
& ||| S:36424 E:36425 ||| CC
# ||| S:36425 E:36426 ||| #
x3bc ||| S:36426 E:36430 ||| CD
; ||| S:36430 E:36431 ||| :
M  ||| S:36431 E:36433 ||| NNP
dNTP ||| S:36433 E:36437 ||| NNP
,  ||| S:36437 E:36439 ||| ,
and  ||| S:36439 E:36443 ||| CC
2  ||| S:36443 E:36445 ||| CD
mM  ||| S:36445 E:36448 ||| JJ
MgCl2 ||| S:36448 E:36453 ||| NN
.  ||| S:36453 E:36455 ||| .
The  ||| S:36455 E:36459 ||| DT
template  ||| S:36459 E:36468 ||| NN
was  ||| S:36468 E:36472 ||| VBD
denatured  ||| S:36472 E:36482 ||| VBN
by  ||| S:36482 E:36485 ||| IN
an  ||| S:36485 E:36488 ||| DT
initial  ||| S:36488 E:36496 ||| JJ
five  ||| S:36496 E:36501 ||| CD
minute  ||| S:36501 E:36508 ||| NN
incubation  ||| S:36508 E:36519 ||| NN
at  ||| S:36519 E:36522 ||| IN
96 ||| S:36522 E:36524 ||| CD
& ||| S:36524 E:36525 ||| CC
# ||| S:36525 E:36526 ||| #
xb0 ||| S:36526 E:36529 ||| CD
;  ||| S:36529 E:36531 ||| :
C.  ||| S:36531 E:36534 ||| NNP
The  ||| S:36534 E:36538 ||| DT
products  ||| S:36538 E:36547 ||| NNS
were  ||| S:36547 E:36552 ||| VBD
amplified  ||| S:36552 E:36562 ||| VBN
by  ||| S:36562 E:36565 ||| IN
35  ||| S:36565 E:36568 ||| CD
thermal  ||| S:36568 E:36576 ||| JJ
cycles  ||| S:36576 E:36583 ||| NNS
of  ||| S:36583 E:36586 ||| IN
96 ||| S:36586 E:36588 ||| CD
& ||| S:36588 E:36589 ||| CC
# ||| S:36589 E:36590 ||| #
xb0 ||| S:36590 E:36593 ||| CD
;  ||| S:36593 E:36595 ||| :
C.  ||| S:36595 E:36598 ||| NNP
for  ||| S:36598 E:36602 ||| IN
1  ||| S:36602 E:36604 ||| CD
min. ||| S:36604 E:36608 ||| CD
,  ||| S:36608 E:36610 ||| ,
55 ||| S:36610 E:36612 ||| CD
& ||| S:36612 E:36613 ||| CC
# ||| S:36613 E:36614 ||| #
xb0 ||| S:36614 E:36617 ||| CD
;  ||| S:36617 E:36619 ||| :
C.  ||| S:36619 E:36622 ||| NNP
for  ||| S:36622 E:36626 ||| IN
30  ||| S:36626 E:36629 ||| CD
sec. ||| S:36629 E:36633 ||| CD
,  ||| S:36633 E:36635 ||| ,
and  ||| S:36635 E:36639 ||| CC
72 ||| S:36639 E:36641 ||| CD
& ||| S:36641 E:36642 ||| CC
# ||| S:36642 E:36643 ||| #
xb0 ||| S:36643 E:36646 ||| CD
;  ||| S:36646 E:36648 ||| :
C.  ||| S:36648 E:36651 ||| NNP
for  ||| S:36651 E:36655 ||| IN
30  ||| S:36655 E:36658 ||| CD
sec ||| S:36658 E:36661 ||| NN
,  ||| S:36661 E:36663 ||| ,
followed  ||| S:36663 E:36672 ||| VBN
by  ||| S:36672 E:36675 ||| IN
5  ||| S:36675 E:36677 ||| CD
min.  ||| S:36677 E:36682 ||| CD
at  ||| S:36682 E:36685 ||| IN
72 ||| S:36685 E:36687 ||| CD
& ||| S:36687 E:36688 ||| CC
# ||| S:36688 E:36689 ||| #
xb0 ||| S:36689 E:36692 ||| CD
;  ||| S:36692 E:36694 ||| :
C.  ||| S:36694 E:36697 ||| NNP
The  ||| S:36697 E:36701 ||| NNP
PCR  ||| S:36701 E:36705 ||| NNP
products  ||| S:36705 E:36714 ||| NNS
from  ||| S:36714 E:36719 ||| IN
the  ||| S:36719 E:36723 ||| DT
successful  ||| S:36723 E:36734 ||| JJ
reactions  ||| S:36734 E:36744 ||| NNS
were  ||| S:36744 E:36749 ||| VBD
purified  ||| S:36749 E:36758 ||| VBN
using  ||| S:36758 E:36764 ||| VBG
the  ||| S:36764 E:36768 ||| DT
Wizard  ||| S:36768 E:36775 ||| NNP
PCR  ||| S:36775 E:36779 ||| NNP
Purification  ||| S:36779 E:36792 ||| NNP
system  ||| S:36792 E:36799 ||| NN
( ||| S:36799 E:36800 ||| -LRB-
Promega ||| S:36800 E:36807 ||| NNP
)  ||| S:36807 E:36809 ||| -RRB-
as  ||| S:36809 E:36812 ||| IN
per  ||| S:36812 E:36816 ||| IN
manufacturer ||| S:36816 E:36828 ||| NN
's  ||| S:36828 E:36831 ||| POS
procedure ||| S:36831 E:36840 ||| NN
.  ||| S:36840 E:36844 ||| .
The  ||| S:36844 E:36848 ||| DT
heavy  ||| S:36848 E:36854 ||| JJ
chain  ||| S:36854 E:36860 ||| NN
PCR  ||| S:36860 E:36864 ||| NN
products  ||| S:36864 E:36873 ||| NNS
( ||| S:36873 E:36874 ||| -LRB-
approximately  ||| S:36874 E:36888 ||| RB
400  ||| S:36888 E:36892 ||| CD
bp ||| S:36892 E:36894 ||| CD
)  ||| S:36894 E:36896 ||| -RRB-
and  ||| S:36896 E:36900 ||| CC
the  ||| S:36900 E:36904 ||| DT
light  ||| S:36904 E:36910 ||| JJ
chain  ||| S:36910 E:36916 ||| NN
PCR  ||| S:36916 E:36920 ||| NN
products  ||| S:36920 E:36929 ||| NNS
( ||| S:36929 E:36930 ||| -LRB-
approximately  ||| S:36930 E:36944 ||| RB
350  ||| S:36944 E:36948 ||| CD
bp ||| S:36948 E:36950 ||| CD
)  ||| S:36950 E:36952 ||| -RRB-
were  ||| S:36952 E:36957 ||| VBD
then  ||| S:36957 E:36962 ||| RB
cloned  ||| S:36962 E:36969 ||| VBN
into  ||| S:36969 E:36974 ||| IN
a  ||| S:36974 E:36976 ||| DT
bacterial  ||| S:36976 E:36986 ||| JJ
vector  ||| S:36986 E:36993 ||| NN
for  ||| S:36993 E:36997 ||| IN
DNA  ||| S:36997 E:37001 ||| NNP
sequence  ||| S:37001 E:37010 ||| NN
determination ||| S:37010 E:37023 ||| NN
.  ||| S:37023 E:37025 ||| .
Ligations  ||| S:37025 E:37035 ||| NNP
of  ||| S:37035 E:37038 ||| IN
the  ||| S:37038 E:37042 ||| DT
PCR  ||| S:37042 E:37046 ||| NNP
fragments  ||| S:37046 E:37056 ||| NNS
were  ||| S:37056 E:37061 ||| VBD
carried  ||| S:37061 E:37069 ||| VBN
out  ||| S:37069 E:37073 ||| RP
into  ||| S:37073 E:37078 ||| IN
the  ||| S:37078 E:37082 ||| DT
pCR2.1  ||| S:37082 E:37089 ||| JJ
T ||| S:37089 E:37090 ||| NN
/ ||| S:37090 E:37091 ||| VBZ
A  ||| S:37091 E:37093 ||| DT
style  ||| S:37093 E:37099 ||| NN
cloning  ||| S:37099 E:37107 ||| NN
vector  ||| S:37107 E:37114 ||| NN
( ||| S:37114 E:37115 ||| -LRB-
Invitrogen ||| S:37115 E:37125 ||| NNP
)  ||| S:37125 E:37127 ||| -RRB-
following  ||| S:37127 E:37137 ||| VBG
the  ||| S:37137 E:37141 ||| DT
manufacturer ||| S:37141 E:37153 ||| NN
's  ||| S:37153 E:37156 ||| POS
procedures  ||| S:37156 E:37167 ||| NNS
using  ||| S:37167 E:37173 ||| VBG
a  ||| S:37173 E:37175 ||| DT
3 ||| S:37175 E:37176 ||| CD
: ||| S:37176 E:37177 ||| :
1  ||| S:37177 E:37179 ||| CD
insert  ||| S:37179 E:37186 ||| NN
to  ||| S:37186 E:37189 ||| TO
vector  ||| S:37189 E:37196 ||| VB
molar  ||| S:37196 E:37202 ||| JJ
ratio ||| S:37202 E:37207 ||| NN
.  ||| S:37207 E:37209 ||| .
Two  ||| S:37209 E:37213 ||| CD
& ||| S:37213 E:37214 ||| CC
# ||| S:37214 E:37215 ||| #
x3bc ||| S:37215 E:37219 ||| CD
; ||| S:37219 E:37220 ||| :
l  ||| S:37220 E:37222 ||| NN
of  ||| S:37222 E:37225 ||| IN
the  ||| S:37225 E:37229 ||| DT
ligation  ||| S:37229 E:37238 ||| JJ
reactions  ||| S:37238 E:37248 ||| NNS
were  ||| S:37248 E:37253 ||| VBD
used  ||| S:37253 E:37258 ||| VBN
to  ||| S:37258 E:37261 ||| TO
transform  ||| S:37261 E:37271 ||| VB
the  ||| S:37271 E:37275 ||| DT
INV ||| S:37275 E:37278 ||| NNP
& ||| S:37278 E:37279 ||| CC
# ||| S:37279 E:37280 ||| #
x3b1 ||| S:37280 E:37284 ||| CD
; ||| S:37284 E:37285 ||| :
F ||| S:37285 E:37286 ||| NNP
& ||| S:37286 E:37287 ||| CC
# ||| S:37287 E:37288 ||| #
x2032 ||| S:37288 E:37293 ||| CD
;  ||| S:37293 E:37295 ||| :
competent  ||| S:37295 E:37305 ||| JJ
cells  ||| S:37305 E:37311 ||| NNS
( ||| S:37311 E:37312 ||| -LRB-
Invitrogen ||| S:37312 E:37322 ||| NNP
)  ||| S:37322 E:37324 ||| -RRB-
as  ||| S:37324 E:37327 ||| IN
per  ||| S:37327 E:37331 ||| IN
the  ||| S:37331 E:37335 ||| DT
manufacturer ||| S:37335 E:37347 ||| NN
's  ||| S:37347 E:37350 ||| POS
procedure ||| S:37350 E:37359 ||| NN
.  ||| S:37359 E:37361 ||| .
Plasmid  ||| S:37361 E:37369 ||| JJ
clones  ||| S:37369 E:37376 ||| NNS
containing  ||| S:37376 E:37387 ||| VBG
DNA  ||| S:37387 E:37391 ||| NN
inserts  ||| S:37391 E:37399 ||| NNS
were  ||| S:37399 E:37404 ||| VBD
identified  ||| S:37404 E:37415 ||| VBN
using  ||| S:37415 E:37421 ||| VBG
diagnostic  ||| S:37421 E:37432 ||| JJ
restriction  ||| S:37432 E:37444 ||| NN
enzyme  ||| S:37444 E:37451 ||| NN
digests ||| S:37451 E:37458 ||| NN
,  ||| S:37458 E:37460 ||| ,
with  ||| S:37460 E:37465 ||| IN
EcoRI  ||| S:37465 E:37471 ||| NNP
( ||| S:37471 E:37472 ||| -LRB-
New  ||| S:37472 E:37476 ||| NNP
England  ||| S:37476 E:37484 ||| NNP
Biolabs ||| S:37484 E:37491 ||| NNP
) ||| S:37491 E:37492 ||| -RRB-
.  ||| S:37492 E:37494 ||| .
The  ||| S:37494 E:37498 ||| DT
DNA  ||| S:37498 E:37502 ||| NN
sequence  ||| S:37502 E:37511 ||| NN
of  ||| S:37511 E:37514 ||| IN
plasmids  ||| S:37514 E:37523 ||| NNS
containing  ||| S:37523 E:37534 ||| VBG
the  ||| S:37534 E:37538 ||| DT
heavy  ||| S:37538 E:37544 ||| JJ
chain  ||| S:37544 E:37550 ||| NN
inserts  ||| S:37550 E:37558 ||| NNS
of  ||| S:37558 E:37561 ||| IN
the  ||| S:37561 E:37565 ||| DT
appropriate  ||| S:37565 E:37577 ||| JJ
size  ||| S:37577 E:37582 ||| NN
( ||| S:37582 E:37583 ||| -LRB-
400  ||| S:37583 E:37587 ||| CD
bp ||| S:37587 E:37589 ||| CD
)  ||| S:37589 E:37591 ||| -RRB-
was  ||| S:37591 E:37595 ||| VBD
then  ||| S:37595 E:37600 ||| RB
determined ||| S:37600 E:37610 ||| VBN
.  ||| S:37610 E:37612 ||| .
The  ||| S:37612 E:37616 ||| DT
final  ||| S:37616 E:37622 ||| JJ
consensus  ||| S:37622 E:37632 ||| NN
DNA  ||| S:37632 E:37636 ||| NN
sequence  ||| S:37636 E:37645 ||| NN
of  ||| S:37645 E:37648 ||| IN
the  ||| S:37648 E:37652 ||| DT
heavy  ||| S:37652 E:37658 ||| JJ
chain  ||| S:37658 E:37664 ||| NN
variable  ||| S:37664 E:37673 ||| NN
region  ||| S:37673 E:37680 ||| NN
of  ||| S:37680 E:37683 ||| IN
11E10  ||| S:37683 E:37689 ||| NNP
is  ||| S:37689 E:37692 ||| VBZ
shown  ||| S:37692 E:37698 ||| VBN
in  ||| S:37698 E:37701 ||| IN
FIG.  ||| S:37701 E:37706 ||| CD
6  ||| S:37706 E:37708 ||| CD
with  ||| S:37708 E:37713 ||| IN
the  ||| S:37713 E:37717 ||| DT
CDRs  ||| S:37717 E:37722 ||| NN
indicated  ||| S:37722 E:37732 ||| VBD
by  ||| S:37732 E:37735 ||| IN
underlining ||| S:37735 E:37746 ||| NN
.  ||| S:37746 E:37750 ||| .
The  ||| S:37750 E:37754 ||| DT
light  ||| S:37754 E:37760 ||| JJ
chain  ||| S:37760 E:37766 ||| NN
plasmid  ||| S:37766 E:37774 ||| NNS
clones  ||| S:37774 E:37781 ||| VBP
needed  ||| S:37781 E:37788 ||| VBN
to  ||| S:37788 E:37791 ||| TO
be  ||| S:37791 E:37794 ||| VB
further  ||| S:37794 E:37802 ||| RB
characterized  ||| S:37802 E:37816 ||| VBN
because  ||| S:37816 E:37824 ||| IN
the  ||| S:37824 E:37828 ||| DT
hybridoma  ||| S:37828 E:37838 ||| JJ
cell  ||| S:37838 E:37843 ||| NN
line  ||| S:37843 E:37848 ||| NN
that  ||| S:37848 E:37853 ||| WDT
expresses  ||| S:37853 E:37863 ||| VBZ
the  ||| S:37863 E:37867 ||| DT
& ||| S:37867 E:37868 ||| CC
# ||| S:37868 E:37869 ||| #
x201c ||| S:37869 E:37874 ||| CD
; ||| S:37874 E:37875 ||| :
11E10 ||| S:37875 E:37880 ||| CD
& ||| S:37880 E:37881 ||| CC
# ||| S:37881 E:37882 ||| #
x201d ||| S:37882 E:37887 ||| CD
;  ||| S:37887 E:37889 ||| :
antibody  ||| S:37889 E:37898 ||| NN
was  ||| S:37898 E:37902 ||| VBD
made  ||| S:37902 E:37907 ||| VBN
by  ||| S:37907 E:37910 ||| IN
fusing  ||| S:37910 E:37917 ||| JJ
mouse  ||| S:37917 E:37923 ||| NN
splenocytes  ||| S:37923 E:37935 ||| NN
with  ||| S:37935 E:37940 ||| IN
SP20  ||| S:37940 E:37945 ||| CD
myeloma  ||| S:37945 E:37953 ||| CD
cells ||| S:37953 E:37958 ||| NNS
.  ||| S:37958 E:37960 ||| .
The  ||| S:37960 E:37964 ||| DT
SP20  ||| S:37964 E:37969 ||| JJ
cell  ||| S:37969 E:37974 ||| NN
line  ||| S:37974 E:37979 ||| NN
transcribes  ||| S:37979 E:37991 ||| VBD
a  ||| S:37991 E:37993 ||| DT
pseudogene  ||| S:37993 E:38004 ||| NN
for  ||| S:38004 E:38008 ||| IN
the  ||| S:38008 E:38012 ||| DT
kappa  ||| S:38012 E:38018 ||| JJ
light  ||| S:38018 E:38024 ||| JJ
chain ||| S:38024 E:38029 ||| NN
.  ||| S:38029 E:38031 ||| .
The  ||| S:38031 E:38035 ||| DT
pseudogene  ||| S:38035 E:38046 ||| JJ
transcript ||| S:38046 E:38056 ||| NN
,  ||| S:38056 E:38058 ||| ,
when  ||| S:38058 E:38063 ||| WRB
converted  ||| S:38063 E:38073 ||| VBN
to  ||| S:38073 E:38076 ||| TO
cDNA  ||| S:38076 E:38081 ||| JJ
by  ||| S:38081 E:38084 ||| IN
RT-PCR ||| S:38084 E:38090 ||| NNP
,  ||| S:38090 E:38092 ||| ,
contains  ||| S:38092 E:38101 ||| VBZ
an  ||| S:38101 E:38104 ||| DT
AflIII  ||| S:38104 E:38111 ||| JJ
restriction  ||| S:38111 E:38123 ||| NN
site ||| S:38123 E:38127 ||| NN
.  ||| S:38127 E:38129 ||| .
For  ||| S:38129 E:38133 ||| IN
this  ||| S:38133 E:38138 ||| DT
reason ||| S:38138 E:38144 ||| NN
,  ||| S:38144 E:38146 ||| ,
the  ||| S:38146 E:38150 ||| DT
plasmid  ||| S:38150 E:38158 ||| JJ
clones  ||| S:38158 E:38165 ||| NNS
for  ||| S:38165 E:38169 ||| IN
the  ||| S:38169 E:38173 ||| DT
light  ||| S:38173 E:38179 ||| JJ
chain  ||| S:38179 E:38185 ||| NN
variable  ||| S:38185 E:38194 ||| NN
region  ||| S:38194 E:38201 ||| NN
were  ||| S:38201 E:38206 ||| VBD
digested  ||| S:38206 E:38215 ||| VBN
with  ||| S:38215 E:38220 ||| IN
AflIII  ||| S:38220 E:38227 ||| JJ
and  ||| S:38227 E:38231 ||| CC
those  ||| S:38231 E:38237 ||| DT
products  ||| S:38237 E:38246 ||| NNS
that  ||| S:38246 E:38251 ||| WDT
did  ||| S:38251 E:38255 ||| VBD
not  ||| S:38255 E:38259 ||| RB
cut  ||| S:38259 E:38263 ||| VB
were  ||| S:38263 E:38268 ||| VBD
then  ||| S:38268 E:38273 ||| RB
submitted  ||| S:38273 E:38283 ||| VBN
for  ||| S:38283 E:38287 ||| IN
DNA  ||| S:38287 E:38291 ||| NNP
sequencing ||| S:38291 E:38301 ||| NN
.  ||| S:38301 E:38303 ||| .
The  ||| S:38303 E:38307 ||| DT
final  ||| S:38307 E:38313 ||| JJ
consensus  ||| S:38313 E:38323 ||| NN
sequence  ||| S:38323 E:38332 ||| NN
of  ||| S:38332 E:38335 ||| IN
the  ||| S:38335 E:38339 ||| DT
light  ||| S:38339 E:38345 ||| JJ
chain  ||| S:38345 E:38351 ||| NN
variable  ||| S:38351 E:38360 ||| NN
region  ||| S:38360 E:38367 ||| NN
is  ||| S:38367 E:38370 ||| VBZ
shown  ||| S:38370 E:38376 ||| VBN
in  ||| S:38376 E:38379 ||| IN
FIG.  ||| S:38379 E:38384 ||| CD
6 ||| S:38384 E:38385 ||| CD
,  ||| S:38385 E:38387 ||| ,
with  ||| S:38387 E:38392 ||| IN
the  ||| S:38392 E:38396 ||| DT
CDRs  ||| S:38396 E:38401 ||| NN
indicated  ||| S:38401 E:38411 ||| VBD
by  ||| S:38411 E:38414 ||| IN
underlining ||| S:38414 E:38425 ||| NN
.  ||| S:38425 E:38429 ||| .
The  ||| S:38429 E:38433 ||| DT
variable  ||| S:38433 E:38442 ||| JJ
region  ||| S:38442 E:38449 ||| NN
gene  ||| S:38449 E:38454 ||| NN
fragments  ||| S:38454 E:38464 ||| NNS
were  ||| S:38464 E:38469 ||| VBD
re-amplified  ||| S:38469 E:38482 ||| JJ
by  ||| S:38482 E:38485 ||| IN
PCR  ||| S:38485 E:38489 ||| NNP
using  ||| S:38489 E:38495 ||| VBG
primers  ||| S:38495 E:38503 ||| NNS
that  ||| S:38503 E:38508 ||| WDT
adapted  ||| S:38508 E:38516 ||| VBD
the  ||| S:38516 E:38520 ||| DT
fragments  ||| S:38520 E:38530 ||| NN
for  ||| S:38530 E:38534 ||| IN
cloning  ||| S:38534 E:38542 ||| NN
into  ||| S:38542 E:38547 ||| IN
the  ||| S:38547 E:38551 ||| DT
expression  ||| S:38551 E:38562 ||| NN
vector  ||| S:38562 E:38569 ||| NN
( ||| S:38569 E:38570 ||| -LRB-
see  ||| S:38570 E:38574 ||| VB
FIGS.  ||| S:38574 E:38580 ||| CD
5  ||| S:38580 E:38582 ||| CD
and  ||| S:38582 E:38586 ||| CC
7 ||| S:38586 E:38587 ||| CD
) ||| S:38587 E:38588 ||| -RRB-
.  ||| S:38588 E:38590 ||| .
The  ||| S:38590 E:38594 ||| DT
heavy  ||| S:38594 E:38600 ||| JJ
chain  ||| S:38600 E:38606 ||| NN
front  ||| S:38606 E:38612 ||| NN
primer  ||| S:38612 E:38619 ||| NNS
( ||| S:38619 E:38620 ||| -LRB-
11E10HF ||| S:38620 E:38627 ||| NNP
,  ||| S:38627 E:38629 ||| ,
SEQ  ||| S:38629 E:38633 ||| UH
ID  ||| S:38633 E:38636 ||| UH
NO ||| S:38636 E:38638 ||| UH
: ||| S:38638 E:38639 ||| :
37 ||| S:38639 E:38641 ||| CD
)  ||| S:38641 E:38643 ||| -RRB-
includes  ||| S:38643 E:38652 ||| VBZ
a  ||| S:38652 E:38654 ||| DT
5 ||| S:38654 E:38655 ||| CD
& ||| S:38655 E:38656 ||| CC
# ||| S:38656 E:38657 ||| #
x2032 ||| S:38657 E:38662 ||| CD
;  ||| S:38662 E:38664 ||| :
tail  ||| S:38664 E:38669 ||| NN
that  ||| S:38669 E:38674 ||| IN
encodes  ||| S:38674 E:38682 ||| VBG
the  ||| S:38682 E:38686 ||| DT
C-terminus  ||| S:38686 E:38697 ||| JJ
of  ||| S:38697 E:38700 ||| IN
the  ||| S:38700 E:38704 ||| DT
heavy  ||| S:38704 E:38710 ||| JJ
chain  ||| S:38710 E:38716 ||| NN
leader  ||| S:38716 E:38723 ||| NN
and  ||| S:38723 E:38727 ||| CC
an  ||| S:38727 E:38730 ||| DT
NruI  ||| S:38730 E:38735 ||| JJ
restriction  ||| S:38735 E:38747 ||| NN
site  ||| S:38747 E:38752 ||| NN
for  ||| S:38752 E:38756 ||| IN
cloning ||| S:38756 E:38763 ||| NN
,  ||| S:38763 E:38765 ||| ,
while  ||| S:38765 E:38771 ||| IN
the  ||| S:38771 E:38775 ||| DT
heavy  ||| S:38775 E:38781 ||| JJ
chain  ||| S:38781 E:38787 ||| NN
reverse  ||| S:38787 E:38795 ||| NN
primer  ||| S:38795 E:38802 ||| NNS
( ||| S:38802 E:38803 ||| -LRB-
11E10HB ||| S:38803 E:38810 ||| NNP
,  ||| S:38810 E:38812 ||| ,
SEQ  ||| S:38812 E:38816 ||| UH
ID  ||| S:38816 E:38819 ||| UH
NO ||| S:38819 E:38821 ||| UH
: ||| S:38821 E:38822 ||| :
38 ||| S:38822 E:38824 ||| CD
)  ||| S:38824 E:38826 ||| -RRB-
adds  ||| S:38826 E:38831 ||| VBZ
a  ||| S:38831 E:38833 ||| DT
3 ||| S:38833 E:38834 ||| CD
& ||| S:38834 E:38835 ||| CC
# ||| S:38835 E:38836 ||| #
x2032 ||| S:38836 E:38841 ||| CD
;  ||| S:38841 E:38843 ||| :
EcoRI  ||| S:38843 E:38849 ||| JJ
restriction  ||| S:38849 E:38861 ||| NN
site  ||| S:38861 E:38866 ||| NN
for  ||| S:38866 E:38870 ||| IN
cloning ||| S:38870 E:38877 ||| NN
.  ||| S:38877 E:38879 ||| .
The  ||| S:38879 E:38883 ||| DT
light  ||| S:38883 E:38889 ||| JJ
chain  ||| S:38889 E:38895 ||| NN
front  ||| S:38895 E:38901 ||| NN
primer  ||| S:38901 E:38908 ||| NNS
( ||| S:38908 E:38909 ||| -LRB-
11E10LF ||| S:38909 E:38916 ||| NNP
,  ||| S:38916 E:38918 ||| ,
SEQ  ||| S:38918 E:38922 ||| UH
ID  ||| S:38922 E:38925 ||| UH
NO ||| S:38925 E:38927 ||| UH
: ||| S:38927 E:38928 ||| :
39 ||| S:38928 E:38930 ||| CD
)  ||| S:38930 E:38932 ||| -RRB-
includes  ||| S:38932 E:38941 ||| VBZ
a  ||| S:38941 E:38943 ||| DT
5 ||| S:38943 E:38944 ||| CD
& ||| S:38944 E:38945 ||| CC
# ||| S:38945 E:38946 ||| #
x2032 ||| S:38946 E:38951 ||| CD
;  ||| S:38951 E:38953 ||| :
tail  ||| S:38953 E:38958 ||| NN
that  ||| S:38958 E:38963 ||| IN
encodes  ||| S:38963 E:38971 ||| VBG
the  ||| S:38971 E:38975 ||| DT
C-terminus  ||| S:38975 E:38986 ||| JJ
of  ||| S:38986 E:38989 ||| IN
the  ||| S:38989 E:38993 ||| DT
light  ||| S:38993 E:38999 ||| JJ
chain  ||| S:38999 E:39005 ||| NN
leader  ||| S:39005 E:39012 ||| NN
and  ||| S:39012 E:39016 ||| CC
an  ||| S:39016 E:39019 ||| DT
EcoRV  ||| S:39019 E:39025 ||| JJ
restriction  ||| S:39025 E:39037 ||| NN
site  ||| S:39037 E:39042 ||| NN
at  ||| S:39042 E:39045 ||| IN
the  ||| S:39045 E:39049 ||| DT
N-terminus  ||| S:39049 E:39060 ||| JJ
of  ||| S:39060 E:39063 ||| IN
the  ||| S:39063 E:39067 ||| DT
light  ||| S:39067 E:39073 ||| JJ
chain  ||| S:39073 E:39079 ||| NN
variable  ||| S:39079 E:39088 ||| NN
region  ||| S:39088 E:39095 ||| NN
for  ||| S:39095 E:39099 ||| IN
cloning ||| S:39099 E:39106 ||| NN
,  ||| S:39106 E:39108 ||| ,
while  ||| S:39108 E:39114 ||| IN
the  ||| S:39114 E:39118 ||| DT
light  ||| S:39118 E:39124 ||| JJ
chain  ||| S:39124 E:39130 ||| NN
reverse  ||| S:39130 E:39138 ||| NN
primer  ||| S:39138 E:39145 ||| NNS
( ||| S:39145 E:39146 ||| -LRB-
11E10LB ||| S:39146 E:39153 ||| NNP
,  ||| S:39153 E:39155 ||| ,
SEQ  ||| S:39155 E:39159 ||| UH
ID  ||| S:39159 E:39162 ||| UH
NO ||| S:39162 E:39164 ||| UH
: ||| S:39164 E:39165 ||| :
40 ||| S:39165 E:39167 ||| CD
)  ||| S:39167 E:39169 ||| -RRB-
adds  ||| S:39169 E:39174 ||| VBZ
a  ||| S:39174 E:39176 ||| DT
3 ||| S:39176 E:39177 ||| CD
& ||| S:39177 E:39178 ||| CC
# ||| S:39178 E:39179 ||| #
x2032 ||| S:39179 E:39184 ||| CD
;  ||| S:39184 E:39186 ||| :
DNA  ||| S:39186 E:39190 ||| NNP
sequence  ||| S:39190 E:39199 ||| NN
for  ||| S:39199 E:39203 ||| IN
the  ||| S:39203 E:39207 ||| DT
joining  ||| S:39207 E:39215 ||| VBG
region-kappa  ||| S:39215 E:39228 ||| JJ
exon  ||| S:39228 E:39233 ||| JJ
splice  ||| S:39233 E:39240 ||| NNS
junction  ||| S:39240 E:39249 ||| VBP
followed  ||| S:39249 E:39258 ||| VBN
by  ||| S:39258 E:39261 ||| IN
a  ||| S:39261 E:39263 ||| DT
BstBI  ||| S:39263 E:39269 ||| JJ
restriction  ||| S:39269 E:39281 ||| NN
site  ||| S:39281 E:39286 ||| NN
for  ||| S:39286 E:39290 ||| IN
cloning ||| S:39290 E:39297 ||| NN
.  ||| S:39297 E:39299 ||| .
PCRs  ||| S:39299 E:39304 ||| NNP
were  ||| S:39304 E:39309 ||| VBD
performed  ||| S:39309 E:39319 ||| VBN
as  ||| S:39319 E:39322 ||| RB
described  ||| S:39322 E:39332 ||| VBN
above  ||| S:39332 E:39338 ||| IN
except ||| S:39338 E:39344 ||| NN
,  ||| S:39344 E:39346 ||| ,
following  ||| S:39346 E:39356 ||| VBG
a  ||| S:39356 E:39358 ||| DT
5  ||| S:39358 E:39360 ||| CD
min.  ||| S:39360 E:39365 ||| CD
incubation  ||| S:39365 E:39376 ||| NN
at  ||| S:39376 E:39379 ||| IN
96 ||| S:39379 E:39381 ||| CD
& ||| S:39381 E:39382 ||| CC
# ||| S:39382 E:39383 ||| #
xb0 ||| S:39383 E:39386 ||| CD
;  ||| S:39386 E:39388 ||| :
C. ||| S:39388 E:39390 ||| NNP
,  ||| S:39390 E:39392 ||| ,
the  ||| S:39392 E:39396 ||| DT
PCR  ||| S:39396 E:39400 ||| NNP
parameters  ||| S:39400 E:39411 ||| NNS
were  ||| S:39411 E:39416 ||| VBD
30  ||| S:39416 E:39419 ||| CD
thermal  ||| S:39419 E:39427 ||| JJ
cycles  ||| S:39427 E:39434 ||| NNS
of  ||| S:39434 E:39437 ||| IN
96 ||| S:39437 E:39439 ||| CD
& ||| S:39439 E:39440 ||| CC
# ||| S:39440 E:39441 ||| #
xb0 ||| S:39441 E:39444 ||| CD
;  ||| S:39444 E:39446 ||| :
C.  ||| S:39446 E:39449 ||| NNP
for  ||| S:39449 E:39453 ||| IN
1  ||| S:39453 E:39455 ||| CD
min. ||| S:39455 E:39459 ||| CD
,  ||| S:39459 E:39461 ||| ,
62 ||| S:39461 E:39463 ||| CD
& ||| S:39463 E:39464 ||| CC
# ||| S:39464 E:39465 ||| #
xb0 ||| S:39465 E:39468 ||| CD
;  ||| S:39468 E:39470 ||| :
C.  ||| S:39470 E:39473 ||| NNP
for  ||| S:39473 E:39477 ||| IN
30  ||| S:39477 E:39480 ||| CD
sec. ||| S:39480 E:39484 ||| CD
,  ||| S:39484 E:39486 ||| ,
and  ||| S:39486 E:39490 ||| CC
70 ||| S:39490 E:39492 ||| CD
& ||| S:39492 E:39493 ||| CC
# ||| S:39493 E:39494 ||| #
xb0 ||| S:39494 E:39497 ||| CD
;  ||| S:39497 E:39499 ||| :
C.  ||| S:39499 E:39502 ||| NNP
for  ||| S:39502 E:39506 ||| IN
30  ||| S:39506 E:39509 ||| CD
sec. ||| S:39509 E:39513 ||| CD
,  ||| S:39513 E:39515 ||| ,
followed  ||| S:39515 E:39524 ||| VBN
by  ||| S:39524 E:39527 ||| IN
5  ||| S:39527 E:39529 ||| CD
min.  ||| S:39529 E:39534 ||| CD
at  ||| S:39534 E:39537 ||| IN
72 ||| S:39537 E:39539 ||| CD
& ||| S:39539 E:39540 ||| CC
# ||| S:39540 E:39541 ||| #
xb0 ||| S:39541 E:39544 ||| CD
;  ||| S:39544 E:39546 ||| :
C ||| S:39546 E:39547 ||| NNP
.  ||| S:39547 E:39551 ||| .
The  ||| S:39551 E:39555 ||| DT
heavy  ||| S:39555 E:39561 ||| JJ
chain  ||| S:39561 E:39567 ||| NN
variable  ||| S:39567 E:39576 ||| NN
region  ||| S:39576 E:39583 ||| NN
PCR  ||| S:39583 E:39587 ||| NNP
product  ||| S:39587 E:39595 ||| NN
was  ||| S:39595 E:39599 ||| VBD
then  ||| S:39599 E:39604 ||| RB
subcloned  ||| S:39604 E:39614 ||| VBN
into  ||| S:39614 E:39619 ||| IN
a  ||| S:39619 E:39621 ||| DT
mammalian  ||| S:39621 E:39631 ||| FW
expression  ||| S:39631 E:39642 ||| FW
plasmid  ||| S:39642 E:39650 ||| FW
vector  ||| S:39650 E:39657 ||| FW
( ||| S:39657 E:39658 ||| -LRB-
pJRS315 ||| S:39658 E:39665 ||| NNP
,  ||| S:39665 E:39667 ||| ,
produced  ||| S:39667 E:39676 ||| VBD
as  ||| S:39676 E:39679 ||| RB
set  ||| S:39679 E:39683 ||| VBN
forth  ||| S:39683 E:39689 ||| RB
below  ||| S:39689 E:39695 ||| RB
in  ||| S:39695 E:39698 ||| IN
Example  ||| S:39698 E:39706 ||| NNP
5 ||| S:39706 E:39707 ||| CD
)  ||| S:39707 E:39709 ||| -RRB-
for  ||| S:39709 E:39713 ||| IN
production  ||| S:39713 E:39724 ||| NN
of  ||| S:39724 E:39727 ||| IN
recombinant  ||| S:39727 E:39739 ||| FW
chimeric  ||| S:39739 E:39748 ||| FW
mouse ||| S:39748 E:39753 ||| FW
/ ||| S:39753 E:39754 ||| FW
human  ||| S:39754 E:39760 ||| FW
antibody  ||| S:39760 E:39769 ||| FW
molecules ||| S:39769 E:39778 ||| FW
.  ||| S:39778 E:39780 ||| .
The  ||| S:39780 E:39784 ||| DT
resulting  ||| S:39784 E:39794 ||| VBG
vector  ||| S:39794 E:39801 ||| JJ
clone  ||| S:39801 E:39807 ||| NN
was  ||| S:39807 E:39811 ||| VBD
designated  ||| S:39811 E:39822 ||| VBN
pACE1 ||| S:39822 E:39827 ||| CD
.  ||| S:39827 E:39829 ||| .
Before  ||| S:39829 E:39836 ||| IN
the  ||| S:39836 E:39840 ||| DT
light  ||| S:39840 E:39846 ||| JJ
chain  ||| S:39846 E:39852 ||| NN
variable  ||| S:39852 E:39861 ||| NN
region  ||| S:39861 E:39868 ||| NN
could  ||| S:39868 E:39874 ||| MD
be  ||| S:39874 E:39877 ||| VB
subcloned  ||| S:39877 E:39887 ||| VBN
into  ||| S:39887 E:39892 ||| IN
the  ||| S:39892 E:39896 ||| DT
mammalian  ||| S:39896 E:39906 ||| JJ
expression  ||| S:39906 E:39917 ||| NN
vector ||| S:39917 E:39923 ||| NN
,  ||| S:39923 E:39925 ||| ,
it  ||| S:39925 E:39928 ||| PRP
was  ||| S:39928 E:39932 ||| VBD
subcloned  ||| S:39932 E:39942 ||| VBN
into  ||| S:39942 E:39947 ||| IN
the  ||| S:39947 E:39951 ||| DT
pCR2.1  ||| S:39951 E:39958 ||| JJ
T ||| S:39958 E:39959 ||| NN
/ ||| S:39959 E:39960 ||| VBZ
A  ||| S:39960 E:39962 ||| DT
style  ||| S:39962 E:39968 ||| NN
cloning  ||| S:39968 E:39976 ||| NNS
vector  ||| S:39976 E:39983 ||| VBP
previously  ||| S:39983 E:39994 ||| RB
described ||| S:39994 E:40003 ||| VBN
.  ||| S:40003 E:40005 ||| .
The  ||| S:40005 E:40009 ||| DT
resulting  ||| S:40009 E:40019 ||| VBG
plasmid  ||| S:40019 E:40027 ||| NNS
was  ||| S:40027 E:40031 ||| VBD
designated  ||| S:40031 E:40042 ||| VBN
pACELC  ||| S:40042 E:40049 ||| JJ
and  ||| S:40049 E:40053 ||| CC
digested ||| S:40053 E:40061 ||| NN
,  ||| S:40061 E:40063 ||| ,
with  ||| S:40063 E:40068 ||| IN
BstBI ||| S:40068 E:40073 ||| NNP
/ ||| S:40073 E:40074 ||| NNP
EcoRV ||| S:40074 E:40079 ||| NNP
,  ||| S:40079 E:40081 ||| ,
to  ||| S:40081 E:40084 ||| TO
cut  ||| S:40084 E:40088 ||| VB
out  ||| S:40088 E:40092 ||| RP
the  ||| S:40092 E:40096 ||| DT
light  ||| S:40096 E:40102 ||| JJ
chain  ||| S:40102 E:40108 ||| NN
variable  ||| S:40108 E:40117 ||| NN
region ||| S:40117 E:40123 ||| NN
.  ||| S:40123 E:40125 ||| .
The  ||| S:40125 E:40129 ||| DT
variable  ||| S:40129 E:40138 ||| JJ
region  ||| S:40138 E:40145 ||| NN
was  ||| S:40145 E:40149 ||| VBD
then  ||| S:40149 E:40154 ||| RB
subcloned  ||| S:40154 E:40164 ||| VBN
into  ||| S:40164 E:40169 ||| IN
the  ||| S:40169 E:40173 ||| DT
mammalian  ||| S:40173 E:40183 ||| JJ
expression  ||| S:40183 E:40194 ||| NN
vector  ||| S:40194 E:40201 ||| NN
containing  ||| S:40201 E:40212 ||| VBG
the  ||| S:40212 E:40216 ||| DT
& ||| S:40216 E:40217 ||| CC
# ||| S:40217 E:40218 ||| #
x201c ||| S:40218 E:40223 ||| CD
; ||| S:40223 E:40224 ||| :
11E10 ||| S:40224 E:40229 ||| CD
& ||| S:40229 E:40230 ||| CC
# ||| S:40230 E:40231 ||| #
x201d ||| S:40231 E:40236 ||| CD
;  ||| S:40236 E:40238 ||| :
heavy  ||| S:40238 E:40244 ||| JJ
chain  ||| S:40244 E:40250 ||| NN
variable  ||| S:40250 E:40259 ||| NN
region  ||| S:40259 E:40266 ||| NN
( ||| S:40266 E:40267 ||| -LRB-
pACE1 ||| S:40267 E:40272 ||| NNP
) ||| S:40272 E:40273 ||| -RRB-
.  ||| S:40273 E:40275 ||| .
The  ||| S:40275 E:40279 ||| DT
final  ||| S:40279 E:40285 ||| JJ
expression  ||| S:40285 E:40296 ||| NN
vector  ||| S:40296 E:40303 ||| NN
clone  ||| S:40303 E:40309 ||| NNS
was  ||| S:40309 E:40313 ||| VBD
designated  ||| S:40313 E:40324 ||| VBN
pACE4 ||| S:40324 E:40329 ||| CD
.  ||| S:40329 E:40331 ||| .
This  ||| S:40331 E:40336 ||| DT
vector  ||| S:40336 E:40343 ||| JJ
results  ||| S:40343 E:40351 ||| NNS
in  ||| S:40351 E:40354 ||| IN
the  ||| S:40354 E:40358 ||| DT
production  ||| S:40358 E:40369 ||| NN
of  ||| S:40369 E:40372 ||| IN
recombinant  ||| S:40372 E:40384 ||| JJ
antibody  ||| S:40384 E:40393 ||| NN
molecules  ||| S:40393 E:40403 ||| NNS
under  ||| S:40403 E:40409 ||| IN
the  ||| S:40409 E:40413 ||| DT
control  ||| S:40413 E:40421 ||| NN
of  ||| S:40421 E:40424 ||| IN
the  ||| S:40424 E:40428 ||| DT
CMV  ||| S:40428 E:40432 ||| NNP
transcriptional  ||| S:40432 E:40448 ||| NN
promoters ||| S:40448 E:40457 ||| NNS
.  ||| S:40457 E:40459 ||| .
The  ||| S:40459 E:40463 ||| DT
heavy  ||| S:40463 E:40469 ||| JJ
chain  ||| S:40469 E:40475 ||| NN
molecules  ||| S:40475 E:40485 ||| NNS
are  ||| S:40485 E:40489 ||| VBP
direct  ||| S:40489 E:40496 ||| JJ
cDNA  ||| S:40496 E:40501 ||| JJ
constructs  ||| S:40501 E:40512 ||| NN
that  ||| S:40512 E:40517 ||| IN
fuse  ||| S:40517 E:40522 ||| VBG
the  ||| S:40522 E:40526 ||| DT
variable  ||| S:40526 E:40535 ||| JJ
region  ||| S:40535 E:40542 ||| NN
sequence  ||| S:40542 E:40551 ||| NN
directly  ||| S:40551 E:40560 ||| RB
into  ||| S:40560 E:40565 ||| IN
the  ||| S:40565 E:40569 ||| DT
human  ||| S:40569 E:40575 ||| JJ
IgG1  ||| S:40575 E:40580 ||| CD
constant  ||| S:40580 E:40589 ||| JJ
domain ||| S:40589 E:40595 ||| NN
.  ||| S:40595 E:40597 ||| .
The  ||| S:40597 E:40601 ||| DT
light  ||| S:40601 E:40607 ||| JJ
chain  ||| S:40607 E:40613 ||| NN
molecules ||| S:40613 E:40622 ||| NNS
,  ||| S:40622 E:40624 ||| ,
on  ||| S:40624 E:40627 ||| IN
the  ||| S:40627 E:40631 ||| DT
other  ||| S:40631 E:40637 ||| JJ
hand ||| S:40637 E:40641 ||| NN
,  ||| S:40641 E:40643 ||| ,
have  ||| S:40643 E:40648 ||| VBP
a  ||| S:40648 E:40650 ||| DT
mouse  ||| S:40650 E:40656 ||| NN
kappa  ||| S:40656 E:40662 ||| VBZ
intron  ||| S:40662 E:40669 ||| JJ
region  ||| S:40669 E:40676 ||| NN
3 ||| S:40676 E:40677 ||| CD
& ||| S:40677 E:40678 ||| CC
# ||| S:40678 E:40679 ||| #
x2032 ||| S:40679 E:40684 ||| CD
;  ||| S:40684 E:40686 ||| :
of  ||| S:40686 E:40689 ||| IN
the  ||| S:40689 E:40693 ||| DT
variable  ||| S:40693 E:40702 ||| JJ
region  ||| S:40702 E:40709 ||| NN
coding  ||| S:40709 E:40716 ||| NN
fragment ||| S:40716 E:40724 ||| NN
.  ||| S:40724 E:40726 ||| .
After  ||| S:40726 E:40732 ||| IN
splicing ||| S:40732 E:40740 ||| NN
,  ||| S:40740 E:40742 ||| ,
the  ||| S:40742 E:40746 ||| DT
variable  ||| S:40746 E:40755 ||| JJ
region  ||| S:40755 E:40762 ||| NN
becomes  ||| S:40762 E:40770 ||| VBZ
fused  ||| S:40770 E:40776 ||| VBN
to  ||| S:40776 E:40779 ||| TO
a  ||| S:40779 E:40781 ||| DT
human  ||| S:40781 E:40787 ||| JJ
kappa  ||| S:40787 E:40793 ||| JJ
constant  ||| S:40793 E:40802 ||| JJ
region  ||| S:40802 E:40809 ||| NN
exon  ||| S:40809 E:40814 ||| NNS
( ||| S:40814 E:40815 ||| -LRB-
see  ||| S:40815 E:40819 ||| VB
FIG.  ||| S:40819 E:40824 ||| CD
7 ||| S:40824 E:40825 ||| CD
) ||| S:40825 E:40826 ||| -RRB-
.  ||| S:40826 E:40828 ||| .
The  ||| S:40828 E:40832 ||| DT
selectable  ||| S:40832 E:40843 ||| JJ
marker  ||| S:40843 E:40850 ||| NN
for  ||| S:40850 E:40854 ||| IN
the  ||| S:40854 E:40858 ||| DT
vector  ||| S:40858 E:40865 ||| NN
in  ||| S:40865 E:40868 ||| IN
mammalian  ||| S:40868 E:40878 ||| JJ
cells  ||| S:40878 E:40884 ||| NNS
is  ||| S:40884 E:40887 ||| VBZ
neomycin  ||| S:40887 E:40896 ||| JJ
( ||| S:40896 E:40897 ||| -LRB-
G418 ||| S:40897 E:40901 ||| NNP
) ||| S:40901 E:40902 ||| -RRB-
.  ||| S:40902 E:40906 ||| .
For  ||| S:40906 E:40910 ||| IN
the  ||| S:40910 E:40914 ||| DT
production  ||| S:40914 E:40925 ||| NN
of  ||| S:40925 E:40928 ||| IN
pACE1 ||| S:40928 E:40933 ||| NNP
,  ||| S:40933 E:40935 ||| ,
the  ||| S:40935 E:40939 ||| DT
& ||| S:40939 E:40940 ||| CC
# ||| S:40940 E:40941 ||| #
x201c ||| S:40941 E:40946 ||| CD
; ||| S:40946 E:40947 ||| :
11E10 ||| S:40947 E:40952 ||| CD
& ||| S:40952 E:40953 ||| CC
# ||| S:40953 E:40954 ||| #
x201d ||| S:40954 E:40959 ||| CD
;  ||| S:40959 E:40961 ||| :
heavy  ||| S:40961 E:40967 ||| JJ
chain  ||| S:40967 E:40973 ||| NN
PCR  ||| S:40973 E:40977 ||| NNP
product  ||| S:40977 E:40985 ||| NN
( ||| S:40985 E:40986 ||| -LRB-
approximately  ||| S:40986 E:41000 ||| RB
400  ||| S:41000 E:41004 ||| CD
bp ||| S:41004 E:41006 ||| CD
)  ||| S:41006 E:41008 ||| -RRB-
was  ||| S:41008 E:41012 ||| VBD
digested  ||| S:41012 E:41021 ||| VBN
with  ||| S:41021 E:41026 ||| IN
NruI  ||| S:41026 E:41031 ||| JJ
and  ||| S:41031 E:41035 ||| CC
EcoRI  ||| S:41035 E:41041 ||| NNP
( ||| S:41041 E:41042 ||| -LRB-
New  ||| S:41042 E:41046 ||| NNP
England  ||| S:41046 E:41054 ||| NNP
Biolabs ||| S:41054 E:41061 ||| NNP
) ||| S:41061 E:41062 ||| -RRB-
,  ||| S:41062 E:41064 ||| ,
purified  ||| S:41064 E:41073 ||| VBZ
using  ||| S:41073 E:41079 ||| VBG
a  ||| S:41079 E:41081 ||| DT
Qiaquick  ||| S:41081 E:41090 ||| NNP
PCR  ||| S:41090 E:41094 ||| NNP
Purification  ||| S:41094 E:41107 ||| NNP
column  ||| S:41107 E:41114 ||| NN
( ||| S:41114 E:41115 ||| -LRB-
Qiagen ||| S:41115 E:41121 ||| NNP
) ||| S:41121 E:41122 ||| -RRB-
,  ||| S:41122 E:41124 ||| ,
as  ||| S:41124 E:41127 ||| RB
described  ||| S:41127 E:41137 ||| VBN
by  ||| S:41137 E:41140 ||| IN
the  ||| S:41140 E:41144 ||| DT
manufacturer ||| S:41144 E:41156 ||| NN
,  ||| S:41156 E:41158 ||| ,
and  ||| S:41158 E:41162 ||| CC
ligated  ||| S:41162 E:41170 ||| NN
into  ||| S:41170 E:41175 ||| IN
NruI ||| S:41175 E:41179 ||| JJ
/ ||| S:41179 E:41180 ||| CD
EcoRI  ||| S:41180 E:41186 ||| JJ
digested  ||| S:41186 E:41195 ||| NN
and  ||| S:41195 E:41199 ||| CC
gel-purified  ||| S:41199 E:41212 ||| NNP
pJRS315 ||| S:41212 E:41219 ||| NNP
,  ||| S:41219 E:41221 ||| ,
resulting  ||| S:41221 E:41231 ||| VBG
in  ||| S:41231 E:41234 ||| IN
plasmid  ||| S:41234 E:41242 ||| CD
pACE1  ||| S:41242 E:41248 ||| CD
( ||| S:41248 E:41249 ||| -LRB-
see  ||| S:41249 E:41253 ||| VB
FIG.  ||| S:41253 E:41258 ||| CD
7 ||| S:41258 E:41259 ||| CD
) ||| S:41259 E:41260 ||| -RRB-
.  ||| S:41260 E:41264 ||| .
The  ||| S:41264 E:41268 ||| DT
& ||| S:41268 E:41269 ||| CC
# ||| S:41269 E:41270 ||| #
x201c ||| S:41270 E:41275 ||| CD
; ||| S:41275 E:41276 ||| :
11E10 ||| S:41276 E:41281 ||| CD
& ||| S:41281 E:41282 ||| CC
# ||| S:41282 E:41283 ||| #
x201d ||| S:41283 E:41288 ||| CD
;  ||| S:41288 E:41290 ||| :
light  ||| S:41290 E:41296 ||| JJ
chain  ||| S:41296 E:41302 ||| NN
PCR  ||| S:41302 E:41306 ||| NNP
product  ||| S:41306 E:41314 ||| NN
( ||| S:41314 E:41315 ||| -LRB-
approximately  ||| S:41315 E:41329 ||| RB
350  ||| S:41329 E:41333 ||| CD
bp ||| S:41333 E:41335 ||| CD
)  ||| S:41335 E:41337 ||| -RRB-
was  ||| S:41337 E:41341 ||| VBD
cloned  ||| S:41341 E:41348 ||| VBN
into  ||| S:41348 E:41353 ||| IN
the  ||| S:41353 E:41357 ||| DT
T ||| S:41357 E:41358 ||| NN
/ ||| S:41358 E:41359 ||| VBZ
A  ||| S:41359 E:41361 ||| DT
cloning  ||| S:41361 E:41369 ||| JJ
vector  ||| S:41369 E:41376 ||| NN
as  ||| S:41376 E:41379 ||| IN
per  ||| S:41379 E:41383 ||| IN
manufacturer ||| S:41383 E:41395 ||| NN
's  ||| S:41395 E:41398 ||| POS
instructions ||| S:41398 E:41410 ||| NNS
.  ||| S:41410 E:41412 ||| .
The  ||| S:41412 E:41416 ||| DT
resulting  ||| S:41416 E:41426 ||| JJ
clone ||| S:41426 E:41431 ||| NN
,  ||| S:41431 E:41433 ||| ,
pACELC ||| S:41433 E:41439 ||| NNP
,  ||| S:41439 E:41441 ||| ,
was  ||| S:41441 E:41445 ||| VBD
digested  ||| S:41445 E:41454 ||| VBN
with  ||| S:41454 E:41459 ||| IN
EcoRV  ||| S:41459 E:41465 ||| JJ
and  ||| S:41465 E:41469 ||| CC
BstBI  ||| S:41469 E:41475 ||| NNP
( ||| S:41475 E:41476 ||| -LRB-
New  ||| S:41476 E:41480 ||| NNP
England  ||| S:41480 E:41488 ||| NNP
Biolabs ||| S:41488 E:41495 ||| NNP
)  ||| S:41495 E:41497 ||| -RRB-
and  ||| S:41497 E:41501 ||| CC
the  ||| S:41501 E:41505 ||| DT
light  ||| S:41505 E:41511 ||| JJ
chain  ||| S:41511 E:41517 ||| NN
fragment  ||| S:41517 E:41526 ||| NN
was  ||| S:41526 E:41530 ||| VBD
gel-purified ||| S:41530 E:41542 ||| JJ
.  ||| S:41542 E:41544 ||| .
This  ||| S:41544 E:41549 ||| DT
fragment  ||| S:41549 E:41558 ||| NN
was  ||| S:41558 E:41562 ||| VBD
then  ||| S:41562 E:41567 ||| RB
ligated  ||| S:41567 E:41575 ||| VBN
into  ||| S:41575 E:41580 ||| IN
the  ||| S:41580 E:41584 ||| DT
EcoRV ||| S:41584 E:41589 ||| JJ
/ ||| S:41589 E:41590 ||| CD
BstBI  ||| S:41590 E:41596 ||| JJ
digested  ||| S:41596 E:41605 ||| NN
and  ||| S:41605 E:41609 ||| CC
gel-purified  ||| S:41609 E:41622 ||| NNP
pACE1 ||| S:41622 E:41627 ||| NNP
,  ||| S:41627 E:41629 ||| ,
resulting  ||| S:41629 E:41639 ||| VBG
in  ||| S:41639 E:41642 ||| IN
plasmid  ||| S:41642 E:41650 ||| CD
pACE4  ||| S:41650 E:41656 ||| CD
( ||| S:41656 E:41657 ||| -LRB-
see  ||| S:41657 E:41661 ||| VB
FIG.  ||| S:41661 E:41666 ||| CD
7 ||| S:41666 E:41667 ||| CD
) ||| S:41667 E:41668 ||| -RRB-
.  ||| S:41668 E:41670 ||| .
The  ||| S:41670 E:41674 ||| DT
sequence  ||| S:41674 E:41683 ||| NN
of  ||| S:41683 E:41686 ||| IN
the  ||| S:41686 E:41690 ||| DT
heavy  ||| S:41690 E:41696 ||| JJ
and  ||| S:41696 E:41700 ||| CC
light  ||| S:41700 E:41706 ||| JJ
chain  ||| S:41706 E:41712 ||| NN
variable  ||| S:41712 E:41721 ||| NN
regions  ||| S:41721 E:41729 ||| NNS
was  ||| S:41729 E:41733 ||| VBD
verified  ||| S:41733 E:41742 ||| VBN
prior  ||| S:41742 E:41748 ||| RB
to  ||| S:41748 E:41751 ||| TO
mammalian  ||| S:41751 E:41761 ||| VB
cell  ||| S:41761 E:41766 ||| NN
transfection ||| S:41766 E:41778 ||| NN
.  ||| S:41778 E:41781 ||| .
The  ||| S:41840 E:41844 ||| DT
plasmid  ||| S:41844 E:41852 ||| JJ
pJRS315  ||| S:41852 E:41860 ||| NN
is  ||| S:41860 E:41863 ||| VBZ
the  ||| S:41863 E:41867 ||| DT
expression  ||| S:41867 E:41878 ||| NN
plasmid  ||| S:41878 E:41886 ||| NN
into  ||| S:41886 E:41891 ||| IN
which  ||| S:41891 E:41897 ||| WDT
the  ||| S:41897 E:41901 ||| DT
variable  ||| S:41901 E:41910 ||| JJ
regions  ||| S:41910 E:41918 ||| NNS
of  ||| S:41918 E:41921 ||| IN
the  ||| S:41921 E:41925 ||| DT
11E10  ||| S:41925 E:41931 ||| JJ
antibody  ||| S:41931 E:41940 ||| NN
were  ||| S:41940 E:41945 ||| VBD
cloned ||| S:41945 E:41951 ||| VBN
.  ||| S:41951 E:41953 ||| .
This  ||| S:41953 E:41958 ||| DT
plasmid  ||| S:41958 E:41966 ||| NN
is  ||| S:41966 E:41969 ||| VBZ
a  ||| S:41969 E:41971 ||| DT
derivative  ||| S:41971 E:41982 ||| JJ
of  ||| S:41982 E:41985 ||| IN
a  ||| S:41985 E:41987 ||| DT
basic  ||| S:41987 E:41993 ||| JJ
expression  ||| S:41993 E:42004 ||| NN
vector ||| S:42004 E:42010 ||| NN
,  ||| S:42010 E:42012 ||| ,
plasmid  ||| S:42012 E:42020 ||| CD
pSUN15 ||| S:42020 E:42026 ||| CD
,  ||| S:42026 E:42028 ||| ,
that  ||| S:42028 E:42033 ||| WDT
contains  ||| S:42033 E:42042 ||| VBZ
no  ||| S:42042 E:42045 ||| DT
antibody  ||| S:42045 E:42054 ||| NN
variable  ||| S:42054 E:42063 ||| NN
region  ||| S:42063 E:42070 ||| NN
coding  ||| S:42070 E:42077 ||| NN
information ||| S:42077 E:42088 ||| NN
,  ||| S:42088 E:42090 ||| ,
pJRS315  ||| S:42090 E:42098 ||| NNP
was  ||| S:42098 E:42102 ||| VBD
created  ||| S:42102 E:42110 ||| VBN
using  ||| S:42110 E:42116 ||| VBG
DNA  ||| S:42116 E:42120 ||| NN
fragment  ||| S:42120 E:42129 ||| NN
ligations  ||| S:42129 E:42139 ||| NNS
and  ||| S:42139 E:42143 ||| CC
site  ||| S:42143 E:42148 ||| NN
directed  ||| S:42148 E:42157 ||| VBD
mutagenesis  ||| S:42157 E:42169 ||| JJ
steps ||| S:42169 E:42174 ||| NNS
.  ||| S:42174 E:42176 ||| .
The  ||| S:42176 E:42180 ||| DT
result  ||| S:42180 E:42187 ||| NN
was  ||| S:42187 E:42191 ||| VBD
a  ||| S:42191 E:42193 ||| DT
vector  ||| S:42193 E:42200 ||| NN
that  ||| S:42200 E:42205 ||| WDT
expresses  ||| S:42205 E:42215 ||| VBZ
both  ||| S:42215 E:42220 ||| DT
antibody  ||| S:42220 E:42229 ||| NN
chains  ||| S:42229 E:42236 ||| NNS
with  ||| S:42236 E:42241 ||| IN
CMV  ||| S:42241 E:42245 ||| NNP
promoter  ||| S:42245 E:42254 ||| FW
driven  ||| S:42254 E:42261 ||| FW
transcription  ||| S:42261 E:42275 ||| FW
( ||| S:42275 E:42276 ||| -LRB-
see  ||| S:42276 E:42280 ||| VB
FIG.  ||| S:42280 E:42285 ||| CD
17 ||| S:42285 E:42287 ||| CD
) ||| S:42287 E:42288 ||| -RRB-
.  ||| S:42288 E:42290 ||| .
Neomycin  ||| S:42290 E:42299 ||| JJ
resistance  ||| S:42299 E:42310 ||| NN
serves  ||| S:42310 E:42317 ||| VBZ
as  ||| S:42317 E:42320 ||| IN
the  ||| S:42320 E:42324 ||| DT
dominant  ||| S:42324 E:42333 ||| JJ
selectable  ||| S:42333 E:42344 ||| JJ
marker  ||| S:42344 E:42351 ||| NN
for  ||| S:42351 E:42355 ||| IN
transfection  ||| S:42355 E:42368 ||| NN
of  ||| S:42368 E:42371 ||| IN
mammalian  ||| S:42371 E:42381 ||| JJ
cells ||| S:42381 E:42386 ||| NNS
.  ||| S:42386 E:42388 ||| .
In  ||| S:42388 E:42391 ||| IN
addition ||| S:42391 E:42399 ||| NN
,  ||| S:42399 E:42401 ||| ,
it  ||| S:42401 E:42404 ||| PRP
has  ||| S:42404 E:42408 ||| VBZ
been  ||| S:42408 E:42413 ||| VBN
designed  ||| S:42413 E:42422 ||| VBN
to  ||| S:42422 E:42425 ||| TO
allow  ||| S:42425 E:42431 ||| VB
convenient  ||| S:42431 E:42442 ||| JJ
cloning  ||| S:42442 E:42450 ||| NN
of  ||| S:42450 E:42453 ||| IN
any  ||| S:42453 E:42457 ||| DT
light  ||| S:42457 E:42463 ||| JJ
chain  ||| S:42463 E:42469 ||| NN
variable  ||| S:42469 E:42478 ||| NN
region  ||| S:42478 E:42485 ||| NN
as  ||| S:42485 E:42488 ||| IN
an  ||| S:42488 E:42491 ||| DT
EcoRV ||| S:42491 E:42496 ||| JJ
/ ||| S:42496 E:42497 ||| CD
BstBI  ||| S:42497 E:42503 ||| JJ
fragment ||| S:42503 E:42511 ||| NN
,  ||| S:42511 E:42513 ||| ,
any  ||| S:42513 E:42517 ||| DT
heavy  ||| S:42517 E:42523 ||| JJ
chain  ||| S:42523 E:42529 ||| NN
variable  ||| S:42529 E:42538 ||| NN
region  ||| S:42538 E:42545 ||| NN
as  ||| S:42545 E:42548 ||| IN
a  ||| S:42548 E:42550 ||| DT
NruI ||| S:42550 E:42554 ||| JJ
/ ||| S:42554 E:42555 ||| CD
EcoRI  ||| S:42555 E:42561 ||| JJ
fragment ||| S:42561 E:42569 ||| NN
,  ||| S:42569 E:42571 ||| ,
and  ||| S:42571 E:42575 ||| CC
any  ||| S:42575 E:42579 ||| DT
heavy  ||| S:42579 E:42585 ||| JJ
chain  ||| S:42585 E:42591 ||| NN
constant  ||| S:42591 E:42600 ||| JJ
domain  ||| S:42600 E:42607 ||| NN
as  ||| S:42607 E:42610 ||| IN
an  ||| S:42610 E:42613 ||| DT
EcoRI ||| S:42613 E:42618 ||| JJ
/ ||| S:42618 E:42619 ||| CD
NotI  ||| S:42619 E:42624 ||| JJ
fragment ||| S:42624 E:42632 ||| NN
.  ||| S:42632 E:42634 ||| .
These  ||| S:42634 E:42640 ||| DT
restriction  ||| S:42640 E:42652 ||| NN
sites  ||| S:42652 E:42658 ||| NNS
were  ||| S:42658 E:42663 ||| VBD
chosen  ||| S:42663 E:42670 ||| VBN
because  ||| S:42670 E:42678 ||| IN
they  ||| S:42678 E:42683 ||| PRP
occur  ||| S:42683 E:42689 ||| VBP
rarely  ||| S:42689 E:42696 ||| RB
( ||| S:42696 E:42697 ||| -LRB-
if  ||| S:42697 E:42700 ||| IN
ever ||| S:42700 E:42704 ||| RB
)  ||| S:42704 E:42706 ||| -RRB-
in  ||| S:42706 E:42709 ||| IN
human  ||| S:42709 E:42715 ||| JJ
and  ||| S:42715 E:42719 ||| CC
mouse  ||| S:42719 E:42725 ||| JJ
variable  ||| S:42725 E:42734 ||| JJ
regions ||| S:42734 E:42741 ||| NNS
.  ||| S:42741 E:42743 ||| .
There  ||| S:42743 E:42749 ||| EX
is  ||| S:42749 E:42752 ||| VBZ
a  ||| S:42752 E:42754 ||| DT
mouse  ||| S:42754 E:42760 ||| NN
J  ||| S:42760 E:42762 ||| NNP
region ||| S:42762 E:42768 ||| FW
/ ||| S:42768 E:42769 ||| FW
kappa  ||| S:42769 E:42775 ||| FW
intron  ||| S:42775 E:42782 ||| FW
fragment  ||| S:42782 E:42791 ||| FW
fused  ||| S:42791 E:42797 ||| FW
to  ||| S:42797 E:42800 ||| TO
a  ||| S:42800 E:42802 ||| DT
human  ||| S:42802 E:42808 ||| JJ
kappa  ||| S:42808 E:42814 ||| NNS
exon  ||| S:42814 E:42819 ||| VBP
so  ||| S:42819 E:42822 ||| RB
that  ||| S:42822 E:42827 ||| IN
after  ||| S:42827 E:42833 ||| IN
post-transcriptional  ||| S:42833 E:42854 ||| FW
splicing  ||| S:42854 E:42863 ||| FW
a  ||| S:42863 E:42865 ||| FW
mouse ||| S:42865 E:42870 ||| FW
/ ||| S:42870 E:42871 ||| FW
human  ||| S:42871 E:42877 ||| FW
chimeric  ||| S:42877 E:42886 ||| FW
kappa  ||| S:42886 E:42892 ||| FW
light  ||| S:42892 E:42898 ||| JJ
chain  ||| S:42898 E:42904 ||| NN
is  ||| S:42904 E:42907 ||| VBZ
produced ||| S:42907 E:42915 ||| VBN
.  ||| S:42915 E:42919 ||| .
The  ||| S:42919 E:42923 ||| DT
backbone  ||| S:42923 E:42932 ||| NN
of  ||| S:42932 E:42935 ||| IN
the  ||| S:42935 E:42939 ||| DT
vector  ||| S:42939 E:42946 ||| NN
was  ||| S:42946 E:42950 ||| VBD
the  ||| S:42950 E:42954 ||| DT
plasmid  ||| S:42954 E:42962 ||| JJ
pCDNA3  ||| S:42962 E:42969 ||| NNP
( ||| S:42969 E:42970 ||| -LRB-
Invitrogen ||| S:42970 E:42980 ||| NNP
) ||| S:42980 E:42981 ||| -RRB-
.  ||| S:42981 E:42983 ||| .
This  ||| S:42983 E:42988 ||| DT
plasmid  ||| S:42988 E:42996 ||| NN
was  ||| S:42996 E:43000 ||| VBD
cut  ||| S:43000 E:43004 ||| VBN
with  ||| S:43004 E:43009 ||| IN
HindIII ||| S:43009 E:43016 ||| NNP
/ ||| S:43016 E:43017 ||| NNP
XhoI  ||| S:43017 E:43022 ||| NNP
and  ||| S:43022 E:43026 ||| CC
a  ||| S:43026 E:43028 ||| DT
& ||| S:43028 E:43029 ||| CC
# ||| S:43029 E:43030 ||| #
x201c ||| S:43030 E:43035 ||| CD
; ||| S:43035 E:43036 ||| :
light  ||| S:43036 E:43042 ||| JJ
chain  ||| S:43042 E:43048 ||| NN
polylinker ||| S:43048 E:43058 ||| NNS
& ||| S:43058 E:43059 ||| CC
# ||| S:43059 E:43060 ||| #
x201d ||| S:43060 E:43065 ||| CD
;  ||| S:43065 E:43067 ||| :
DNA  ||| S:43067 E:43071 ||| NNP
fragment  ||| S:43071 E:43080 ||| NN
was  ||| S:43080 E:43084 ||| VBD
inserted  ||| S:43084 E:43093 ||| VBN
to  ||| S:43093 E:43096 ||| TO
create  ||| S:43096 E:43103 ||| VB
the  ||| S:43103 E:43107 ||| DT
starting  ||| S:43107 E:43116 ||| VBG
& ||| S:43116 E:43117 ||| CC
# ||| S:43117 E:43118 ||| #
x201c ||| S:43118 E:43123 ||| CD
; ||| S:43123 E:43124 ||| :
light  ||| S:43124 E:43130 ||| JJ
chain  ||| S:43130 E:43136 ||| NN
vector ||| S:43136 E:43142 ||| NN
& ||| S:43142 E:43143 ||| CC
# ||| S:43143 E:43144 ||| #
x201d ||| S:43144 E:43149 ||| CD
; ||| S:43149 E:43150 ||| :
.  ||| S:43150 E:43152 ||| .
This  ||| S:43152 E:43157 ||| DT
linker  ||| S:43157 E:43164 ||| NN
contained  ||| S:43164 E:43174 ||| VBD
the  ||| S:43174 E:43178 ||| DT
restriction  ||| S:43178 E:43190 ||| NN
sites  ||| S:43190 E:43196 ||| NNS
HindIII ||| S:43196 E:43203 ||| JJ
,  ||| S:43203 E:43205 ||| ,
KpnI ||| S:43205 E:43209 ||| NNP
,  ||| S:43209 E:43211 ||| ,
ClaI ||| S:43211 E:43215 ||| NNP
,  ||| S:43215 E:43217 ||| ,
PmlI ||| S:43217 E:43221 ||| NNP
,  ||| S:43221 E:43223 ||| ,
EcoRV ||| S:43223 E:43228 ||| NNP
,  ||| S:43228 E:43230 ||| ,
XmaI ||| S:43230 E:43234 ||| NNP
,  ||| S:43234 E:43236 ||| ,
BamHI  ||| S:43236 E:43242 ||| JJ
and  ||| S:43242 E:43246 ||| CC
XhoI  ||| S:43246 E:43251 ||| JJ
to  ||| S:43251 E:43254 ||| TO
facilitate  ||| S:43254 E:43265 ||| VB
subsequent  ||| S:43265 E:43276 ||| JJ
cloning  ||| S:43276 E:43284 ||| JJ
steps  ||| S:43284 E:43290 ||| NNS
to  ||| S:43290 E:43293 ||| TO
create  ||| S:43293 E:43300 ||| VB
the  ||| S:43300 E:43304 ||| DT
plasmid  ||| S:43304 E:43312 ||| JJ
pCDNA3.LCPL ||| S:43312 E:43323 ||| NN
.  ||| S:43323 E:43325 ||| .
A  ||| S:43325 E:43327 ||| DT
SmaI ||| S:43327 E:43331 ||| JJ
/ ||| S:43331 E:43332 ||| NNP
BclI  ||| S:43332 E:43337 ||| NNP
DNA  ||| S:43337 E:43341 ||| NNP
fragment  ||| S:43341 E:43350 ||| VBZ
containing  ||| S:43350 E:43361 ||| VBG
a  ||| S:43361 E:43363 ||| DT
light  ||| S:43363 E:43369 ||| JJ
chain  ||| S:43369 E:43375 ||| NN
leader ||| S:43375 E:43381 ||| NN
,  ||| S:43381 E:43383 ||| ,
anti-CKMB  ||| S:43383 E:43393 ||| JJ
kappa  ||| S:43393 E:43399 ||| JJ
light  ||| S:43399 E:43405 ||| JJ
chain  ||| S:43405 E:43411 ||| NN
genomic  ||| S:43411 E:43419 ||| NN
fragment ||| S:43419 E:43427 ||| NN
,  ||| S:43427 E:43429 ||| ,
and  ||| S:43429 E:43433 ||| CC
3 ||| S:43433 E:43434 ||| CD
& ||| S:43434 E:43435 ||| CC
# ||| S:43435 E:43436 ||| #
x2032 ||| S:43436 E:43441 ||| CD
;  ||| S:43441 E:43443 ||| :
UTR  ||| S:43443 E:43447 ||| NNP
was  ||| S:43447 E:43451 ||| VBD
cloned  ||| S:43451 E:43458 ||| VBN
into  ||| S:43458 E:43463 ||| IN
the  ||| S:43463 E:43467 ||| DT
EcoRV ||| S:43467 E:43472 ||| JJ
/ ||| S:43472 E:43473 ||| CD
BamHI  ||| S:43473 E:43479 ||| JJ
sites  ||| S:43479 E:43485 ||| NNS
of  ||| S:43485 E:43488 ||| IN
pCDNA3.LCPL ||| S:43488 E:43499 ||| CD
.  ||| S:43499 E:43501 ||| .
The  ||| S:43501 E:43505 ||| DT
mouse  ||| S:43505 E:43511 ||| NN
kappa  ||| S:43511 E:43517 ||| NN
intron ||| S:43517 E:43523 ||| NN
,  ||| S:43523 E:43525 ||| ,
exon  ||| S:43525 E:43530 ||| NN
and  ||| S:43530 E:43534 ||| CC
3 ||| S:43534 E:43535 ||| CD
& ||| S:43535 E:43536 ||| CC
# ||| S:43536 E:43537 ||| #
x2032 ||| S:43537 E:43542 ||| CD
;  ||| S:43542 E:43544 ||| :
UTR  ||| S:43544 E:43548 ||| NNP
in  ||| S:43548 E:43551 ||| IN
this  ||| S:43551 E:43556 ||| DT
fragment  ||| S:43556 E:43565 ||| NN
was  ||| S:43565 E:43569 ||| VBD
derived  ||| S:43569 E:43577 ||| VBN
from  ||| S:43577 E:43582 ||| IN
LCPXK2  ||| S:43582 E:43589 ||| NNP
received  ||| S:43589 E:43598 ||| VBD
from  ||| S:43598 E:43603 ||| IN
Dr.  ||| S:43603 E:43607 ||| NNP
Richard  ||| S:43607 E:43615 ||| NNP
Near  ||| S:43615 E:43620 ||| NNP
( ||| S:43620 E:43621 ||| -LRB-
Near ||| S:43621 E:43625 ||| NNP
,  ||| S:43625 E:43627 ||| ,
R.  ||| S:43627 E:43630 ||| NNP
I.  ||| S:43630 E:43633 ||| NNP
et  ||| S:43633 E:43636 ||| NNP
al. ||| S:43636 E:43639 ||| NNP
,  ||| S:43639 E:43641 ||| ,
Mol ||| S:43641 E:43644 ||| NNP
.  ||| S:43644 E:43646 ||| .
Immunol.  ||| S:43646 E:43655 ||| CD
27 ||| S:43655 E:43657 ||| CD
: ||| S:43657 E:43658 ||| :
901-909 ||| S:43658 E:43665 ||| CD
,  ||| S:43665 E:43667 ||| ,
( ||| S:43667 E:43668 ||| -LRB-
1990 ||| S:43668 E:43672 ||| CD
) ||| S:43672 E:43673 ||| -RRB-
) ||| S:43673 E:43674 ||| -RRB-
.  ||| S:43674 E:43676 ||| .
Mutagenesis  ||| S:43676 E:43688 ||| NNP
was  ||| S:43688 E:43692 ||| VBD
then  ||| S:43692 E:43697 ||| RB
performed  ||| S:43697 E:43707 ||| VBN
to  ||| S:43707 E:43710 ||| TO
eliminate  ||| S:43710 E:43720 ||| VB
an  ||| S:43720 E:43723 ||| DT
NruI  ||| S:43723 E:43728 ||| JJ
( ||| S:43728 E:43729 ||| -LRB-
209 ||| S:43729 E:43732 ||| LS
) ||| S:43732 E:43733 ||| -RRB-
,  ||| S:43733 E:43735 ||| ,
MluI  ||| S:43735 E:43740 ||| NNP
( ||| S:43740 E:43741 ||| -LRB-
229 ||| S:43741 E:43744 ||| CD
) ||| S:43744 E:43745 ||| -RRB-
,  ||| S:43745 E:43747 ||| ,
and  ||| S:43747 E:43751 ||| CC
BstBI  ||| S:43751 E:43757 ||| NNP
( ||| S:43757 E:43758 ||| -LRB-
2962 ||| S:43758 E:43762 ||| CD
)  ||| S:43762 E:43764 ||| -RRB-
and  ||| S:43764 E:43768 ||| CC
to  ||| S:43768 E:43771 ||| TO
introduce  ||| S:43771 E:43781 ||| VB
an  ||| S:43781 E:43784 ||| DT
NheI  ||| S:43784 E:43789 ||| JJ
( ||| S:43789 E:43790 ||| -LRB-
1229 ||| S:43790 E:43794 ||| CD
)  ||| S:43794 E:43796 ||| -RRB-
and  ||| S:43796 E:43800 ||| CC
a  ||| S:43800 E:43802 ||| DT
BamHI  ||| S:43802 E:43808 ||| JJ
( ||| S:43808 E:43809 ||| -LRB-
1214 ||| S:43809 E:43813 ||| CD
)  ||| S:43813 E:43815 ||| -RRB-
site  ||| S:43815 E:43820 ||| NN
to  ||| S:43820 E:43823 ||| TO
create  ||| S:43823 E:43830 ||| VB
pcDNA3mut.LCPL.LCVK  ||| S:43830 E:43850 ||| NNP
( ||| S:43850 E:43851 ||| -LRB-
see  ||| S:43851 E:43855 ||| VB
FIG.  ||| S:43855 E:43860 ||| CD
12 ||| S:43860 E:43862 ||| CD
) ||| S:43862 E:43863 ||| -RRB-
.  ||| S:43863 E:43867 ||| .
A  ||| S:43867 E:43869 ||| DT
second  ||| S:43869 E:43876 ||| JJ
& ||| S:43876 E:43877 ||| CC
# ||| S:43877 E:43878 ||| #
x201c ||| S:43878 E:43883 ||| CD
; ||| S:43883 E:43884 ||| :
heavy  ||| S:43884 E:43890 ||| JJ
chain  ||| S:43890 E:43896 ||| NN
vector ||| S:43896 E:43902 ||| NN
& ||| S:43902 E:43903 ||| CC
# ||| S:43903 E:43904 ||| #
x201d ||| S:43904 E:43909 ||| CD
;  ||| S:43909 E:43911 ||| :
was  ||| S:43911 E:43915 ||| VBD
constructed  ||| S:43915 E:43927 ||| VBN
from  ||| S:43927 E:43932 ||| IN
the  ||| S:43932 E:43936 ||| DT
pcDNA3mut.LCPL.LCVK  ||| S:43936 E:43956 ||| JJ
plasmid  ||| S:43956 E:43964 ||| NN
by  ||| S:43964 E:43967 ||| IN
replacing  ||| S:43967 E:43977 ||| VBG
the  ||| S:43977 E:43981 ||| DT
light  ||| S:43981 E:43987 ||| JJ
chain  ||| S:43987 E:43993 ||| NN
expression  ||| S:43993 E:44004 ||| NN
region  ||| S:44004 E:44011 ||| NN
( ||| S:44011 E:44012 ||| -LRB-
HindIII ||| S:44012 E:44019 ||| NNP
/ ||| S:44019 E:44020 ||| NNP
XhoI ||| S:44020 E:44024 ||| NNP
)  ||| S:44024 E:44026 ||| -RRB-
with  ||| S:44026 E:44031 ||| IN
a  ||| S:44031 E:44033 ||| DT
& ||| S:44033 E:44034 ||| CC
# ||| S:44034 E:44035 ||| #
x201c ||| S:44035 E:44040 ||| CD
; ||| S:44040 E:44041 ||| :
heavy  ||| S:44041 E:44047 ||| JJ
chain  ||| S:44047 E:44053 ||| NN
polylinker ||| S:44053 E:44063 ||| NNS
& ||| S:44063 E:44064 ||| CC
# ||| S:44064 E:44065 ||| #
x201d ||| S:44065 E:44070 ||| CD
;  ||| S:44070 E:44072 ||| :
consisting  ||| S:44072 E:44083 ||| VBG
of  ||| S:44083 E:44086 ||| IN
restriction  ||| S:44086 E:44098 ||| NN
sites  ||| S:44098 E:44104 ||| NNS
HpaI ||| S:44104 E:44108 ||| JJ
,  ||| S:44108 E:44110 ||| ,
BspEI ||| S:44110 E:44115 ||| NNP
,  ||| S:44115 E:44117 ||| ,
EcoRV ||| S:44117 E:44122 ||| NNP
,  ||| S:44122 E:44124 ||| ,
KpnI ||| S:44124 E:44128 ||| NNP
,  ||| S:44128 E:44130 ||| ,
and  ||| S:44130 E:44134 ||| CC
XhoI ||| S:44134 E:44138 ||| JJ
.  ||| S:44138 E:44140 ||| .
This  ||| S:44140 E:44145 ||| DT
plasmid  ||| S:44145 E:44153 ||| NN
was  ||| S:44153 E:44157 ||| VBD
digested  ||| S:44157 E:44166 ||| VBN
with  ||| S:44166 E:44171 ||| IN
EcorRV  ||| S:44171 E:44178 ||| JJ
and  ||| S:44178 E:44182 ||| CC
KpnI ||| S:44182 E:44186 ||| JJ
.  ||| S:44186 E:44188 ||| .
A  ||| S:44188 E:44190 ||| DT
SmaI ||| S:44190 E:44194 ||| JJ
/ ||| S:44194 E:44195 ||| CD
KpnI  ||| S:44195 E:44200 ||| JJ
digested  ||| S:44200 E:44209 ||| JJ
DNA  ||| S:44209 E:44213 ||| NN
fragment  ||| S:44213 E:44222 ||| NN
containing  ||| S:44222 E:44233 ||| VBG
a  ||| S:44233 E:44235 ||| DT
heavy  ||| S:44235 E:44241 ||| JJ
chain  ||| S:44241 E:44247 ||| NN
leader  ||| S:44247 E:44254 ||| NN
and  ||| S:44254 E:44258 ||| CC
an  ||| S:44258 E:44261 ||| DT
anti-CKMB  ||| S:44261 E:44271 ||| JJ
IgG2b  ||| S:44271 E:44277 ||| CD
mouse  ||| S:44277 E:44283 ||| NN
heavy  ||| S:44283 E:44289 ||| JJ
chain  ||| S:44289 E:44295 ||| NN
genomic  ||| S:44295 E:44303 ||| NN
fragment  ||| S:44303 E:44312 ||| NN
was  ||| S:44312 E:44316 ||| VBD
then  ||| S:44316 E:44321 ||| RB
ligated  ||| S:44321 E:44329 ||| VBN
into  ||| S:44329 E:44334 ||| IN
the  ||| S:44334 E:44338 ||| DT
EcoRV ||| S:44338 E:44343 ||| JJ
/ ||| S:44343 E:44344 ||| FW
KpnI  ||| S:44344 E:44349 ||| FW
digested  ||| S:44349 E:44358 ||| FW
plasmid ||| S:44358 E:44365 ||| FW
.  ||| S:44365 E:44367 ||| .
A  ||| S:44367 E:44369 ||| DT
KpnI ||| S:44369 E:44373 ||| JJ
/ ||| S:44373 E:44374 ||| CD
SalI  ||| S:44374 E:44379 ||| JJ
oligonucleotide  ||| S:44379 E:44395 ||| NNS
fragment  ||| S:44395 E:44404 ||| VBP
containing  ||| S:44404 E:44415 ||| VBG
a  ||| S:44415 E:44417 ||| DT
3 ||| S:44417 E:44418 ||| CD
& ||| S:44418 E:44419 ||| CC
# ||| S:44419 E:44420 ||| #
x2032 ||| S:44420 E:44425 ||| CD
;  ||| S:44425 E:44427 ||| :
UTR  ||| S:44427 E:44431 ||| NNP
and  ||| S:44431 E:44435 ||| CC
a  ||| S:44435 E:44437 ||| DT
NotI  ||| S:44437 E:44442 ||| JJ
upstream  ||| S:44442 E:44451 ||| NN
of  ||| S:44451 E:44454 ||| IN
the  ||| S:44454 E:44458 ||| DT
SalI  ||| S:44458 E:44463 ||| JJ
site  ||| S:44463 E:44468 ||| NN
was  ||| S:44468 E:44472 ||| VBD
subsequently  ||| S:44472 E:44485 ||| RB
cloned  ||| S:44485 E:44492 ||| VBN
into  ||| S:44492 E:44497 ||| IN
the  ||| S:44497 E:44501 ||| DT
KpnI ||| S:44501 E:44505 ||| JJ
/ ||| S:44505 E:44506 ||| FW
XhoI  ||| S:44506 E:44511 ||| FW
digested  ||| S:44511 E:44520 ||| FW
plasmid  ||| S:44520 E:44528 ||| FW
( ||| S:44528 E:44529 ||| -LRB-
knocking  ||| S:44529 E:44538 ||| VBG
out  ||| S:44538 E:44542 ||| RP
the  ||| S:44542 E:44546 ||| DT
XhoI  ||| S:44546 E:44551 ||| JJ
site ||| S:44551 E:44555 ||| NN
) ||| S:44555 E:44556 ||| -RRB-
,  ||| S:44556 E:44558 ||| ,
to  ||| S:44558 E:44561 ||| TO
create  ||| S:44561 E:44568 ||| VB
the  ||| S:44568 E:44572 ||| DT
plasmid  ||| S:44572 E:44580 ||| JJ
pCDNA3mUt.HCPL.HCV2b  ||| S:44580 E:44601 ||| NNP
( ||| S:44601 E:44602 ||| -LRB-
see  ||| S:44602 E:44606 ||| VB
FIG.  ||| S:44606 E:44611 ||| CD
13 ||| S:44611 E:44613 ||| CD
) ||| S:44613 E:44614 ||| -RRB-
.  ||| S:44614 E:44618 ||| .
From  ||| S:44618 E:44623 ||| IN
this  ||| S:44623 E:44628 ||| DT
point ||| S:44628 E:44633 ||| NN
,  ||| S:44633 E:44635 ||| ,
two  ||| S:44635 E:44639 ||| CD
vectors  ||| S:44639 E:44647 ||| NNS
were  ||| S:44647 E:44652 ||| VBD
created  ||| S:44652 E:44660 ||| VBN
that  ||| S:44660 E:44665 ||| WDT
did  ||| S:44665 E:44669 ||| VBD
not  ||| S:44669 E:44673 ||| RB
have  ||| S:44673 E:44678 ||| VB
any  ||| S:44678 E:44682 ||| DT
of  ||| S:44682 E:44685 ||| IN
the  ||| S:44685 E:44689 ||| DT
anti-CKMB  ||| S:44689 E:44699 ||| JJ
variable  ||| S:44699 E:44708 ||| NN
or  ||| S:44708 E:44711 ||| CC
constant  ||| S:44711 E:44720 ||| JJ
domain  ||| S:44720 E:44727 ||| NN
DNA  ||| S:44727 E:44731 ||| NN
sequences ||| S:44731 E:44740 ||| NN
.  ||| S:44740 E:44742 ||| .
This  ||| S:44742 E:44747 ||| DT
was  ||| S:44747 E:44751 ||| VBD
done  ||| S:44751 E:44756 ||| VBN
by  ||| S:44756 E:44759 ||| IN
cutting  ||| S:44759 E:44767 ||| VBG
the  ||| S:44767 E:44771 ||| DT
plasmid  ||| S:44771 E:44779 ||| JJ
pcDNA3mut.LCPL.LCVK  ||| S:44779 E:44799 ||| NN
with  ||| S:44799 E:44804 ||| IN
EcoRV ||| S:44804 E:44809 ||| NNP
/ ||| S:44809 E:44810 ||| NNP
XhoI  ||| S:44810 E:44815 ||| NNP
and  ||| S:44815 E:44819 ||| CC
inserting  ||| S:44819 E:44829 ||| VBG
a  ||| S:44829 E:44831 ||| DT
linker  ||| S:44831 E:44838 ||| JJ
oligonucleotide  ||| S:44838 E:44854 ||| NNS
fragment  ||| S:44854 E:44863 ||| VBP
containing  ||| S:44863 E:44874 ||| VBG
EcoRV ||| S:44874 E:44879 ||| JJ
,  ||| S:44879 E:44881 ||| ,
BstBI ||| S:44881 E:44886 ||| NNP
,  ||| S:44886 E:44888 ||| ,
and  ||| S:44888 E:44892 ||| CC
XhoI  ||| S:44892 E:44897 ||| JJ
sites  ||| S:44897 E:44903 ||| NNS
to  ||| S:44903 E:44906 ||| TO
create  ||| S:44906 E:44913 ||| VB
pSUN9  ||| S:44913 E:44919 ||| NNP
( ||| S:44919 E:44920 ||| -LRB-
see  ||| S:44920 E:44924 ||| VB
FIG.  ||| S:44924 E:44929 ||| CD
14 ||| S:44929 E:44931 ||| CD
) ||| S:44931 E:44932 ||| -RRB-
.  ||| S:44932 E:44934 ||| .
In  ||| S:44934 E:44937 ||| IN
a  ||| S:44937 E:44939 ||| DT
similar  ||| S:44939 E:44947 ||| JJ
way ||| S:44947 E:44950 ||| NN
,  ||| S:44950 E:44952 ||| ,
the  ||| S:44952 E:44956 ||| DT
anti-CKMB  ||| S:44956 E:44966 ||| JJ
fragment  ||| S:44966 E:44975 ||| NN
in  ||| S:44975 E:44978 ||| IN
pCDNA3mut.HCPL.HCV2b  ||| S:44978 E:44999 ||| NNP
( ||| S:44999 E:45000 ||| -LRB-
NruI ||| S:45000 E:45004 ||| NNP
/ ||| S:45004 E:45005 ||| NNP
NotI ||| S:45005 E:45009 ||| NNP
)  ||| S:45009 E:45011 ||| -RRB-
was  ||| S:45011 E:45015 ||| VBD
replaced  ||| S:45015 E:45024 ||| VBN
by  ||| S:45024 E:45027 ||| IN
a  ||| S:45027 E:45029 ||| DT
linker  ||| S:45029 E:45036 ||| JJ
oligonucleotide  ||| S:45036 E:45052 ||| NNS
fragment  ||| S:45052 E:45061 ||| VBP
containing  ||| S:45061 E:45072 ||| VBG
NruI ||| S:45072 E:45076 ||| JJ
,  ||| S:45076 E:45078 ||| ,
EcoRI  ||| S:45078 E:45084 ||| JJ
and  ||| S:45084 E:45088 ||| CC
NotI  ||| S:45088 E:45093 ||| JJ
sites  ||| S:45093 E:45099 ||| NNS
to  ||| S:45099 E:45102 ||| TO
create  ||| S:45102 E:45109 ||| VB
pSUN10  ||| S:45109 E:45116 ||| NNP
( ||| S:45116 E:45117 ||| -LRB-
see  ||| S:45117 E:45121 ||| VB
FIG.  ||| S:45121 E:45126 ||| CD
15 ||| S:45126 E:45128 ||| CD
) ||| S:45128 E:45129 ||| -RRB-
.  ||| S:45129 E:45131 ||| .
A  ||| S:45131 E:45133 ||| DT
human  ||| S:45133 E:45139 ||| JJ
kappa  ||| S:45139 E:45145 ||| JJ
light  ||| S:45145 E:45151 ||| JJ
chain  ||| S:45151 E:45157 ||| NN
constant  ||| S:45157 E:45166 ||| JJ
domain  ||| S:45166 E:45173 ||| NN
was  ||| S:45173 E:45177 ||| VBD
then  ||| S:45177 E:45182 ||| RB
cloned  ||| S:45182 E:45189 ||| VBN
into  ||| S:45189 E:45194 ||| IN
pSUN9  ||| S:45194 E:45200 ||| CD
as  ||| S:45200 E:45203 ||| IN
a  ||| S:45203 E:45205 ||| DT
BstBI ||| S:45205 E:45210 ||| JJ
/ ||| S:45210 E:45211 ||| CD
XhoI  ||| S:45211 E:45216 ||| JJ
fragment ||| S:45216 E:45224 ||| NN
,  ||| S:45224 E:45226 ||| ,
and  ||| S:45226 E:45230 ||| CC
a  ||| S:45230 E:45232 ||| DT
human  ||| S:45232 E:45238 ||| JJ
IgG1  ||| S:45238 E:45243 ||| CD
constant  ||| S:45243 E:45252 ||| JJ
domain  ||| S:45252 E:45259 ||| NN
was  ||| S:45259 E:45263 ||| VBD
cloned  ||| S:45263 E:45270 ||| VBN
into  ||| S:45270 E:45275 ||| IN
pSUN10  ||| S:45275 E:45282 ||| CD
as  ||| S:45282 E:45285 ||| IN
a  ||| S:45285 E:45287 ||| DT
EcoRI ||| S:45287 E:45292 ||| JJ
/ ||| S:45292 E:45293 ||| CD
NotI  ||| S:45293 E:45298 ||| JJ
fragment ||| S:45298 E:45306 ||| NN
.  ||| S:45306 E:45310 ||| .
A  ||| S:45310 E:45312 ||| DT
BglII ||| S:45312 E:45317 ||| JJ
/ ||| S:45317 E:45318 ||| CD
NheI  ||| S:45318 E:45323 ||| JJ
fragment  ||| S:45323 E:45332 ||| NN
from  ||| S:45332 E:45337 ||| IN
the  ||| S:45337 E:45341 ||| DT
human  ||| S:45341 E:45347 ||| JJ
heavy  ||| S:45347 E:45353 ||| JJ
chain  ||| S:45353 E:45359 ||| NN
vector  ||| S:45359 E:45366 ||| NN
was  ||| S:45366 E:45370 ||| VBD
then  ||| S:45370 E:45375 ||| RB
cloned  ||| S:45375 E:45382 ||| VBN
into  ||| S:45382 E:45387 ||| IN
the  ||| S:45387 E:45391 ||| DT
human  ||| S:45391 E:45397 ||| JJ
light  ||| S:45397 E:45403 ||| JJ
chain  ||| S:45403 E:45409 ||| NN
vector  ||| S:45409 E:45416 ||| NN
cut  ||| S:45416 E:45420 ||| NN
with  ||| S:45420 E:45425 ||| IN
BamHI ||| S:45425 E:45430 ||| JJ
/ ||| S:45430 E:45431 ||| CD
NheI  ||| S:45431 E:45436 ||| JJ
to  ||| S:45436 E:45439 ||| TO
create  ||| S:45439 E:45446 ||| VB
pSUN15  ||| S:45446 E:45453 ||| NNP
( ||| S:45453 E:45454 ||| -LRB-
see  ||| S:45454 E:45458 ||| VB
FIG.  ||| S:45458 E:45463 ||| CD
16 ||| S:45463 E:45465 ||| CD
) ||| S:45465 E:45466 ||| -RRB-
.  ||| S:45466 E:45470 ||| .
The  ||| S:45470 E:45474 ||| DT
plasmid  ||| S:45474 E:45482 ||| JJ
pJRS315  ||| S:45482 E:45490 ||| NN
was  ||| S:45490 E:45494 ||| VBD
then  ||| S:45494 E:45499 ||| RB
constructed  ||| S:45499 E:45511 ||| VBN
using  ||| S:45511 E:45517 ||| VBG
pSUN15  ||| S:45517 E:45524 ||| NN
through  ||| S:45524 E:45532 ||| IN
the  ||| S:45532 E:45536 ||| DT
following  ||| S:45536 E:45546 ||| JJ
process ||| S:45546 E:45553 ||| NN
.  ||| S:45553 E:45555 ||| .
A  ||| S:45555 E:45557 ||| DT
heavy  ||| S:45557 E:45563 ||| JJ
chain  ||| S:45563 E:45569 ||| NN
variable  ||| S:45569 E:45578 ||| NN
region  ||| S:45578 E:45585 ||| NN
from  ||| S:45585 E:45590 ||| IN
another ||| S:45590 E:45597 ||| DT
,  ||| S:45597 E:45599 ||| ,
unrelated ||| S:45599 E:45608 ||| JJ
,  ||| S:45608 E:45610 ||| ,
hybridoma  ||| S:45610 E:45620 ||| JJ
cell  ||| S:45620 E:45625 ||| NN
line  ||| S:45625 E:45630 ||| NN
( ||| S:45630 E:45631 ||| -LRB-
approximately  ||| S:45631 E:45645 ||| RB
400  ||| S:45645 E:45649 ||| CD
bp ||| S:45649 E:45651 ||| CD
)  ||| S:45651 E:45653 ||| -RRB-
was  ||| S:45653 E:45657 ||| VBD
digested  ||| S:45657 E:45666 ||| VBN
with  ||| S:45666 E:45671 ||| IN
NruI  ||| S:45671 E:45676 ||| JJ
and  ||| S:45676 E:45680 ||| CC
EcoRI  ||| S:45680 E:45686 ||| NNP
( ||| S:45686 E:45687 ||| -LRB-
New  ||| S:45687 E:45691 ||| NNP
England  ||| S:45691 E:45699 ||| NNP
Biolabs ||| S:45699 E:45706 ||| NNP
) ||| S:45706 E:45707 ||| -RRB-
,  ||| S:45707 E:45709 ||| ,
purified  ||| S:45709 E:45718 ||| VBZ
using  ||| S:45718 E:45724 ||| VBG
a  ||| S:45724 E:45726 ||| DT
Qiaquick  ||| S:45726 E:45735 ||| NNP
PCR  ||| S:45735 E:45739 ||| NNP
Purification  ||| S:45739 E:45752 ||| NNP
column  ||| S:45752 E:45759 ||| NN
( ||| S:45759 E:45760 ||| -LRB-
Qiagen ||| S:45760 E:45766 ||| NNP
) ||| S:45766 E:45767 ||| -RRB-
,  ||| S:45767 E:45769 ||| ,
as  ||| S:45769 E:45772 ||| RB
described  ||| S:45772 E:45782 ||| VBN
by  ||| S:45782 E:45785 ||| IN
the  ||| S:45785 E:45789 ||| DT
manufacturer ||| S:45789 E:45801 ||| NN
,  ||| S:45801 E:45803 ||| ,
and  ||| S:45803 E:45807 ||| CC
ligated  ||| S:45807 E:45815 ||| NN
into  ||| S:45815 E:45820 ||| IN
NruI ||| S:45820 E:45824 ||| JJ
/ ||| S:45824 E:45825 ||| CD
EcoRI  ||| S:45825 E:45831 ||| JJ
digested  ||| S:45831 E:45840 ||| NN
and  ||| S:45840 E:45844 ||| CC
gel-purified  ||| S:45844 E:45857 ||| NNP
pSUN15 ||| S:45857 E:45863 ||| NNP
,  ||| S:45863 E:45865 ||| ,
resulting  ||| S:45865 E:45875 ||| VBG
in  ||| S:45875 E:45878 ||| IN
plasmid  ||| S:45878 E:45886 ||| CD
pJRS311  ||| S:45886 E:45894 ||| CD
( ||| S:45894 E:45895 ||| -LRB-
see  ||| S:45895 E:45899 ||| VB
FIG.  ||| S:45899 E:45904 ||| CD
16 ||| S:45904 E:45906 ||| CD
) ||| S:45906 E:45907 ||| -RRB-
.  ||| S:45907 E:45911 ||| .
At  ||| S:45911 E:45914 ||| IN
this  ||| S:45914 E:45919 ||| DT
point ||| S:45919 E:45924 ||| NN
,  ||| S:45924 E:45926 ||| ,
a  ||| S:45926 E:45928 ||| DT
BstBI ||| S:45928 E:45933 ||| JJ
/ ||| S:45933 E:45934 ||| NNP
NotI  ||| S:45934 E:45939 ||| NNP
( ||| S:45939 E:45940 ||| -LRB-
New  ||| S:45940 E:45944 ||| NNP
England  ||| S:45944 E:45952 ||| NNP
Biolabs ||| S:45952 E:45959 ||| NNP
)  ||| S:45959 E:45961 ||| -RRB-
DNA  ||| S:45961 E:45965 ||| NNP
fragment  ||| S:45965 E:45974 ||| FW
containing  ||| S:45974 E:45985 ||| FW
a  ||| S:45985 E:45987 ||| FW
mouse  ||| S:45987 E:45993 ||| FW
kappa  ||| S:45993 E:45999 ||| FW
J-kappa  ||| S:45999 E:46007 ||| FW
intron  ||| S:46007 E:46014 ||| FW
fragment  ||| S:46014 E:46023 ||| FW
fused  ||| S:46023 E:46029 ||| FW
to  ||| S:46029 E:46032 ||| TO
a  ||| S:46032 E:46034 ||| DT
human  ||| S:46034 E:46040 ||| JJ
kappa  ||| S:46040 E:46046 ||| JJ
exon  ||| S:46046 E:46051 ||| JJ
fragment  ||| S:46051 E:46060 ||| NN
was  ||| S:46060 E:46064 ||| VBD
digested  ||| S:46064 E:46073 ||| VBN
and  ||| S:46073 E:46077 ||| CC
gel-purified  ||| S:46077 E:46090 ||| JJ
from  ||| S:46090 E:46095 ||| IN
the  ||| S:46095 E:46099 ||| DT
vector  ||| S:46099 E:46106 ||| JJ
tKMC180C2 ||| S:46106 E:46115 ||| NN
.  ||| S:46115 E:46117 ||| .
This  ||| S:46117 E:46122 ||| DT
fragment  ||| S:46122 E:46131 ||| NN
was  ||| S:46131 E:46135 ||| VBD
ligated  ||| S:46135 E:46143 ||| VBN
into  ||| S:46143 E:46148 ||| IN
the  ||| S:46148 E:46152 ||| DT
backbone  ||| S:46152 E:46161 ||| NN
of  ||| S:46161 E:46164 ||| IN
pJRS311  ||| S:46164 E:46172 ||| CD
digested  ||| S:46172 E:46181 ||| NN
with  ||| S:46181 E:46186 ||| IN
BstBI ||| S:46186 E:46191 ||| NNP
/ ||| S:46191 E:46192 ||| NNP
NotI  ||| S:46192 E:46197 ||| NNP
and  ||| S:46197 E:46201 ||| CC
gel-purified  ||| S:46201 E:46214 ||| JJ
resulting  ||| S:46214 E:46224 ||| VBG
in  ||| S:46224 E:46227 ||| IN
the  ||| S:46227 E:46231 ||| DT
plasmid  ||| S:46231 E:46239 ||| JJ
pJRS315  ||| S:46239 E:46247 ||| NNP
( ||| S:46247 E:46248 ||| -LRB-
see  ||| S:46248 E:46252 ||| VB
FIG.  ||| S:46252 E:46257 ||| CD
17 ||| S:46257 E:46259 ||| CD
) ||| S:46259 E:46260 ||| -RRB-
.  ||| S:46260 E:46263 ||| .
A.  ||| S:46361 E:46364 ||| NNP
Transfection  ||| S:46364 E:46377 ||| NNP
of  ||| S:46377 E:46380 ||| IN
NSO  ||| S:46380 E:46384 ||| NNP
Cells  ||| S:46384 E:46392 ||| NNPS
The  ||| S:46392 E:46396 ||| DT
plasmid  ||| S:46396 E:46404 ||| JJ
pACE4  ||| S:46404 E:46410 ||| NN
was  ||| S:46410 E:46414 ||| VBD
transfected  ||| S:46414 E:46426 ||| VBN
into  ||| S:46426 E:46431 ||| IN
NSO  ||| S:46431 E:46435 ||| NNP
cells  ||| S:46435 E:46441 ||| NNS
using  ||| S:46441 E:46447 ||| VBG
electroporation ||| S:46447 E:46462 ||| NNS
.  ||| S:46462 E:46464 ||| .
The  ||| S:46464 E:46468 ||| DT
plasmid  ||| S:46468 E:46476 ||| NN
was  ||| S:46476 E:46480 ||| VBD
linearized  ||| S:46480 E:46491 ||| VBN
with  ||| S:46491 E:46496 ||| IN
a  ||| S:46496 E:46498 ||| DT
PvuI  ||| S:46498 E:46503 ||| JJ
restriction  ||| S:46503 E:46515 ||| NN
enzyme  ||| S:46515 E:46522 ||| VBD
digestion.  ||| S:46522 E:46533 ||| CD
40  ||| S:46533 E:46536 ||| CD
& ||| S:46536 E:46537 ||| CC
# ||| S:46537 E:46538 ||| #
x3bc ||| S:46538 E:46542 ||| CD
; ||| S:46542 E:46543 ||| :
g  ||| S:46543 E:46545 ||| NN
of  ||| S:46545 E:46548 ||| IN
digested  ||| S:46548 E:46557 ||| JJ
plasmid  ||| S:46557 E:46565 ||| JJ
DNA  ||| S:46565 E:46569 ||| NN
was  ||| S:46569 E:46573 ||| VBD
mixed  ||| S:46573 E:46579 ||| VBN
with  ||| S:46579 E:46584 ||| IN
7 ||| S:46584 E:46585 ||| CD
& ||| S:46585 E:46586 ||| CC
# ||| S:46586 E:46587 ||| #
xd7 ||| S:46587 E:46590 ||| CD
; ||| S:46590 E:46591 ||| :
106  ||| S:46591 E:46595 ||| CD
cells  ||| S:46595 E:46601 ||| NNS
in  ||| S:46601 E:46604 ||| IN
a  ||| S:46604 E:46606 ||| DT
total  ||| S:46606 E:46612 ||| JJ
volume  ||| S:46612 E:46619 ||| NN
of  ||| S:46619 E:46622 ||| IN
400  ||| S:46622 E:46626 ||| CD
& ||| S:46626 E:46627 ||| CC
# ||| S:46627 E:46628 ||| #
x3bc ||| S:46628 E:46632 ||| CD
; ||| S:46632 E:46633 ||| :
L  ||| S:46633 E:46635 ||| NNP
and  ||| S:46635 E:46639 ||| CC
incubated  ||| S:46639 E:46649 ||| NN
at  ||| S:46649 E:46652 ||| IN
room  ||| S:46652 E:46657 ||| NN
temperature  ||| S:46657 E:46669 ||| NN
with  ||| S:46669 E:46674 ||| IN
gentle  ||| S:46674 E:46681 ||| JJ
agitation  ||| S:46681 E:46691 ||| NN
for  ||| S:46691 E:46695 ||| IN
one  ||| S:46695 E:46699 ||| CD
minute.  ||| S:46699 E:46707 ||| CD
10  ||| S:46707 E:46710 ||| CD
& ||| S:46710 E:46711 ||| CC
# ||| S:46711 E:46712 ||| #
x3bc ||| S:46712 E:46716 ||| CD
; ||| S:46716 E:46717 ||| :
L  ||| S:46717 E:46719 ||| NNP
of  ||| S:46719 E:46722 ||| IN
DMSO  ||| S:46722 E:46727 ||| NNP
( ||| S:46727 E:46728 ||| -LRB-
Sigma ||| S:46728 E:46733 ||| NNP
)  ||| S:46733 E:46735 ||| -RRB-
were  ||| S:46735 E:46740 ||| VBD
added  ||| S:46740 E:46746 ||| VBN
to  ||| S:46746 E:46749 ||| TO
a  ||| S:46749 E:46751 ||| DT
final  ||| S:46751 E:46757 ||| JJ
concentration  ||| S:46757 E:46771 ||| NN
of  ||| S:46771 E:46774 ||| IN
1.25 ||| S:46774 E:46778 ||| CD
% ||| S:46778 E:46779 ||| NN
.  ||| S:46779 E:46781 ||| .
The  ||| S:46781 E:46785 ||| DT
cells ||| S:46785 E:46790 ||| NNS
/ ||| S:46790 E:46791 ||| NNP
DNA ||| S:46791 E:46794 ||| NNP
/ ||| S:46794 E:46795 ||| NNP
DMSO  ||| S:46795 E:46800 ||| NNP
mix  ||| S:46800 E:46804 ||| NN
was  ||| S:46804 E:46808 ||| VBD
transferred  ||| S:46808 E:46820 ||| VBN
to  ||| S:46820 E:46823 ||| TO
a  ||| S:46823 E:46825 ||| DT
cold  ||| S:46825 E:46830 ||| JJ
0.4  ||| S:46830 E:46834 ||| CD
centimeter  ||| S:46834 E:46845 ||| CD
cuvette  ||| S:46845 E:46853 ||| NNS
and  ||| S:46853 E:46857 ||| CC
subjected  ||| S:46857 E:46867 ||| VBN
to  ||| S:46867 E:46870 ||| TO
one  ||| S:46870 E:46874 ||| CD
pulse  ||| S:46874 E:46880 ||| NN
of  ||| S:46880 E:46883 ||| IN
250  ||| S:46883 E:46887 ||| CD
volts ||| S:46887 E:46892 ||| NN
,  ||| S:46892 E:46894 ||| ,
960  ||| S:46894 E:46898 ||| CD
& ||| S:46898 E:46899 ||| CC
# ||| S:46899 E:46900 ||| #
x3bc ||| S:46900 E:46904 ||| CD
; ||| S:46904 E:46905 ||| :
F ||| S:46905 E:46906 ||| NN
.  ||| S:46906 E:46908 ||| .
The  ||| S:46908 E:46912 ||| DT
cells  ||| S:46912 E:46918 ||| NNS
were  ||| S:46918 E:46923 ||| VBD
transferred  ||| S:46923 E:46935 ||| VBN
to  ||| S:46935 E:46938 ||| TO
one  ||| S:46938 E:46942 ||| CD
well  ||| S:46942 E:46947 ||| RB
of  ||| S:46947 E:46950 ||| IN
a  ||| S:46950 E:46952 ||| DT
six-well  ||| S:46952 E:46961 ||| JJ
plate  ||| S:46961 E:46967 ||| NN
containing  ||| S:46967 E:46978 ||| VBG
5  ||| S:46978 E:46980 ||| CD
ml  ||| S:46980 E:46983 ||| NN
of  ||| S:46983 E:46986 ||| IN
non-selective  ||| S:46986 E:47000 ||| JJ
media  ||| S:47000 E:47006 ||| NNS
supplemented  ||| S:47006 E:47019 ||| VBN
with  ||| S:47019 E:47024 ||| IN
DMSO  ||| S:47024 E:47029 ||| NNP
( ||| S:47029 E:47030 ||| -LRB-
final  ||| S:47030 E:47036 ||| JJ
concentration  ||| S:47036 E:47050 ||| NN
of  ||| S:47050 E:47053 ||| IN
1.25 ||| S:47053 E:47057 ||| CD
% ||| S:47057 E:47058 ||| NN
) ||| S:47058 E:47059 ||| -RRB-
.  ||| S:47059 E:47061 ||| .
After  ||| S:47061 E:47067 ||| IN
24  ||| S:47067 E:47070 ||| CD
hours  ||| S:47070 E:47076 ||| NNS
at  ||| S:47076 E:47079 ||| IN
37 ||| S:47079 E:47081 ||| CD
& ||| S:47081 E:47082 ||| CC
# ||| S:47082 E:47083 ||| #
xb0 ||| S:47083 E:47086 ||| CD
;  ||| S:47086 E:47088 ||| :
C.  ||| S:47088 E:47091 ||| NNP
and  ||| S:47091 E:47095 ||| CC
10 ||| S:47095 E:47097 ||| CD
%  ||| S:47097 E:47099 ||| NN
C02 ||| S:47099 E:47102 ||| NN
,  ||| S:47102 E:47104 ||| ,
the  ||| S:47104 E:47108 ||| DT
cells  ||| S:47108 E:47114 ||| NNS
were  ||| S:47114 E:47119 ||| VBD
plated  ||| S:47119 E:47126 ||| VBN
out  ||| S:47126 E:47130 ||| RP
into  ||| S:47130 E:47135 ||| IN
96-well  ||| S:47135 E:47143 ||| CD
microtiter  ||| S:47143 E:47154 ||| CD
plates ||| S:47154 E:47160 ||| NNS
.  ||| S:47160 E:47162 ||| .
As  ||| S:47162 E:47165 ||| IN
colonies  ||| S:47165 E:47174 ||| NNS
appeared ||| S:47174 E:47182 ||| VBD
,  ||| S:47182 E:47184 ||| ,
the  ||| S:47184 E:47188 ||| DT
supernatants  ||| S:47188 E:47201 ||| NN
were  ||| S:47201 E:47206 ||| VBD
assayed  ||| S:47206 E:47214 ||| VBN
for  ||| S:47214 E:47218 ||| IN
the  ||| S:47218 E:47222 ||| DT
production  ||| S:47222 E:47233 ||| NN
of  ||| S:47233 E:47236 ||| IN
& ||| S:47236 E:47237 ||| CC
# ||| S:47237 E:47238 ||| #
x201c ||| S:47238 E:47243 ||| CD
; ||| S:47243 E:47244 ||| :
humanized ||| S:47244 E:47253 ||| NNS
& ||| S:47253 E:47254 ||| CC
# ||| S:47254 E:47255 ||| #
x201d ||| S:47255 E:47260 ||| CD
;  ||| S:47260 E:47262 ||| :
antibody  ||| S:47262 E:47271 ||| NN
and  ||| S:47271 E:47275 ||| CC
for  ||| S:47275 E:47279 ||| IN
the  ||| S:47279 E:47283 ||| DT
capability  ||| S:47283 E:47294 ||| NN
for  ||| S:47294 E:47298 ||| IN
the  ||| S:47298 E:47302 ||| DT
expressed  ||| S:47302 E:47312 ||| JJ
antibody  ||| S:47312 E:47321 ||| NN
to  ||| S:47321 E:47324 ||| TO
bind  ||| S:47324 E:47329 ||| VB
to  ||| S:47329 E:47332 ||| TO
the  ||| S:47332 E:47336 ||| DT
Stx2  ||| S:47336 E:47341 ||| JJ
toxin ||| S:47341 E:47346 ||| NN
.  ||| S:47346 E:47350 ||| .
B.  ||| S:47350 E:47353 ||| NNP
Assay  ||| S:47353 E:47359 ||| NNP
for  ||| S:47359 E:47363 ||| IN
Antibody  ||| S:47363 E:47372 ||| NNP
Production  ||| S:47372 E:47385 ||| NNPS
Antibody  ||| S:47385 E:47394 ||| NN
production  ||| S:47394 E:47405 ||| NN
and  ||| S:47405 E:47409 ||| CC
activity  ||| S:47409 E:47418 ||| NN
assays  ||| S:47418 E:47425 ||| NN
for  ||| S:47425 E:47429 ||| IN
the  ||| S:47429 E:47433 ||| DT
stable  ||| S:47433 E:47440 ||| JJ
transfectants  ||| S:47440 E:47454 ||| NN
were  ||| S:47454 E:47459 ||| VBD
performed  ||| S:47459 E:47469 ||| VBN
in  ||| S:47469 E:47472 ||| IN
8-well  ||| S:47472 E:47479 ||| CD
strips  ||| S:47479 E:47486 ||| NNS
from  ||| S:47486 E:47491 ||| IN
96-well  ||| S:47491 E:47499 ||| FW
microtiter  ||| S:47499 E:47510 ||| FW
plates  ||| S:47510 E:47517 ||| FW
( ||| S:47517 E:47518 ||| -LRB-
Maxisorp  ||| S:47518 E:47527 ||| NNP
F8 ||| S:47527 E:47529 ||| NNP
;  ||| S:47529 E:47531 ||| :
Nunc ||| S:47531 E:47535 ||| NNP
,  ||| S:47535 E:47537 ||| ,
Inc. ||| S:47537 E:47541 ||| NNP
)  ||| S:47541 E:47543 ||| -RRB-
coated  ||| S:47543 E:47550 ||| VBN
with  ||| S:47550 E:47555 ||| IN
a  ||| S:47555 E:47557 ||| DT
1 ||| S:47557 E:47558 ||| CD
: ||| S:47558 E:47559 ||| :
500  ||| S:47559 E:47563 ||| CD
dilution  ||| S:47563 E:47572 ||| NN
of  ||| S:47572 E:47575 ||| IN
goat  ||| S:47575 E:47580 ||| JJ
anti-Human  ||| S:47580 E:47591 ||| JJ
F ||| S:47591 E:47592 ||| NN
( ||| S:47592 E:47593 ||| -LRB-
ab ||| S:47593 E:47595 ||| NN
& ||| S:47595 E:47596 ||| CC
# ||| S:47596 E:47597 ||| #
x2032 ||| S:47597 E:47602 ||| CD
; ||| S:47602 E:47603 ||| :
) ||| S:47603 E:47604 ||| CD
2  ||| S:47604 E:47606 ||| CD
anti-IgG  ||| S:47606 E:47615 ||| JJ
antibody  ||| S:47615 E:47624 ||| NN
( ||| S:47624 E:47625 ||| -LRB-
Southern  ||| S:47625 E:47634 ||| NNP
Biotechnology ||| S:47634 E:47647 ||| NNP
)  ||| S:47647 E:47649 ||| -RRB-
using  ||| S:47649 E:47655 ||| VBG
a  ||| S:47655 E:47657 ||| DT
bicarbonate  ||| S:47657 E:47669 ||| JJ
coating  ||| S:47669 E:47677 ||| NN
buffer ||| S:47677 E:47683 ||| NN
,  ||| S:47683 E:47685 ||| ,
pH  ||| S:47685 E:47688 ||| JJ
8.5 ||| S:47688 E:47691 ||| CD
.  ||| S:47691 E:47693 ||| .
The  ||| S:47693 E:47697 ||| DT
plates  ||| S:47697 E:47704 ||| NN
were  ||| S:47704 E:47709 ||| VBD
covered  ||| S:47709 E:47717 ||| VBN
with  ||| S:47717 E:47722 ||| IN
pressure  ||| S:47722 E:47731 ||| NN
sensitive  ||| S:47731 E:47741 ||| JJ
film  ||| S:47741 E:47746 ||| NN
( ||| S:47746 E:47747 ||| -LRB-
Falcon ||| S:47747 E:47753 ||| NNP
,  ||| S:47753 E:47755 ||| ,
Becton  ||| S:47755 E:47762 ||| NNP
Dickinson ||| S:47762 E:47771 ||| NNP
)  ||| S:47771 E:47773 ||| -RRB-
and  ||| S:47773 E:47777 ||| CC
incubated  ||| S:47777 E:47787 ||| JJ
overnight  ||| S:47787 E:47797 ||| JJ
at  ||| S:47797 E:47800 ||| IN
4 ||| S:47800 E:47801 ||| CD
& ||| S:47801 E:47802 ||| CC
# ||| S:47802 E:47803 ||| #
xb0 ||| S:47803 E:47806 ||| CD
;  ||| S:47806 E:47808 ||| :
C.  ||| S:47808 E:47811 ||| NNP
Plates  ||| S:47811 E:47818 ||| NNPS
are  ||| S:47818 E:47822 ||| VBP
then  ||| S:47822 E:47827 ||| RB
washed  ||| S:47827 E:47834 ||| VBN
once  ||| S:47834 E:47839 ||| RB
with  ||| S:47839 E:47844 ||| IN
wash  ||| S:47844 E:47849 ||| JJ
solution  ||| S:47849 E:47858 ||| NN
( ||| S:47858 E:47859 ||| -LRB-
imidazole ||| S:47859 E:47868 ||| FW
/ ||| S:47868 E:47869 ||| FW
NaCl ||| S:47869 E:47873 ||| FW
/ ||| S:47873 E:47874 ||| NNP
0.4 ||| S:47874 E:47877 ||| CD
%  ||| S:47877 E:47879 ||| NN
Tween-20 ||| S:47879 E:47887 ||| CD
) ||| S:47887 E:47888 ||| -RRB-
.  ||| S:47888 E:47890 ||| .
100  ||| S:47890 E:47894 ||| CD
& ||| S:47894 E:47895 ||| CC
# ||| S:47895 E:47896 ||| #
x3bc ||| S:47896 E:47900 ||| CD
; ||| S:47900 E:47901 ||| :
L  ||| S:47901 E:47903 ||| NNP
of  ||| S:47903 E:47906 ||| IN
culture  ||| S:47906 E:47914 ||| NN
supernatant  ||| S:47914 E:47926 ||| NNS
was  ||| S:47926 E:47930 ||| VBD
then  ||| S:47930 E:47935 ||| RB
applied  ||| S:47935 E:47943 ||| VBN
and  ||| S:47943 E:47947 ||| CC
allowed  ||| S:47947 E:47955 ||| VBN
to  ||| S:47955 E:47958 ||| TO
incubate  ||| S:47958 E:47967 ||| VB
for  ||| S:47967 E:47971 ||| IN
30  ||| S:47971 E:47974 ||| CD
minutes  ||| S:47974 E:47982 ||| NNS
on  ||| S:47982 E:47985 ||| IN
a  ||| S:47985 E:47987 ||| DT
plate  ||| S:47987 E:47993 ||| NN
rotator  ||| S:47993 E:48001 ||| NN
at  ||| S:48001 E:48004 ||| IN
room  ||| S:48004 E:48009 ||| NN
temperature ||| S:48009 E:48020 ||| NN
.  ||| S:48020 E:48022 ||| .
The  ||| S:48022 E:48026 ||| DT
plates  ||| S:48026 E:48033 ||| NN
were  ||| S:48033 E:48038 ||| VBD
washed  ||| S:48038 E:48045 ||| VBN
five  ||| S:48045 E:48050 ||| CD
times  ||| S:48050 E:48056 ||| NNS
with  ||| S:48056 E:48061 ||| IN
wash  ||| S:48061 E:48066 ||| JJ
solution  ||| S:48066 E:48075 ||| NN
( ||| S:48075 E:48076 ||| -LRB-
imidazole ||| S:48076 E:48085 ||| FW
/ ||| S:48085 E:48086 ||| FW
NaCl ||| S:48086 E:48090 ||| FW
/ ||| S:48090 E:48091 ||| NNP
0.4 ||| S:48091 E:48094 ||| CD
%  ||| S:48094 E:48096 ||| NN
Tween-20 ||| S:48096 E:48104 ||| CD
) ||| S:48104 E:48105 ||| -RRB-
.  ||| S:48105 E:48107 ||| .
A  ||| S:48107 E:48109 ||| DT
goat  ||| S:48109 E:48114 ||| JJ
anti-human  ||| S:48114 E:48125 ||| JJ
kappa-HRP  ||| S:48125 E:48135 ||| NN
( ||| S:48135 E:48136 ||| -LRB-
Southern  ||| S:48136 E:48145 ||| NNP
Biotechnology ||| S:48145 E:48158 ||| NNP
)  ||| S:48158 E:48160 ||| -RRB-
conjugate  ||| S:48160 E:48170 ||| NN
was  ||| S:48170 E:48174 ||| VBD
diluted  ||| S:48174 E:48182 ||| VBN
1 ||| S:48182 E:48183 ||| CD
: ||| S:48183 E:48184 ||| :
800  ||| S:48184 E:48188 ||| CD
in  ||| S:48188 E:48191 ||| IN
the  ||| S:48191 E:48195 ||| DT
sample ||| S:48195 E:48201 ||| FW
/ ||| S:48201 E:48202 ||| FW
conjugate  ||| S:48202 E:48212 ||| FW
diluent  ||| S:48212 E:48220 ||| FW
and  ||| S:48220 E:48224 ||| CC
100  ||| S:48224 E:48228 ||| CD
& ||| S:48228 E:48229 ||| CC
# ||| S:48229 E:48230 ||| #
x3bc ||| S:48230 E:48234 ||| CD
; ||| S:48234 E:48235 ||| :
L  ||| S:48235 E:48237 ||| NNP
was  ||| S:48237 E:48241 ||| VBD
added  ||| S:48241 E:48247 ||| VBN
to  ||| S:48247 E:48250 ||| TO
the  ||| S:48250 E:48254 ||| DT
samples ||| S:48254 E:48261 ||| NNS
,  ||| S:48261 E:48263 ||| ,
then  ||| S:48263 E:48268 ||| RB
incubated  ||| S:48268 E:48278 ||| VBN
on  ||| S:48278 E:48281 ||| IN
a  ||| S:48281 E:48283 ||| DT
plate  ||| S:48283 E:48289 ||| NN
rotator  ||| S:48289 E:48297 ||| NN
for  ||| S:48297 E:48301 ||| IN
30  ||| S:48301 E:48304 ||| CD
minutes  ||| S:48304 E:48312 ||| NNS
at  ||| S:48312 E:48315 ||| IN
room  ||| S:48315 E:48320 ||| NN
temperature ||| S:48320 E:48331 ||| NN
.  ||| S:48331 E:48333 ||| .
The  ||| S:48333 E:48337 ||| DT
samples  ||| S:48337 E:48345 ||| NNS
were  ||| S:48345 E:48350 ||| VBD
washed  ||| S:48350 E:48357 ||| VBN
as  ||| S:48357 E:48360 ||| IN
above  ||| S:48360 E:48366 ||| JJ
and  ||| S:48366 E:48370 ||| CC
then  ||| S:48370 E:48375 ||| RB
incubated  ||| S:48375 E:48385 ||| VBN
with  ||| S:48385 E:48390 ||| IN
100  ||| S:48390 E:48394 ||| CD
& ||| S:48394 E:48395 ||| CC
# ||| S:48395 E:48396 ||| #
x3bc ||| S:48396 E:48400 ||| CD
; ||| S:48400 E:48401 ||| :
L  ||| S:48401 E:48403 ||| NNP
per  ||| S:48403 E:48407 ||| IN
well  ||| S:48407 E:48412 ||| RB
of  ||| S:48412 E:48415 ||| IN
ABTS  ||| S:48415 E:48420 ||| NNP
developing  ||| S:48420 E:48431 ||| VBG
substrate  ||| S:48431 E:48441 ||| NNS
( ||| S:48441 E:48442 ||| -LRB-
Kirkgaard  ||| S:48442 E:48452 ||| NNP
& ||| S:48452 E:48453 ||| CC
# ||| S:48453 E:48454 ||| #
x26 ||| S:48454 E:48457 ||| CD
;  ||| S:48457 E:48459 ||| :
Perry  ||| S:48459 E:48465 ||| NNP
Laboratories ||| S:48465 E:48477 ||| NNPS
)  ||| S:48477 E:48479 ||| -RRB-
and  ||| S:48479 E:48483 ||| CC
the  ||| S:48483 E:48487 ||| DT
absorbance  ||| S:48487 E:48498 ||| JJ
value  ||| S:48498 E:48504 ||| NN
at  ||| S:48504 E:48507 ||| IN
405  ||| S:48507 E:48511 ||| CD
nm  ||| S:48511 E:48514 ||| NNS
was  ||| S:48514 E:48518 ||| VBD
determined  ||| S:48518 E:48529 ||| VBN
using  ||| S:48529 E:48535 ||| VBG
an  ||| S:48535 E:48538 ||| DT
automated  ||| S:48538 E:48548 ||| JJ
microtiter  ||| S:48548 E:48559 ||| JJ
plate  ||| S:48559 E:48565 ||| NN
ELISA  ||| S:48565 E:48571 ||| NNP
Reader  ||| S:48571 E:48578 ||| NNP
( ||| S:48578 E:48579 ||| -LRB-
Ceres  ||| S:48579 E:48585 ||| NNP
UV900Hl ||| S:48585 E:48592 ||| NNP
,  ||| S:48592 E:48594 ||| ,
BioTek  ||| S:48594 E:48601 ||| NNP
Instruments ||| S:48601 E:48612 ||| NNP
,  ||| S:48612 E:48614 ||| ,
Winooski ||| S:48614 E:48622 ||| NNP
,  ||| S:48622 E:48624 ||| ,
Vt. ||| S:48624 E:48627 ||| NNP
) ||| S:48627 E:48628 ||| -RRB-
.  ||| S:48628 E:48630 ||| .
This  ||| S:48630 E:48635 ||| DT
assay  ||| S:48635 E:48641 ||| NN
( ||| S:48641 E:48642 ||| -LRB-
see  ||| S:48642 E:48646 ||| VB
FIG.  ||| S:48646 E:48651 ||| CD
10 ||| S:48651 E:48653 ||| CD
)  ||| S:48653 E:48655 ||| -RRB-
demonstrates  ||| S:48655 E:48668 ||| VBZ
that  ||| S:48668 E:48673 ||| IN
the  ||| S:48673 E:48677 ||| DT
transfection  ||| S:48677 E:48690 ||| NN
of  ||| S:48690 E:48693 ||| IN
cells  ||| S:48693 E:48699 ||| NNS
with  ||| S:48699 E:48704 ||| IN
this  ||| S:48704 E:48709 ||| DT
plasmid  ||| S:48709 E:48717 ||| JJ
construct  ||| S:48717 E:48727 ||| JJ
results  ||| S:48727 E:48735 ||| NNS
in  ||| S:48735 E:48738 ||| IN
cells  ||| S:48738 E:48744 ||| NNS
producing  ||| S:48744 E:48754 ||| VBG
a  ||| S:48754 E:48756 ||| DT
molecule  ||| S:48756 E:48765 ||| NN
containing  ||| S:48765 E:48776 ||| VBG
both  ||| S:48776 E:48781 ||| DT
human  ||| S:48781 E:48787 ||| JJ
IgG  ||| S:48787 E:48791 ||| JJ
and  ||| S:48791 E:48795 ||| CC
kappa  ||| S:48795 E:48801 ||| JJ
domains ||| S:48801 E:48808 ||| NN
.  ||| S:48808 E:48812 ||| .
The  ||| S:48812 E:48816 ||| DT
supernatants  ||| S:48816 E:48829 ||| NN
were  ||| S:48829 E:48834 ||| VBD
then  ||| S:48834 E:48839 ||| RB
assayed  ||| S:48839 E:48847 ||| VBN
for  ||| S:48847 E:48851 ||| IN
the  ||| S:48851 E:48855 ||| DT
ability  ||| S:48855 E:48863 ||| NN
of  ||| S:48863 E:48866 ||| IN
the  ||| S:48866 E:48870 ||| DT
expressed  ||| S:48870 E:48880 ||| JJ
antibodies  ||| S:48880 E:48891 ||| NNS
to  ||| S:48891 E:48894 ||| TO
bind  ||| S:48894 E:48899 ||| VB
to  ||| S:48899 E:48902 ||| TO
EHEC  ||| S:48902 E:48907 ||| NNP
Stx2  ||| S:48907 E:48912 ||| NNP
toxin ||| S:48912 E:48917 ||| NN
.  ||| S:48917 E:48919 ||| .
The  ||| S:48919 E:48923 ||| DT
activity  ||| S:48923 E:48932 ||| NN
assay  ||| S:48932 E:48938 ||| NNS
was  ||| S:48938 E:48942 ||| VBD
performed ||| S:48942 E:48951 ||| VBN
,  ||| S:48951 E:48953 ||| ,
as  ||| S:48953 E:48956 ||| RB
above ||| S:48956 E:48961 ||| RB
,  ||| S:48961 E:48963 ||| ,
using  ||| S:48963 E:48969 ||| VBG
plates  ||| S:48969 E:48976 ||| JJ
coated  ||| S:48976 E:48983 ||| NN
at  ||| S:48983 E:48986 ||| IN
1  ||| S:48986 E:48988 ||| CD
& ||| S:48988 E:48989 ||| CC
# ||| S:48989 E:48990 ||| #
x3bc ||| S:48990 E:48994 ||| CD
; ||| S:48994 E:48995 ||| :
g ||| S:48995 E:48996 ||| CD
/ ||| S:48996 E:48997 ||| CD
ml  ||| S:48997 E:49000 ||| NN
with  ||| S:49000 E:49005 ||| IN
Stx2  ||| S:49005 E:49010 ||| CD
toxin  ||| S:49010 E:49016 ||| NN
( ||| S:49016 E:49017 ||| -LRB-
obtained  ||| S:49017 E:49026 ||| VBN
as  ||| S:49026 E:49029 ||| IN
in  ||| S:49029 E:49032 ||| IN
Example  ||| S:49032 E:49040 ||| NNP
7  ||| S:49040 E:49042 ||| CD
from  ||| S:49042 E:49047 ||| IN
Dr.  ||| S:49047 E:49051 ||| NNP
O ||| S:49051 E:49052 ||| NNP
' ||| S:49052 E:49053 ||| POS
Brien ||| S:49053 E:49058 ||| NNP
's  ||| S:49058 E:49061 ||| POS
lab ||| S:49061 E:49064 ||| NN
)  ||| S:49064 E:49066 ||| -RRB-
in  ||| S:49066 E:49069 ||| IN
a  ||| S:49069 E:49071 ||| DT
bicarbonate  ||| S:49071 E:49083 ||| JJ
coating  ||| S:49083 E:49091 ||| NN
buffer ||| S:49091 E:49097 ||| NN
,  ||| S:49097 E:49099 ||| ,
pH  ||| S:49099 E:49102 ||| JJ
8.5 ||| S:49102 E:49105 ||| CD
.  ||| S:49105 E:49107 ||| .
This  ||| S:49107 E:49112 ||| DT
assay  ||| S:49112 E:49118 ||| NN
demonstrates  ||| S:49118 E:49131 ||| VBZ
that  ||| S:49131 E:49136 ||| IN
the  ||| S:49136 E:49140 ||| DT
transfection  ||| S:49140 E:49153 ||| NN
of  ||| S:49153 E:49156 ||| IN
cells  ||| S:49156 E:49162 ||| NNS
with  ||| S:49162 E:49167 ||| IN
this  ||| S:49167 E:49172 ||| DT
plasmid  ||| S:49172 E:49180 ||| JJ
construct  ||| S:49180 E:49190 ||| NN
can  ||| S:49190 E:49194 ||| MD
result  ||| S:49194 E:49201 ||| VB
in  ||| S:49201 E:49204 ||| IN
the  ||| S:49204 E:49208 ||| DT
production  ||| S:49208 E:49219 ||| NN
of  ||| S:49219 E:49222 ||| IN
a  ||| S:49222 E:49224 ||| DT
humanized  ||| S:49224 E:49234 ||| JJ
chimeric  ||| S:49234 E:49243 ||| JJ
version  ||| S:49243 E:49251 ||| NN
of  ||| S:49251 E:49254 ||| IN
the  ||| S:49254 E:49258 ||| DT
11E10  ||| S:49258 E:49264 ||| JJ
mouse  ||| S:49264 E:49270 ||| NN
monoclonal  ||| S:49270 E:49281 ||| NN
antibody  ||| S:49281 E:49290 ||| NN
which  ||| S:49290 E:49296 ||| WDT
effectively  ||| S:49296 E:49308 ||| RB
binds  ||| S:49308 E:49314 ||| JJ
Shiga  ||| S:49314 E:49320 ||| JJ
toxin  ||| S:49320 E:49326 ||| NN
type  ||| S:49326 E:49331 ||| NN
2  ||| S:49331 E:49333 ||| CD
( ||| S:49333 E:49334 ||| -LRB-
FIG.  ||| S:49334 E:49339 ||| CD
11 ||| S:49339 E:49341 ||| CD
) ||| S:49341 E:49342 ||| -RRB-
.  ||| S:49342 E:49346 ||| .
Together ||| S:49346 E:49354 ||| RB
,  ||| S:49354 E:49356 ||| ,
these  ||| S:49356 E:49362 ||| DT
assays  ||| S:49362 E:49369 ||| JJ
demonstrate  ||| S:49369 E:49381 ||| NN
that  ||| S:49381 E:49386 ||| IN
the  ||| S:49386 E:49390 ||| DT
transfection  ||| S:49390 E:49403 ||| NN
of  ||| S:49403 E:49406 ||| IN
cells  ||| S:49406 E:49412 ||| NNS
with  ||| S:49412 E:49417 ||| IN
this  ||| S:49417 E:49422 ||| DT
plasmid  ||| S:49422 E:49430 ||| JJ
construct  ||| S:49430 E:49440 ||| NN
can  ||| S:49440 E:49444 ||| MD
result  ||| S:49444 E:49451 ||| VB
in  ||| S:49451 E:49454 ||| IN
the  ||| S:49454 E:49458 ||| DT
production  ||| S:49458 E:49469 ||| NN
of  ||| S:49469 E:49472 ||| IN
a  ||| S:49472 E:49474 ||| DT
stable  ||| S:49474 E:49481 ||| JJ
cell  ||| S:49481 E:49486 ||| NN
line  ||| S:49486 E:49491 ||| NN
that  ||| S:49491 E:49496 ||| WDT
produces  ||| S:49496 E:49505 ||| VBZ
a  ||| S:49505 E:49507 ||| DT
humanized  ||| S:49507 E:49517 ||| JJ
chimeric  ||| S:49517 E:49526 ||| JJ
version  ||| S:49526 E:49534 ||| NN
of  ||| S:49534 E:49537 ||| IN
the  ||| S:49537 E:49541 ||| DT
11E10  ||| S:49541 E:49547 ||| JJ
mouse  ||| S:49547 E:49553 ||| NN
hybridoma  ||| S:49553 E:49563 ||| NN
antibody ||| S:49563 E:49571 ||| NN
.  ||| S:49571 E:49574 ||| .
A.  ||| S:49674 E:49677 ||| NNP
Vero  ||| S:49677 E:49682 ||| NNP
Cell  ||| S:49682 E:49687 ||| NNP
Cytotoxicity  ||| S:49687 E:49700 ||| NNP
Assay  ||| S:49700 E:49708 ||| NNPS
The  ||| S:49708 E:49712 ||| DT
efficacy  ||| S:49712 E:49721 ||| NN
of  ||| S:49721 E:49724 ||| IN
the  ||| S:49724 E:49728 ||| DT
humanized  ||| S:49728 E:49738 ||| JJ
antibodies  ||| S:49738 E:49749 ||| NNS
to  ||| S:49749 E:49752 ||| TO
Shiga  ||| S:49752 E:49758 ||| NNP
toxin  ||| S:49758 E:49764 ||| NN
obtained  ||| S:49764 E:49773 ||| VBD
as  ||| S:49773 E:49776 ||| RB
detailed  ||| S:49776 E:49785 ||| VBN
in  ||| S:49785 E:49788 ||| IN
Examples  ||| S:49788 E:49797 ||| NNP
1  ||| S:49797 E:49799 ||| CD
through  ||| S:49799 E:49807 ||| IN
6  ||| S:49807 E:49809 ||| CD
was  ||| S:49809 E:49813 ||| VBD
determined  ||| S:49813 E:49824 ||| VBN
by  ||| S:49824 E:49827 ||| IN
assaying  ||| S:49827 E:49836 ||| VBG
their  ||| S:49836 E:49842 ||| PRP$
ability  ||| S:49842 E:49850 ||| NN
to  ||| S:49850 E:49853 ||| TO
protect  ||| S:49853 E:49861 ||| VB
Vero  ||| S:49861 E:49866 ||| JJ
cells  ||| S:49866 E:49872 ||| NNS
from  ||| S:49872 E:49877 ||| IN
toxin ||| S:49877 E:49882 ||| NN
.  ||| S:49882 E:49884 ||| .
Cytotoxicity  ||| S:49884 E:49897 ||| JJ
assays  ||| S:49897 E:49904 ||| NN
were  ||| S:49904 E:49909 ||| VBD
performed  ||| S:49909 E:49919 ||| VBN
essentially  ||| S:49919 E:49931 ||| RB
as  ||| S:49931 E:49934 ||| RB
described  ||| S:49934 E:49944 ||| VBN
by  ||| S:49944 E:49947 ||| IN
Gentry  ||| S:49947 E:49954 ||| NNP
and  ||| S:49954 E:49958 ||| CC
Dalrymple ||| S:49958 E:49967 ||| NNP
,  ||| S:49967 E:49969 ||| ,
J.  ||| S:49969 E:49972 ||| NNP
Clin ||| S:49972 E:49976 ||| NNP
.  ||| S:49976 E:49978 ||| .
Microbiol ||| S:49978 E:49987 ||| NNP
,  ||| S:49987 E:49989 ||| ,
12 ||| S:49989 E:49991 ||| CD
:  ||| S:49991 E:49993 ||| :
361-366  ||| S:49993 E:50001 ||| CD
( ||| S:50001 E:50002 ||| -LRB-
1980 ||| S:50002 E:50006 ||| CD
) ||| S:50006 E:50007 ||| -RRB-
.  ||| S:50007 E:50009 ||| .
Briefly ||| S:50009 E:50016 ||| RB
,  ||| S:50016 E:50018 ||| ,
toxin  ||| S:50018 E:50024 ||| NN
was  ||| S:50024 E:50028 ||| VBD
obtained  ||| S:50028 E:50037 ||| VBN
from  ||| S:50037 E:50042 ||| IN
cultures  ||| S:50042 E:50051 ||| NNS
of  ||| S:50051 E:50054 ||| IN
E.  ||| S:50054 E:50057 ||| NNP
coli  ||| S:50057 E:50062 ||| VBD
K-12  ||| S:50062 E:50067 ||| CD
strains  ||| S:50067 E:50075 ||| NNS
that  ||| S:50075 E:50080 ||| WDT
contained  ||| S:50080 E:50090 ||| VBD
either  ||| S:50090 E:50097 ||| DT
plasmid  ||| S:50097 E:50105 ||| JJ
pLPSH3  ||| S:50105 E:50112 ||| NNP
( ||| S:50112 E:50113 ||| -LRB-
encodes  ||| S:50113 E:50121 ||| UH
Stx ||| S:50121 E:50124 ||| UH
;  ||| S:50124 E:50126 ||| :
J.  ||| S:50126 E:50129 ||| NNP
Infect ||| S:50129 E:50135 ||| NNP
.  ||| S:50135 E:50137 ||| .
Disease  ||| S:50137 E:50145 ||| NNP
164 ||| S:50145 E:50148 ||| CD
: ||| S:50148 E:50149 ||| :
344-352  ||| S:50149 E:50157 ||| CD
( ||| S:50157 E:50158 ||| -LRB-
1991 ||| S:50158 E:50162 ||| CD
) ||| S:50162 E:50163 ||| -RRB-
)  ||| S:50163 E:50165 ||| -RRB-
or  ||| S:50165 E:50168 ||| CC
pMJ  ||| S:50168 E:50172 ||| JJ
100  ||| S:50172 E:50176 ||| CD
( ||| S:50176 E:50177 ||| -LRB-
encodes  ||| S:50177 E:50185 ||| FW
Stx2 ||| S:50185 E:50189 ||| FW
;  ||| S:50189 E:50191 ||| :
Inf.  ||| S:50191 E:50196 ||| CD
and  ||| S:50196 E:50200 ||| CC
Immunity ||| S:50200 E:50208 ||| NNP
,  ||| S:50208 E:50210 ||| ,
57 ||| S:50210 E:50212 ||| CD
: ||| S:50212 E:50213 ||| :
3743-3750  ||| S:50213 E:50223 ||| CD
( ||| S:50223 E:50224 ||| -LRB-
1989 ||| S:50224 E:50228 ||| CD
) ||| S:50228 E:50229 ||| -RRB-
) ||| S:50229 E:50230 ||| -RRB-
.  ||| S:50230 E:50232 ||| .
Bacteria  ||| S:50232 E:50241 ||| NNS
were  ||| S:50241 E:50246 ||| VBD
disrupted  ||| S:50246 E:50256 ||| VBN
by  ||| S:50256 E:50259 ||| IN
sonic  ||| S:50259 E:50265 ||| JJ
lysis  ||| S:50265 E:50271 ||| NN
and  ||| S:50271 E:50275 ||| CC
clarified  ||| S:50275 E:50285 ||| VBN
by  ||| S:50285 E:50288 ||| IN
centrifugation ||| S:50288 E:50302 ||| NN
.  ||| S:50302 E:50304 ||| .
The  ||| S:50304 E:50308 ||| DT
extracts  ||| S:50308 E:50317 ||| NN
were  ||| S:50317 E:50322 ||| VBD
serially  ||| S:50322 E:50331 ||| VBN
diluted  ||| S:50331 E:50339 ||| VBN
in  ||| S:50339 E:50342 ||| IN
tissue  ||| S:50342 E:50349 ||| NN
culture  ||| S:50349 E:50357 ||| NN
medium  ||| S:50357 E:50364 ||| NN
( ||| S:50364 E:50365 ||| -LRB-
Dulbecco  ||| S:50365 E:50374 ||| NNP
modified  ||| S:50374 E:50383 ||| VBD
Eagle  ||| S:50383 E:50389 ||| NNP
medium  ||| S:50389 E:50396 ||| NN
containing  ||| S:50396 E:50407 ||| VBG
10 ||| S:50407 E:50409 ||| CD
%  ||| S:50409 E:50411 ||| NN
fetal  ||| S:50411 E:50417 ||| JJ
calf  ||| S:50417 E:50422 ||| JJ
serum ||| S:50422 E:50427 ||| NN
,  ||| S:50427 E:50429 ||| ,
0.8  ||| S:50429 E:50433 ||| CD
mM  ||| S:50433 E:50436 ||| JJ
glutamine ||| S:50436 E:50445 ||| NN
,  ||| S:50445 E:50447 ||| ,
500  ||| S:50447 E:50451 ||| CD
U  ||| S:50451 E:50453 ||| NNP
of  ||| S:50453 E:50456 ||| IN
penicillin  ||| S:50456 E:50467 ||| JJ
G  ||| S:50467 E:50469 ||| NNP
per  ||| S:50469 E:50473 ||| FW
ml ||| S:50473 E:50475 ||| FW
,  ||| S:50475 E:50477 ||| ,
and  ||| S:50477 E:50481 ||| CC
500  ||| S:50481 E:50485 ||| CD
mg  ||| S:50485 E:50488 ||| NN
of  ||| S:50488 E:50491 ||| IN
streptomycin  ||| S:50491 E:50504 ||| FW
per  ||| S:50504 E:50508 ||| FW
ml ||| S:50508 E:50510 ||| FW
) ||| S:50510 E:50511 ||| -RRB-
.  ||| S:50511 E:50513 ||| .
One  ||| S:50513 E:50517 ||| CD
hundred  ||| S:50517 E:50525 ||| CD
microliters  ||| S:50525 E:50537 ||| NN
of  ||| S:50537 E:50540 ||| IN
10-fold  ||| S:50540 E:50548 ||| JJ
dilutions  ||| S:50548 E:50558 ||| NN
of  ||| S:50558 E:50561 ||| IN
the  ||| S:50561 E:50565 ||| DT
lysates  ||| S:50565 E:50573 ||| NN
were  ||| S:50573 E:50578 ||| VBD
added  ||| S:50578 E:50584 ||| VBN
to  ||| S:50584 E:50587 ||| TO
microtiter  ||| S:50587 E:50598 ||| VB
plate  ||| S:50598 E:50604 ||| NN
wells  ||| S:50604 E:50610 ||| NNS
containing  ||| S:50610 E:50621 ||| VBG
about  ||| S:50621 E:50627 ||| IN
104  ||| S:50627 E:50631 ||| CD
Vero  ||| S:50631 E:50636 ||| JJ
cells  ||| S:50636 E:50642 ||| NNS
in  ||| S:50642 E:50645 ||| IN
100  ||| S:50645 E:50649 ||| CD
& ||| S:50649 E:50650 ||| CC
# ||| S:50650 E:50651 ||| #
x3bc ||| S:50651 E:50655 ||| CD
; ||| S:50655 E:50656 ||| :
l  ||| S:50656 E:50658 ||| NN
of  ||| S:50658 E:50661 ||| IN
medium ||| S:50661 E:50667 ||| NN
.  ||| S:50667 E:50669 ||| .
The  ||| S:50669 E:50673 ||| DT
tissue  ||| S:50673 E:50680 ||| NN
culture  ||| S:50680 E:50688 ||| NN
cells  ||| S:50688 E:50694 ||| NNS
were  ||| S:50694 E:50699 ||| VBD
incubated  ||| S:50699 E:50709 ||| VBN
at  ||| S:50709 E:50712 ||| IN
37 ||| S:50712 E:50714 ||| CD
& ||| S:50714 E:50715 ||| CC
# ||| S:50715 E:50716 ||| #
xb0 ||| S:50716 E:50719 ||| CD
;  ||| S:50719 E:50721 ||| :
C.  ||| S:50721 E:50724 ||| NNP
in  ||| S:50724 E:50727 ||| IN
5 ||| S:50727 E:50728 ||| CD
%  ||| S:50728 E:50730 ||| NN
CO2  ||| S:50730 E:50734 ||| NN
for  ||| S:50734 E:50738 ||| IN
48  ||| S:50738 E:50741 ||| CD
hours  ||| S:50741 E:50747 ||| NNS
and  ||| S:50747 E:50751 ||| CC
then  ||| S:50751 E:50756 ||| RB
fixed  ||| S:50756 E:50762 ||| VBN
and  ||| S:50762 E:50766 ||| CC
stained  ||| S:50766 E:50774 ||| NN
with  ||| S:50774 E:50779 ||| IN
crystal  ||| S:50779 E:50787 ||| NN
violet ||| S:50787 E:50793 ||| NN
.  ||| S:50793 E:50795 ||| .
The  ||| S:50795 E:50799 ||| DT
intensity  ||| S:50799 E:50809 ||| NN
of  ||| S:50809 E:50812 ||| IN
color  ||| S:50812 E:50818 ||| NN
of  ||| S:50818 E:50821 ||| IN
the  ||| S:50821 E:50825 ||| DT
fixed  ||| S:50825 E:50831 ||| JJ
and  ||| S:50831 E:50835 ||| CC
stained  ||| S:50835 E:50843 ||| JJ
cells  ||| S:50843 E:50849 ||| NNS
was  ||| S:50849 E:50853 ||| VBD
measured  ||| S:50853 E:50862 ||| VBN
with  ||| S:50862 E:50867 ||| IN
a  ||| S:50867 E:50869 ||| DT
Titertek  ||| S:50869 E:50878 ||| JJ
reader  ||| S:50878 E:50885 ||| NN
at  ||| S:50885 E:50888 ||| IN
620  ||| S:50888 E:50892 ||| CD
nm ||| S:50892 E:50894 ||| NNS
.  ||| S:50894 E:50896 ||| .
Incubation  ||| S:50896 E:50907 ||| NNP
without  ||| S:50907 E:50915 ||| IN
antibody  ||| S:50915 E:50924 ||| NN
provides  ||| S:50924 E:50933 ||| VBZ
a  ||| S:50933 E:50935 ||| DT
standard  ||| S:50935 E:50944 ||| JJ
toxicity  ||| S:50944 E:50953 ||| JJ
curve  ||| S:50953 E:50959 ||| NN
for  ||| S:50959 E:50963 ||| IN
the  ||| S:50963 E:50967 ||| DT
Stx ||| S:50967 E:50970 ||| NNP
.  ||| S:50970 E:50974 ||| .
B.  ||| S:50974 E:50977 ||| NNP
Antisera  ||| S:50977 E:50986 ||| NNP
Neutralization  ||| S:50986 E:51001 ||| NNP
Assay  ||| S:51001 E:51009 ||| NNPS
Humanized  ||| S:51009 E:51019 ||| JJ
mouse  ||| S:51019 E:51025 ||| NN
antibodies  ||| S:51025 E:51036 ||| NNS
obtained  ||| S:51036 E:51045 ||| VBD
according  ||| S:51045 E:51055 ||| VBG
to  ||| S:51055 E:51058 ||| TO
the  ||| S:51058 E:51062 ||| DT
methods  ||| S:51062 E:51070 ||| NNS
described  ||| S:51070 E:51080 ||| VBN
in  ||| S:51080 E:51083 ||| IN
Examples  ||| S:51083 E:51092 ||| NNP
1  ||| S:51092 E:51094 ||| CD
through  ||| S:51094 E:51102 ||| IN
6  ||| S:51102 E:51104 ||| CD
were  ||| S:51104 E:51109 ||| VBD
tested  ||| S:51109 E:51116 ||| VBN
for  ||| S:51116 E:51120 ||| IN
toxin  ||| S:51120 E:51126 ||| NN
neutralization ||| S:51126 E:51140 ||| NN
.  ||| S:51140 E:51142 ||| .
Neutralization  ||| S:51142 E:51157 ||| NN
of  ||| S:51157 E:51160 ||| IN
cytotoxic  ||| S:51160 E:51170 ||| JJ
activity  ||| S:51170 E:51179 ||| NN
was  ||| S:51179 E:51183 ||| VBD
described  ||| S:51183 E:51193 ||| VBN
in  ||| S:51193 E:51196 ||| IN
great  ||| S:51196 E:51202 ||| JJ
detail  ||| S:51202 E:51209 ||| NN
in  ||| S:51209 E:51212 ||| IN
Schmitt  ||| S:51212 E:51220 ||| NNP
et  ||| S:51220 E:51223 ||| NNP
al. ||| S:51223 E:51226 ||| NNP
,  ||| S:51226 E:51228 ||| ,
Infect.  ||| S:51228 E:51236 ||| NNP
and  ||| S:51236 E:51240 ||| CC
Immun. ||| S:51240 E:51246 ||| NNP
,  ||| S:51246 E:51248 ||| ,
59 ||| S:51248 E:51250 ||| CD
: ||| S:51250 E:51251 ||| :
1065-1073  ||| S:51251 E:51261 ||| CD
( ||| S:51261 E:51262 ||| -LRB-
1991 ||| S:51262 E:51266 ||| CD
) ||| S:51266 E:51267 ||| -RRB-
.  ||| S:51267 E:51269 ||| .
Briefly ||| S:51269 E:51276 ||| RB
,  ||| S:51276 E:51278 ||| ,
lysates  ||| S:51278 E:51286 ||| NN
were  ||| S:51286 E:51291 ||| VBD
incubated  ||| S:51291 E:51301 ||| VBN
with  ||| S:51301 E:51306 ||| IN
serial  ||| S:51306 E:51313 ||| JJ
dilutions  ||| S:51313 E:51323 ||| NN
of  ||| S:51323 E:51326 ||| IN
the  ||| S:51326 E:51330 ||| DT
humanized  ||| S:51330 E:51340 ||| JJ
mouse  ||| S:51340 E:51346 ||| NN
antibodies  ||| S:51346 E:51357 ||| NNS
at  ||| S:51357 E:51360 ||| IN
37 ||| S:51360 E:51362 ||| CD
& ||| S:51362 E:51363 ||| CC
# ||| S:51363 E:51364 ||| #
xb0 ||| S:51364 E:51367 ||| CD
;  ||| S:51367 E:51369 ||| :
C.  ||| S:51369 E:51372 ||| NNP
for  ||| S:51372 E:51376 ||| IN
2  ||| S:51376 E:51378 ||| CD
hours ||| S:51378 E:51383 ||| NNS
.  ||| S:51383 E:51385 ||| .
One  ||| S:51385 E:51389 ||| CD
hundred  ||| S:51389 E:51397 ||| CD
microliters  ||| S:51397 E:51409 ||| NN
of  ||| S:51409 E:51412 ||| IN
the  ||| S:51412 E:51416 ||| DT
samples  ||| S:51416 E:51424 ||| NNS
were  ||| S:51424 E:51429 ||| VBD
then  ||| S:51429 E:51434 ||| RB
added  ||| S:51434 E:51440 ||| VBD
to  ||| S:51440 E:51443 ||| TO
Vero  ||| S:51443 E:51448 ||| NNP
cells  ||| S:51448 E:51454 ||| NNS
as  ||| S:51454 E:51457 ||| RB
described  ||| S:51457 E:51467 ||| VBN
above ||| S:51467 E:51472 ||| IN
.  ||| S:51472 E:51482 ||| .
TABLE  ||| S:51482 E:51488 ||| NN
1  ||| S:51488 E:51500 ||| CD
Vero  ||| S:51500 E:51505 ||| NNP
Cell  ||| S:51505 E:51510 ||| NNP
Neutralization  ||| S:51510 E:51525 ||| NNP
Assay  ||| S:51525 E:51541 ||| NNP
Antibody  ||| S:51541 E:51550 ||| NNP
Required  ||| S:51550 E:51559 ||| NNP
ng  ||| S:51559 E:51562 ||| VBD
to  ||| S:51562 E:51565 ||| TO
Neut.  ||| S:51565 E:51571 ||| CD
1  ||| S:51571 E:51573 ||| CD
CD50*  ||| S:51573 E:51593 ||| CD
Mouse  ||| S:51593 E:51599 ||| CD
13C4  ||| S:51599 E:51604 ||| CD
25  ||| S:51604 E:51610 ||| CD
Humanized  ||| S:51610 E:51620 ||| CD
13C4  ||| S:51620 E:51625 ||| CD
26  ||| S:51625 E:51631 ||| CD
Mouse  ||| S:51631 E:51637 ||| CD
11E10  ||| S:51637 E:51643 ||| CD
2.7  ||| S:51643 E:51650 ||| CD
Humanized  ||| S:51650 E:51660 ||| CD
11E10  ||| S:51660 E:51666 ||| CD
82.8  ||| S:51666 E:51678 ||| CD
* ||| S:51678 E:51679 ||| CD
( ||| S:51679 E:51680 ||| -LRB-
1  ||| S:51680 E:51682 ||| CD
CD50  ||| S:51682 E:51687 ||| CD
=  ||| S:51687 E:51689 ||| SYM
1  ||| S:51689 E:51691 ||| CD
pg  ||| S:51691 E:51694 ||| CD
pure  ||| S:51694 E:51699 ||| JJ
toxin ||| S:51699 E:51704 ||| NN
)  ||| S:51704 E:51713 ||| -RRB-
A.  ||| S:51773 E:51776 ||| NNP
Protection  ||| S:51776 E:51787 ||| NNP
Against  ||| S:51787 E:51795 ||| NNP
Injection  ||| S:51795 E:51805 ||| NNP
with  ||| S:51805 E:51810 ||| IN
Crude  ||| S:51810 E:51816 ||| NNP
Stx1  ||| S:51816 E:51821 ||| NNP
Toxin ||| S:51821 E:51826 ||| NNP
.  ||| S:51826 E:51830 ||| .
At  ||| S:51830 E:51833 ||| IN
day  ||| S:51833 E:51837 ||| NN
zero ||| S:51837 E:51841 ||| CD
,  ||| S:51841 E:51843 ||| ,
groups  ||| S:51843 E:51850 ||| NNS
of  ||| S:51850 E:51853 ||| IN
five  ||| S:51853 E:51858 ||| CD
CD-1  ||| S:51858 E:51863 ||| CD
mice  ||| S:51863 E:51868 ||| NNS
were  ||| S:51868 E:51873 ||| VBD
injected  ||| S:51873 E:51882 ||| VBN
intraperitoneally  ||| S:51882 E:51900 ||| NNS
( ||| S:51900 E:51901 ||| -LRB-
0.1  ||| S:51901 E:51905 ||| CD
ml ||| S:51905 E:51907 ||| CD
)  ||| S:51907 E:51909 ||| -RRB-
with  ||| S:51909 E:51914 ||| IN
antibody  ||| S:51914 E:51923 ||| CD
H13C4  ||| S:51923 E:51929 ||| CD
( ||| S:51929 E:51930 ||| -LRB-
humanized  ||| S:51930 E:51940 ||| NN
& ||| S:51940 E:51941 ||| CC
# ||| S:51941 E:51942 ||| #
x3b1 ||| S:51942 E:51946 ||| CD
; ||| S:51946 E:51947 ||| :
-Stx1B ||| S:51947 E:51953 ||| CD
) ||| S:51953 E:51954 ||| -RRB-
,  ||| S:51954 E:51956 ||| ,
13C4  ||| S:51956 E:51961 ||| NNP
( ||| S:51961 E:51962 ||| -LRB-
mouse  ||| S:51962 E:51968 ||| NN
& ||| S:51968 E:51969 ||| CC
# ||| S:51969 E:51970 ||| #
x3b1 ||| S:51970 E:51974 ||| CD
; ||| S:51974 E:51975 ||| :
-Stx1B ||| S:51975 E:51981 ||| CD
) ||| S:51981 E:51982 ||| -RRB-
,  ||| S:51982 E:51984 ||| ,
H11E10  ||| S:51984 E:51991 ||| NNP
( ||| S:51991 E:51992 ||| -LRB-
humanized  ||| S:51992 E:52002 ||| NN
& ||| S:52002 E:52003 ||| CC
# ||| S:52003 E:52004 ||| #
x3b1 ||| S:52004 E:52008 ||| CD
; ||| S:52008 E:52009 ||| :
-Stx2A ||| S:52009 E:52015 ||| CD
) ||| S:52015 E:52016 ||| -RRB-
,  ||| S:52016 E:52018 ||| ,
or  ||| S:52018 E:52021 ||| CC
phosphate  ||| S:52021 E:52031 ||| FW
buffered  ||| S:52031 E:52040 ||| FW
saline  ||| S:52040 E:52047 ||| FW
( ||| S:52047 E:52048 ||| -LRB-
PBS ||| S:52048 E:52051 ||| NNP
) ||| S:52051 E:52052 ||| -RRB-
.  ||| S:52052 E:52054 ||| .
These  ||| S:52054 E:52060 ||| DT
injections  ||| S:52060 E:52071 ||| NNS
were  ||| S:52071 E:52076 ||| VBD
repeated  ||| S:52076 E:52085 ||| VBN
at  ||| S:52085 E:52088 ||| IN
day  ||| S:52088 E:52092 ||| NN
1 ||| S:52092 E:52093 ||| CD
.  ||| S:52093 E:52095 ||| .
The  ||| S:52095 E:52099 ||| DT
mice  ||| S:52099 E:52104 ||| NNS
were  ||| S:52104 E:52109 ||| VBD
then  ||| S:52109 E:52114 ||| RB
challenged  ||| S:52114 E:52125 ||| VBN
by  ||| S:52125 E:52128 ||| IN
intravenous  ||| S:52128 E:52140 ||| JJ
injection  ||| S:52140 E:52150 ||| NN
with  ||| S:52150 E:52155 ||| IN
crude  ||| S:52155 E:52161 ||| JJ
Stx1  ||| S:52161 E:52166 ||| CD
toxin  ||| S:52166 E:52172 ||| NN
( ||| S:52172 E:52173 ||| -LRB-
obtained  ||| S:52173 E:52182 ||| VBN
as  ||| S:52182 E:52185 ||| RB
described  ||| S:52185 E:52195 ||| VBN
in  ||| S:52195 E:52198 ||| IN
Example  ||| S:52198 E:52206 ||| NNP
7 ||| S:52206 E:52207 ||| CD
)  ||| S:52207 E:52209 ||| -RRB-
at  ||| S:52209 E:52212 ||| IN
doses  ||| S:52212 E:52218 ||| NNS
of  ||| S:52218 E:52221 ||| IN
1.7 ||| S:52221 E:52224 ||| CD
& ||| S:52224 E:52225 ||| CC
# ||| S:52225 E:52226 ||| #
xd7 ||| S:52226 E:52229 ||| CD
; ||| S:52229 E:52230 ||| :
105  ||| S:52230 E:52234 ||| CD
or  ||| S:52234 E:52237 ||| CC
1.7 ||| S:52237 E:52240 ||| CD
& ||| S:52240 E:52241 ||| CC
# ||| S:52241 E:52242 ||| #
xd7 ||| S:52242 E:52245 ||| CD
; ||| S:52245 E:52246 ||| :
106  ||| S:52246 E:52250 ||| CD
CD50 ||| S:52250 E:52254 ||| CD
.  ||| S:52254 E:52256 ||| .
These  ||| S:52256 E:52262 ||| DT
doses  ||| S:52262 E:52268 ||| NN
of  ||| S:52268 E:52271 ||| IN
toxin  ||| S:52271 E:52277 ||| NN
were  ||| S:52277 E:52282 ||| VBD
chosen  ||| S:52282 E:52289 ||| VBN
following  ||| S:52289 E:52299 ||| VBG
preliminary  ||| S:52299 E:52311 ||| JJ
experiments  ||| S:52311 E:52323 ||| NNS
with  ||| S:52323 E:52328 ||| IN
varying  ||| S:52328 E:52336 ||| VBG
amounts  ||| S:52336 E:52344 ||| NNS
of  ||| S:52344 E:52347 ||| IN
toxin ||| S:52347 E:52352 ||| NN
.  ||| S:52352 E:52354 ||| .
Mice  ||| S:52354 E:52359 ||| NNS
were  ||| S:52359 E:52364 ||| VBD
monitored  ||| S:52364 E:52374 ||| VBN
for  ||| S:52374 E:52378 ||| IN
21  ||| S:52378 E:52381 ||| CD
days ||| S:52381 E:52385 ||| NNS
.  ||| S:52385 E:52389 ||| .
The  ||| S:52389 E:52393 ||| DT
results  ||| S:52393 E:52401 ||| NNS
( ||| S:52401 E:52402 ||| -LRB-
Table  ||| S:52402 E:52408 ||| NNP
2 ||| S:52408 E:52409 ||| CD
)  ||| S:52409 E:52411 ||| -RRB-
show  ||| S:52411 E:52416 ||| VBP
clearly  ||| S:52416 E:52424 ||| RB
that  ||| S:52424 E:52429 ||| IN
the  ||| S:52429 E:52433 ||| DT
injected  ||| S:52433 E:52442 ||| JJ
antibodies  ||| S:52442 E:52453 ||| NNS
protect  ||| S:52453 E:52461 ||| VB
the  ||| S:52461 E:52465 ||| DT
mice  ||| S:52465 E:52470 ||| NNS
against  ||| S:52470 E:52478 ||| IN
at  ||| S:52478 E:52481 ||| IN
least  ||| S:52481 E:52487 ||| JJS
10  ||| S:52487 E:52490 ||| CD
times  ||| S:52490 E:52496 ||| NNS
the  ||| S:52496 E:52500 ||| DT
normal  ||| S:52500 E:52507 ||| JJ
lethal  ||| S:52507 E:52514 ||| JJ
toxin  ||| S:52514 E:52520 ||| NN
dose ||| S:52520 E:52524 ||| NN
.  ||| S:52524 E:52526 ||| .
As  ||| S:52526 E:52529 ||| IN
a  ||| S:52529 E:52531 ||| DT
negative  ||| S:52531 E:52540 ||| JJ
control ||| S:52540 E:52547 ||| NN
,  ||| S:52547 E:52549 ||| ,
the  ||| S:52549 E:52553 ||| DT
antibodies  ||| S:52553 E:52564 ||| NNS
to  ||| S:52564 E:52567 ||| TO
Stx2  ||| S:52567 E:52572 ||| NNP
did  ||| S:52572 E:52576 ||| VBD
not  ||| S:52576 E:52580 ||| RB
protect  ||| S:52580 E:52588 ||| VB
against  ||| S:52588 E:52596 ||| IN
Stx1  ||| S:52596 E:52601 ||| CD
toxin  ||| S:52601 E:52607 ||| NN
challenge ||| S:52607 E:52616 ||| NN
,  ||| S:52616 E:52618 ||| ,
indicating  ||| S:52618 E:52629 ||| VBG
that  ||| S:52629 E:52634 ||| IN
the  ||| S:52634 E:52638 ||| DT
protection  ||| S:52638 E:52649 ||| NN
was  ||| S:52649 E:52653 ||| VBD
specific  ||| S:52653 E:52662 ||| JJ
to  ||| S:52662 E:52665 ||| TO
the  ||| S:52665 E:52669 ||| DT
toxin ||| S:52669 E:52674 ||| NN
/ ||| S:52674 E:52675 ||| CD
antibody  ||| S:52675 E:52684 ||| NN
pair ||| S:52684 E:52688 ||| NN
,  ||| S:52688 E:52690 ||| ,
and  ||| S:52690 E:52694 ||| CC
was  ||| S:52694 E:52698 ||| VBD
not  ||| S:52698 E:52702 ||| RB
an  ||| S:52702 E:52705 ||| DT
artifact  ||| S:52705 E:52714 ||| NN
of  ||| S:52714 E:52717 ||| IN
the  ||| S:52717 E:52721 ||| DT
antibody  ||| S:52721 E:52730 ||| NN
preparation  ||| S:52730 E:52742 ||| NN
process ||| S:52742 E:52749 ||| NN
.  ||| S:52749 E:52759 ||| .
TABLE  ||| S:52759 E:52765 ||| NN
2  ||| S:52765 E:52777 ||| CD
CD-1  ||| S:52777 E:52782 ||| CD
Mice  ||| S:52782 E:52787 ||| NNP
Injected  ||| S:52787 E:52796 ||| NNP
Intravenously  ||| S:52796 E:52810 ||| NNP
with  ||| S:52810 E:52815 ||| IN
Crude  ||| S:52815 E:52821 ||| NNP
Stx1  ||| S:52821 E:52837 ||| NNP
& ||| S:52837 E:52838 ||| CC
# ||| S:52838 E:52839 ||| #
x3bc ||| S:52839 E:52843 ||| CD
; ||| S:52843 E:52844 ||| :
g ||| S:52844 E:52845 ||| CD
/ ||| S:52845 E:52846 ||| CD
kg  ||| S:52846 E:52849 ||| NN
of  ||| S:52849 E:52852 ||| IN
Ab  ||| S:52852 E:52859 ||| NNP
to  ||| S:52859 E:52862 ||| TO
Protect  ||| S:52862 E:52870 ||| NNP
from  ||| S:52870 E:52877 ||| IN
Antibody  ||| S:52877 E:52886 ||| NNP
( ||| S:52886 E:52887 ||| -LRB-
dose ||| S:52887 E:52891 ||| FW
/ ||| S:52891 E:52892 ||| FW
mouse ||| S:52892 E:52897 ||| FW
)  ||| S:52897 E:52899 ||| -RRB-
# ||| S:52899 E:52900 ||| #
LD50  ||| S:52900 E:52905 ||| CD
Protected  ||| S:52905 E:52915 ||| NNP
Against  ||| S:52915 E:52923 ||| NNP
1LD50*  ||| S:52923 E:52942 ||| NNP
Murine  ||| S:52942 E:52949 ||| NNP
13C4  ||| S:52949 E:52954 ||| NNP
( ||| S:52954 E:52955 ||| -LRB-
1.4  ||| S:52955 E:52959 ||| CD
& ||| S:52959 E:52960 ||| CC
# ||| S:52960 E:52961 ||| #
x3bc ||| S:52961 E:52965 ||| CD
; ||| S:52965 E:52966 ||| :
g ||| S:52966 E:52967 ||| LS
)  ||| S:52967 E:52969 ||| -RRB-
10  ||| S:52969 E:52972 ||| CD
6.1  ||| S:52972 E:52978 ||| CD
Humanized  ||| S:52978 E:52988 ||| NNP
13C4  ||| S:52988 E:52993 ||| NNP
( ||| S:52993 E:52994 ||| -LRB-
4.1  ||| S:52994 E:52998 ||| CD
& ||| S:52998 E:52999 ||| CC
# ||| S:52999 E:53000 ||| #
x3bc ||| S:53000 E:53004 ||| CD
; ||| S:53004 E:53005 ||| :
g ||| S:53005 E:53006 ||| LS
)  ||| S:53006 E:53008 ||| -RRB-
20  ||| S:53008 E:53011 ||| CD
8.9  ||| S:53011 E:53017 ||| CD
Humanized  ||| S:53017 E:53027 ||| NNP
11E10  ||| S:53027 E:53033 ||| NNP
( ||| S:53033 E:53034 ||| -LRB-
232  ||| S:53034 E:53038 ||| CD
& ||| S:53038 E:53039 ||| CC
# ||| S:53039 E:53040 ||| #
x3bc ||| S:53040 E:53044 ||| CD
; ||| S:53044 E:53045 ||| :
g ||| S:53045 E:53046 ||| LS
)  ||| S:53046 E:53048 ||| -RRB-
0  ||| S:53048 E:53050 ||| CD
No  ||| S:53050 E:53053 ||| DT
protection  ||| S:53053 E:53069 ||| NN
* ||| S:53069 E:53070 ||| NNP
( ||| S:53070 E:53071 ||| -LRB-
1  ||| S:53071 E:53073 ||| CD
LD50  ||| S:53073 E:53078 ||| CD
=  ||| S:53078 E:53080 ||| SYM
30  ||| S:53080 E:53083 ||| CD
ng  ||| S:53083 E:53086 ||| JJ
crude  ||| S:53086 E:53092 ||| NN
Stx1 ||| S:53092 E:53096 ||| CD
)  ||| S:53096 E:53106 ||| -RRB-
B.  ||| S:53106 E:53109 ||| NNP
Protection  ||| S:53109 E:53120 ||| NNP
Against  ||| S:53120 E:53128 ||| NNP
Oral  ||| S:53128 E:53133 ||| NNP
Infection  ||| S:53133 E:53143 ||| NNP
with  ||| S:53143 E:53148 ||| IN
Stx2-Producing  ||| S:53148 E:53163 ||| NNP
EHEC  ||| S:53163 E:53168 ||| NNP
Strains ||| S:53168 E:53175 ||| NNP
.  ||| S:53175 E:53180 ||| .
Two  ||| S:53180 E:53184 ||| CD
different  ||| S:53184 E:53194 ||| JJ
strains  ||| S:53194 E:53202 ||| NNS
of  ||| S:53202 E:53205 ||| IN
mice  ||| S:53205 E:53210 ||| NNS
and  ||| S:53210 E:53214 ||| CC
bacteria  ||| S:53214 E:53223 ||| NNS
were  ||| S:53223 E:53228 ||| VBD
used  ||| S:53228 E:53233 ||| VBN
in  ||| S:53233 E:53236 ||| IN
these  ||| S:53236 E:53242 ||| DT
studies  ||| S:53242 E:53250 ||| NNS
to  ||| S:53250 E:53253 ||| TO
test  ||| S:53253 E:53258 ||| VB
efficacy  ||| S:53258 E:53267 ||| VBN
against  ||| S:53267 E:53275 ||| IN
both  ||| S:53275 E:53280 ||| DT
Stx2  ||| S:53280 E:53285 ||| NNP
and  ||| S:53285 E:53289 ||| CC
Stx2-variant ||| S:53289 E:53301 ||| NNP
.  ||| S:53301 E:53303 ||| .
DBA ||| S:53303 E:53306 ||| NNP
/ ||| S:53306 E:53307 ||| CD
2J  ||| S:53307 E:53310 ||| CD
mice  ||| S:53310 E:53315 ||| NNS
were  ||| S:53315 E:53320 ||| VBD
challenged  ||| S:53320 E:53331 ||| VBN
with  ||| S:53331 E:53336 ||| IN
EHEC  ||| S:53336 E:53341 ||| NNP
strain  ||| S:53341 E:53348 ||| FW
86-24  ||| S:53348 E:53354 ||| FW
( ||| S:53354 E:53355 ||| -LRB-
O157 ||| S:53355 E:53359 ||| NNP
: ||| S:53359 E:53360 ||| :
H7 ||| S:53360 E:53362 ||| CD
,  ||| S:53362 E:53364 ||| ,
Stx2+ ||| S:53364 E:53369 ||| CD
)  ||| S:53369 E:53371 ||| -RRB-
and  ||| S:53371 E:53375 ||| CC
CD-1  ||| S:53375 E:53380 ||| CD
mice  ||| S:53380 E:53385 ||| NNS
were  ||| S:53385 E:53390 ||| VBD
challenged  ||| S:53390 E:53401 ||| VBN
with  ||| S:53401 E:53406 ||| IN
strain  ||| S:53406 E:53413 ||| NN
B2F1  ||| S:53413 E:53418 ||| NNP
( ||| S:53418 E:53419 ||| -LRB-
O91 ||| S:53419 E:53422 ||| NNP
: ||| S:53422 E:53423 ||| :
H21 ||| S:53423 E:53426 ||| CD
,  ||| S:53426 E:53428 ||| ,
Stx2-variant+ ||| S:53428 E:53441 ||| CD
) ||| S:53441 E:53442 ||| -RRB-
.  ||| S:53442 E:53444 ||| .
While  ||| S:53444 E:53450 ||| IN
E.  ||| S:53450 E:53453 ||| NNP
coli  ||| S:53453 E:53458 ||| FW
strain  ||| S:53458 E:53465 ||| FW
B2F1  ||| S:53465 E:53470 ||| FW
is  ||| S:53470 E:53473 ||| VBZ
normally  ||| S:53473 E:53482 ||| RB
fatal  ||| S:53482 E:53488 ||| JJ
to  ||| S:53488 E:53491 ||| TO
both  ||| S:53491 E:53496 ||| DT
mice  ||| S:53496 E:53501 ||| JJ
strains ||| S:53501 E:53508 ||| NNS
,  ||| S:53508 E:53510 ||| ,
E.  ||| S:53510 E:53513 ||| NNP
coli  ||| S:53513 E:53518 ||| FW
strain  ||| S:53518 E:53525 ||| FW
86-24  ||| S:53525 E:53531 ||| FW
is  ||| S:53531 E:53534 ||| VBZ
fatal  ||| S:53534 E:53540 ||| JJ
to  ||| S:53540 E:53543 ||| TO
DBA ||| S:53543 E:53546 ||| NNP
/ ||| S:53546 E:53547 ||| CD
2J  ||| S:53547 E:53550 ||| CD
mice ||| S:53550 E:53554 ||| NNS
,  ||| S:53554 E:53556 ||| ,
while  ||| S:53556 E:53562 ||| IN
CD-1  ||| S:53562 E:53567 ||| CD
mice  ||| S:53567 E:53572 ||| NNS
will  ||| S:53572 E:53577 ||| MD
survive  ||| S:53577 E:53585 ||| VB
86-24  ||| S:53585 E:53591 ||| CD
infection ||| S:53591 E:53600 ||| NN
.  ||| S:53600 E:53604 ||| .
At  ||| S:53604 E:53607 ||| IN
day  ||| S:53607 E:53611 ||| NN
zero ||| S:53611 E:53615 ||| CD
,  ||| S:53615 E:53617 ||| ,
antibody  ||| S:53617 E:53626 ||| FW
H11E10  ||| S:53626 E:53633 ||| FW
( ||| S:53633 E:53634 ||| -LRB-
humanized  ||| S:53634 E:53644 ||| NN
& ||| S:53644 E:53645 ||| CC
# ||| S:53645 E:53646 ||| #
x3b1 ||| S:53646 E:53650 ||| CD
; ||| S:53650 E:53651 ||| :
-Stx2A ||| S:53651 E:53657 ||| CD
)  ||| S:53657 E:53659 ||| -RRB-
or  ||| S:53659 E:53662 ||| CC
11E10  ||| S:53662 E:53668 ||| NNP
( ||| S:53668 E:53669 ||| -LRB-
mouse  ||| S:53669 E:53675 ||| NN
& ||| S:53675 E:53676 ||| CC
# ||| S:53676 E:53677 ||| #
x3b1 ||| S:53677 E:53681 ||| CD
; ||| S:53681 E:53682 ||| :
-Stx2A ||| S:53682 E:53688 ||| CD
)  ||| S:53688 E:53690 ||| -RRB-
was  ||| S:53690 E:53694 ||| VBD
injected  ||| S:53694 E:53703 ||| VBN
intraperitoneally  ||| S:53703 E:53721 ||| NNS
( ||| S:53721 E:53722 ||| -LRB-
0.1  ||| S:53722 E:53726 ||| CD
ml ||| S:53726 E:53728 ||| CD
)  ||| S:53728 E:53730 ||| -RRB-
into  ||| S:53730 E:53735 ||| IN
groups  ||| S:53735 E:53742 ||| NNS
of  ||| S:53742 E:53745 ||| IN
four  ||| S:53745 E:53750 ||| CD
or  ||| S:53750 E:53753 ||| CC
five  ||| S:53753 E:53758 ||| CD
mice ||| S:53758 E:53762 ||| NNS
.  ||| S:53762 E:53764 ||| .
Control  ||| S:53764 E:53772 ||| NN
groups  ||| S:53772 E:53779 ||| NNS
included  ||| S:53779 E:53788 ||| VBD
mice  ||| S:53788 E:53793 ||| NNS
that  ||| S:53793 E:53798 ||| WDT
had  ||| S:53798 E:53802 ||| VBD
received  ||| S:53802 E:53811 ||| VBN
antibody  ||| S:53811 E:53820 ||| NN
13C4  ||| S:53820 E:53825 ||| NNP
( ||| S:53825 E:53826 ||| -LRB-
mouse  ||| S:53826 E:53832 ||| NN
& ||| S:53832 E:53833 ||| CC
# ||| S:53833 E:53834 ||| #
x3b1 ||| S:53834 E:53838 ||| CD
; ||| S:53838 E:53839 ||| :
-Stx1B ||| S:53839 E:53845 ||| CD
) ||| S:53845 E:53846 ||| -RRB-
,  ||| S:53846 E:53848 ||| ,
mice  ||| S:53848 E:53853 ||| NNS
that  ||| S:53853 E:53858 ||| WDT
had  ||| S:53858 E:53862 ||| VBD
received  ||| S:53862 E:53871 ||| VBN
11E10  ||| S:53871 E:53877 ||| CD
ascites  ||| S:53877 E:53885 ||| JJ
fluid  ||| S:53885 E:53891 ||| NN
( ||| S:53891 E:53892 ||| -LRB-
mouse  ||| S:53892 E:53898 ||| NN
& ||| S:53898 E:53899 ||| CC
# ||| S:53899 E:53900 ||| #
x3b1 ||| S:53900 E:53904 ||| CD
; ||| S:53904 E:53905 ||| :
-Stx2A ||| S:53905 E:53911 ||| CD
) ||| S:53911 E:53912 ||| -RRB-
,  ||| S:53912 E:53914 ||| ,
or  ||| S:53914 E:53917 ||| CC
mice  ||| S:53917 E:53922 ||| NNS
that  ||| S:53922 E:53927 ||| WDT
had  ||| S:53927 E:53931 ||| VBD
received  ||| S:53931 E:53940 ||| VBN
PBS  ||| S:53940 E:53944 ||| NNP
instead  ||| S:53944 E:53952 ||| RB
of  ||| S:53952 E:53955 ||| IN
antibody ||| S:53955 E:53963 ||| NN
.  ||| S:53963 E:53965 ||| .
Mice  ||| S:53965 E:53970 ||| NNS
were  ||| S:53970 E:53975 ||| VBD
given  ||| S:53975 E:53981 ||| VBN
streptomycin  ||| S:53981 E:53994 ||| NNS
( ||| S:53994 E:53995 ||| -LRB-
5  ||| S:53995 E:53997 ||| CD
g ||| S:53997 E:53998 ||| CD
/ ||| S:53998 E:53999 ||| CD
L ||| S:53999 E:54000 ||| NNP
)  ||| S:54000 E:54002 ||| -RRB-
in  ||| S:54002 E:54005 ||| IN
their  ||| S:54005 E:54011 ||| PRP$
drinking  ||| S:54011 E:54020 ||| NN
water  ||| S:54020 E:54026 ||| NN
to  ||| S:54026 E:54029 ||| TO
decrease  ||| S:54029 E:54038 ||| VB
normal  ||| S:54038 E:54045 ||| JJ
intestinal  ||| S:54045 E:54056 ||| JJ
flora  ||| S:54056 E:54062 ||| NNS
and  ||| S:54062 E:54066 ||| CC
their  ||| S:54066 E:54072 ||| PRP$
food  ||| S:54072 E:54077 ||| NN
was  ||| S:54077 E:54081 ||| VBD
removed ||| S:54081 E:54088 ||| VBN
.  ||| S:54088 E:54090 ||| .
Streptomycin  ||| S:54090 E:54103 ||| JJ
resistant  ||| S:54103 E:54113 ||| JJ
derivatives  ||| S:54113 E:54125 ||| NNS
of  ||| S:54125 E:54128 ||| IN
strains  ||| S:54128 E:54136 ||| CD
86-24  ||| S:54136 E:54142 ||| CD
( ||| S:54142 E:54143 ||| -LRB-
O157 ||| S:54143 E:54147 ||| NNP
: ||| S:54147 E:54148 ||| :
H7 ||| S:54148 E:54150 ||| CD
,  ||| S:54150 E:54152 ||| ,
Stx2+ ||| S:54152 E:54157 ||| CD
)  ||| S:54157 E:54159 ||| -RRB-
and  ||| S:54159 E:54163 ||| CC
B2F1  ||| S:54163 E:54168 ||| NNP
( ||| S:54168 E:54169 ||| -LRB-
O91 ||| S:54169 E:54172 ||| NNP
: ||| S:54172 E:54173 ||| :
H21 ||| S:54173 E:54176 ||| CD
,  ||| S:54176 E:54178 ||| ,
Stx2-variant+ ||| S:54178 E:54191 ||| CD
)  ||| S:54191 E:54193 ||| -RRB-
were  ||| S:54193 E:54198 ||| VBD
grown  ||| S:54198 E:54204 ||| VBN
overnight  ||| S:54204 E:54214 ||| JJ
in  ||| S:54214 E:54217 ||| IN
L  ||| S:54217 E:54219 ||| NNP
broth ||| S:54219 E:54224 ||| NN
.  ||| S:54224 E:54228 ||| .
The  ||| S:54228 E:54232 ||| DT
following  ||| S:54232 E:54242 ||| JJ
day  ||| S:54242 E:54246 ||| NN
( ||| S:54246 E:54247 ||| -LRB-
day  ||| S:54247 E:54251 ||| NN
1 ||| S:54251 E:54252 ||| CD
)  ||| S:54252 E:54254 ||| -RRB-
the  ||| S:54254 E:54258 ||| DT
mice  ||| S:54258 E:54263 ||| NNS
received  ||| S:54263 E:54272 ||| VBD
a  ||| S:54272 E:54274 ||| DT
second  ||| S:54274 E:54281 ||| JJ
injection  ||| S:54281 E:54291 ||| NN
of  ||| S:54291 E:54294 ||| IN
test  ||| S:54294 E:54299 ||| NN
antibody ||| S:54299 E:54307 ||| NN
,  ||| S:54307 E:54309 ||| ,
control  ||| S:54309 E:54317 ||| NN
antibody ||| S:54317 E:54325 ||| NN
,  ||| S:54325 E:54327 ||| ,
or  ||| S:54327 E:54330 ||| CC
PBS ||| S:54330 E:54333 ||| NNP
.  ||| S:54333 E:54335 ||| .
The  ||| S:54335 E:54339 ||| DT
mice  ||| S:54339 E:54344 ||| NNS
were  ||| S:54344 E:54349 ||| VBD
immediately  ||| S:54349 E:54361 ||| RB
fed  ||| S:54361 E:54365 ||| VBN
1010  ||| S:54365 E:54370 ||| CD
CFU  ||| S:54370 E:54374 ||| NN
of  ||| S:54374 E:54377 ||| IN
86-24  ||| S:54377 E:54383 ||| NNP
that  ||| S:54383 E:54388 ||| WDT
had  ||| S:54388 E:54392 ||| VBD
been  ||| S:54392 E:54397 ||| VBN
pelleted  ||| S:54397 E:54406 ||| NNS
and  ||| S:54406 E:54410 ||| CC
resuspended  ||| S:54410 E:54422 ||| NN
in  ||| S:54422 E:54425 ||| IN
20 ||| S:54425 E:54427 ||| CD
%  ||| S:54427 E:54429 ||| NN
sucrose  ||| S:54429 E:54437 ||| NNS
or  ||| S:54437 E:54440 ||| CC
103  ||| S:54440 E:54444 ||| CD
CFU  ||| S:54444 E:54448 ||| NN
of  ||| S:54448 E:54451 ||| IN
B2F1  ||| S:54451 E:54456 ||| NNP
that  ||| S:54456 E:54461 ||| WDT
had  ||| S:54461 E:54465 ||| VBD
been  ||| S:54465 E:54470 ||| VBN
serially  ||| S:54470 E:54479 ||| RB
diluted  ||| S:54479 E:54487 ||| VBN
in  ||| S:54487 E:54490 ||| IN
20 ||| S:54490 E:54492 ||| CD
%  ||| S:54492 E:54494 ||| NN
sucrose ||| S:54494 E:54501 ||| NN
.  ||| S:54501 E:54503 ||| .
Food  ||| S:54503 E:54508 ||| NNP
was  ||| S:54508 E:54512 ||| VBD
returned  ||| S:54512 E:54521 ||| VBN
to  ||| S:54521 E:54524 ||| TO
the  ||| S:54524 E:54528 ||| DT
cage  ||| S:54528 E:54533 ||| NN
and  ||| S:54533 E:54537 ||| CC
the  ||| S:54537 E:54541 ||| DT
mice  ||| S:54541 E:54546 ||| NNS
were  ||| S:54546 E:54551 ||| VBD
monitored  ||| S:54551 E:54561 ||| VBN
for  ||| S:54561 E:54565 ||| IN
21  ||| S:54565 E:54568 ||| CD
days ||| S:54568 E:54572 ||| NNS
.  ||| S:54572 E:54574 ||| .
( ||| S:54574 E:54575 ||| -LRB-
CFU=Colony  ||| S:54575 E:54586 ||| NNP
Forming  ||| S:54586 E:54594 ||| NNP
Units ||| S:54594 E:54599 ||| NNP
)  ||| S:54599 E:54603 ||| -RRB-
As  ||| S:54603 E:54606 ||| RB
shown  ||| S:54606 E:54612 ||| VBN
in  ||| S:54612 E:54615 ||| IN
Table  ||| S:54615 E:54621 ||| NNP
3 ||| S:54621 E:54622 ||| CD
,  ||| S:54622 E:54624 ||| ,
immunization  ||| S:54624 E:54637 ||| VBG
of  ||| S:54637 E:54640 ||| IN
the  ||| S:54640 E:54644 ||| DT
mice  ||| S:54644 E:54649 ||| NNS
with  ||| S:54649 E:54654 ||| IN
the  ||| S:54654 E:54658 ||| DT
either  ||| S:54658 E:54665 ||| RB
the  ||| S:54665 E:54669 ||| DT
murine  ||| S:54669 E:54676 ||| NN
or  ||| S:54676 E:54679 ||| CC
the  ||| S:54679 E:54683 ||| DT
humanized  ||| S:54683 E:54693 ||| JJ
anti-Stx2  ||| S:54693 E:54703 ||| CD
antibodies  ||| S:54703 E:54714 ||| NNS
resulted  ||| S:54714 E:54723 ||| VBD
in  ||| S:54723 E:54726 ||| IN
complete  ||| S:54726 E:54735 ||| JJ
protection  ||| S:54735 E:54746 ||| NN
from  ||| S:54746 E:54751 ||| IN
a  ||| S:54751 E:54753 ||| DT
lethal  ||| S:54753 E:54760 ||| JJ
oral  ||| S:54760 E:54765 ||| JJ
dose  ||| S:54765 E:54770 ||| NN
of  ||| S:54770 E:54773 ||| IN
EHEC ||| S:54773 E:54777 ||| NNP
.  ||| S:54777 E:54779 ||| .
Immunization  ||| S:54779 E:54792 ||| NNP
with  ||| S:54792 E:54797 ||| IN
mouse  ||| S:54797 E:54803 ||| CD
13C4  ||| S:54803 E:54808 ||| CD
antibody ||| S:54808 E:54816 ||| NN
,  ||| S:54816 E:54818 ||| ,
prepared  ||| S:54818 E:54827 ||| VBN
in  ||| S:54827 E:54830 ||| IN
the  ||| S:54830 E:54834 ||| DT
same  ||| S:54834 E:54839 ||| JJ
way  ||| S:54839 E:54843 ||| NN
but  ||| S:54843 E:54847 ||| CC
immunoreactive  ||| S:54847 E:54862 ||| NN
with  ||| S:54862 E:54867 ||| IN
the  ||| S:54867 E:54871 ||| DT
Stx1  ||| S:54871 E:54876 ||| JJ
toxin  ||| S:54876 E:54882 ||| NN
instead  ||| S:54882 E:54890 ||| RB
of  ||| S:54890 E:54893 ||| IN
the  ||| S:54893 E:54897 ||| DT
Stx2  ||| S:54897 E:54902 ||| JJ
toxin  ||| S:54902 E:54908 ||| NN
did  ||| S:54908 E:54912 ||| VBD
not  ||| S:54912 E:54916 ||| RB
protect  ||| S:54916 E:54924 ||| VB
the  ||| S:54924 E:54928 ||| DT
mice  ||| S:54928 E:54933 ||| NNS
from  ||| S:54933 E:54938 ||| IN
challenge  ||| S:54938 E:54948 ||| NN
with  ||| S:54948 E:54953 ||| IN
86-24 ||| S:54953 E:54958 ||| NNP
,  ||| S:54958 E:54960 ||| ,
a  ||| S:54960 E:54962 ||| DT
result  ||| S:54962 E:54969 ||| NN
that  ||| S:54969 E:54974 ||| WDT
indicates  ||| S:54974 E:54984 ||| VBZ
the  ||| S:54984 E:54988 ||| DT
immunospecificity  ||| S:54988 E:55006 ||| NN
of  ||| S:55006 E:55009 ||| IN
the  ||| S:55009 E:55013 ||| DT
response ||| S:55013 E:55021 ||| NN
.  ||| S:55021 E:55031 ||| .
TABLE  ||| S:55031 E:55037 ||| NN
3  ||| S:55037 E:55049 ||| CD
DBA ||| S:55049 E:55052 ||| NNP
/ ||| S:55052 E:55053 ||| NNP
2J  ||| S:55053 E:55056 ||| NNP
Mice  ||| S:55056 E:55061 ||| NNP
Fed  ||| S:55061 E:55065 ||| NNP
1010  ||| S:55065 E:55070 ||| CD
CFU  ||| S:55070 E:55074 ||| CD
0157  ||| S:55074 E:55079 ||| CD
( ||| S:55079 E:55080 ||| -LRB-
Stx2 ||| S:55080 E:55084 ||| NNP
)  ||| S:55084 E:55096 ||| -RRB-
Antibody  ||| S:55096 E:55105 ||| NNP
( ||| S:55105 E:55106 ||| -LRB-
dose ||| S:55106 E:55110 ||| FW
/ ||| S:55110 E:55111 ||| FW
mouse ||| S:55111 E:55116 ||| FW
)  ||| S:55116 E:55118 ||| -RRB-
Survivors  ||| S:55118 E:55135 ||| NNP
Murine  ||| S:55135 E:55142 ||| NNP
13C4  ||| S:55142 E:55147 ||| NNP
( ||| S:55147 E:55148 ||| -LRB-
1.4  ||| S:55148 E:55152 ||| CD
& ||| S:55152 E:55153 ||| CC
# ||| S:55153 E:55154 ||| #
x3bc ||| S:55154 E:55158 ||| CD
; ||| S:55158 E:55159 ||| :
g ||| S:55159 E:55160 ||| LS
)  ||| S:55160 E:55162 ||| -RRB-
0 ||| S:55162 E:55163 ||| CD
/ ||| S:55163 E:55164 ||| CD
5  ||| S:55164 E:55169 ||| CD
Murine  ||| S:55169 E:55176 ||| NNP
11E10  ||| S:55176 E:55182 ||| NNP
( ||| S:55182 E:55183 ||| -LRB-
1.0  ||| S:55183 E:55187 ||| CD
& ||| S:55187 E:55188 ||| CC
# ||| S:55188 E:55189 ||| #
x3bc ||| S:55189 E:55193 ||| CD
; ||| S:55193 E:55194 ||| :
g ||| S:55194 E:55195 ||| LS
)  ||| S:55195 E:55197 ||| -RRB-
5 ||| S:55197 E:55198 ||| CD
/ ||| S:55198 E:55199 ||| CD
5  ||| S:55199 E:55204 ||| CD
Humanized  ||| S:55204 E:55214 ||| NNP
11E10  ||| S:55214 E:55220 ||| NNP
( ||| S:55220 E:55221 ||| -LRB-
1.0  ||| S:55221 E:55225 ||| CD
& ||| S:55225 E:55226 ||| CC
# ||| S:55226 E:55227 ||| #
x3bc ||| S:55227 E:55231 ||| CD
; ||| S:55231 E:55232 ||| :
g ||| S:55232 E:55233 ||| LS
)  ||| S:55233 E:55235 ||| -RRB-
5 ||| S:55235 E:55236 ||| CD
/ ||| S:55236 E:55237 ||| CD
5  ||| S:55237 E:55250 ||| CD
Similar  ||| S:55250 E:55258 ||| JJ
results  ||| S:55258 E:55266 ||| NNS
are  ||| S:55266 E:55270 ||| VBP
illustrated  ||| S:55270 E:55282 ||| VBN
in  ||| S:55282 E:55285 ||| IN
Table  ||| S:55285 E:55291 ||| NNP
4 ||| S:55291 E:55292 ||| CD
,  ||| S:55292 E:55294 ||| ,
where  ||| S:55294 E:55300 ||| WRB
the  ||| S:55300 E:55304 ||| DT
more  ||| S:55304 E:55309 ||| RBR
resistant  ||| S:55309 E:55319 ||| JJ
CD-1  ||| S:55319 E:55324 ||| CD
mice  ||| S:55324 E:55329 ||| NNS
were  ||| S:55329 E:55334 ||| VBD
fed  ||| S:55334 E:55338 ||| VBN
the  ||| S:55338 E:55342 ||| DT
B2F1  ||| S:55342 E:55347 ||| NNP
E.  ||| S:55347 E:55350 ||| NNP
coli  ||| S:55350 E:55355 ||| JJ
strain  ||| S:55355 E:55362 ||| NN
which  ||| S:55362 E:55368 ||| WDT
produces  ||| S:55368 E:55377 ||| VBZ
Stx2-variant  ||| S:55377 E:55390 ||| CD
toxin ||| S:55390 E:55395 ||| NN
.  ||| S:55395 E:55397 ||| .
Without  ||| S:55397 E:55405 ||| IN
treatment  ||| S:55405 E:55415 ||| NN
with  ||| S:55415 E:55420 ||| IN
antibody ||| S:55420 E:55428 ||| NN
,  ||| S:55428 E:55430 ||| ,
mortality  ||| S:55430 E:55440 ||| NN
was  ||| S:55440 E:55444 ||| VBD
total ||| S:55444 E:55449 ||| JJ
,  ||| S:55449 E:55451 ||| ,
but  ||| S:55451 E:55455 ||| CC
both  ||| S:55455 E:55460 ||| PDT
the  ||| S:55460 E:55464 ||| DT
mouse  ||| S:55464 E:55470 ||| NN
and  ||| S:55470 E:55474 ||| CC
the  ||| S:55474 E:55478 ||| DT
humanized  ||| S:55478 E:55488 ||| JJ
antibodies  ||| S:55488 E:55499 ||| NNS
protected  ||| S:55499 E:55509 ||| VBN
against  ||| S:55509 E:55517 ||| IN
Stx2-variant  ||| S:55517 E:55530 ||| CD
in  ||| S:55530 E:55533 ||| IN
a  ||| S:55533 E:55535 ||| DT
dose  ||| S:55535 E:55540 ||| JJ
dependent  ||| S:55540 E:55550 ||| JJ
manner ||| S:55550 E:55556 ||| NN
.  ||| S:55556 E:55566 ||| .
TABLE  ||| S:55566 E:55572 ||| NN
4  ||| S:55572 E:55584 ||| CD
CD-1  ||| S:55584 E:55589 ||| CD
Mice  ||| S:55589 E:55594 ||| NNP
Fed  ||| S:55594 E:55598 ||| NNP
103  ||| S:55598 E:55602 ||| CD
CFU  ||| S:55602 E:55606 ||| NNP
O91 ||| S:55606 E:55609 ||| NNP
: ||| S:55609 E:55610 ||| :
H21  ||| S:55610 E:55614 ||| CD
( ||| S:55614 E:55615 ||| -LRB-
Stx2-variant ||| S:55615 E:55627 ||| NNP
)  ||| S:55627 E:55639 ||| -RRB-
Antibody  ||| S:55639 E:55648 ||| NNP
( ||| S:55648 E:55649 ||| -LRB-
dose ||| S:55649 E:55653 ||| FW
/ ||| S:55653 E:55654 ||| FW
mouse ||| S:55654 E:55659 ||| FW
)  ||| S:55659 E:55661 ||| -RRB-
Survivors  ||| S:55661 E:55678 ||| NNP
PBS  ||| S:55678 E:55682 ||| NNP
0 ||| S:55682 E:55683 ||| CD
/ ||| S:55683 E:55684 ||| CD
5  ||| S:55684 E:55689 ||| CD
Murine  ||| S:55689 E:55696 ||| NNP
11E10  ||| S:55696 E:55702 ||| NNP
( ||| S:55702 E:55703 ||| -LRB-
8.7  ||| S:55703 E:55707 ||| CD
& ||| S:55707 E:55708 ||| CC
# ||| S:55708 E:55709 ||| #
x3bc ||| S:55709 E:55713 ||| CD
; ||| S:55713 E:55714 ||| :
g ||| S:55714 E:55715 ||| LS
)  ||| S:55715 E:55717 ||| -RRB-
& ||| S:55717 E:55718 ||| CC
# ||| S:55718 E:55719 ||| #
x2002 ||| S:55719 E:55724 ||| CD
; ||| S:55724 E:55725 ||| :
1 ||| S:55725 E:55726 ||| CD
/ ||| S:55726 E:55727 ||| CD
4*  ||| S:55727 E:55733 ||| CD
Murine  ||| S:55733 E:55740 ||| NNP
11E10  ||| S:55740 E:55746 ||| NNP
( ||| S:55746 E:55747 ||| -LRB-
6.45  ||| S:55747 E:55752 ||| CD
mg ||| S:55752 E:55754 ||| CD
)  ||| S:55754 E:55756 ||| -RRB-
5 ||| S:55756 E:55757 ||| CD
/ ||| S:55757 E:55758 ||| CD
5  ||| S:55758 E:55763 ||| CD
Humanized  ||| S:55763 E:55773 ||| NNP
11E10  ||| S:55773 E:55779 ||| NNP
( ||| S:55779 E:55780 ||| -LRB-
23.2  ||| S:55780 E:55785 ||| CD
& ||| S:55785 E:55786 ||| CC
# ||| S:55786 E:55787 ||| #
x3bc ||| S:55787 E:55791 ||| CD
; ||| S:55791 E:55792 ||| :
g ||| S:55792 E:55793 ||| LS
)  ||| S:55793 E:55795 ||| -RRB-
0 ||| S:55795 E:55796 ||| CD
/ ||| S:55796 E:55797 ||| CD
5  ||| S:55797 E:55802 ||| CD
Humanized  ||| S:55802 E:55812 ||| NNP
11E10  ||| S:55812 E:55818 ||| NNP
( ||| S:55818 E:55819 ||| -LRB-
232  ||| S:55819 E:55823 ||| CD
& ||| S:55823 E:55824 ||| CC
# ||| S:55824 E:55825 ||| #
x3bc ||| S:55825 E:55829 ||| CD
; ||| S:55829 E:55830 ||| :
g ||| S:55830 E:55831 ||| LS
)  ||| S:55831 E:55833 ||| -RRB-
5 ||| S:55833 E:55834 ||| CD
/ ||| S:55834 E:55835 ||| CD
5  ||| S:55835 E:55844 ||| CD
Protective  ||| S:55844 E:55855 ||| JJ
dose  ||| S:55855 E:55860 ||| NN
between  ||| S:55860 E:55868 ||| IN
10.1  ||| S:55868 E:55873 ||| CD
and  ||| S:55873 E:55877 ||| CC
1.0  ||| S:55877 E:55881 ||| CD
mg ||| S:55881 E:55883 ||| CD
/ ||| S:55883 E:55884 ||| CD
kg  ||| S:55884 E:55891 ||| CD
*Delayed  ||| S:55891 E:55900 ||| CD
mean  ||| S:55900 E:55905 ||| JJ
time  ||| S:55905 E:55910 ||| NN
to  ||| S:55910 E:55913 ||| TO
death  ||| S:55913 E:55919 ||| NN
by  ||| S:55919 E:55922 ||| IN
3.4  ||| S:55922 E:55926 ||| CD
days  ||| S:55926 E:55938 ||| NNS
The  ||| S:56013 E:56017 ||| DT
subject  ||| S:56017 E:56025 ||| JJ
invention  ||| S:56025 E:56035 ||| NN
also  ||| S:56035 E:56040 ||| RB
provides  ||| S:56040 E:56049 ||| VBZ
for  ||| S:56049 E:56053 ||| IN
a  ||| S:56053 E:56055 ||| DT
variety  ||| S:56055 E:56063 ||| NN
of  ||| S:56063 E:56066 ||| IN
methods  ||| S:56066 E:56074 ||| NNS
of  ||| S:56074 E:56077 ||| IN
treating ||| S:56077 E:56085 ||| VBG
,  ||| S:56085 E:56087 ||| ,
ameliorating ||| S:56087 E:56099 ||| NN
,  ||| S:56099 E:56101 ||| ,
or  ||| S:56101 E:56104 ||| CC
preventing ||| S:56104 E:56114 ||| VBG
,  ||| S:56114 E:56116 ||| ,
the  ||| S:56116 E:56120 ||| DT
diseases  ||| S:56120 E:56129 ||| NNS
and  ||| S:56129 E:56133 ||| CC
effects  ||| S:56133 E:56141 ||| NNS
associated  ||| S:56141 E:56152 ||| VBN
with  ||| S:56152 E:56157 ||| IN
exposure  ||| S:56157 E:56166 ||| NN
to  ||| S:56166 E:56169 ||| TO
Shiga  ||| S:56169 E:56175 ||| NNP
toxin ||| S:56175 E:56180 ||| NN
.  ||| S:56180 E:56182 ||| .
Positive  ||| S:56182 E:56191 ||| JJ
clinical  ||| S:56191 E:56200 ||| JJ
responses  ||| S:56200 E:56210 ||| NNS
in  ||| S:56210 E:56213 ||| IN
humans  ||| S:56213 E:56220 ||| NNS
have  ||| S:56220 E:56225 ||| VBP
been  ||| S:56225 E:56230 ||| VBN
obtained  ||| S:56230 E:56239 ||| VBN
with  ||| S:56239 E:56244 ||| IN
monoclonal  ||| S:56244 E:56255 ||| JJ
antibodies ||| S:56255 E:56265 ||| NNS
,  ||| S:56265 E:56267 ||| ,
and  ||| S:56267 E:56271 ||| CC
one  ||| S:56271 E:56275 ||| CD
skilled  ||| S:56275 E:56283 ||| NN
in  ||| S:56283 E:56286 ||| IN
the  ||| S:56286 E:56290 ||| DT
art  ||| S:56290 E:56294 ||| NN
would  ||| S:56294 E:56300 ||| MD
know  ||| S:56300 E:56305 ||| VB
how  ||| S:56305 E:56309 ||| WRB
to  ||| S:56309 E:56312 ||| TO
employ  ||| S:56312 E:56319 ||| VB
anti-Stx  ||| S:56319 E:56328 ||| JJ
humanized  ||| S:56328 E:56338 ||| JJ
monoclonal  ||| S:56338 E:56349 ||| JJ
antibodies  ||| S:56349 E:56360 ||| NNS
in  ||| S:56360 E:56363 ||| IN
humans ||| S:56363 E:56369 ||| NNS
.  ||| S:56369 E:56371 ||| .
( ||| S:56371 E:56372 ||| -LRB-
See  ||| S:56372 E:56376 ||| FW
Fagerberg  ||| S:56376 E:56386 ||| FW
et  ||| S:56386 E:56389 ||| FW
al. ||| S:56389 E:56392 ||| FW
,  ||| S:56392 E:56394 ||| ,
Cancer  ||| S:56394 E:56401 ||| NNP
Research ||| S:56401 E:56409 ||| NNP
,  ||| S:56409 E:56411 ||| ,
55 ||| S:56411 E:56413 ||| CD
: ||| S:56413 E:56414 ||| :
1824-27  ||| S:56414 E:56422 ||| CD
( ||| S:56422 E:56423 ||| -LRB-
1995 ||| S:56423 E:56427 ||| CD
) ||| S:56427 E:56428 ||| -RRB-
;  ||| S:56428 E:56430 ||| :
Eur ||| S:56430 E:56433 ||| NNP
.  ||| S:56433 E:56435 ||| .
J.  ||| S:56435 E:56438 ||| NNP
Cancer ||| S:56438 E:56444 ||| NNP
,  ||| S:56444 E:56446 ||| ,
2 ||| S:56446 E:56447 ||| CD
: ||| S:56447 E:56448 ||| :
261-267  ||| S:56448 E:56456 ||| CD
( ||| S:56456 E:56457 ||| -LRB-
1995 ||| S:56457 E:56461 ||| CD
) ||| S:56461 E:56462 ||| -RRB-
) ||| S:56462 E:56463 ||| -RRB-
.  ||| S:56463 E:56465 ||| .
The  ||| S:56465 E:56469 ||| DT
precise  ||| S:56469 E:56477 ||| JJ
dosage  ||| S:56477 E:56484 ||| NN
of  ||| S:56484 E:56487 ||| IN
humanized  ||| S:56487 E:56497 ||| JJ
anti-Shiga  ||| S:56497 E:56508 ||| JJ
toxin  ||| S:56508 E:56514 ||| NN
antibody  ||| S:56514 E:56523 ||| NN
administered  ||| S:56523 E:56536 ||| VBN
to  ||| S:56536 E:56539 ||| TO
a  ||| S:56539 E:56541 ||| DT
patient  ||| S:56541 E:56549 ||| NN
for  ||| S:56549 E:56553 ||| IN
treatment  ||| S:56553 E:56563 ||| NN
of  ||| S:56563 E:56566 ||| IN
these  ||| S:56566 E:56572 ||| DT
diseases  ||| S:56572 E:56581 ||| NNS
will  ||| S:56581 E:56586 ||| MD
vary  ||| S:56586 E:56591 ||| VB
in  ||| S:56591 E:56594 ||| IN
accordance  ||| S:56594 E:56605 ||| NN
with  ||| S:56605 E:56610 ||| IN
factors  ||| S:56610 E:56618 ||| NNS
appreciated  ||| S:56618 E:56630 ||| VBN
by  ||| S:56630 E:56633 ||| IN
the  ||| S:56633 E:56637 ||| DT
typical  ||| S:56637 E:56645 ||| JJ
clinician ||| S:56645 E:56654 ||| NN
.  ||| S:56654 E:56656 ||| .
These  ||| S:56656 E:56662 ||| DT
factors  ||| S:56662 E:56670 ||| NNS
include  ||| S:56670 E:56678 ||| VBP
( ||| S:56678 E:56679 ||| -LRB-
but  ||| S:56679 E:56683 ||| CC
are  ||| S:56683 E:56687 ||| VBP
not  ||| S:56687 E:56691 ||| RB
limited  ||| S:56691 E:56699 ||| VBN
to ||| S:56699 E:56701 ||| TO
)  ||| S:56701 E:56703 ||| -RRB-
size ||| S:56703 E:56707 ||| NN
,  ||| S:56707 E:56709 ||| ,
age ||| S:56709 E:56712 ||| NN
,  ||| S:56712 E:56714 ||| ,
overall  ||| S:56714 E:56722 ||| JJ
health ||| S:56722 E:56728 ||| NN
,  ||| S:56728 E:56730 ||| ,
the  ||| S:56730 E:56734 ||| DT
extent  ||| S:56734 E:56741 ||| NN
of  ||| S:56741 E:56744 ||| IN
infection ||| S:56744 E:56753 ||| NN
,  ||| S:56753 E:56755 ||| ,
and  ||| S:56755 E:56759 ||| CC
other  ||| S:56759 E:56765 ||| JJ
medications  ||| S:56765 E:56777 ||| NNS
being  ||| S:56777 E:56783 ||| VBG
administered  ||| S:56783 E:56796 ||| VBN
to  ||| S:56796 E:56799 ||| TO
said  ||| S:56799 E:56804 ||| VBD
patient ||| S:56804 E:56811 ||| NN
.  ||| S:56811 E:56813 ||| .
The  ||| S:56813 E:56817 ||| DT
development  ||| S:56817 E:56829 ||| NN
of  ||| S:56829 E:56832 ||| IN
a  ||| S:56832 E:56834 ||| DT
precise  ||| S:56834 E:56842 ||| JJ
treatment  ||| S:56842 E:56852 ||| NN
regimen  ||| S:56852 E:56860 ||| NN
will  ||| S:56860 E:56865 ||| MD
require  ||| S:56865 E:56873 ||| VB
optimization  ||| S:56873 E:56886 ||| VBN
through  ||| S:56886 E:56894 ||| IN
routine  ||| S:56894 E:56902 ||| JJ
medical  ||| S:56902 E:56910 ||| JJ
procedures  ||| S:56910 E:56921 ||| NNS
well  ||| S:56921 E:56926 ||| RB
known  ||| S:56926 E:56932 ||| VBN
to  ||| S:56932 E:56935 ||| TO
those  ||| S:56935 E:56941 ||| DT
in  ||| S:56941 E:56944 ||| IN
the  ||| S:56944 E:56948 ||| DT
medical  ||| S:56948 E:56956 ||| JJ
arts ||| S:56956 E:56960 ||| NNS
.  ||| S:56960 E:56962 ||| .
Examples  ||| S:56962 E:56971 ||| NNS
of  ||| S:56971 E:56974 ||| IN
potential  ||| S:56974 E:56984 ||| JJ
patient  ||| S:56984 E:56992 ||| NN
groups  ||| S:56992 E:56999 ||| NNS
would  ||| S:56999 E:57005 ||| MD
include  ||| S:57005 E:57013 ||| VB
( ||| S:57013 E:57014 ||| -LRB-
but  ||| S:57014 E:57018 ||| CC
not  ||| S:57018 E:57022 ||| RB
be  ||| S:57022 E:57025 ||| VB
limited  ||| S:57025 E:57033 ||| VBN
to ||| S:57033 E:57035 ||| TO
)  ||| S:57035 E:57037 ||| -RRB-
young  ||| S:57037 E:57043 ||| JJ
children  ||| S:57043 E:57052 ||| NNS
with  ||| S:57052 E:57057 ||| IN
bloody  ||| S:57057 E:57064 ||| JJ
diarrhea  ||| S:57064 E:57073 ||| NN
but  ||| S:57073 E:57077 ||| CC
no  ||| S:57077 E:57080 ||| DT
white  ||| S:57080 E:57086 ||| JJ
cells  ||| S:57086 E:57092 ||| NNS
in  ||| S:57092 E:57095 ||| IN
the  ||| S:57095 E:57099 ||| DT
stool ||| S:57099 E:57104 ||| NN
,  ||| S:57104 E:57106 ||| ,
patients  ||| S:57106 E:57115 ||| NNS
with  ||| S:57115 E:57120 ||| IN
indications  ||| S:57120 E:57132 ||| NNS
of  ||| S:57132 E:57135 ||| IN
HUS ||| S:57135 E:57138 ||| NNP
,  ||| S:57138 E:57140 ||| ,
patients  ||| S:57140 E:57149 ||| NNS
with  ||| S:57149 E:57154 ||| IN
positive  ||| S:57154 E:57163 ||| JJ
stool  ||| S:57163 E:57169 ||| JJ
sample  ||| S:57169 E:57176 ||| NN
tests  ||| S:57176 E:57182 ||| NNS
for  ||| S:57182 E:57186 ||| IN
Shiga  ||| S:57186 E:57192 ||| NNP
toxin ||| S:57192 E:57197 ||| NN
,  ||| S:57197 E:57199 ||| ,
siblings  ||| S:57199 E:57208 ||| NNS
or  ||| S:57208 E:57211 ||| CC
daycare  ||| S:57211 E:57219 ||| JJ
cohorts  ||| S:57219 E:57227 ||| NNS
in  ||| S:57227 E:57230 ||| IN
contact  ||| S:57230 E:57238 ||| NN
with  ||| S:57238 E:57243 ||| IN
a  ||| S:57243 E:57245 ||| DT
case  ||| S:57245 E:57250 ||| NN
( ||| S:57250 E:57251 ||| -LRB-
as  ||| S:57251 E:57254 ||| IN
a  ||| S:57254 E:57256 ||| DT
passive  ||| S:57256 E:57264 ||| JJ
preventative  ||| S:57264 E:57277 ||| JJ
measure ||| S:57277 E:57284 ||| NN
) ||| S:57284 E:57285 ||| -RRB-
,  ||| S:57285 E:57287 ||| ,
and  ||| S:57287 E:57291 ||| CC
any  ||| S:57291 E:57295 ||| DT
patient  ||| S:57295 E:57303 ||| NN
with  ||| S:57303 E:57308 ||| IN
diarrhea  ||| S:57308 E:57317 ||| NNS
( ||| S:57317 E:57318 ||| -LRB-
not  ||| S:57318 E:57322 ||| RB
necessarily  ||| S:57322 E:57334 ||| RB
bloody ||| S:57334 E:57340 ||| JJ
)  ||| S:57340 E:57342 ||| -RRB-
that  ||| S:57342 E:57347 ||| WDT
has  ||| S:57347 E:57351 ||| VBZ
been  ||| S:57351 E:57356 ||| VBN
in  ||| S:57356 E:57359 ||| IN
contact  ||| S:57359 E:57367 ||| NN
with  ||| S:57367 E:57372 ||| IN
an  ||| S:57372 E:57375 ||| DT
identified  ||| S:57375 E:57386 ||| JJ
case ||| S:57386 E:57390 ||| NN
.  ||| S:57390 E:57392 ||| .
A  ||| S:57392 E:57394 ||| DT
typical  ||| S:57394 E:57402 ||| JJ
dosage  ||| S:57402 E:57409 ||| NN
of  ||| S:57409 E:57412 ||| IN
about  ||| S:57412 E:57418 ||| IN
5  ||| S:57418 E:57420 ||| CD
mg ||| S:57420 E:57422 ||| CD
/ ||| S:57422 E:57423 ||| CD
kg  ||| S:57423 E:57426 ||| JJ
body  ||| S:57426 E:57431 ||| NN
weight  ||| S:57431 E:57438 ||| NN
of  ||| S:57438 E:57441 ||| IN
humanized  ||| S:57441 E:57451 ||| NNS
13C4  ||| S:57451 E:57456 ||| VBP
combined  ||| S:57456 E:57465 ||| VBN
with  ||| S:57465 E:57470 ||| IN
about  ||| S:57470 E:57476 ||| IN
10  ||| S:57476 E:57479 ||| CD
mg ||| S:57479 E:57481 ||| CD
/ ||| S:57481 E:57482 ||| CD
kg  ||| S:57482 E:57485 ||| JJ
body  ||| S:57485 E:57490 ||| NN
weight  ||| S:57490 E:57497 ||| NN
of  ||| S:57497 E:57500 ||| IN
humanized  ||| S:57500 E:57510 ||| JJ
11E10  ||| S:57510 E:57516 ||| NN
would  ||| S:57516 E:57522 ||| MD
be  ||| S:57522 E:57525 ||| VB
contemplated ||| S:57525 E:57537 ||| VBN
.  ||| S:57537 E:57539 ||| .
This  ||| S:57539 E:57544 ||| DT
combined  ||| S:57544 E:57553 ||| JJ
formulation  ||| S:57553 E:57565 ||| NN
could  ||| S:57565 E:57571 ||| MD
be  ||| S:57571 E:57574 ||| VB
administered  ||| S:57574 E:57587 ||| VBN
to  ||| S:57587 E:57590 ||| TO
the  ||| S:57590 E:57594 ||| DT
patient  ||| S:57594 E:57602 ||| NN
twice  ||| S:57602 E:57608 ||| RB
to  ||| S:57608 E:57611 ||| TO
ensure  ||| S:57611 E:57618 ||| VB
effectiveness ||| S:57618 E:57631 ||| NN
.  ||| S:57631 E:57633 ||| .
Inclusion  ||| S:57633 E:57643 ||| NN
of  ||| S:57643 E:57646 ||| IN
both  ||| S:57646 E:57651 ||| DT
types  ||| S:57651 E:57657 ||| NNS
of  ||| S:57657 E:57660 ||| IN
humanized  ||| S:57660 E:57670 ||| JJ
antibodies  ||| S:57670 E:57681 ||| NNS
together  ||| S:57681 E:57690 ||| RB
provides  ||| S:57690 E:57699 ||| VBZ
assurance  ||| S:57699 E:57709 ||| NN
that  ||| S:57709 E:57714 ||| IN
the  ||| S:57714 E:57718 ||| DT
patient  ||| S:57718 E:57726 ||| NN
will  ||| S:57726 E:57731 ||| MD
be  ||| S:57731 E:57734 ||| VB
protected  ||| S:57734 E:57744 ||| VBN
against  ||| S:57744 E:57752 ||| IN
all  ||| S:57752 E:57756 ||| DT
types  ||| S:57756 E:57762 ||| NNS
of  ||| S:57762 E:57765 ||| IN
Shiga  ||| S:57765 E:57771 ||| NNP
toxin ||| S:57771 E:57776 ||| NN
.  ||| S:57776 E:57780 ||| .
The  ||| S:57780 E:57784 ||| DT
person  ||| S:57784 E:57791 ||| NN
skilled  ||| S:57791 E:57799 ||| NN
in  ||| S:57799 E:57802 ||| IN
the  ||| S:57802 E:57806 ||| DT
art  ||| S:57806 E:57810 ||| NN
would  ||| S:57810 E:57816 ||| MD
understand  ||| S:57816 E:57827 ||| VB
how  ||| S:57827 E:57831 ||| WRB
to  ||| S:57831 E:57834 ||| TO
use  ||| S:57834 E:57838 ||| VB
and  ||| S:57838 E:57842 ||| CC
practice  ||| S:57842 E:57851 ||| VB
the  ||| S:57851 E:57855 ||| DT
invention  ||| S:57855 E:57865 ||| NN
based  ||| S:57865 E:57871 ||| VBN
on  ||| S:57871 E:57874 ||| IN
the  ||| S:57874 E:57878 ||| DT
above  ||| S:57878 E:57884 ||| JJ
disclosure ||| S:57884 E:57894 ||| NN
.  ||| S:57894 E:57896 ||| .
Other  ||| S:57896 E:57902 ||| JJ
embodiments  ||| S:57902 E:57914 ||| NN
of  ||| S:57914 E:57917 ||| IN
the  ||| S:57917 E:57921 ||| DT
invention  ||| S:57921 E:57931 ||| NN
will  ||| S:57931 E:57936 ||| MD
be  ||| S:57936 E:57939 ||| VB
apparent  ||| S:57939 E:57948 ||| JJ
to  ||| S:57948 E:57951 ||| TO
those  ||| S:57951 E:57957 ||| DT
skilled  ||| S:57957 E:57965 ||| JJ
in  ||| S:57965 E:57968 ||| IN
the  ||| S:57968 E:57972 ||| DT
art  ||| S:57972 E:57976 ||| NN
from  ||| S:57976 E:57981 ||| IN
consideration  ||| S:57981 E:57995 ||| NN
of  ||| S:57995 E:57998 ||| IN
the  ||| S:57998 E:58002 ||| DT
specification  ||| S:58002 E:58016 ||| NN
and  ||| S:58016 E:58020 ||| CC
practice  ||| S:58020 E:58029 ||| NN
of  ||| S:58029 E:58032 ||| IN
the  ||| S:58032 E:58036 ||| DT
invention  ||| S:58036 E:58046 ||| NN
disclosed  ||| S:58046 E:58056 ||| VBD
herein ||| S:58056 E:58062 ||| VBN
.  ||| S:58062 E:58064 ||| .
It  ||| S:58064 E:58067 ||| PRP
is  ||| S:58067 E:58070 ||| VBZ
intended  ||| S:58070 E:58079 ||| VBN
that  ||| S:58079 E:58084 ||| IN
the  ||| S:58084 E:58088 ||| DT
specification  ||| S:58088 E:58102 ||| NN
and  ||| S:58102 E:58106 ||| CC
examples  ||| S:58106 E:58115 ||| NNS
be  ||| S:58115 E:58118 ||| VB
considered  ||| S:58118 E:58129 ||| VBN
as  ||| S:58129 E:58132 ||| IN
exemplary  ||| S:58132 E:58142 ||| VBG
only ||| S:58142 E:58146 ||| RB
,  ||| S:58146 E:58148 ||| ,
with  ||| S:58148 E:58153 ||| IN
the  ||| S:58153 E:58157 ||| DT
true  ||| S:58157 E:58162 ||| JJ
scope  ||| S:58162 E:58168 ||| NN
and  ||| S:58168 E:58172 ||| CC
spirit  ||| S:58172 E:58179 ||| NN
of  ||| S:58179 E:58182 ||| IN
the  ||| S:58182 E:58186 ||| DT
invention  ||| S:58186 E:58196 ||| NN
being  ||| S:58196 E:58202 ||| VBG
indicated  ||| S:58202 E:58212 ||| VBN
by  ||| S:58212 E:58215 ||| IN
the  ||| S:58215 E:58219 ||| DT
following  ||| S:58219 E:58229 ||| JJ
claims ||| S:58229 E:58235 ||| NNS
.  ||| S:58235 E:58243 ||| .
What  ||| S:58243 E:58248 ||| WP
is  ||| S:58248 E:58251 ||| VBZ
claimed  ||| S:58251 E:58259 ||| VBN
is ||| S:58259 E:58261 ||| VBZ
:  ||| S:58261 E:58266 ||| :
1 ||| S:58266 E:58267 ||| LS
.  ||| S:58267 E:58269 ||| .
An  ||| S:58269 E:58272 ||| DT
isolated  ||| S:58272 E:58281 ||| FW
nucleic  ||| S:58281 E:58289 ||| FW
acid  ||| S:58289 E:58294 ||| FW
molecule  ||| S:58294 E:58303 ||| FW
comprising  ||| S:58303 E:58314 ||| FW
a  ||| S:58314 E:58316 ||| FW
sequence  ||| S:58316 E:58325 ||| FW
encoding  ||| S:58325 E:58334 ||| FW
an  ||| S:58334 E:58337 ||| FW
anti-Stx2  ||| S:58337 E:58347 ||| FW
antibody  ||| S:58347 E:58356 ||| FW
heavy  ||| S:58356 E:58362 ||| JJ
chain  ||| S:58362 E:58368 ||| NN
variable  ||| S:58368 E:58377 ||| NN
domain ||| S:58377 E:58383 ||| NN
,  ||| S:58383 E:58385 ||| ,
wherein  ||| S:58385 E:58393 ||| NN
said  ||| S:58393 E:58398 ||| VBD
anti-Stx2  ||| S:58398 E:58408 ||| CD
heavy  ||| S:58408 E:58414 ||| JJ
chain  ||| S:58414 E:58420 ||| NN
variable  ||| S:58420 E:58429 ||| NN
domain  ||| S:58429 E:58436 ||| NN
comprises  ||| S:58436 E:58446 ||| VBZ
a  ||| S:58446 E:58448 ||| DT
CDR  ||| S:58448 E:58452 ||| NNP
selected  ||| S:58452 E:58461 ||| VBD
from  ||| S:58461 E:58466 ||| IN
the  ||| S:58466 E:58470 ||| DT
group  ||| S:58470 E:58476 ||| NN
consisting  ||| S:58476 E:58487 ||| VBG
of ||| S:58487 E:58489 ||| IN
:  ||| S:58489 E:58491 ||| :
CDR1  ||| S:58491 E:58496 ||| CD
amino  ||| S:58496 E:58502 ||| CD
acids  ||| S:58502 E:58508 ||| CD
11-15  ||| S:58508 E:58514 ||| CD
of  ||| S:58514 E:58517 ||| IN
SEQ  ||| S:58517 E:58521 ||| NNP
ID  ||| S:58521 E:58524 ||| NNP
NO ||| S:58524 E:58526 ||| NNP
:  ||| S:58526 E:58528 ||| :
44 ||| S:58528 E:58530 ||| CD
,  ||| S:58530 E:58532 ||| ,
CDR2  ||| S:58532 E:58537 ||| FW
amino  ||| S:58537 E:58543 ||| FW
acids  ||| S:58543 E:58549 ||| FW
50-66  ||| S:58549 E:58555 ||| FW
of  ||| S:58555 E:58558 ||| IN
SEQ  ||| S:58558 E:58562 ||| NNP
ID  ||| S:58562 E:58565 ||| NNP
NO ||| S:58565 E:58567 ||| NNP
:  ||| S:58567 E:58569 ||| :
44 ||| S:58569 E:58571 ||| CD
,  ||| S:58571 E:58573 ||| ,
and  ||| S:58573 E:58577 ||| CC
CDR3  ||| S:58577 E:58582 ||| CD
amino  ||| S:58582 E:58588 ||| CD
acids  ||| S:58588 E:58594 ||| CD
99-108  ||| S:58594 E:58601 ||| CD
of  ||| S:58601 E:58604 ||| IN
SEQ  ||| S:58604 E:58608 ||| NNP
ID  ||| S:58608 E:58611 ||| NNP
NO ||| S:58611 E:58613 ||| NNP
:  ||| S:58613 E:58615 ||| :
44.  ||| S:58615 E:58623 ||| CD
2 ||| S:58623 E:58624 ||| CD
.  ||| S:58624 E:58626 ||| .
The  ||| S:58626 E:58630 ||| DT
isolated  ||| S:58630 E:58639 ||| JJ
nucleic  ||| S:58639 E:58647 ||| JJ
acid  ||| S:58647 E:58652 ||| NN
molecule  ||| S:58652 E:58661 ||| NN
of  ||| S:58661 E:58664 ||| IN
claim  ||| S:58664 E:58670 ||| NN
1 ||| S:58670 E:58671 ||| CD
,  ||| S:58671 E:58673 ||| ,
wherein  ||| S:58673 E:58681 ||| VBG
the  ||| S:58681 E:58685 ||| DT
anti-Stx2  ||| S:58685 E:58695 ||| JJ
heavy  ||| S:58695 E:58701 ||| JJ
chain  ||| S:58701 E:58707 ||| NN
variable  ||| S:58707 E:58716 ||| NN
domain  ||| S:58716 E:58723 ||| NN
comprises  ||| S:58723 E:58733 ||| VBZ
the  ||| S:58733 E:58737 ||| DT
amino  ||| S:58737 E:58743 ||| JJ
acid  ||| S:58743 E:58748 ||| NN
sequence  ||| S:58748 E:58757 ||| NN
of  ||| S:58757 E:58760 ||| IN
SEQ  ||| S:58760 E:58764 ||| NNP
ID  ||| S:58764 E:58767 ||| NNP
NO ||| S:58767 E:58769 ||| NNP
:  ||| S:58769 E:58771 ||| :
44.  ||| S:58771 E:58779 ||| CD
3 ||| S:58779 E:58780 ||| CD
.  ||| S:58780 E:58782 ||| .
The  ||| S:58782 E:58786 ||| DT
isolated  ||| S:58786 E:58795 ||| JJ
nucleic  ||| S:58795 E:58803 ||| JJ
acid  ||| S:58803 E:58808 ||| NN
molecule  ||| S:58808 E:58817 ||| NN
of  ||| S:58817 E:58820 ||| IN
claim  ||| S:58820 E:58826 ||| NN
1 ||| S:58826 E:58827 ||| CD
,  ||| S:58827 E:58829 ||| ,
wherein  ||| S:58829 E:58837 ||| VBG
the  ||| S:58837 E:58841 ||| DT
anti-Stx2  ||| S:58841 E:58851 ||| JJ
heavy  ||| S:58851 E:58857 ||| JJ
chain  ||| S:58857 E:58863 ||| NN
variable  ||| S:58863 E:58872 ||| NN
domain  ||| S:58872 E:58879 ||| NN
comprises  ||| S:58879 E:58889 ||| VBZ
the  ||| S:58889 E:58893 ||| DT
amino  ||| S:58893 E:58899 ||| JJ
acid  ||| S:58899 E:58904 ||| NN
sequence  ||| S:58904 E:58913 ||| NN
of  ||| S:58913 E:58916 ||| IN
the  ||| S:58916 E:58920 ||| DT
heavy  ||| S:58920 E:58926 ||| JJ
chain  ||| S:58926 E:58932 ||| NN
variable  ||| S:58932 E:58941 ||| NN
domain  ||| S:58941 E:58948 ||| NN
of  ||| S:58948 E:58951 ||| IN
the  ||| S:58951 E:58955 ||| DT
murine  ||| S:58955 E:58962 ||| JJ
11E10  ||| S:58962 E:58968 ||| CD
antibody  ||| S:58968 E:58977 ||| NN
( ||| S:58977 E:58978 ||| -LRB-
ATCC  ||| S:58978 E:58983 ||| UH
Accession  ||| S:58983 E:58993 ||| UH
No ||| S:58993 E:58995 ||| UH
.  ||| S:58995 E:58997 ||| .
CRL  ||| S:58997 E:59001 ||| NNP
1987 ||| S:59001 E:59005 ||| CD
) ||| S:59005 E:59006 ||| -RRB-
.  ||| S:59006 E:59012 ||| .
4 ||| S:59012 E:59013 ||| LS
.  ||| S:59013 E:59015 ||| .
The  ||| S:59015 E:59019 ||| DT
isolated  ||| S:59019 E:59028 ||| JJ
nucleic  ||| S:59028 E:59036 ||| JJ
acid  ||| S:59036 E:59041 ||| NN
molecule  ||| S:59041 E:59050 ||| NN
of  ||| S:59050 E:59053 ||| IN
claim  ||| S:59053 E:59059 ||| NN
2 ||| S:59059 E:59060 ||| CD
,  ||| S:59060 E:59062 ||| ,
wherein  ||| S:59062 E:59070 ||| VBG
the  ||| S:59070 E:59074 ||| DT
isolated  ||| S:59074 E:59083 ||| JJ
nucleic  ||| S:59083 E:59091 ||| JJ
acid  ||| S:59091 E:59096 ||| NN
molecule  ||| S:59096 E:59105 ||| NN
comprises  ||| S:59105 E:59115 ||| VBZ
the  ||| S:59115 E:59119 ||| DT
nucleic  ||| S:59119 E:59127 ||| JJ
acid  ||| S:59127 E:59132 ||| NN
sequence  ||| S:59132 E:59141 ||| NN
of  ||| S:59141 E:59144 ||| IN
SEQ  ||| S:59144 E:59148 ||| NNP
ID  ||| S:59148 E:59151 ||| NNP
NO ||| S:59151 E:59153 ||| NNP
:  ||| S:59153 E:59155 ||| :
43.  ||| S:59155 E:59163 ||| CD
5 ||| S:59163 E:59164 ||| CD
.  ||| S:59164 E:59166 ||| .
An  ||| S:59166 E:59169 ||| DT
isolated  ||| S:59169 E:59178 ||| JJ
nucleic  ||| S:59178 E:59186 ||| JJ
acid  ||| S:59186 E:59191 ||| NN
molecule  ||| S:59191 E:59200 ||| NN
comprising  ||| S:59200 E:59211 ||| VBG
a  ||| S:59211 E:59213 ||| DT
sequence  ||| S:59213 E:59222 ||| NN
encoding  ||| S:59222 E:59231 ||| VBD
an  ||| S:59231 E:59234 ||| DT
anti-Stx2  ||| S:59234 E:59244 ||| JJ
antibody  ||| S:59244 E:59253 ||| NN
light  ||| S:59253 E:59259 ||| NN
chain  ||| S:59259 E:59265 ||| NN
variable  ||| S:59265 E:59274 ||| NN
domain ||| S:59274 E:59280 ||| NN
,  ||| S:59280 E:59282 ||| ,
wherein  ||| S:59282 E:59290 ||| NN
said  ||| S:59290 E:59295 ||| VBD
anti-Stx2  ||| S:59295 E:59305 ||| CD
light  ||| S:59305 E:59311 ||| JJ
chain  ||| S:59311 E:59317 ||| NN
variable  ||| S:59317 E:59326 ||| NN
domain  ||| S:59326 E:59333 ||| NN
comprises  ||| S:59333 E:59343 ||| VBZ
a  ||| S:59343 E:59345 ||| DT
CDR  ||| S:59345 E:59349 ||| NNP
selected  ||| S:59349 E:59358 ||| VBD
from  ||| S:59358 E:59363 ||| IN
the  ||| S:59363 E:59367 ||| DT
group  ||| S:59367 E:59373 ||| NN
consisting  ||| S:59373 E:59384 ||| VBG
of ||| S:59384 E:59386 ||| IN
:  ||| S:59386 E:59388 ||| :
CDR1  ||| S:59388 E:59393 ||| CD
amino  ||| S:59393 E:59399 ||| CD
acids  ||| S:59399 E:59405 ||| CD
4-40  ||| S:59405 E:59410 ||| CD
of  ||| S:59410 E:59413 ||| IN
SEQ  ||| S:59413 E:59417 ||| NNP
ID  ||| S:59417 E:59420 ||| NNP
NO ||| S:59420 E:59422 ||| NNP
:  ||| S:59422 E:59424 ||| :
42 ||| S:59424 E:59426 ||| CD
,  ||| S:59426 E:59428 ||| ,
CDR2  ||| S:59428 E:59433 ||| FW
amino  ||| S:59433 E:59439 ||| FW
acids  ||| S:59439 E:59445 ||| FW
56-62  ||| S:59445 E:59451 ||| FW
of  ||| S:59451 E:59454 ||| IN
SEQ  ||| S:59454 E:59458 ||| NNP
ID  ||| S:59458 E:59461 ||| NNP
NO ||| S:59461 E:59463 ||| NNP
:  ||| S:59463 E:59465 ||| :
42 ||| S:59465 E:59467 ||| CD
,  ||| S:59467 E:59469 ||| ,
and  ||| S:59469 E:59473 ||| CC
CDR3  ||| S:59473 E:59478 ||| CD
amino  ||| S:59478 E:59484 ||| CD
acids  ||| S:59484 E:59490 ||| CD
95-103  ||| S:59490 E:59497 ||| CD
of  ||| S:59497 E:59500 ||| IN
SEQ  ||| S:59500 E:59504 ||| NNP
ID  ||| S:59504 E:59507 ||| NNP
NO ||| S:59507 E:59509 ||| NNP
:  ||| S:59509 E:59511 ||| :
42.  ||| S:59511 E:59519 ||| CD
6 ||| S:59519 E:59520 ||| CD
.  ||| S:59520 E:59522 ||| .
The  ||| S:59522 E:59526 ||| DT
isolated  ||| S:59526 E:59535 ||| JJ
nucleic  ||| S:59535 E:59543 ||| JJ
acid  ||| S:59543 E:59548 ||| NN
molecule  ||| S:59548 E:59557 ||| NN
of  ||| S:59557 E:59560 ||| IN
claim  ||| S:59560 E:59566 ||| NN
5 ||| S:59566 E:59567 ||| CD
,  ||| S:59567 E:59569 ||| ,
wherein  ||| S:59569 E:59577 ||| VBG
the  ||| S:59577 E:59581 ||| DT
anti-Stx2  ||| S:59581 E:59591 ||| JJ
light  ||| S:59591 E:59597 ||| JJ
chain  ||| S:59597 E:59603 ||| NN
variable  ||| S:59603 E:59612 ||| NN
domain  ||| S:59612 E:59619 ||| NN
comprises  ||| S:59619 E:59629 ||| VBZ
the  ||| S:59629 E:59633 ||| DT
amino  ||| S:59633 E:59639 ||| JJ
acid  ||| S:59639 E:59644 ||| NN
sequence  ||| S:59644 E:59653 ||| NN
of  ||| S:59653 E:59656 ||| IN
SEQ  ||| S:59656 E:59660 ||| NNP
ID  ||| S:59660 E:59663 ||| NNP
NO ||| S:59663 E:59665 ||| NNP
:  ||| S:59665 E:59667 ||| :
42.  ||| S:59667 E:59675 ||| CD
7 ||| S:59675 E:59676 ||| CD
.  ||| S:59676 E:59678 ||| .
The  ||| S:59678 E:59682 ||| DT
isolated  ||| S:59682 E:59691 ||| JJ
nucleic  ||| S:59691 E:59699 ||| JJ
acid  ||| S:59699 E:59704 ||| NN
molecule  ||| S:59704 E:59713 ||| NN
of  ||| S:59713 E:59716 ||| IN
claim  ||| S:59716 E:59722 ||| NN
5 ||| S:59722 E:59723 ||| CD
,  ||| S:59723 E:59725 ||| ,
wherein  ||| S:59725 E:59733 ||| VBG
the  ||| S:59733 E:59737 ||| DT
anti-Stx2  ||| S:59737 E:59747 ||| JJ
light  ||| S:59747 E:59753 ||| JJ
chain  ||| S:59753 E:59759 ||| NN
variable  ||| S:59759 E:59768 ||| NN
domain  ||| S:59768 E:59775 ||| NN
comprises  ||| S:59775 E:59785 ||| VBZ
the  ||| S:59785 E:59789 ||| DT
amino  ||| S:59789 E:59795 ||| JJ
acid  ||| S:59795 E:59800 ||| NN
sequence  ||| S:59800 E:59809 ||| NN
of  ||| S:59809 E:59812 ||| IN
the  ||| S:59812 E:59816 ||| DT
light  ||| S:59816 E:59822 ||| JJ
chain  ||| S:59822 E:59828 ||| NN
variable  ||| S:59828 E:59837 ||| NN
domain  ||| S:59837 E:59844 ||| NN
of  ||| S:59844 E:59847 ||| IN
the  ||| S:59847 E:59851 ||| DT
murine  ||| S:59851 E:59858 ||| JJ
11E10  ||| S:59858 E:59864 ||| CD
antibody  ||| S:59864 E:59873 ||| NN
( ||| S:59873 E:59874 ||| -LRB-
ATCC  ||| S:59874 E:59879 ||| UH
Accession  ||| S:59879 E:59889 ||| UH
No ||| S:59889 E:59891 ||| UH
.  ||| S:59891 E:59893 ||| .
CRL  ||| S:59893 E:59897 ||| NNP
1987 ||| S:59897 E:59901 ||| CD
) ||| S:59901 E:59902 ||| -RRB-
.  ||| S:59902 E:59908 ||| .
8 ||| S:59908 E:59909 ||| CD
.  ||| S:59909 E:59911 ||| .
The  ||| S:59911 E:59915 ||| DT
isolated  ||| S:59915 E:59924 ||| JJ
nucleic  ||| S:59924 E:59932 ||| JJ
acid  ||| S:59932 E:59937 ||| NN
molecule  ||| S:59937 E:59946 ||| NN
of  ||| S:59946 E:59949 ||| IN
claim  ||| S:59949 E:59955 ||| NN
6 ||| S:59955 E:59956 ||| CD
,  ||| S:59956 E:59958 ||| ,
wherein  ||| S:59958 E:59966 ||| VBG
the  ||| S:59966 E:59970 ||| DT
isolated  ||| S:59970 E:59979 ||| JJ
nucleic  ||| S:59979 E:59987 ||| JJ
acid  ||| S:59987 E:59992 ||| NN
molecule  ||| S:59992 E:60001 ||| NN
comprises  ||| S:60001 E:60011 ||| VBZ
the  ||| S:60011 E:60015 ||| DT
nucleic  ||| S:60015 E:60023 ||| JJ
acid  ||| S:60023 E:60028 ||| NN
sequence  ||| S:60028 E:60037 ||| NN
of  ||| S:60037 E:60040 ||| IN
SEQ  ||| S:60040 E:60044 ||| NNP
ID  ||| S:60044 E:60047 ||| NNP
NO ||| S:60047 E:60049 ||| NNP
:  ||| S:60049 E:60051 ||| :
41.  ||| S:60051 E:60059 ||| CD
9 ||| S:60059 E:60060 ||| CD
.  ||| S:60060 E:60062 ||| .
The  ||| S:60062 E:60066 ||| DT
isolated  ||| S:60066 E:60075 ||| JJ
nucleic  ||| S:60075 E:60083 ||| JJ
acid  ||| S:60083 E:60088 ||| NN
molecule  ||| S:60088 E:60097 ||| NN
of  ||| S:60097 E:60100 ||| IN
claims  ||| S:60100 E:60107 ||| NNS
1  ||| S:60107 E:60109 ||| CD
or  ||| S:60109 E:60112 ||| CC
5 ||| S:60112 E:60113 ||| CD
,  ||| S:60113 E:60115 ||| ,
wherein  ||| S:60115 E:60123 ||| NN
said  ||| S:60123 E:60128 ||| VBD
nucleic  ||| S:60128 E:60136 ||| JJ
acid  ||| S:60136 E:60141 ||| NN
molecule  ||| S:60141 E:60150 ||| NN
further  ||| S:60150 E:60158 ||| RB
comprises  ||| S:60158 E:60168 ||| VBZ
a  ||| S:60168 E:60170 ||| DT
sequence  ||| S:60170 E:60179 ||| NN
encoding  ||| S:60179 E:60188 ||| VBD
a  ||| S:60188 E:60190 ||| DT
human  ||| S:60190 E:60196 ||| JJ
constant  ||| S:60196 E:60205 ||| JJ
region.  ||| S:60205 E:60217 ||| CD
10 ||| S:60217 E:60219 ||| CD
.  ||| S:60219 E:60221 ||| .
An  ||| S:60221 E:60224 ||| DT
isolated  ||| S:60224 E:60233 ||| JJ
nucleic  ||| S:60233 E:60241 ||| JJ
acid  ||| S:60241 E:60246 ||| NN
molecule  ||| S:60246 E:60255 ||| NN
comprising  ||| S:60255 E:60266 ||| VBG
a  ||| S:60266 E:60268 ||| DT
sequence  ||| S:60268 E:60277 ||| NN
encoding  ||| S:60277 E:60286 ||| VBD
an  ||| S:60286 E:60289 ||| DT
anti-Stx2  ||| S:60289 E:60299 ||| JJ
antibody ||| S:60299 E:60307 ||| NN
,  ||| S:60307 E:60309 ||| ,
said  ||| S:60309 E:60314 ||| VBD
antibody  ||| S:60314 E:60323 ||| VBN
comprising  ||| S:60323 E:60334 ||| VBG
a  ||| S:60334 E:60336 ||| DT
heavy  ||| S:60336 E:60342 ||| JJ
and  ||| S:60342 E:60346 ||| CC
a  ||| S:60346 E:60348 ||| DT
light  ||| S:60348 E:60354 ||| JJ
chain  ||| S:60354 E:60360 ||| NN
variable  ||| S:60360 E:60369 ||| NN
domain ||| S:60369 E:60375 ||| NN
,  ||| S:60375 E:60377 ||| ,
wherein  ||| S:60377 E:60385 ||| NN
said  ||| S:60385 E:60390 ||| VBD
heavy  ||| S:60390 E:60396 ||| JJ
chain  ||| S:60396 E:60402 ||| NN
variable  ||| S:60402 E:60411 ||| NN
domain  ||| S:60411 E:60418 ||| NN
comprises  ||| S:60418 E:60428 ||| VBZ
a  ||| S:60428 E:60430 ||| DT
CDR  ||| S:60430 E:60434 ||| NNP
selected  ||| S:60434 E:60443 ||| VBD
from  ||| S:60443 E:60448 ||| IN
the  ||| S:60448 E:60452 ||| DT
group  ||| S:60452 E:60458 ||| NN
consisting  ||| S:60458 E:60469 ||| VBG
of ||| S:60469 E:60471 ||| IN
:  ||| S:60471 E:60473 ||| :
CDR1  ||| S:60473 E:60478 ||| CD
amino  ||| S:60478 E:60484 ||| CD
acids  ||| S:60484 E:60490 ||| CD
11-15  ||| S:60490 E:60496 ||| CD
of  ||| S:60496 E:60499 ||| IN
SEQ  ||| S:60499 E:60503 ||| NNP
ID  ||| S:60503 E:60506 ||| NNP
NO ||| S:60506 E:60508 ||| NNP
:  ||| S:60508 E:60510 ||| :
44 ||| S:60510 E:60512 ||| CD
,  ||| S:60512 E:60514 ||| ,
CDR2  ||| S:60514 E:60519 ||| FW
amino  ||| S:60519 E:60525 ||| FW
acids  ||| S:60525 E:60531 ||| FW
50-66  ||| S:60531 E:60537 ||| FW
of  ||| S:60537 E:60540 ||| IN
SEQ  ||| S:60540 E:60544 ||| NNP
ID  ||| S:60544 E:60547 ||| NNP
NO ||| S:60547 E:60549 ||| NNP
:  ||| S:60549 E:60551 ||| :
44 ||| S:60551 E:60553 ||| CD
,  ||| S:60553 E:60555 ||| ,
and  ||| S:60555 E:60559 ||| CC
CDR3  ||| S:60559 E:60564 ||| CD
amino  ||| S:60564 E:60570 ||| CD
acids  ||| S:60570 E:60576 ||| CD
99-108  ||| S:60576 E:60583 ||| CD
and  ||| S:60583 E:60587 ||| CC
SEQ  ||| S:60587 E:60591 ||| UH
ID  ||| S:60591 E:60594 ||| UH
NO ||| S:60594 E:60596 ||| UH
:  ||| S:60596 E:60598 ||| :
44.  ||| S:60598 E:60606 ||| CD
11 ||| S:60606 E:60608 ||| CD
.  ||| S:60608 E:60610 ||| .
The  ||| S:60610 E:60614 ||| DT
nucleic  ||| S:60614 E:60622 ||| JJ
acid  ||| S:60622 E:60627 ||| NN
molecule  ||| S:60627 E:60636 ||| NN
of  ||| S:60636 E:60639 ||| IN
claim  ||| S:60639 E:60645 ||| NN
10 ||| S:60645 E:60647 ||| CD
,  ||| S:60647 E:60649 ||| ,
wherein  ||| S:60649 E:60657 ||| VBG
the  ||| S:60657 E:60661 ||| DT
heavy  ||| S:60661 E:60667 ||| JJ
chain  ||| S:60667 E:60673 ||| NN
variable  ||| S:60673 E:60682 ||| NN
domain  ||| S:60682 E:60689 ||| NN
of  ||| S:60689 E:60692 ||| IN
the  ||| S:60692 E:60696 ||| DT
antibody  ||| S:60696 E:60705 ||| NN
comprises  ||| S:60705 E:60715 ||| VBZ
the  ||| S:60715 E:60719 ||| DT
amino  ||| S:60719 E:60725 ||| JJ
acid  ||| S:60725 E:60730 ||| NN
sequence  ||| S:60730 E:60739 ||| NN
of  ||| S:60739 E:60742 ||| IN
SEQ  ||| S:60742 E:60746 ||| NNP
ID  ||| S:60746 E:60749 ||| NNP
NO ||| S:60749 E:60751 ||| NNP
:  ||| S:60751 E:60753 ||| :
44.  ||| S:60753 E:60761 ||| CD
12 ||| S:60761 E:60763 ||| CD
.  ||| S:60763 E:60765 ||| .
The  ||| S:60765 E:60769 ||| DT
nucleic  ||| S:60769 E:60777 ||| JJ
acid  ||| S:60777 E:60782 ||| NN
molecule  ||| S:60782 E:60791 ||| NN
of  ||| S:60791 E:60794 ||| IN
claim  ||| S:60794 E:60800 ||| NN
10 ||| S:60800 E:60802 ||| CD
,  ||| S:60802 E:60804 ||| ,
wherein  ||| S:60804 E:60812 ||| VBG
the  ||| S:60812 E:60816 ||| DT
heavy  ||| S:60816 E:60822 ||| JJ
chain  ||| S:60822 E:60828 ||| NN
variable  ||| S:60828 E:60837 ||| NN
domain  ||| S:60837 E:60844 ||| NN
of  ||| S:60844 E:60847 ||| IN
the  ||| S:60847 E:60851 ||| DT
antibody  ||| S:60851 E:60860 ||| NN
comprises  ||| S:60860 E:60870 ||| VBZ
the  ||| S:60870 E:60874 ||| DT
amino  ||| S:60874 E:60880 ||| JJ
acid  ||| S:60880 E:60885 ||| NN
sequence  ||| S:60885 E:60894 ||| NN
of  ||| S:60894 E:60897 ||| IN
the  ||| S:60897 E:60901 ||| DT
heavy  ||| S:60901 E:60907 ||| JJ
chain  ||| S:60907 E:60913 ||| NN
variable  ||| S:60913 E:60922 ||| NN
domain  ||| S:60922 E:60929 ||| NN
of  ||| S:60929 E:60932 ||| IN
the  ||| S:60932 E:60936 ||| DT
murine  ||| S:60936 E:60943 ||| JJ
11E10  ||| S:60943 E:60949 ||| CD
antibody  ||| S:60949 E:60958 ||| NN
( ||| S:60958 E:60959 ||| -LRB-
ATCC  ||| S:60959 E:60964 ||| UH
Accession  ||| S:60964 E:60974 ||| UH
No ||| S:60974 E:60976 ||| UH
.  ||| S:60976 E:60978 ||| .
CRL  ||| S:60978 E:60982 ||| NNP
1987 ||| S:60982 E:60986 ||| CD
) ||| S:60986 E:60987 ||| -RRB-
.  ||| S:60987 E:60993 ||| .
13 ||| S:60993 E:60995 ||| CD
.  ||| S:60995 E:60997 ||| .
The  ||| S:60997 E:61001 ||| DT
nucleic  ||| S:61001 E:61009 ||| JJ
acid  ||| S:61009 E:61014 ||| NN
molecule  ||| S:61014 E:61023 ||| NN
of  ||| S:61023 E:61026 ||| IN
claim  ||| S:61026 E:61032 ||| NN
11 ||| S:61032 E:61034 ||| CD
,  ||| S:61034 E:61036 ||| ,
wherein  ||| S:61036 E:61044 ||| VBG
the  ||| S:61044 E:61048 ||| DT
heavy  ||| S:61048 E:61054 ||| JJ
chain  ||| S:61054 E:61060 ||| NN
variable  ||| S:61060 E:61069 ||| NN
domain  ||| S:61069 E:61076 ||| NN
of  ||| S:61076 E:61079 ||| IN
the  ||| S:61079 E:61083 ||| DT
antibody  ||| S:61083 E:61092 ||| NN
comprises  ||| S:61092 E:61102 ||| VBZ
the  ||| S:61102 E:61106 ||| DT
nucleic  ||| S:61106 E:61114 ||| JJ
acid  ||| S:61114 E:61119 ||| NN
sequence  ||| S:61119 E:61128 ||| NN
of  ||| S:61128 E:61131 ||| IN
SEQ  ||| S:61131 E:61135 ||| NNP
ID  ||| S:61135 E:61138 ||| NNP
NO ||| S:61138 E:61140 ||| NNP
:  ||| S:61140 E:61142 ||| :
43.  ||| S:61142 E:61150 ||| CD
14 ||| S:61150 E:61152 ||| CD
.  ||| S:61152 E:61154 ||| .
The  ||| S:61154 E:61158 ||| DT
nucleic  ||| S:61158 E:61166 ||| JJ
acid  ||| S:61166 E:61171 ||| NN
molecule  ||| S:61171 E:61180 ||| NN
of  ||| S:61180 E:61183 ||| IN
claim  ||| S:61183 E:61189 ||| NN
10 ||| S:61189 E:61191 ||| CD
,  ||| S:61191 E:61193 ||| ,
wherein  ||| S:61193 E:61201 ||| VBG
the  ||| S:61201 E:61205 ||| DT
light  ||| S:61205 E:61211 ||| JJ
chain  ||| S:61211 E:61217 ||| NN
variable  ||| S:61217 E:61226 ||| NN
domain  ||| S:61226 E:61233 ||| NN
comprises  ||| S:61233 E:61243 ||| VBZ
a  ||| S:61243 E:61245 ||| DT
CDR  ||| S:61245 E:61249 ||| NNP
selected  ||| S:61249 E:61258 ||| VBD
from  ||| S:61258 E:61263 ||| IN
the  ||| S:61263 E:61267 ||| DT
group  ||| S:61267 E:61273 ||| NN
consisting  ||| S:61273 E:61284 ||| VBG
of ||| S:61284 E:61286 ||| IN
:  ||| S:61286 E:61288 ||| :
CDR1  ||| S:61288 E:61293 ||| CD
amino  ||| S:61293 E:61299 ||| CD
acids  ||| S:61299 E:61305 ||| CD
4-40  ||| S:61305 E:61310 ||| CD
of  ||| S:61310 E:61313 ||| IN
SEQ  ||| S:61313 E:61317 ||| NNP
ID  ||| S:61317 E:61320 ||| NNP
NO ||| S:61320 E:61322 ||| NNP
:  ||| S:61322 E:61324 ||| :
42 ||| S:61324 E:61326 ||| CD
,  ||| S:61326 E:61328 ||| ,
CDR2  ||| S:61328 E:61333 ||| FW
amino  ||| S:61333 E:61339 ||| FW
acids  ||| S:61339 E:61345 ||| FW
56-62  ||| S:61345 E:61351 ||| FW
of  ||| S:61351 E:61354 ||| IN
SEQ  ||| S:61354 E:61358 ||| NNP
ID  ||| S:61358 E:61361 ||| NNP
NO ||| S:61361 E:61363 ||| NNP
:  ||| S:61363 E:61365 ||| :
42 ||| S:61365 E:61367 ||| CD
,  ||| S:61367 E:61369 ||| ,
and  ||| S:61369 E:61373 ||| CC
CDR3  ||| S:61373 E:61378 ||| CD
amino  ||| S:61378 E:61384 ||| CD
acids  ||| S:61384 E:61390 ||| CD
95-103  ||| S:61390 E:61397 ||| CD
of  ||| S:61397 E:61400 ||| IN
SEQ  ||| S:61400 E:61404 ||| NNP
ID  ||| S:61404 E:61407 ||| NNP
NO ||| S:61407 E:61409 ||| NNP
:  ||| S:61409 E:61411 ||| :
42.  ||| S:61411 E:61419 ||| CD
15 ||| S:61419 E:61421 ||| CD
.  ||| S:61421 E:61423 ||| .
The  ||| S:61423 E:61427 ||| DT
nucleic  ||| S:61427 E:61435 ||| JJ
acid  ||| S:61435 E:61440 ||| NN
molecule  ||| S:61440 E:61449 ||| NN
according  ||| S:61449 E:61459 ||| VBG
to  ||| S:61459 E:61462 ||| TO
claim  ||| S:61462 E:61468 ||| VB
14 ||| S:61468 E:61470 ||| CD
,  ||| S:61470 E:61472 ||| ,
wherein  ||| S:61472 E:61480 ||| VBG
the  ||| S:61480 E:61484 ||| DT
light  ||| S:61484 E:61490 ||| JJ
chain  ||| S:61490 E:61496 ||| NN
variable  ||| S:61496 E:61505 ||| NN
domain  ||| S:61505 E:61512 ||| NN
of  ||| S:61512 E:61515 ||| IN
the  ||| S:61515 E:61519 ||| DT
antibody  ||| S:61519 E:61528 ||| NN
comprises  ||| S:61528 E:61538 ||| VBZ
the  ||| S:61538 E:61542 ||| DT
amino  ||| S:61542 E:61548 ||| JJ
acid  ||| S:61548 E:61553 ||| NN
sequence  ||| S:61553 E:61562 ||| NN
of  ||| S:61562 E:61565 ||| IN
SEQ  ||| S:61565 E:61569 ||| NNP
ID  ||| S:61569 E:61572 ||| NNP
NO ||| S:61572 E:61574 ||| NNP
:  ||| S:61574 E:61576 ||| :
42.  ||| S:61576 E:61584 ||| CD
16 ||| S:61584 E:61586 ||| CD
.  ||| S:61586 E:61588 ||| .
The  ||| S:61588 E:61592 ||| DT
nucleic  ||| S:61592 E:61600 ||| JJ
acid  ||| S:61600 E:61605 ||| NN
molecule  ||| S:61605 E:61614 ||| NN
of  ||| S:61614 E:61617 ||| IN
claim  ||| S:61617 E:61623 ||| NN
14 ||| S:61623 E:61625 ||| CD
,  ||| S:61625 E:61627 ||| ,
wherein  ||| S:61627 E:61635 ||| VBG
the  ||| S:61635 E:61639 ||| DT
light  ||| S:61639 E:61645 ||| JJ
chain  ||| S:61645 E:61651 ||| NN
variable  ||| S:61651 E:61660 ||| NN
domain  ||| S:61660 E:61667 ||| NN
of  ||| S:61667 E:61670 ||| IN
the  ||| S:61670 E:61674 ||| DT
antibody  ||| S:61674 E:61683 ||| NN
comprises  ||| S:61683 E:61693 ||| VBZ
the  ||| S:61693 E:61697 ||| DT
amino  ||| S:61697 E:61703 ||| JJ
acid  ||| S:61703 E:61708 ||| NN
sequence  ||| S:61708 E:61717 ||| NN
of  ||| S:61717 E:61720 ||| IN
the  ||| S:61720 E:61724 ||| DT
light  ||| S:61724 E:61730 ||| JJ
chain  ||| S:61730 E:61736 ||| NN
variable  ||| S:61736 E:61745 ||| NN
domain  ||| S:61745 E:61752 ||| NN
of  ||| S:61752 E:61755 ||| IN
the  ||| S:61755 E:61759 ||| DT
murine  ||| S:61759 E:61766 ||| JJ
11E10  ||| S:61766 E:61772 ||| CD
antibody  ||| S:61772 E:61781 ||| NN
( ||| S:61781 E:61782 ||| -LRB-
ATCC  ||| S:61782 E:61787 ||| UH
Accession  ||| S:61787 E:61797 ||| UH
No ||| S:61797 E:61799 ||| UH
.  ||| S:61799 E:61801 ||| .
CRL  ||| S:61801 E:61805 ||| NNP
1987 ||| S:61805 E:61809 ||| CD
) ||| S:61809 E:61810 ||| -RRB-
.  ||| S:61810 E:61816 ||| .
17 ||| S:61816 E:61818 ||| CD
.  ||| S:61818 E:61820 ||| .
The  ||| S:61820 E:61824 ||| DT
nucleic  ||| S:61824 E:61832 ||| JJ
acid  ||| S:61832 E:61837 ||| NN
molecule  ||| S:61837 E:61846 ||| NN
of  ||| S:61846 E:61849 ||| IN
claim  ||| S:61849 E:61855 ||| NN
15 ||| S:61855 E:61857 ||| CD
,  ||| S:61857 E:61859 ||| ,
wherein  ||| S:61859 E:61867 ||| VBG
the  ||| S:61867 E:61871 ||| DT
light  ||| S:61871 E:61877 ||| JJ
chain  ||| S:61877 E:61883 ||| NN
variable  ||| S:61883 E:61892 ||| NN
domain  ||| S:61892 E:61899 ||| NN
of  ||| S:61899 E:61902 ||| IN
the  ||| S:61902 E:61906 ||| DT
antibody  ||| S:61906 E:61915 ||| NN
comprises  ||| S:61915 E:61925 ||| VBZ
the  ||| S:61925 E:61929 ||| DT
nucleic  ||| S:61929 E:61937 ||| JJ
acid  ||| S:61937 E:61942 ||| NN
sequence  ||| S:61942 E:61951 ||| NN
of  ||| S:61951 E:61954 ||| IN
SEQ  ||| S:61954 E:61958 ||| NNP
ID  ||| S:61958 E:61961 ||| NNP
NO ||| S:61961 E:61963 ||| NNP
:  ||| S:61963 E:61965 ||| :
41.  ||| S:61965 E:61973 ||| CD
18 ||| S:61973 E:61975 ||| CD
.  ||| S:61975 E:61977 ||| .
A  ||| S:61977 E:61979 ||| DT
vector  ||| S:61979 E:61986 ||| JJ
comprising  ||| S:61986 E:61997 ||| NN
and  ||| S:61997 E:62001 ||| CC
capable  ||| S:62001 E:62009 ||| JJ
of  ||| S:62009 E:62012 ||| IN
expressing  ||| S:62012 E:62023 ||| VBG
the  ||| S:62023 E:62027 ||| DT
nucleic  ||| S:62027 E:62035 ||| JJ
acid  ||| S:62035 E:62040 ||| NN
molecule  ||| S:62040 E:62049 ||| NN
of  ||| S:62049 E:62052 ||| IN
any  ||| S:62052 E:62056 ||| DT
one  ||| S:62056 E:62060 ||| NN
of  ||| S:62060 E:62063 ||| IN
claims  ||| S:62063 E:62070 ||| NNS
1 ||| S:62070 E:62071 ||| CD
,  ||| S:62071 E:62073 ||| ,
5 ||| S:62073 E:62074 ||| CD
,  ||| S:62074 E:62076 ||| ,
10 ||| S:62076 E:62078 ||| CD
,  ||| S:62078 E:62080 ||| ,
and  ||| S:62080 E:62084 ||| CC
14.  ||| S:62084 E:62092 ||| CD
19 ||| S:62092 E:62094 ||| CD
.  ||| S:62094 E:62096 ||| .
A  ||| S:62096 E:62098 ||| DT
host  ||| S:62098 E:62103 ||| NN
cell  ||| S:62103 E:62108 ||| NN
transformed  ||| S:62108 E:62120 ||| VBN
with  ||| S:62120 E:62125 ||| IN
the  ||| S:62125 E:62129 ||| DT
vector  ||| S:62129 E:62136 ||| NN
of  ||| S:62136 E:62139 ||| IN
claim  ||| S:62139 E:62145 ||| NN
18.  ||| S:62145 E:62153 ||| CD
20 ||| S:62153 E:62155 ||| CD
.  ||| S:62155 E:62157 ||| .
A  ||| S:62157 E:62159 ||| DT
method  ||| S:62159 E:62166 ||| NN
of  ||| S:62166 E:62169 ||| IN
producing  ||| S:62169 E:62179 ||| VBG
an  ||| S:62179 E:62182 ||| DT
anti-Stx2  ||| S:62182 E:62192 ||| JJ
antibody  ||| S:62192 E:62201 ||| NN
comprising  ||| S:62201 E:62212 ||| VBG
the  ||| S:62212 E:62216 ||| DT
steps  ||| S:62216 E:62222 ||| NNS
of  ||| S:62222 E:62225 ||| IN
culturing  ||| S:62225 E:62235 ||| VBG
a  ||| S:62235 E:62237 ||| DT
host  ||| S:62237 E:62242 ||| NN
cell  ||| S:62242 E:62247 ||| NN
comprising  ||| S:62247 E:62258 ||| VBG
the  ||| S:62258 E:62262 ||| DT
nucleic  ||| S:62262 E:62270 ||| JJ
acid  ||| S:62270 E:62275 ||| NN
molecule  ||| S:62275 E:62284 ||| NN
according  ||| S:62284 E:62294 ||| VBG
to  ||| S:62294 E:62297 ||| TO
any  ||| S:62297 E:62301 ||| DT
one  ||| S:62301 E:62305 ||| NN
of  ||| S:62305 E:62308 ||| IN
claims  ||| S:62308 E:62315 ||| NNS
1 ||| S:62315 E:62316 ||| CD
,  ||| S:62316 E:62318 ||| ,
5 ||| S:62318 E:62319 ||| CD
,  ||| S:62319 E:62321 ||| ,
10 ||| S:62321 E:62323 ||| CD
,  ||| S:62323 E:62325 ||| ,
and  ||| S:62325 E:62329 ||| CC
14 ||| S:62329 E:62331 ||| CD
,  ||| S:62331 E:62333 ||| ,
under  ||| S:62333 E:62339 ||| IN
conditions  ||| S:62339 E:62350 ||| NNS
suitable  ||| S:62350 E:62359 ||| JJ
for  ||| S:62359 E:62363 ||| IN
expression  ||| S:62363 E:62374 ||| NN
of  ||| S:62374 E:62377 ||| IN
the  ||| S:62377 E:62381 ||| DT
antibody  ||| S:62381 E:62390 ||| NN
and  ||| S:62390 E:62394 ||| CC
recovering  ||| S:62394 E:62405 ||| VBG
the  ||| S:62405 E:62409 ||| DT
antibody ||| S:62409 E:62417 ||| NN
.  ||| S:62417 E:62423 ||| .
